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1 Overview 
Over the last decades, industry’s interest in organometallic chemistry has never ceased growing as it 
represents a preponderant tool for the formation of carbon-carbon bonds.1 Indeed, organometallics have 
been widely used since the early 1950s to help with the formation of complex structures in the 
agrochemical and medicinal industries as well as in many other fields.2 For instance, chemical crop 
protection has been greatly improved by the use of synthetic insecticides, fungicides and herbicides3 as 
an answer to the raising need for food production resulting from a steadily growing population (2019: 
approx. 7.7 billion)4 and however limited resources on Earth.5 This rise of world population being 
accompanied by an increase of life expectancy,6 an increasing number of diseases such as cancer should 
be expected. While not less than 19 million new cases and almost 10 million cancer-related deaths have 
been recorced in 2020,7 scientists have been attempting to find new ways of designing and preparing 
target molecules. 
 
Figure 1: Examples for top-selling drugs synthesized using organometallic reagents. 
As a matter of fact, many of the 200 top-selling drugs8 are small molecules which can be prepared 
involving organometallics, proving that organometallic chemistry is nowadays widely needed in 
modern drug discovery and organic chemistry. Examples for those compounds (Figure 1) are 
 
1 a) Transition Metals for Organic Synthesis (Eds.: M. Beller, C. Bolm), Wiley-VCH, Weinheim, 2004; b) 
Handbook of Functionalized Organometallics: Applications in Synthesis (Ed.: P. Knochel), Wiley-VCH, 
Weinheim, 2005; c) Generation and Trapping of Functionalized Aryl- and Heteroarylmagnesium and –Zinc 
Compounds, F. H. Lutter, M. S. Hofmayer, J. M. Hammann, V. Malakhov, P. Knochel. In Organic Reactions, 
Wiley-VCH, Weinheim, 2019.   
2 a) G. W. Parshall, Organometallics 1987, 6, 687; b) Applications of Organometallic compounds (Ed.: I. Omae), 
Wiley-VCH, Weinheim, 1998. 
3 P. A. Urech, Plant Pathol. 1999, 48, 689. 
4 United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population 
Prospects 2019, Online Edition. 
5 Food and Agriculture Organization of the United Nations (FAO), World Agriculture Towards 2030/2050. The 
2012 Revision. 
6 V. Kontis, J. E. Bennett, C. D. Mathers, G. Li, K. Foreman, M. Ezzati, Lancet 2017, 389, 1323. 
7 H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, CA-Cancer J. Clin. 2021, 
71, 209. 
8 N. A. McGrath, M. Brichacek, J. T. Njardarson, J. Chem. Educ. 2010, 87, 1348. 
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Rivaroxaban9 (cardiovascular diseases), Sitagliptin10 (diabetes) and Nilotinib11 (oncology). Thus, the 
development of new organometallic reagents is of great importance for the chemical industry. 
When developing an organometallic reagent, the choice of the metal remains crucial: not only the price 
and the toxicity of the metal matter, but also its own unique properties and reactivity. In general, they 
directly rely on the nature of the carbon-metal bond. The most common way to study this bond is to 
consider the difference in electronegativity between carbon and the metal attached to it. Starting from 
here, chemists can choose from a whole range of different compromises located between two extremes. 
Due to this fact, a carbon-metal bond which is very polarized (almost considered ionic) will be mighty 
but will only reach a low functional group tolerance whereas an almost covalent carbon-metal bond 
(slightly polarized) will display an enhanced functional group compatibility but inhibited reactivity. 
That way, well differentiable and fine-tuned reactivities can be achieved through a broad range of 
organometallic species (Figure 2). 
 
Metal (M) Li Mg Sc Mn Al Zn Cu Sn B 
Electronegativity (χ) 0.98 1.31 1.36 1.55 1.61 1.65 1.90 1.96 2.04 
Figure 2: Electronegativity scale of selected metals compared to carbon (Pauling scale).12 
Based on Figure 2, organolithium reagents exhibit a highly polarized carbon-metal bond. They are 
therefore amongst the most reactive organometallic derivatives while having a low functional group 
tolerance: esters and nitriles are for example not compatible. In contrast, organomagnesium, 
organomanganese and especially organozinc or even organoboron compounds possess a relatively more 
covalent carbon-metal bond. They are shown to be less reactive but can often be used in the presence 
of various substituents at the appropriate low – or even sometimes at ambient – temperatures. With this 
high versatility in hand, various synthetic problems can be solved using organometallics. This is also 
one of the reasons why organometallic chemistry plays an important role in modern synthetic chemistry. 
 
9 X. Berzosa Rodríguez, F. Marquillas Olondriz, A. Llebaria Soldevilla, C. Serra Comas US2014/128601, 2014. 
10 S. G. Davies, A. M. Fletcher, L. Lv, P. M. Roberts, J. E. Thomson, Tetrahedron Lett. 2012, 53, 3052. 
11 M. D. Hopkin, I. R. Baxendale, S. V. Ley, Org. Biomol. Chem. 2013, 11, 1822. 
12 L. Pauling, J. Am. Chem. Soc. 1932, 54, 3570. 
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2 Preparation of Polyfunctional Magnesium, Zinc and Manganese 
Organometallic Reagents 
With an increasing interest for organometallics,13 the use of magnesium1b and zinc14 derivatives is well 
established in modern organic synthesis. Those metals are therefore of high interest for the development 
of new organometallic reagents. Also, an important point for chemical industry is to look for the most 
sustainable, atom-economic15 and eco-friendly synthetic solutions to waste as little as possible. As an 
alternative to those metals, manganese can be considered. Indeed, organomanganese species have a 
slightly more polarized carbon-metal bond than organozinc compounds (χ(Mn) = 1.55 and χ(Zn) = 
1.65). Being more reactive than organozincs but less reactive than organomagnesiums, 
organomanganese species display an intermediate reactivity with interesting properties. Thus, they also 
possess a well-balanced reactivity and compatibility towards sensitive functional groups. Noteworthy, 
manganese is an abundant, relatively cheap metal and is toxicologically benign. From this point of view, 
the only transition metal which is better is iron.16  
To generate organometallics, a first pathway consists of the oxidative insertion of a metal into a carbon-
halogen bond. The second major method is the halogen/metal exchange reaction, in which a 
thermodynamically less stable organometallic reacts with an organic halide to form a more stable 
species. The stability is in pair with the one of the corresponding carbanions: it is directly related to the 
hybridization of the carbon atom bearing the metal but also depends on the conjugation and inductive 
effects present in the molecule.17 The third method is called deprotonation and consists of the abstraction 
of a proton by a base, forming a “metalated” species. The last one, transmetalation, is also an 
equilibrium process during which an existing metal species reacts with another one, often a metal salt, 
generating more stable (and more covalent in the case of a metal salt) carbon-metal bond (Scheme 1). 
 
Scheme 1: Preparation of organometallic reagents via different pathways. 
 
13 Comprehensive Organometallic Chemistry III: From Fundamentals to Applications (Eds.: R. Crabtree, M. 
Mingos), Elsevier Ltd., Oxford, 2007.   
14 The Chemistry of Organozinc Compounds (Eds.: Z. Rappoport, I. Marek), John Wiley & Sons Ltd., Chichester, 
2006.   
15 B. M. Trost, Science 1991, 254, 1471.   
16 C. Duplais, J. Buendia, G. Cahiez, Chem. Rev. 2009, 109, 1434. 
17 D. E. Applequist, D. F. O’Brien, J. Am. Chem. Soc. 1963, 85, 743. 
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2.1 Oxidative Insertion 
The first oxidative insertion was realized by Frankland in 1849, who prepared diethylzinc by the 
reaction of granulated zinc with ethyliodide.18 Another pioneer work was the one of Grignard on 
organomagnesium reagents. Based on the first findings of Barbier in 1899 (in situ formation and 
consumption of the organomagnesium, also known as Barbier-type conditions),19 he generated and 
isolated the first organomagnesium compound by reaction of methyliodide with magnesium turnings in 
diethylether.20 For his work, he got the Nobel Prize in Chemistry in 1912. In the 1980s, Hiyama et al.21 
and Cahiez22 described the first Barbier-type reactions with organomanganese compounds starting from 
commercially available manganese powder. Since then, numerous investigations have been made as the 
rise of organometallic chemistry occurred. Most of those were conducted to activate the zerovalent 
metal, which normally possesses an oxide layer at its surface, reducing its reactivity. Different solutions 
were found: amongst them, addition of iodine, trimethylsilyl chloride or 1,2-dibromoethane, grinding 
or sonification of the metal or even the use of a Zn(Cu) couple can be cited.23 Rieke has made huge 
improvements when he prepared the so-called activated Rieke magnesium (Mg*),24 Rieke zinc (Zn*)25 
and Rieke manganese (Mn*)26 by reduction of metal salts with lithium or potassium. As an example, 
bromoarene 1 reacts with Mg* to form the magnesium compound 2, which is quenched with 
benzaldehyde to yield the corresponding alcohol 3 in 85% yield.24 Additionally, ethyl 4-iodobenzoate 
(4) reacts with Zn* within 3 h at room temperature to give the corresponding zinc reagent 5, which 
provides 6 in 68% yield after subsequent copper-mediated 1,4-addition on cyclohex-2-en-1-one.27 
Analogically, Bromocyclohexane (7) reacts with Mn* within 1 h 20 min to form the corresponding 
organomanganese bromide 8 which can be quenched by benzoyl chloride to give the ketone 9 in 68% 
yield (Scheme 2).26 
 
18 E. Frankland, Liebigs Ann. Chem. 1849, 71, 171. 
19 P. Barbier, Compt. Rend. Acad. Sci. Paris 1899, 128, 110. 
20 V. Grignard, Compt. Rend. Acad. Sci. Paris yOS, 130, 1322. 
21 T. Hiyama, M. Sawahata, M. Obayashi, Chem. Lett. 1983, 8, 1237. 
22 G. Cahiez, P.-Y. Chavant, Tetrahedron Lett. 1989, 30, 7373. 
23 a) R. D. Rieke, Acc. Chem. Res. 1977, 10, 301; b) Y. Tamaru, H. Ochiai, T. Nakamura, K. Tsubaki, Z.-I. 
Yoshida, Tetrahedron Lett., 1985, 26, 5559; c) M. Gaudemar, Bull. Soc. Chim. Fr. 1962, 974; d) T. Kentaro, 
Chem. Lett. 1993, 22, 469; e) K. Takai, T. Ueda, T. Hayashi, T. Moriwake, Tetrahedron Lett. 1996, 37, 7049. 
24 R. D. Rieke, S. E. Bales, P. M. Hudnall, T. P. Burns, G. S. Poindexter, Org. Synth. 1979, 59, 85. 
25 R. D. Rieke, P. T.-J. Li, T. P. Burns, S. T. Uhm, J. Org. Chem. 1981, 46, 4323. 
26 S.-H. Kim, M. V. Hanson, R. D. Rieke, Tetrahedron Lett. 1996, 37, 2197. 
27 a) J.-S. Lee, R. Velarde-Ortiz, A. Guijarro, R. D. Rieke, J. Org. Chem. 2000, 65, 5428; b) L. Zhu, R. M. 
Wehmeyer, R. D. Rieke, J. Org. Chem. 1991, 56, 1445. 
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Scheme 2: Oxidative insertion of Rieke magnesium, zinc and manganese into organic halides. 
Later, in 2006, Knochel and co-workers showed that the use of LiCl as an additive led to improved 
results in the formation of sensitive organometallics. They were able to prepare a wide variety of 
organomagnesium and zinc species bearing sensitive functional groups.28 The magnesium insertion to 
2-bromobenzonitrile (10) in the presence of lithium chloride proceeds smoothly, producing the 
magnesium species 11 which, after transmetallation to zinc, undergoes a Pd-catalyzed Negishi cross-
coupling29 with 4-iodoanisole, giving the arylated benzonitrile 12 in 85% yield.28 Zinc insertion to 1-
(4-iodophenyl)ethan-1-one (13) followed by quenching with benzoyl chloride in the presence of 20 
mol% CuCN·2LiCl gives the benzophenone derivative 14 in 88% yield.28 Interestingly, in the case of 
the di-iodo substituted arene 15, only the halogen which is positioned ortho to a directing group is 
reacting. This phenomenon is known as the directed orthoinsertion (DoI).30 The zinc species 16 
prepared via DoI readily reacts with methyl 2-iodobenzoate in the presence of Pd(PPh3)4 (1 mol%) to 
give the product 17 in 76% yield (Scheme 3).30 In 2016, Blum et al. studied the role of LiCl during 
oxidative insertions thanks to fluorescence microscopy.31 They found that LiCl actually helps to 
solubilize the newly formed organometallic generated at the surface of the metal, providing a constantly 
clean metal surface.32 
 
 
28 a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040; b) F. M. 
Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802; c) A. 
Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107. 
29 E. Negishi, S. Baba, J. Am. Chem. Soc. 1976, 98, 6729. 
30 N. Boudet, S. Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 12358. 
31 C. Feng, D. W. Cunningham, Q. T. Easter, S. A. Blum, J. Am. Chem. Soc. 2016, 138, 11156. 
32 C. Feng, Q. T. Easter, S. A. Blum, Organometallics 2017, 36, 2389. 
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Scheme 3: Preparation of organomagnesium and organozinc reagents by metal insertion in the 
presence of LiCl. 
While LiCl alone is not sufficient to activate powdered manganese, prior reports have shown that 
combinations of Lewis-acids (TiCl4, PbCl2, InCl3 or BiCl3) with LiCl are beneficial for the oxidative 
insertion of aluminum into organic halides.33 Based on those observations, Knochel and co-workers 
reported in 2011 the preparation of functionalized aryl and benzyl manganese reagents by manganese 
insertion in the presence of LiCl and catalytic amounts of InCl3 and PbCl2.34 Thus, the oxidative 
insertion of manganese into an aryl or benzyl halide 18 and 19 proceeded under the above mentioned 
conditions, leading to the corresponding functionalized manganese halides 20 and 21. Trapping with 3-
formylbenzonitrile and ethyl 2-(bromomethyl)acrylate gave the desired products 22 and 23 in 45–68% 
yield. It is worth stating that in the case of benzyl halides, the insertion was performed without LiCl. In 
fact, this salt favoured the formation of undesired homocoupling (Scheme 4). Due to their exceptional 
reactivity, organomanganese species do not need any transition-metal catalysts for many further 
transformations (acylations, allylic substitutions and 1,4-additions).34 
 
33 T. Blümke, Y.-H. Chen, Z. Peng, P. Knochel, Nat. Chem. 2010, 2, 313. 
34 Z. Peng, P. Knochel, Org. Lett. 2011, 13, 3198. 
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Scheme 4: Preparation of organomanganese species by manganese insertion promoted by InCl3 and 
PbCl2. 
2.2 Halogen/Metal Exchange 
Another commonly used method for the preparation of organometallics is the halogen/metal exchange. 
In general, the driving force for this reaction type is the formation of a more stable organometallic 
species compared to the exchange reagent itself. As said before, the stability of the organometallic 
reagent decreases that way: C(sp) > C(sp2vinyl) > C(sp2aryl) > C(sp3primary) > C(sp3secondary) > C(sp3tertiary).17,35 
The halogen/lithium exchange was discovered by Gilman36 and Wittig37 and has proven its synthetic 
utility over the last decades for preparing a wide range of organometallic species derived from lithium.38 
Still, the high reactivity of the carbon-lithium bond has limited the use of this method for preparing 
polyfunctional lithium compounds at convenient reaction temperatures.39 For that reason, halogen/metal 
exchange reagents with a more covalent carbon-metal bond like organo-magnesium, -zinc or -
manganese should be more advantageous. Nevertheless, the halogen/lithium exchange is one of the 
fastest reactions in organic synthesis,40 especially compared to the other halogen/metal exchange 
reactions like halogen/magnesium,41 which are considered to be relatively slow. 
 
35 D. Hauk, S. Lang, A. Murso, Org. Process Res. Dev. 2006, 10, 733. 
36 a) H. Gilman, W. Langham, A. L. Jacoby, J. Am. Chem. Soc. 1939, 61, 106; b) R. G. Jones, H. Gilman, Org. 
React. 1951, 6, 339. 
37 G. Wittig, U. Pockels, H. Dröge, Ber. dtsch. Chem. Ges. 1938, 71, 1903. 
38 a) J. Clayden, Organolithiums: Selectivity for Synthesis (Ed.: J. Clayden), Pergamon, Oxford, 2002; b) C. 
Nájera, J. M. Sansano, M. Yus, Tetrahedron 2003, 59, 9255. 
39 Remarkable exceptions: a) A. Nagaki, H. Kim, H. Usutani, C. Matsuo, J.-i. Yoshida, Org. Biomol. Chem. 2010, 
8, 1212; b) H. Kim, A. Nagaki, J.-i. Yoshida, Nat. Comm. 2011, 2, 264; c) A. Nagaki, K. Imai, S. Ishiuchi, J.-i. 
Yoshida, Angew. Chem. Int. Ed. 2015, 54, 1914; d) H. Kim, H.-J. Lee, D.-P. Kim, Angew. Chem. Int. Ed. 2015, 
54, 1877. 
40 W. F. Bailey, J. J. Patricia, T. T. Nurmi, W. Wang, Tetrahedron Lett. 1986, 27, 1861. 
41 a) L. Shi, Y. Chu. P. Knochel, H. Mayr, Angew. Chem. Int. Ed. 2008, 47, 202; b) L. Shi, Y. Chu, P. Knochel, 
H. Mayr, Org. Lett. 2009, 11, 3502; c) L. Shi, Y. Chu, P. Knochel, H. Mayr, J. Org. Chem. 2009, 74, 2760; d) L. 
Shi, Y. Chu, P. Knochel, H. Mayr, Org. Lett. 2012, 14, 2602. 
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2.2.1 Halogen/Magnesium Exchange 
In 1931, Prévost observed the first example of a bromine/magnesium exchange.42 Even if he obtained 
really low conversions of starting material, this technique could be used by others on some electron-
deficient substrates such as heteroaromatic rings and/or electro-deficient aromatics. Köbrich43 and 
Villieras44 used the halogen/magnesium exchange to generate magnesium carbenoids. In 2003, 
Christophersen produced the 3-magnesiated bromothiophene 25a via an iodine/magnesium exchange 
on 2-bromo-3-iodothiophene (24a) while he obtained the 2-magnesiated bromothiophene 25b when 
2,3-dibromothiophene (24b) was used as starting material (Scheme 5).45 The formation of 25a can be 
explained by the increased exchange rate of iodine towards bromine. Indeed, the reactivity order of the 
halogen (I>Br>Cl>>F) is influenced by the bond strength of the carbon-halogen bond and the halide’s 
electronegativity and polarizability.46 The generation of 25b can be explained by the improved stability 
– due to the close proximity of a heteroatom47 – of this one compared to the corresponding 3-
magnesiated bromothiophene 24a. 
 
Scheme 5: Regioselectivity of the halide/magnesium exchange on electron poor heteroaromatic 
halides. 
A regioselectivity can also sometimes be triggered by the presence of a strong directing group. When 
in proximity of the halogen, this last one coordinates the exchange reagent, directs the exchange reaction 
and stabilizes the newly formed carbon-magnesium bond. For example, the ethoxy group of the 
 
42 Prévost, C. Bull. Soc. Chim. Fr. 1931, 49, 1372 
43 G. Köbrich, P. Buck, Chem. Ber. 1970, 103, 1412. 
44 J. Villieras, B. Kirschleger, R. Tarhouni, M. Rambaud, Bull. Soc. Chim. Fr. 1986, 470. 
45 C. Christophersen, M. Begtrup, S. Ebdrup, H. Petersen, P. Vedso, J. Org. Chem. 2003, 68, 9513. 
46 C. Tamborski, G. J. Moore, J. Organomet. Chem. 1971, 26, 153. 
47 P. Beak, D. B. Reitz, Chem. Rev. 1978, 78, 275. 
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dibromoimidazole derivative 26 complexed iPrMgBr, producing the very stable Grignard reagent 27 
which, after trapping with NC-CO2Et provided the bromoimidazole 28 in 59% yield.48 As already 
stated, apart from heterocycles, the presence of an electron-withdrawing substituent can help getting 
suitable conversions during a halogen/magnesium exchange. Around 2000, for the first time, access to 
arylmagnesium reagents bearing an ester or a nitro group was enabled.49 Indeed, previous attempts 
through oxidative insertion of magnesium resulted in a total reaction inhibition and only led to reduced 
products.50 Thus, ethyl 4-iodobenzoate (4) reacted with iPrMgBr at –40 °C within 1 h, providing the 
functionalized arylmagnesium bromide 29. After addition of benzaldehyde, the expected alcohol 30 
was obtained in 90% yield.49a Similarly, the reaction of 2-iodo-1,5-dinitrobenzene (31) with PhMgCl at 
–40 °C for 5 min provided the corresponding Grignard reagent 32. After reaction with PhCHO, the 
alcohol 33 was obtained in 81% yield (Scheme 6).51 
 
Scheme 6: Chemoselective iodine/magnesium exchange reaction. 
Thanks to this kind of exchange reagents, alkaloids such as kealiinines A–C have been synthesized.52 
However, as said earlier, a general methodology for aryl and heteroaryl halides was not always 
possible53 and the use of lithium trialkylmagnesiates54 was often required, reducing the chemoselectivity 
of this type of exchange. Fortunately, in 2004, Knochel et al. found that the use of LiCl was enhancing 
 
48 a) M. Abarbri, F. Dehmel, P. Knochel, Tetrahedron Lett. 1999, 40, 7449; b) M. Abarbri, J. Thibonnet, L. 
Berillon, F. Dehmel, M. Rottlaender, P. Knochel, J. Org. Chem. 2000, 65, 4618. 
49 a) L. Boymond, M. Rottländer, G. Cahiez, P. Knochel, Angew. Chem. Int. Ed. 1998, 37, 1701; b) G. Varchi, A. 
Ricci, G. Cahiez, P. Knochel, Tetrahedron 2000, 56, 2727; c) W. Dohle, D. M. Lindsay, P. Knochel, Org. Lett. 
2001, 3, 2871; d) Y. Nakamura, S. Yoshida, T. Hosoya, Chem. Lett. 2017, 46, 858. 
50 a) T. Severin, D. Bätz, H. Krämer, Chem. Ber. 1971, 104, 950; b) G. Bartoli, G. Palmieri, M. Bosco, R. 
Dalpozzo, Tetrahedron Lett. 1989, 30, 2129; c) M. Bosco, R. Dalpozzo, G. Bartoli, G. Palmieri, M. Petrini, J. 
Chem. Soc. 1991, 657. 
51 a) I. Sapountzis, P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 1610; b) I. Sapountzis, H. Dube, R. Lewis, N. 
Gommermann, P. Knochel, J. Org. Chem. 2005, 70, 2445. 
52 J. Das, P. B. Koswatta, J. D. Jones, M. Yousufuddin, C. J. Lovely, Org. Lett. 2012, 14, 6210. 
53 a) J. Thibonnet, P. Knochel, Tetrahedron Lett. 2000, 41, 3319; b) O. Ryabtsova, T. Verhelst, M. Baeten, C. M. 
L. Vande Velde, B. U. W. Maes, J. Org. Chem. 2009, 74, 9440. 
54 a) K. Kitagawa, A. Inoue, H. Shinokubo, K. Oshima, Angew. Chem. Int. Ed. 2000, 39, 2481; b) A. Inoue, K. 
Kitagawa, H. Shinokubo, K. Oshima, J. Org. Chem. 2001, 66, 4333; c) A. Inoue, J. Kondo, H. Shinokubo, K. 
Oshima, Chem. - Eur. J. 2002, 8, 1730; d) L. Struk, J. G. Sosnicki, Synthesis 2012, 44, 735. 
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the kinetic activity of this type of exchange reagents. The development of the reagent iPrMgCl·LiCl – 
also known as “turbo-Grignard” – made accessible the preparation of a wide range of functionalized 
magnesium organometallics.55  For example, 3-bromobenzonitrile (34) was converted by iPrMgCl·LiCl 
to the corresponding Grignard reagent 35 at 0 °C within 3 h. Quenching with benzoyl chloride led to 
the benzophenone derivative 36 in 88% yield.55a Polybromides such as the dibromopyridine 37 
underwent an exchange at position C(3), since this position leads to the most stabilized Grignard reagent 
38. After addition of N,N-dimethylformamide (DMF), the aldehyde 39 was obtained in 88% yield 
(Scheme 7).56 
 
Scheme 7: Bromine/magnesium exchange reaction triggered by iPrMgCl·LiCl. 
Thanks to the turbo-Grignard, alkenyl magnesium derivatives could also be obtained. For example, the 
polyfunctional alkenyl iodide 40 reacted with turbo-Grignard at –40 °C furnishing 
(E)-alkenylmagnesium derivative 41. After reaction with TsCN, the product 42 was obtained in 75% 
yield (Scheme 8).57 
 
Scheme 8: Preparation of alkenylmagnesium reagents using iPrMgCl·LiCl. 
 
55 a) A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333; b) A. Krasovskiy, B. F. Straub, P. Knochel, 
Angew. Chem. Int. Ed. 2006, 45, 159; c) T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 1958; d) J. Nickel, 
M. Fernandez, L. Klier, P. Knochel, Chem. - Eur. J. 2016, 22, 14397; e) C.-Y. Liu, P. Knochel, Org. Lett. 2005, 
7, 2543. 
56 H. Ren, P. Knochel, Chem. Commun. 2006, 726. 
57 H. Ren, A. Krasovskiy, P. Knochel, Org. Lett. 2004, 6, 4215. 
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Interestingly, the sulfoxide/magnesium exchange, which was well studied by Satoh58 and Hoffmann,59 
could also be performed by iPrMgCl·LiCl. Remarkably, the polyfunctional sulfoxide 43 underwent a 
fast sulfoxide/magnesium exchange at –50 °C within 5 min, producing an intermediate Grignard 
reagent. By addition of 3,4-dichlorobenzaldehyde, benzonitrile 44 was furnished in 88% yield (Scheme 
9).60 
 
Scheme 9: Preparation of polyfunctional arenes using a sulfoxide/magnesium exchange.  
Since its initial report,55a turbo-Grignard has become very popular and numerous applications have been 
reported.61 It was also for example used for natural product synthesis.62 Gosselin also used it to 
synthesize a selective estrogen receptor degrader. In the presence of bis(2-dimethylaminoethyl)ether, 
he converted the aryl iodide 45 into the corresponding Grignard 46 and made it react on the ketone 47 
to obtain the alcohol 48 as a single diastereoisomer (Scheme 10).63 Halide/magnesium exchanges with 
turbo-Grignard were also performed with microreactors in flow chemistry.64  
 
58 a) T. Satoh, T. Oohara, Y. Ueda, K. Yamakawa, J. Org. Chem. 1989, 54, 3130; b) T. Satoh, K. Horiguchi, 
Tetrahedron Lett. 1995, 36, 8235; c) T. Satoh, K. Takano, H. Ota, H. Someya, K. Matsuda, M. Koyama, 
Tetrahedron 1998, 54, 5557. 
59 a) R. W. Hoffmann, P. G. Nell, Angew. Chem. Int. Ed. 1999, 38, 338; b) R. W. Hoffmann, B. Hölzer, O. Knopff, 
K. Harms, Angew. Chem. Int. Ed. 2000, 39, 3072; c) R. W. Hoffmann, B. Hölzer, O. Knopff, Org. Lett. 2001, 3, 
1945; d) B. Holzer, R. W. Hoffmann, Chem. Commun. 2003, 732; e) R. W. Hoffmann, Chem. Soc. Rev. 2003, 32, 
225. 
60 a) C. B. Rauhut, L. Melzig, P. Knochel, Org. Lett. 2008, 10, 3891; b) L. Melzig, C. B. Rauhut, P. Knochel, 
Synthesis 2009, 1041; c) L. Melzig, C. B. Rauhut, N. Naredi-Rainer, P. Knochel, Chem. - Eur. J. 2011, 17, 5362; 
d) N. M. Barl, E. S. Sansiaume-Dagousset, K. Karaghiosoff, P. Knochel, Angew. Chem. Int. Ed. 2013, 52, 10093; 
e) D. Nath, F. F. Fleming, Chem. - Eur. J. 2013, 19, 2023; f) M. Hughes, T. Boultwood, G. Zeppetelli, J. A. Bull, 
J. Org. Chem. 2013, 78, 844; g) C. Sämann, E. Coya, P. Knochel, Angew. Chem. Int. Ed. 2014, 53, 1430. 
61 a) T. Leermann, F. R. Leroux, F. Colobert, Org. Lett. 2011, 13, 4479; b) E. Demory, V. Blandin, J. Einhorn, P. 
Y. Chavant, Org. Process Res. Dev. 2011, 15, 710; c) X.-F. Duan, Z.-Q. Ma, F. Zhang, Z.-B. Zhang, J. Org. 
Chem. 2009, 74, 939; d) K. C. Nicolaou, A. Krasovskiy, V. É. Trépanier, D. Y. K. Chen, Angew. Chem. Int. Ed. 
2008, 47, 4217; e) K. C. Nicolaou, A. Krasovskiy, U. Majumder, V. É. Trépanier, D. Y. K. Chen, J. Am. Chem. 
Soc. 2009, 131, 3690; f) J. T. Reeves, K. Camara, Z. S. Han, Y. Xu, H. Lee, C. A. Busacca, C. H. Senanayake, 
Org. Lett. 2014, 16, 1196; g) M. Döbele, M. S. Wiehn, S. Bräse, Angew. Chem. Int. Ed. 2011, 50, 11533; h) V. 
Diemer, F. R. Leroux, F. Colobert, Eur. J. Org. Chem. 2011, 327. 
62 A. O. Termath, S. Ritter, M. König, D. P. Kranz, J. M. Neudörfl, A. Prokop, H. G. Schmalz, Eur. J. Org. Chem. 
2012, 4501. 
63 N.-K. Lim, T. Cravillion, S. Savage, A. McClory, C. Han, H. Zhang, A. Di Pasquale, F. Gosselin, Org. Lett. 
2018, 20, 1114. 
64 a) H. Wakami, J.-i. Yoshida, Org. Process Res. Dev. 2005, 9, 787; b) T. Tricotet, D. F. O’Shea, Chem. - Eur. 
J. 2010, 16, 6678; c) T. Brodmann, P. Koos, A. Metzger, P. Knochel, S. V. Ley, Org. Process Res. Dev. 2012, 
16, 1102; d) Q. Deng, R. Shen, Z. Zhao, M. Yan, L. Zhang, Chem. Eng. J. 2015, 262, 1168; e) S. Korwar, S. Amir, 
P. N. Tosso, B. K. Desai, C. J. Kong, S. Fadnis, N. S. Telang, S. Ahmad, T. D. Roper, B. F. Gupton, Eur. J. Org. 
Chem. 2017, 6495. 
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Scheme 10: Preparation of drug intermediate 48 using iPrMgCl·LiCl.  
Furthermore, polymers could also be prepared using turbo-Grignard.65 For instance, the Grignard 
reagent 49 could be selectively prepared by treatment of the dihalogenofluorene derivative 50 with 
iPrMgCl·LiCl at –20 °C in THF, which polymerized at 0 °C in the presence of catalytic amounts of 
Ni(dppp)Cl2, leading to poly(9,9-dioctylfluorene) (51) with a high Mn of 8.6·104 and a polydispersity 
index (PDI) of 1.49. Interestingly, without LiCl, the polymerization afforded a lower molecular weight 
product (Scheme 11).66 
 
Scheme 11: LiCl-promoted polymerization using turbo-Grignard reagent. 
When replacing the secondary alkyl chain of the turbo-Grignard by a mesityl moiety, affording 
MesMgBr·LiCl, Knochel and co-workers could increase the bulkiness of this type of exchange reagents. 
They could selectively exchange the bromine at the position C(3) on 2,3,4-tribromoquinoline (52) to 
afford the corresponding Grignard 53, which gave in presence of NC-CO2Et the ester 54 in 90% yield.67 
Interestingly, when replacing the methyl groups of the mesityl moiety by isopropyl chains, a selective 
bromine/magnesium exchange could be performed on the thiophene 55 in the presence of bis(2-
dimethylaminoethyl)ether, affording the Grignard 56 which provided the ester 57 in 83% yield upon 
reaction with (tBuO2C)2O (Scheme 12).68  
 
65 a) S. Wu, L. Huang, H. Tian, Y. Geng, F. Wang, Macromolecules 2011, 44, 7558; b) Y. Nanashima, A. 
Yokoyama, T. Yokozawa, Macromolecules 2012, 45, 2609; c) Y. Takeoka, K. Umezawa, T. Oshima, M. Yoshida, 
M. Yoshizawa-Fujita, M. Rikukawa, Polym. Chem. 2014, 5, 4132; d) F. Pammer, U. Passlack, ACS Macro Lett. 
2014, 3, 170; e) Z.-K. Yang, N.-X. Xu, R. Takita, A. Muranaka, C. Wang, M. Uchiyama, Nature Comm. 2018, 9, 
1587. 
66 a) L. Huang, S. Wu, Y. Qu, Y. Geng, F. Wang, Macromolecules 2008, 41, 8944; b) E. L. Lanni, A. J. McNeil, 
J. Am. Chem. Soc. 2009, 131, 16573; c) M. C. Stefan, A. E. Javier, I. Osaka, R. D. McCullough, Macromolecules 
2009, 42, 30. 
67 N. Boudet, J. R. Lachs, P. Knochel, Org. Lett. 2007, 9, 5525. 
68 C. Sämann, B. Haag, P. Knochel, Chem. Eur. J. 2012, 18, 16145. 
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Scheme 12: Regioselective bromine/magnesium exchange by the use of bulky exchange reagents.  
Although it was stated in the original patent that anion donor ligands such as alkoxides and amides 
could enhance the rate of exchange,69 efforts were made to improve the turbo-Grignard by synthesizing 
dialkylmagnesium species complexed with LiCl, for example by treating sBuMgCl with sBuLi.55b Also, 
the treatment of two equivalents of iPrMgCl·LiCl with 10 vol% of 1,4-dioxane displaced the Schlenk-
equilibrium towards the formation of 58. The reaction of the electron-rich aryl bromide 4-bromo-N,N-
dimethylaniline (59) with turbo-Grignard produced the corresponding Grignard species with only 16% 
conversion, whereas the reagent 58 led to the di(4-dimethyl,aminophenyl)magnesium (60) complexed 
with LiCl with 96% conversion after 48 h at 25 °C. Addition of benzaldehyde provided the alcohol 61 
in 95% yield (Scheme 13).55b 
 
Scheme 13: Preparation of magnesium reagents using iPr2Mg·LiCl (58). 
Brückner showed that in the presence of various additives like the binol-derivative 62, iPr2Mg 
underwent a complete bromine/magnesium exchange on bis(2-bromophenyl)methanol (63) within 6 h 
at 25 °C in ether. After solvent switch to toluene, he obtained the chiral alcohol 64 in 51% yield and 
52% ee. After o-alkylation and methylation, (R)-orphenadine (65) was obtained (Scheme 14).70 
 
69 a) J. Farkas, S. J. Stoudt, E. M. Hanawalt, A. D. Pajerski, H. G. Richey, Organometallics 2004, 23, 423; b) P. 
Knochel, A. Krasovskiy, EP1582523A1 2005. 
70 D. Sälinger, R. Brückner, Chem. - Eur. J. 2009, 15, 6688. 
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Scheme 14: Desymmetrization of benzhydryl alcohol 57 via an enantioselective bromine/magnesium 
exchange. 
Recently, in 2018, a new class of exchange reagents has been developed.71 Using lithium alkoxides, for 
the first time, organomagnesium species could be prepared in apolar solvents. The use of this new type 
of reagents induced an extremely fast bromine/magnesium as well as, in some cases, a 
chlorine/magnesium exchange. For instance, the electron-rich 2-bromo-N,N-dimethylaniline (66) was 
converted into the corresponding magnesium species 67 using sBuMgOR·LiOR (R = 2-ethylhexyl, 1.20 
equiv) in the presence of TMEDA at room temperature within 2 h. When MeSO2SMe was added, it 
provided the product 68 in 84% yield. Also, in combination with PMDTA, the dialkylmagnesium 
reagent sBu2Mg·2LiOR (R = 2-ethylhexyl, 0.60 equiv) reacts with an electron-rich aryl chloride 69 
bearing a methoxy group in ortho position, to afford, after quenching with 1-methyl-1H-indole-2-
carbaldehyde, the functionalized anisole 70 in 70% yield (Scheme 15).  
 
Scheme 15: Halogen/magnesium exchange on aryl bromides and chlorides in toluene. 
 
71 D. S. Ziegler, K. Karaghiosoff, P. Knochel, Angew. Chem. Int. Ed. 2018, 57, 6701. 
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2.2.2 Halogen/Zn and Halogen/Mn Exchange Reactions 
In 1988, for the first time, lithium zincates of the type R3ZnLi have been used to perform a bromine/zinc 
exchange on alkenyl bromides.72 Those species could then undergo alkylation when warming up the 
reaction mixture to 0 °C. It was attempted by Kondo and Sakamoto73 to generalize this approach with 
the use of R4ZnLi2, but unfortunately, those lithium zincates behaving more or less like the 
corresponding lithium derivatives, the scope of the reaction remained unsatisfactory. As an example, 
when 71 was put in the presence of nBu3ZnLi at –85 °C and warmed to 0 °C, the alkylated product 72 
was obtained in 64% yield. Also, bromobenzene (73) reacted with Me4ZnLi2 in THF at –20 °C within 
2 h to provide after quenching with benzaldehyde diphenylmethanol (74) in 47% yield (Scheme 16). 
  
Scheme 16: Bromine/zinc exchange using lithium zincates. 
A few years later, in the mid-1990s, huge improvements have been made. Knochel reported the 
iodine/zinc exchange of primary and secondary alkyl iodides based on the use of R2Zn.74 For the first 
time, those mild conditions allowed the preparation of highly functionalized organozinc species by 
exchange reactions, which have for example been used to perform Reformatsky-type reactions.75 For 
instance, when the α-iodo ester 75 was put in presence of Me2Zn, a chiral binol derivative and 
benzaldehyde, the zinc species 76 was formed and reacted in situ to give the chiral alcohol 77 (Scheme 
17).76 
 
72 a) T. Harada, D. Hara, K. Hattori, A. Oku, Tetrahedron Lett. 1988, 29, 3821; b) T. Harada, T. Katsuhira, A. 
Oku, J. Org. Chem. 1992, 57, 5805. 
73 M. Uchiyama, M. Koike, M. Kameda, Y. Kondo, T. Sakamoto, J. Am. Chem. Soc. 1996, 118, 8733. 
74 a) M. J. Rozema, S. AchyuthaRao, P. Knochel, J. Org. Chem. 1992, 57, 1956; b) M. J. Rozema, C. Eisenberg, 
H. Lütjens, K. Belyk, P. Knochel, Tetrahedron Lett. 1993, 34, 3115; c) P. Knochel, Synlett 1995, 393; d) L. 
Micouin, P. Knochel, Synlett 1997, 327. 
75 a) S. Reformatskii, J. Russ. Phys. Chem. Soc. 1890, 22, 44; b) S. Miki, K. Nakamoto, J.-I. Kawakami, S. Handa, 
S. Nuwa, Synthesis 2008, 409. 
76 a) M. A. Fernández-Ibáñez, B. Maciá, A. J. Minnaard, B. L. Feringa, Angew. Chem. Int. Ed. 2008, 47, 1317; b) 
E. Mileo, F. Benfatti, P. G. Cozzi, M. Lucarini, Chem. Commun. 2009, 469. 
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Scheme 17: Use of Me2Zn for generating a Reformatsky reagent. 
Later, in 2004, Knochel and co-workers found that 10% of Li(acac) associated with iPr2Zn and NMP 
could perform iodine/zinc exchange on aryl iodides with an outstanding scope, since the carbon-zinc 
bond is quite covalent.77 The polyfunctional aldehyde 78 reacts under the previously stated conditions 
to give the zinc species 79, which underwent a Pd-catalyzed Negishi cross-coupling with methyl 4-
iodobenzoate to give the product 80 in 60% yield (Scheme 18). 
 
Scheme 18: Iodine/zinc exchange reaction catalyzed by Li(acac) in NMP. 
Sadly, studies on the halogen/manganese exchange are scarce. In 1997, Hosomi78 and Oshima79 both 
reported a case of halogen/manganese exchange by using an aryl iodide 81 and lithium tri- or 
tetraalkylmanganates of type R3MnLi or R4MnLi2. Unfortunately, the manganese species such as 82 are 
rarely stable, suffering from β-hydride elimination. For that reason, reactive electrophiles like allyl 
bromide must be used right away to give, for instance, the desired product 83 (Scheme 19). 
 
Scheme 19: Iodine/manganese exchange reaction. 
 
77 a) F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 1017; b) L.-Z. Gong, P. Knochel, 
Synlett 2005, 267. 
78 a) M. Hojo, H. Harada, H. Ito, A. Hosomi, Chem. Commun. 1997, 2077; b) M. Hojo, H. Harada, H. Ito, A. 
Hosomi, J. Am. Chem. Soc. 1997, 119, 5459; c) M. Hojo, R. Sakuragi, Y. Murakami, Y. Baba, A. Hosomi, 
Organometallics 2000, 19, 4941.   
79 J. Nakao, R. Inoue, H. Shinokubo, K. Oshima, J. Org. Chem. 1997, 62, 1910.   
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2.3 Deprotonation 
A third approach towards organometallics, the deprotonation, was originally discovered in the late 
1920s by Schlenk when he prepared 9-fluorenyllithium by using EtLi and fluorene.80 This has led other 
chemists like Gilman81 and Wittig82 to work on deprotonations. Pioneered by Snieckus,83 Quéguiner84 
and Schlosser,85 lithium dialkylamides (R2NLi) have been widely used for low-temperature metalations 
of organic compounds. Once again, the high reactivity of those lithium reagents was not compatible 
with functionalized substrates and other bases had to be developed. Despite the work of Mulvey, 
Mongrin, Uchiyama and Kondo since 1999 on lithium magnesiates and zincates which considerably 
broadened the scope of metalations,86 magnesium amides, developed by Hauser (R2NMgX or 
(R2N)2Mg) and Eaton (TMP2Mg), provided higher tolerance towards sensitive functional groups.87 For 
instance, Mulzer demonstrated their use for natural product synthesis. However, due to their low kinetic 
basicity and solubility, a large excess of magnesium bases and electrophiles were required.88 These 
limitations have hampered their use until Knochel and co-workers developed in 2006 a highly reactive 
metal amide base, TMPMgCl·LiCl (84), by mixing TMPMgCl with one equivalent of lithium chloride 
in THF (Scheme 20). The resulting base exhibited an excellent solubility in common organic solvents 
(ca. 1.4 M in THF) as well as improved kinetic basicity.89 
 
Scheme 20: Preparation of TMPMgCl·LiCl (84) using iPrMgCl·LiCl and TMP-H. 
 
80 W. Schlenk, E. Bergmann, Justus Liebigs Ann. Chem. 1928, 463, 98. 
81 H. Gilman, R. L. Bebb, J. Am. Chem. Soc. 1939, 61, 109. 
82 G. Wittig, G. Fuhrmann, Ber. Dtsch. Chem. Ges. 1940, 73, 1197. 
83 a) P. Beak, V. Snieckus, Acc. Chem. Res. 1982, 15, 306; b) V. Snieckus, Chem. Rev. 1990, 90, 879; c) L. Green, 
B. Chauder, V. Snieckus, J. Heterocyclic Chem. 1999, 36, 1453; d) K. R. Campos, Chem. Soc. Rev. 2007, 36, 
1069. 
84 a) A. Turck, N. Plé, F. Mongin, G. Quéguiner, Tetrahedron 2001, 57, 4489; b) F. Mongin, G. Quéguiner, 
Tetrahedron 2001, 57, 4059. 
85 a) M. Schlosser, Angew. Chem. Int. Ed. 2005, 44, 376; b) M. Schlosser, F. Mongin, Chem. Soc. Rev. 2007, 36, 
1161. 
86 a) R. E. Mulvey, Organometallics 2006, 25, 1060; b) R. E. Mulvey, F. Mongin, M. Uchiyama, Y. Kondo, 
Angew. Chem. Int. Ed. 2007, 46, 3802; c) R. E. Mulvey, Acc. Chem. Res. 2009, 42, 743; d) S. D. Robertson, M. 
Uzelac, R. E. Mulvey, Chem. Rev. 2019, 119, 8332; e) Y. Kondo, H. Shilai, M. Uchiyama, T. Sakamoto, J. Am. 
Chem. Soc. 1999, 121, 3539; f) T. Imahori, M. Uchiyama, Y. Kondo, Chem. Commun. 2001, 2450; g) M. 
Uchiyama, T. Miyoshi, Y. Kajihana, T. Sakamoto, Y. Otami, T. Ohwada, Y. Kondo, J. Am. Chem. Soc. 2002, 
124, 8514; h) M. Uchiyama, Y. Kobayashi, T. Furuyama, S. Nakamura, Z. Kajihara, T. Miyoshi, T. Sakamoto, 
Y. Kondo, K. Morokuma, J. Am. Chem. Soc. 2008, 130, 472. 
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The high functional group tolerance of TMPMgCl·LiCl (84) allowed a huge variety of polyfunctional 
aromatics and heteroaromatics to be magnesiated.89 For example, the magnesiation with 
TMPMgCl·LiCl (84) of the highly functionalized ketone 85 by using an OBoc as a directing group 
smoothly generated the magnesium derivative 86 which was converted into 87 in 90% yield.90 
Moreover, electron-deficient substrates such as the nonaflate-substituted derivative 88 were 
magnesiated with 84 providing the Grignard reagent 89. Addition of MeSO2SMe led to the expected 
methyl thioether 90 in 81% yield (Scheme 21).91 
 
Scheme 21: Metalation of polyfunctional aromatics using TMPMgCl·LiCl (84). 
Furthermore, various electron-poor and -rich heteroaromatics was magnesiated with TMPMgCl·LiCl 
(84). Thus, protected uracil 91 reacted regioselectively with TMPMgCl·LiCl (84) at –40 °C in 4 h and 
provided the C(5) metalated heterocycle 92. Transmetalation with ZnCl2, followed by a Pd-catalyzed 
Negishi cross-coupling with 4-iodobenzonitrile led to the arylated methyl protected uracil 93 in 78% 
yield (Scheme 22).92 Interestingly, N-heterocycles such as the pyridine 94 bearing a N,N,N’,N’-
tetramethyldiaminophosphorodiamidate directing group were metalated at 0 °C within 1 h. By using 
84, the desired product 95 was afforded in 83% yield after quench with C2Cl3F3 (Scheme 22).93 
 
Scheme 22: Metalation of heteroaromatics using TMPMgCl·LiCl (84). 
 
90 W. Lin, O. Baron, P. Knochel, Org. Lett. 2006, 8, 5673. 
91 G. Monzon, P. Knochel, Synlett 2010, 304. 
92 L. Klier, E. Aranzamendi, D. Ziegler, J. Nickel, K. Karaghiosoff, T. Carell, P. Knochel, Org. Lett. 2016, 18, 
1068. 
93 C. J. Rohbogner, S. Wirth, P. Knochel, Org. Lett. 2010, 12, 1984. 
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In the following years, a number of new TMP-bases were established94 like TMP2Mg·2MgCl2·2LiCl 
(96),95 TMPZnCl·LiCl (97),96 TMP2Zn·2MgCl2·2LiCl (98)97 and TMP2Mn·2MgCl2·4LiCl (99)98 
(Figure 3). Since then, the metalation scope of unsaturated substrates has been considerably expanded. 
Thanks to their high kinetic basicity, TMP-bases offered the possibility to metalate chemo- and 
regioselectively a wide range of aromatic systems, as well as highly functionalized heterocycles and 
non-aromatic, unsaturated systems under practical conditions.94 
 
Figure 3: TMP-derived, mixed metal/lithium amide bases. 
Aromatic substrates bearing electron-donating or weakly-accepting substituents were difficult to 
magnesiate with 84. The higher reactivity of TMP2Mg·2MgCl2·2LiCl (96) solved this problem by 
enabling the magnesiation of moderately activated aromatics and heteroraromatics. For instance, 
TMP2Mg·2MgCl2·2LiCl (96) allowed the magnesiation of dimethyl-1,3-benzodioxan-4-one (100) at –
40 °C in 10 min. After transmetalation with ZnCl2 and Pd-catalyzed Negishi cross-coupling with (E)-
1-hexenyl iodide, the magnesiated species 101 was converted into the corresponding 6-substituted 
benzodioxane. Subsequent hydrogenation and deprotection gave the natural product found in the 
essential oil of Pelargonium sidoides DC 102 in 69% yield (Scheme 23).95 
 
Scheme 23: Magnesiation of dimethyl-1,3-benzodioxan-4-one (100) using TMP2Mg·2MgCl2·2LiCl 
(96). 
On the one hand, TMPMgCl·LiCl (84) and TMP2Mg·2MgCl2·2LiCl (96) were unfortunately not 
adapted for the metalation of several sensitive aromatics and heterocyclic substrates such as electron-
poor N-heterocycles. On the other hand, they could smoothly be metalated with TMPZnCl·LiCl (97). 
Consequently, 97 tolerates more sensitive functional groups such as nitro, aldehyde or methyl ketone 
 
94 B. Haag, M. Mosrin, H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9794.   
95 G. C. Clososki, C. J. Rohbogner, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7681. 
96 M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 1837. 
97 S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685. 
98 S. H. Wunderlich, M. Kienle, P. Knochel, Angew. Chem. Int. Ed. 2009, 48, 7256. 
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groups and the high thermal stability of these zinc organometallics (up to 120 °C) enabled the directed 
metalation under a wide range of conditions.94,96 For instance, the sensitive pyridazine heterocycle 103, 
which previously could only be metalated at low temperatures in moderate yields,84a was zincated to 
give 104 at 25 °C within 30 min. An iodination led to the trihalogenated pyridazine 105 in 84% yield 
(Scheme 24).96 
 
Scheme 24: Zincation of sensitive pyrazine 103 using TMPZnCl·LiCl (97). 
Furthermore, TMPZnCl·LiCl (97) allowed the coordination-induced regioselective zincation of 
chromones of type 106 at the position C(3) through the intermediate 107, giving the organozinc 108. 
Interestingly, the regioselectivity of those bases can be modulated by the presence of Lewis acids. 
Although BF3·OEt2 has been frequently selected,99 milder Lewis acids such as MgCl2 can also be 
employed.92,99d,100 The C(2)-selective zincation was then achieved using the more powerful zinc base 
TMP2Zn·2MgCl2·2LiCl (98). The coordination of MgCl2 to the most basic oxygen provided the 
intermediate 109, triggering by Complex-Induced Proximity Effect (CIPE)101 the formation of the bis-
heterocyclic zinc reagent 110 (Scheme 25).100 
 
Scheme 25: Regioselective zincation of chromone 106 using TMPZnCl·LiCl (97) and 
TMP2Zn·2MgCl2·2LiCl (98). 
 
99 a) M. Jaric, B. A. Haag, A. Unsinn, K. Karaghiosoff, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 5451; b) M. 
Jaric, B. A. Haag, S. M. Manolikakes, P. Knochel, Org. Lett. 2011, 13, 2306; c) S. M. Manolikakes, M. Jaric, K. 
Karaghiosoff, P. Knochel, Chem. Commun. 2013, 49, 2124; d) T. Klatt, D. S. Roman, T. Léon, P. Knochel, Org. 
Lett. 2014, 16, 1232; e) see: M. Balkenhohl, Ph.D. Dissertation, LMU München, 2019. 
100 L. Klier, T. Bresser, T. A. Nigst, K. Karaghiosoff, P. Knochel, J. Am. Chem. Soc. 2012, 134, 13584. 
101 M. C. Whisler, S. MacNeil, V. Snieckus, P. Beak, Angew. Chem. Int. Ed. 2004, 43, 2206. 
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The zinc base 98 was also used for the metalation of sensitive heterocycles such as triazole 111, which 
was prone to undergo fragmentation during metalation process.97,102 After transmetalation of 112 to 
copper and allylation, the product 113 was obtained in 85% yield. Also, 98 could tolerate various 
sensitive functional groups. Thus, 6-nitrobenzo[d]thiazole (114) was zincated at –50 °C within 0.5 h, 
leading to benzothiazole 115 in 75% yield after copper catalyzed allylation (Scheme 26).97 
 
Scheme 26: Zincation of sensitive heterocycles using TMP2Zn·2MgCl2·2LiCl (98). 
Although directed manganation has been rarely studied, TMP2Mn·2MgCl2·4LiCl (99) has been proven 
to be a base of choice for the metalation of a variety of functionalized arenes and heteroarenes under 
mild conditions.98 Thus, 99 was used for the functionalization of the benzothiadiazole scaffold, which 
possesses potential applications in the preparation of new materials.103 Indeed, 3,6-
dibromobenzothiadiazole (116) was metalated by 99 at 0 °C within 2.5 h to give the manganese species 
117. After pivaldehyde was added, the alcohol 118 was isolated in 78% yield (Scheme 27).98 
 
Scheme 27: Manganation of 3,6-dibromobenzothiadiazole (116) using TMP2Mn·2MgCl2·4LiCl (99). 
2.4 Transmetalation 
The transmetalation of organometallic compounds offers another approach for the preparation of 
organozinc, organomagnesium and organomanganese compounds by addition of an inorganic metal salt 
such as ZnCl2. It has been found to be useful for the preparation of sensitive reagents and allowed the 
 
102 a) A. Turck, N. Plé, L. Mojovic, G. Quéguiner, J. Heterocycl. Chem. 1990, 27, 1377; b) L. Mojovic, A. Turck, 
N. Plé, M. Dorsy, B. Ndzi, G. Quéguiner, Tetrahedron 1996, 52, 10417. 
103 a) J. Y. Kim, K. Lee, N. E. Coates, D. Moses, T.-C. Nguyen, M. Dante, A. J. Heeger, Science 2007, 317, 222; 
b) T. Clarke, A. Ballantyne, F. Jamieson, C. Brabec, J. Nelson, J. Durrant, Chem. Commun. 2009, 89. 
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metalation of certain scaffolds with new selectivies.104 Furthermore, this transmetalation process is used 
for many reactions with electrophiles e.g. cross-coupling, acylation or allylation reactions where the 
organometallic species must be either a zinc or a copper species.105 As exposed earlier, the driving force 
for the transmetalation reaction is the formation of a more covalent carbon-metal bond and along with 
it the formation of a more stable reagent. For example, the sensitive isoxazole 119 was prepared by a 
magnesium insertion in the presence of ZnCl2. Thereby, the unstable magnesium reagent 120 was 
directly transmetalated using ZnCl2 to form the comparatively stable zinc reagent 121. After a Negishi 
cross-coupling, the arylated product 122 was obtained in 90% yield. Transmetalation can also accelerate 
the generation of an organometallic species compared to the oxidative insertion. For instance, the 
fluorated benzylic zinc species 123 can be generated from 124 by oxidative zinc insertion in the 
presence of LiCl within 24 h at 25 °C while the magnesium insertion in the presence of LiCl and ZnCl2 
provides 123 within 45 min (Scheme 28).106 
 
Scheme 28: Preparation of the functionalized isoxazole 122 via an in situ generated zinc reagent. 
Although not being common, transmetalation from magnesium to manganese was already described in 
1937 by Gilman and Bailie.107 During the rest of the 20th century, further reports remained sporadic 
until the pioneer work of Cahiez et al. on organomanganese chemistry. He described, amongst other 
methods,16 the transmetalation of already prepared Grignard reagents when mixed with MnCl2·2LiCl 
in THF.108 Later, a more practical version of this method using in situ generation of Grignards in the 
 
104 A. Frischmuth, M. Fernández, N. M. Barl, F. Achrainer, H. Zipse, G. Berionni, H. Mayr, K. Karaghiosoff, P. 
Knochel, Angew. Chem. Int. Ed. 2014, 53, 7928. 
105 a) T. Klatt, J. T. Markiewicz, C. Sämann, P. Knochel, J. Org. Chem. 2014, 79, 4253; b) M. Balkenhohl, P. 
Knochel, SynOpen 2018, 2, 78. 
106 F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. - Eur. J. 2009, 15, 
7192. 
107 a) H. Gilman, J. C. Bailie, J. Org. Chem. 1937, 2, 84; b) H. Gilman, R. Kirby, J. Am. Chem. Soc. 1941, 63, 
2046. 
108 G. Friour, G. Cahiez, J. F. Normant, Synthesis 1984, 37. 
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presence of MnCl2·2LiCl has been developed.109 Indeed, the aryl or benzyl halide 125 or 126 underwent 
smooth magnesium insertion and were successfully in situ transmetalated to manganese to furnish 127 
and 128. Subsequent trapping reactions with either an acyl chloride or an aldehyde could be performed, 
yielding the desired products 129 and 130 (Scheme 29).109 
 
Scheme 29: Direct insertion of magnesium into aryl and benzyl halides in the presence of MnCl2·2LiCl. 
2.5 Transition-Metal-Catalyzed Cross-Coupling Reactions of Organomanganese Reagents 
Transition-metal-catalyzed cross-couplings are of great interest and play an important role for 
organometallic chemistry.110 Many metals have been applied to such transformations and a variety of 
catalysts have been developed. So far, Kumada-Corriu (organomagnesium),111 Negishi (organozinc),29 
Stille (organotin),112 and Suzuki-Miyaura (organoboron)113 cross-couplings are well established and 
found numerous applications. In 2013, Feringa described a Pd-catalyzed cross-coupling of 
organolithium reagents in toluene.114 Regarding organomanganese reagents, the first palladium-
catalyzed cross-coupling reaction with aryl halides and triflates was performed by Cahiez and co-
workers in 1997. As an exemple, the functionalized arylmanganese chloride 131 underwent a fast 
coupling with ethyl 4-bromobenzoate in the presence of Pd(PPh3)2Cl2, leading to the unsymmetrical 
biaryl 132 in 91% yield (Scheme 30).115 
 
109 a) Z. Peng, N. Li, X. Sun, F. Wang, L. Xu, C. Jiang, L. Song, Z.-F. Yan, Org. Biomol. Chem. 2014, 12, 7800; 
b) P. Quinio, A. D. Benischke, A. Moyeux, G. Cahiez, P. Knochel, Synlett 2015, 26, 514.   
110 a) Metal-Catalyzed Cross-Coupling Reactions (Eds.: F. Diederich, P. J. Stang), Wiley-VCH, Weinheim, 1998; 
b) Metal-Catalyzed Cross-Coupling Reactions and More (Eds.: A. de Meijere, S. Bräse, M. Oestreich), Wiley-
VCH, Weinheim, 2014.   
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Wangelin, Chem. Soc. Rev. 2011, 40, 4948. 
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113 a) N. Miyaura, K. Yamada, A. Suzuki, Tetrahedron Lett. 1979, 20, 3437; b) A. Suzuki, Angew. Chem. Int. Ed. 
2011, 50, 6722.   
114 M. Giannerini, M. Fananás-Mastral, B. L. Feringa, Nat. Chem. 2013, 5, 667. 
115 E. Riguet, M. Alami, G. Cahiez, Tetrahedron Lett. 1997, 38, 4397. 
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Scheme 30: Pd-catalyzed cross-coupling of arylmanganese chlorides and aryl halides or triflates. 
Besides palladium, nickel catalysts are considered to be powerful and cheap alternatives. In 2006, 
Schneider reported a catalytic system involving Ni(acac)2 and a NHC ligand, which allowed couplings 
of arylmanganese chlorides with aryl halides.116 In 2012, Wang et al. developed a nickel-catalyzed 
cross-coupling procedure of arene- or heteroarenecarbonitriles with aryl- and heteroarylmanganese 
reagents.117 In 2017 was reported a nickel-catalyzed cross-coupling of functionalized benzyl- and 
arylmanganese reagents with aryl- and heteroaryl halides promoted by 4-fluorostyrene. For instance, 3-
methoxybenzylmanganese chloride (133) underwent a cross-coupling with 2-chloronicotinonitrile in 
the presence of Ni(acac)2 and 4-fluorostyrene in THF to yield within 30 min the corresponding product 
134 (Scheme 31). 
 
Scheme 31: Ni-catalyzed cross-coupling of benzyl- and arylmanganese chlorides with (hetero)aryl 
halides promoted by 4-fluorostyrene. 
In addition, several cross-coupling methodologies of organomanganese reagents involving iron,118 
copper119 or cobalt120 catalysts have been studied. Since it allows to replace palladium or nickel catalysts 
with inexpensive and non-toxic iron salts, iron-catalyzed cross-couplings are really crucial in a 
perspective of an always greener chemistry. For that matter, since recently, many extensive studies were 
carried out on the catalytic activity of iron catalysts and their application in organometallic chemistry.121 
 
116 A. Leleu, Y. Fort, R. Schneider, Adv. Synth. Catal. 2006, 348, 1086. 
117 N. Liu, Z.-X. Wang, Adv. Synth. Catal. 2012, 354, 1641. 
118 a) G. Cahiez, S. Marquais, Tetrahedron Lett. 1996, 37, 1773; b) G. Cahiez, S. Marquais, Pure Appl. Chem. 
1996, 68, 53; c) M. S. Hofmayer, J. M. Hammann, G. Cahiez, P. Knochel, Synlett 2018, 29, 65; d) A. D. Benischke, 
A. J. A. Breuillac, A. Moyeux, G. Cahiez, P. Knochel, Synlett 2016, 27, 471. 
119 a) J. G. Donkervoort, J. L. Vicario, J. T. B. H. Jastrzebski, R. A. Gossage, G. Cahiez, G. van Koten, Recl. Trav. 
Chim. Pays-Bas Belg. 1996, 115, 547; b) J. G. Donkervoort, J. L. Vicario, J. T. B. H. Jastrzebski, R. A. Gossage, 
G. Cahiez, G. van Koten, J. Organomet. Chem. 1998, 558, 61.   
120 M. S. Hofmayer, J. M. Hammann, D. Haas, P. Knochel, Org. Lett. 2016, 18, 6456.   
121 a) C. Bolm, J. Legros, J. Le Paih, L. Zani, Chem. Rev. 2004, 104, 6217; b) B. D. Sherry, A. Fürstner, Acc. 
Chem. Res. 2008, 41, 1500; c) W. M. Czaplik, M. Mayer, J. Cvengros, A. J. von Wangelin, ChemSusChem 2009, 
2, 396. 
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3 Objectives 
Based on previous results on halogen/magnesium exchange in apolar solvents, the aim of the first 
project was the development of a method for the regioselective bromine/magnesium exchange on 
polyhalogenated (hetero)arenes in toluene using lithium alkoxide complexed alkyl magnesium reagents. 
It was anticipated that due to the lack of coordination of the magnesium species in toluene, these 
exchange reagents would display unprecedented regioselectivities. The resulting halogenated 
(hetero)aryl magnesium species should then give access to new building blocks for the functionalization 
of (hetero)aromatic compounds of interest in an industrial friendly solvent (Scheme 32). 
 
Scheme 32: Regioselective bromine/magnesium exchange on polyhalogenated (hetero)arenes using 
lithium alkoxide complexed alkylmagnesium reagents. 
In addition, it was also envisioned for this thesis to design a complementary halogen/magnesium 
exchange reagent in toluene that would not require the use of any lithium alkoxides nor magnesiates.122 
This kind of milder reagent allowed a greater functional group tolerance compared with the powerful 
halogen/magnesium exchange reagents that were previously reported in toluene (Scheme 33). 
 
Scheme 33: a) Preparation of new magnesium exchange reagents in toluene. b) Halogen/magnesium 
exchange on sensitive (hetero)aryl halides in toluene. 
Another objective was the development of a halogen/zinc exchange reaction using lithium alkoxide 
complexed dialkyl or diarylzinc reagents.123 It was anticipated that these reagents are suitable for the 
preparation of organometallic species in toluene. Since zinc organometallics are very mild compared to 
 
122 This project was developed in cooperation with Dr. F. Danton. 
123 This project was developed in cooperation with Dr. D. S. Ziegler and Dr. M. Balkenhohl, see: M. Balkenhohl, 
Dissertation, 2019, LMU München. 
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organomagnesium species, sensitive functional groups such as ketones or aldehydes were tolerated by 
these novel exchange reagents (Scheme 34). 
 
Scheme 34: The halogen/zinc exchange reaction using lithium alkoxide complexed dialkyl or diarylzinc 
reagents. 
With analogy to the first topic of this thesis, we aimed at performing regioselective I/Zn exchanges on 
polyiodinated hetero(arenes). The advantage of using Zn instead of Mg laid in the fact that organozincs 
can tolerate more functional groups than Grignard reagents, allowing us to prepare functionalized 
(hetero)aryl iodides bearing more sensitive functions (Scheme 35).124 
 
Scheme 35: Regioselective iodine/zinc exchange on polyiodinated (hetero)arenes using lithium 
alkoxide complexed arylzinc reagents. 
A further topic of interest for this thesis involved the preparation of functionalized benzylic manganese 
reagents from the corresponding benzylic chlorides, which underwent novel Fe-catalyzed cross-
coupling reactions with alkenyl halides and triflates, leading to polyfunctionalized alkenes while 
promoting greener chemistry (Scheme 36).  
 
Scheme 36: Preparation of benzylic manganese reagents followed by iron-catalyzed cross-couplings 
with alkenyl halides and triflates. 
 
124 This project was developed in cooperation with F. Sanchez under the guidance of A. Desaintjean. 
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The last study of this thesis was meant to develop a new one-pot preparation method of functionalized 
bis-(aryl)manganese reagents from the corresponding aryl bromides, followed by an iron-catalyzed 
cross-coupling with various alkenyl halides (Scheme 37). 
 
Scheme 37: One-pot preparation of bis-(aryl)manganese reagents by in situ transmetalation, followed 
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1 Regioselective Bromine/Magnesium Exchange for the Selective 
Functionalization of Polyhalogenated Arenes and Heterocycles 
1.1 Introduction 
Functionalized halogenated arenes and heteroarenes constitute key tools for building pharmaceuticals, 
materials and natural products.8,125 A few metal-mediated methods such as regioselective zinc insertion 
in the presence of LiCl on dihalogenated (hetero)arenes30 have been developed to access these valuable 
molecules.126 Although being one of the most powerful approaches to functionalize haloarenes, 
halogen/magnesium exchange has shown limited success for this type of substrates in terms of 
versatility and regioselective tunability. Some exceptions include the use of the turbo-Grignard,55a,127 
which can trigger selective Br/Mg exchanges in THF.56,128 Bulkier variations of iPrMgCl·LiCl 
containing mesityl or 2,4,6-triisopropylphenyl substituents have displayed improved 
regioselectivities.67,68 It was recently shown by Knochel et al. that mixed-metal compositions 
sBuMgOR·LiOR (134a) and to a greater extent the stoichiometric variant sBu2Mg·2LiOR (R = 2-
ethylhexyl, 134b) can promote Br/Mg and in a few cases Cl/Mg exchanges in toluene or other non-
polar solvents with an excellent substrate scope at room temperature.71 Expanding further the synthetic 
utility  of these alkyl/alkoxide s-block metal combinations, herein, we report fast and highly 
regioselective Br/Mg exchanges on various dibromo(hetero)arenes using 134b in the industrially 
friendly solvent toluene. In addition, the use of Lewis donors such as PMDTA activates in some cases 
a regioselectivity switch. 
1.2 Optimization and Scope of the Regioselective Br/Mg Exchange on Polybrominated Arenes 
and Heteroarenes 
We commenced our studies evaluationg the regioselectivity of the Br/Mg exchange on 2,4-
dibromoanisole (135a) with several mixed Li/Mg combinations (Table 1). We first treated 135a with 
the turbo-Grignard in THF at 25 °C and obtained within 2 h an 85:15 ratio of the two regioisomeric 
Grignard species 136a and 137a respectively (87% conversion, entry 1). The preferential formation of 
 
125 a) D. G. Brown, J. Boström, J. Med. Chem. 2016, 59, 4443; b) J. H. Koo, H. D. Maynard, Chem. Soc. Rev. 
2018, 47, 8998. 
126 a) I. J. S. Fairlamb, Chem. Soc. Rev. 2007, 36, 1036; b) Y. Garcia, F. Schoenebeck, C. Y. Legault, C. A. Merlic, 
K. N. Houk, J. Am. Chem. Soc. 2009, 131, 6632; c) C. J. Diehl, T. Scattolin, U. Englert, F. Schoenebeck, Angew. 
Chem. Int. Ed. 2019, 58, 211; d) T. Bach, M. Bartels, Synlett 2001, 1284. 
127 a) A. Murso, P. Rittmeyer, Spec. Chem. Mag. 2006, 26, 40; b) C. Schnegelsberg, S. Bachmann, M. Kolter, T. 
Auth, M. John, D. Stalke, K. Koszinowski, Chem. Eur. J. 2016, 22, 7752. 
128 a) S. Gross, S. Heuser, C. Ammer, G. Heckmann, T. Bach, Synthesis 2011, 199; b) C. Stock, F. Höfer, T. Bach, 
Synlett 2005, 511. 
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136a may be rationalized by assuming a coordination of the exchange reagent to the neighboring 
methoxy substituent, reminiscent of the CIPE in aromatic ortho-lithiations.101 
Table 1: Screening of the regioselective Br/Mg exchange on 2,4-dibromoanisole (135a). 
 
Entry Exchange reagent[d] Solvent Time (min) Ratio 136a:137a Conv. [%][e] 
1 iPrMgCl·LiCl THF 120 85:15 87[a] 
2 sBuMgOR·LiOR (134a) toluene 30 99:1 75[b] 
3 sBu2Mg·2LiOR (134b) toluene 5 99:1 99[c] 
[a] Y = Cl·LiCl. [b] Y = OR·LiOR. [c] Y = anisyl·2LiOR. [d] R = 2-ethylhexyl, these reactions were carried 
out at 0.50  using 1.20 equiv of alkylmagnesium species. Reagents are displayed accordingly to their 
stoichiometry and not their actual structure. [e] Conversion determined by GC-analysis of reaction aliquots 
after aqueous quench. 
In an attempt to maximize coordination effects between the substrate and the exchange reagent to 
improve the regioselectivity, ethereal THF was replaced by non-polar toluene129 and sBuMgOR·LiOR 
(R = 2-ethylhexyl, 134a) was used as exchange reagent. Thus, treatment of 135a with 134a generated 
the 2-anisylmagnesium species 136a solely (136a:137a = 99:1) within 30 min of reaction, however 
with a lower conversion than with iPrMgCl·LiCl (75%, entry 2). To our delight, the more activated 
reagent sBu2Mg·2LiOR (134b, 0.60 equiv), which was readily prepared by mixing sBuLi (2.00 equiv) 
with Mg(OR)2,71 completed the magnesiation of 135a after just 5 min affording 136a (99% conversion, 
136a:137a = 99:1, entry 3). 
Different sets of substrates and electrophiles were investigated next. Thus, Cu-catalyzed allylation130 of 
136a furmished 138a in 72% yield (Scheme 38). Similarly, electron-rich 2-bromoaryl ethers 135b–
135d underwent complete Br/Mg exchange at C(2) position upon treatment with 134b (25 °C, 5 min). 
The corresponding diarylmagnesium (136b–136d) were smoothly thiomethylated with MeSO2SMe, 
acylated with N-methoxy-N-methylacetamide or allylated with methallyl bromide, producing the 
bromoaryl ethers 138b–138d in 64–87% yield. Analogously, 3,5-dibromo-2-methoxypyridine (135e) 
was regioselectively converted into the ortho-methalated compound 136e. After allylation with 
 
129 Regioselective lithiation in non-polar solvents: a) P. C. Gros, F. Elaachbouni, Chem. Commun. 2008, 4813; b) 
A. Doudouh, C. Woltermann, P. C. Gros, J. Org. Chem. 2007, 72, 4978; c) W. E. Parham, R. M. Piccirilli, J. Org. 
Chem. 1977, 42, 257. 
130 P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2390. 
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methallyl bromide, addition to a ketone, or transmetalation with ZnCl2,131 followed by Pd-catalyzed 
Negishi cross-coupling with 4-iodobenzonitrile,132 the functionalized bromopyridines 138ea–138ec 
were isolated in 53–81% yield. In addition, 2-bromopyridines (135f–135g) led to the corresponding 2-
magnesiated pyridines (136f–136g), which gave after thiomethylation or acylation with a Weinreb 
amide133 the products 138f–138g in 60–66% yield. 
 
Scheme 38: Reaction of various polybrominated (hetero)aromatics with sBu2Mg·2LiOR (134b), 
followed by electrophilic functionalization. 
 
131 A. Metzger, F. M. Piller, P. Knochel, Chem. Commun. 2008, 5824. 
132 E. Negishi, Z. Huang, G. Wang, S. Mohan, C. Wang, H. Hattori, Acc. Chem. Res. 2008, 41, 1474. 
133 S. M. Weinreb, S. Nahm, Tetrahedron Lett. 1981, 22, 3815. 
B. RESULTS AND DISCUSSION    34 
As an application, we have prepared the xanthone 138ab, a precursor of a type II dehydroquinase 
inhibitor (antibacterial properties).134 Thus, the selective magnesiation of 135a followed by a Cu-
catalyzed acylation with 2-fluorobenzoyl chloride produced the benzophenone 138aa in 75% yield. 
BBr3-deprotection of the methoxy group and mild K2CO3-mediated ring closure furnished the target 
xanthone in 96% yield (Scheme 38).135 
We next got interested in 2,5-dibromo-3-methylthiophene (139a), for which the exchange reagent 134b 
did not provide satisfactory regioselectivity (99% conversion, 140a:141a = 90:10, Scheme 39). Since 
previous works have shown that, used as additives, Lewis donors68,129 can enhance regioselectivities in 
halogen/metal exchange processes, we next probed the effect of adding TMEDA136 or PMDTA (0.60 
equiv) to 134b, which led to the formation of 140a with a better control of regioselectivity (96:4, 99% 
conversion for TMEDA, and 99:1, 99% conversion for PMDTA). 
 
Scheme 39: Screening of the regioselective Br/Mg exchange on 2,5-dibromo-3-methylthiophene 
(139a). 
Trapping of 140a with 3-methoxybenzaldehyde afforded the alcohol 142a in 80% yield (Scheme 40). 
 
Scheme 40: Reaction of various polybrominated (hetero)aromatics with sBu2Mg·2LiOR in the 
presence of PMDTA (134b·PMDTA), followed by electrophilic functionalization. 
 
134 a) P. J. Ballester, M. Mangold, N. I. Howard, R. L. Marchese Robinson, C. Abell, J. Blumberger, J. B. O. 
Mitchell, J. R. Soc. Interface 2012, 9, 3196; b) D. A. Robinson, K. A. Stewart, N. C. Price, P. A. Chalk, J. R. 
Coggins, A. J. Lapthorn, J. Med. Chem. 2006, 49, 1282. 
135 C. Zhou, R. C. Larock, J. Org. Chem. 2006, 71, 3551. 
136 F. M. Perna, A. Salomone, M. Dammacco, S. Florio, V. Capriati, Chem. Eur. J. 2011, 17, 8216. 
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This donor effect was quite general and the same procedure was extended to other polyhalogenated 
(hetero)arenes. Thus, 140b–140d underwent complete Br/Mg exchange upon treatment with 
134b·PMDTA, leading to the less sterically hindered Grignard species. After allylation or addition to 
Michler’s ketone, the polyfunctionalized products 142b–142d were isolated in 61–83% yield. 
1.3 Tunable Regioselectivity of the Br/Mg Exchange on Dibrominated Pyridines and Quinolines 
Interestingly, investigating the reactivity of 134b towards 2,5-dibromopyridine (143a)129 established 
that the regioselectivity of the Br/Mg exchange can be finely tuned, changing from C(2) to C(5) in the 
presence of a Lewis donor such PMDTA (Table 2). 
Table 2: Br/Mg exchange on 2,5-dibromopyridine (143a) using various exchange reagents. 
 
Entry Exchange reagent[c] Solvent Time (min) Ratio 144a:145a Conv. [%][d] 
1 iPrMgCl·LiCl THF 120 99:1 94[a] 
2 sBu2Mg·2LiOR (134b) toluene 30 1:99 99[b] 
3 134b·PMDTA toluene 30 99:1 99[b] 
[a] Y = Cl·LiCl. [b] Y =pyridyl·2LiOR(·PMDTA). [c] R = 2-ethylhexyl, these reactions were carried out 
at 0.50  using 1.20 equiv of alkylmagnesium species. Reagents are displayed accordingly to their 
stoichiometry and not their actual structure. [d] Conversion determined by GC-analysis of reaction aliquots 
after aqueous quench. 
Thus, 143a underwent selective Br/Mg exchange with turbo-Grignard iPrMgCl·LiCl at C(5) position 
to give the thermodynamically more favored product 144a (entry 1). Alternatively, using 
sBu2Mg·2LiOR (134b) in neat toluene furnished the kinetic C(2)-magnesiation product 145a (entry 2).  
While this regioselectivity is unprecedented for Br/Mg exchanges,137 previous studies using 
organolithium reagents have shown that the C(2)-lithiation product isomerizes quickly to the more 
stable C(5)-lithiated species.129 Furthermore this unusual regioselectivity can be switched to C(5)-
magnesiation by adding PMDTA (0.60 equiv) to 134b (entry 3). Conditions A and B described 
 
137 Song has reported C(2)-functionalization of 143a, by replacing the Br at the C(2) position by I, followed by an 
I/Mg exchange step using iPrMgCl: J. J. Song, N. K. Yee, Z. Tan, J. Xu, S. R. Kapadia, C. H. Senanayake, Org. 
Lett. 2004, 6, 4905. 
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respectively in entries 3 and 2 of Table 2 were then applied to various dibromo-pyridines and -
quinolines (Scheme 41). 
 
Scheme 41: Reaction of various dibrominated heteroaromatics with sBu2Mg·2LiOR·PMDTA 
(134b·PMDTA, Conditions A) or 134b alone (Conditions B), followed by electrophilic quench. 
Thus, following Conditions A (134b·PMDTA, 0.60 equiv, toluene, –20 °C, 30 min), 143a was 
regioselectively converted into 144a which was trapped with 3-bromocyclohexene, affording the C(5)-
allylated product 146a in 72% yield. Using Conditions B (134b, 0.60 equiv, toluene, –20 °C, 30 min), 
143a was regioselectively converted into 145a, which was quenched with benzaldehyde, leading to the 
alcohol 147a in 74% yield. Analogously, the methyl-substituted pyridines 143b–143d produced either 
using Conditions A or B the expected regioisomeric pyridylmagnesium derivatives which were trapped 
by allylation, thioalkylation or acylation, affording 146b–146d and 147b–147d in 52–98% yield. The 
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electron-deficient 2,5-dibromo-4-chloro-3-fluoropyridine (143e) underwent smooth Br/Mg exchange 
under Conditions A or B, forming after addition of allyl bromide the allylated compounds 146e–147e 
in 72–84% yield. This Br/Mg exchange was extended to 2,4-dibromopyridine (143f) and 2,4-
dibromoquinoline (143g). The expected regioisomeric products 146f–146g and 147f–147g were 
isolated after thioalkylation, allylation or addition of dicyclopropyl ketone in 57–78% yield. 
1.4 Competition between Br/Mg and I/Mg exchanges 
Building on these findings we next assessed the reactivities of iPrMgCl·LiCl and nBu2Mg·2LiOR 
(134c) towards 2-bromo-4-iodoanisole (148a, Scheme 42).138 For this substrate, Li-directing effects 
should favor the Br/Mg exchange ortho to the donating OMe group, whereas considering purely the 
activation of the C-halogen bond, functionalization at the C(4) position via I/Mg exchange should be 
preferred. Unsurprisingly, turbo-Grignard in neat THF reacts with the most activated site of 148a, 
undergoing exclusively I/Mg exchange, affording, after allylation, the anisole derivative 149 in 85% 
yield. However, a completely different scenario plays out for 134c in toluene, where coordination 
effects dominate, encouraging reactivity ortho to the directing OMe group and hence triggering a Br/Mg 
exchange with a selectivity of 4:1. Subsequent allylation and chromatographical separation furnished 
150a in 65% yield (Scheme 42). Supporting this interpretation, and demonstrating the importance of 
non-coordinating solvent toluene, addition of polydentate donor PMDTA which can chelate Li, 
switches off this Br/Mg exchange preference, offering an I/Mg exchange only.138 
 
Scheme 42: Selective Br/Mg exchange on 2-bromo-4-iodoanisole (148a) with nBu2Mg·2LiOR (134c) 
followed by allylation reaction: comparison with iPrMgCl·LiCl. 
Finally, replacing 2-bromo-4-iodoanisole (148a) with 2-bromo-4-iodo-5-methylanisole (148b) or 2-
bromo-4-iodo-5-isopropylanisole (148c) allowed an improvement of selectivity to 9:1 when using 134c. 
After reaction with dicyclohexyl ketone or N-methoxy-N-methyl-4-(trifluoromethyl)benzamide 
followed by chromatographical separation, the alcohol 150b and ketone 150c could be isolated in 79–
82% yield (Scheme 43). 
 
138 See Experimental Part (p. 95–98) for a complete table of optimization as well as additional results. 
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Scheme 43: Selective Br/Mg exchange on 2-bromo-4-iodo-5-methylanisole (148b) and 2-bromo-4-
iodo-5-isopropylanisole (148c) with nBu2Mg·2LiOR (134c) followed by electrophilic quench.  
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2 Preparation of Functionalized Diorganomagnesium Reagents in Toluene 
via Bromine or Iodine/Magnesium Exchange Reactions 
2.1 Introduction 
Polyfunctionalized organometallic reagents are essential intermediates in modern organic 
chemistry.1b,8,125a,139 Furthermore, organomagnesium reagents are ideal for industrial applications as 
they combine excellent functional group tolerance with high reactivity while being available at 
moderate cost and having moderate toxicity.1c,140 One of the best methods for preparing Grignard 
reagents in ethereal solvents is the halogen/magnesium exchange, which has been well-established since 
the development of iPrMgCl·LiCl (turbo-Grignard; Scheme 44a).55a-b,127b  
 
Scheme 44: Current halogen/magnesium exchange reagents, preparation and use of sBu2Mg (151a) in 
apolar solvents. 
 
139 a) R. H. V. Nishimura, N. Weidmann, P. Knochel, Synthesis 2020, 52, 3036; b) C. P. Tüllmann, S. Steiner, P. 
Knochel, Synthesis 2020, 52, 2357; c) J. Skotnitzki, A. Kremsmair, B. Kicin, R. Saeb, V. Ruf, P. Knochel, 
Synthesis 2020, 52, 873; d) J. Skotnitzki, A. Kremsmair, P. Knochel, Synthesis 2020, 52, 189; e) N. Weidmann, 
R. H. V. Nishimura, J. H. Harenberg, P. Knochel, Synthesis 2021, 53, 557; f) A. Kremsmair, S. Graßl, C. J. B. 
Seifert, E. Godineau, P. Knochel, Synthesis 2021, ahead of print,  10.1055/a-1534-0624. 
140 A. Kremsmair, J. H. Harenberg, K. Schwärzer, A. Hess, P. Knochel, Chem. Sci. 2021, 12, 6011. 
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Recently, we have reported a halogen/magnesium exchange in apolar solvents using new reagents of 
the type sBuMgOR·LiOR (134a, R = 2-ethylhexyl) and sBu2Mg·2LiOR (134b; Scheme 44b).71,141,142  
The use of toluene or related hydrocarbon solvents was attractive for industrial applications and 
deserved further investigation.143 
Herein, we now report new I/Mg- and Br/Mg-exchange reactions on various (hetero)aryl halides in 
apolar solvents using sBu2Mg (151a),144 which was readily prepared by reaction of sBuMgCl in diethyl 
ether with sBuLi (1.00 equiv) in cyclohexane at 25 °C (2 h). After a solvent switch to toluene and 
filtration, sBu2Mg was obtained in 96% yield as a 0.43–0.48  solution in toluene (Scheme 44c).145 
This method was successfully extended to alkenyl iodides to provide dialkenylmagnesium species in 
toluene that reacted well with various electrophiles. 
2.2 Optimization and Scope of the I/Mg Exchange on Aryl and Heteroaryl Iodides 
First, we investigated the I/Mg exchange on 2-iodobenzonitrile (152a) in toluene using various 
exchange reagents (Table 3). 
Table 3: Optimization of the I/Mg exchange on 2-iodobenzonitrile (152a), leading to magnesium 
reagents of type 153. 
 
Entry Exchange reagent (equiv)[a] Yield [%][b] 
1 sBuMgOR·LiOR (134a, 1.20 equiv) 42 
2 sBu2Mg·2LiOR (134b, 0.60 equiv) 61 
3 sBu2Mg (151a, 0.60 equiv) 98 
[a] R = 2-ethylhexyl, these reactions were carried out at a concentration of 0.50 . All reagents were 
displayed accordingly to their stoichiometry and not their actual structure. [b] Calibrated yields determined 
by GC-analysis of reaction aliquots after Cu-catalyzed allylation. 
 
141 a) D. S. Ziegler, B. Wei, P. Knochel, Chem. Eur. J. 2019, 25, 2695; b) A. Desaintjean, T. Haupt, L. J. Bole, N. 
R. Judge, E. Hevia, P. Knochel, Angew. Chem. Int. Ed. 2021, 60, 1513; c) L. J. Bole, N. R. Judge, E. Hevia, 
Angew. Chem. Int. Ed. 2021, 60, 7626. 
142 For a related halogen/zinc exchange, see: M. Balkenhohl, D. S. Ziegler, A. Desaintjean, L. J. Bole, A. R. 
Kennedy, E. Hevia, P. Knochel, Angew. Chem. Int. Ed. 2019, 58, 12898. 
143 a) Solvent Recovery Handbook (Ed.: I. M. Smallwood), Blackwell Science Ltd., Oxford, 2002; b) L. Delhaye, 
A. Ceccato, P. Jacobs, C. Köttgen, A. Merschaert, Org. Process Res. Dev. 2007, 11, 160. 
144 This reagent still contained 0.50 equiv of Et2O, having the formula sBu2Mg·0.5Et2O (determined by 1H-NMR 
analysis) that we abbreviated sBu2Mg for the sake of clarity: A. Hess, J. P. Prohaska, S. B. Doerrich, F. Trauner, 
F. H. Lutter, S. Lemaire, S. Wagschal, K. Karaghiosoff, P. Knochel, Chem. Sci. 2021, 12, 8424. 
145 The same reactivity was observed after 5 days of storage of the sBu2Mg toluene solution at –20 °C. 
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We treated 152a with sBuMgOR·LiOR (R = 2-ethylhexyl, 134a)71,141 in toluene at −78 °C for 10 min, 
which led to the organomagnesium species 153a (Y = OR·LiOR) in 42% yield (Table 3, entry 1). In an 
attempt to improve the yield of this exchange reaction, 134a was replaced with sBu2Mg·2LiOR 
(134b).71,141 Thus, treatment of 152a with 134b at −78 °C led after 10 min to the magnesium reagent 
153a (Y = aryl·2LiOR) in 61% yield (Table 3, entry 2). However, using sBu2Mg (151a, 0.60 equiv), 
the magnesiation of 152a was complete after 10 min at −78 °C, affording 153a (Y = aryl) in 98% yield 
(Table 3, entry 3). 
Subsequently, after Cu(I)-catalyzed allylation130 of 153a with 3-bromocyclohexene and ethyl 2-
(bromomethyl)acrylate, transmetalation with ZnCl2131 followed by Pd-catalyzed Negishi cross-coupling 
with 4-iodoanisole,132 or addition to a ketone, the functionalized benzonitriles 154aa–154ad were 
isolated in 55–98% yield (Table 4, entries 1–4). Similarly, the iodobenzonitrile derivatives 152b–152d 
underwent a complete I/Mg exchange upon treatment with 151a (−78 °C, 10 min). The corresponding 
diarylmagnesium reagent (153b–153d) underwent Pd-catalyzed cross-couplings with ethyl 4-
iodobenzoate, or a Cu-mediated acylation with 4-chlorobenzoyl chloride, producing the biaryl 
compounds 154b–154d in 70–76% yield (entries 5–7). Analogously, ethyl 2-iodobenzoate (152e) was 
converted into the corresponding organomagnesium compound 153e, which gave after allylation with 
methallyl bromide the ester 154e in 92% yield (entry 8). Also, the reaction of sBu2Mg (151a, 0.60 
equiv) with the halogenated iodopyridines 152f–152g generated within 15 min the corresponding 
heteroaryl organomagnesium compounds 153f–153g. After acylation or addition to 2-adamantanone, 
the polyfunctionalized heterocycles 154fa–154fb and 154g were obtained in 73–75% yield (entries 9–
11). The diiodoanisole derivatives 152h–152i reacted smoothly with 151a and provided after allylation 
and addition to benzaldehyde the products 154h–154i in 51–53% yield (entries 12–13). Electron-rich 
substrates such as the anisole derivatives 152j–152l and the silyl ether 152m were quantitatively 
converted into the corresponding diorganomagnesium reagents 153j–153m. They reacted with a range 
of electrophiles to afford 154ja–154jb, 154ka–154kc and 154l–154m in 60–94% yield (entries 14–20). 
Interestingly, 2-bromo-4-iodotoluene (152n) underwent selective I/Mg exchange to provide, after 
reaction with a ketone, the alcohol 154n in 53% yield (entry 21). In addition, aryl polyiodides (152o–
152q) led to the corresponding mono-magnesiated aryl iodides 153o–153q when the exchange was 
performed in the presence of DMPU (N,N′-dimethylpropyleneurea, 1.00 equiv),146 which furnished after 
allylation, addition to benzaldehyde derivatives or to ethyl cyanoformate the products 154oa–154ob, 
154pa–154pb, and 154q in 45–73% yield (entries 22–26). An extension of this method was possible 
by switching from sBu2Mg (151a) to Mes2Mg (151b, Mes = mesityl) in the case of particularly sensitive 
 
146 When used in association with R2Mg (151a, R = sBu; 151b, R = Mes), DMPU increases the exchange rate, 
thus improving conversions and diminishing side reactions: a) T. Mukhopadhyay, D. Seebach, Helv. Chim. Acta 
1982, 65, 385; b) A. D. Benischke, G. Le Corre, P. Knochel, Chem. Eur. J. 2017, 23, 778; c) M. Bengtsson, T. 
Liljefors, Synthesis 1988, 250; d) E. Riguet, I. Klement, C. K. Reddy, G. Cahiez, P. Knochel, Tetrahedron Lett. 
1996, 37, 5865; e) M. Ellwart, I. S. Makarov, F. Achrainer, H. Zipse, P. Knochel, Angew. Chem. Int. Ed. 2016, 
55, 10502. 
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aryl iodides.147 This exchange reagent was prepared analogously to sBu2Mg (151a). Thus, mixing the 
aryl iodide bearing a triazine moiety (152r) with 151b in the presence of DMPU (1.00–4.00 equiv)146 
afforded after allylation with allyl bromide the arene 154r in 79% yield (entry 27). Under similar 
conditions, the diarylmagnesium species generated from 2-iodo-nitrobenzene derivatives 152s–152t 
were allylated, providing the nitro-substituted compounds 154s–154t in 60–71% yield (entries 28–29). 
Table 4: Reaction of various aryl iodides with R2Mg (151a, R = sBu; 151b, R = Mes), followed by 
electrophilic functionalization.148  
 
Entry Magnesium reagent (°C, min) 
Electrophile[a] 
(0.80–1.20 equiv) 
Product, yield [%][b] 
1  
153a (–78, 10)   154aa: 98 




3 153a (–78, 10) 
  154ac: 73 




153b (–78, 10)   
154b: 72 
6  
153c (–78, 10)   
154c: 70 
 
147 Arylmetal reagents tolerate more functional groups than their alkyl counterparts: A. D. Benischke, L. Anthore-
Dalion, F. Kohl, P. Knochel, Chem. Eur. J. 2018, 24, 11103. 
148 The synthesis of all starting materials as well as the corresponding literature were depicted in the Experimental 
Part (p. 127–134). 
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7  
153d (–78, 10)   154d: 76 
8  





153f (–78, 15)   
154fa: 73 



















153j (25, 30)   154ja: 78 
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16[c]  
153k (25, 30)   154ka: 88 




18[c] 153k (25, 30) 
  154kc: 94 
19[c]  
153l (25, 30)   154l: 75 
20[c]  
153m (25, 30)   154m: 65 
21[c]  
153n (25, 30)   154n: 53 
22[d]  
153o (–20, 60)  
 
154oa: 65 





153p (–20, 60) 
  154pa: 45 
25[d] 153p (–20, 60) 
  154pb: 64 
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26[d] 
 
153q (–20, 60) 
  154q: 66 
27[e] 
 




153s (–50, 60)   154s: 71 
29[e]  
153t (–70, 60)  
 
154t: 60 
[a] See Experimental Part (p. 135–154) for detailed electrophilic trappings. [b] Isolated yield of 
analytically pure product. [c] THF (1.20 equiv) was used. [d] DMPU (1.00 equiv) was used. [e] 
Mes2Mg (0.60 equiv) in the presence of DMPU (1.00–4.00 equiv) were used. 
 
2.3 Optimization and Scope of the Br/Mg Exchange on Aryl and Heteroaryl Bromides 
We next turned our attention to (hetero)aryl bromides (Table 5). Thus, the bromobenzonitrile 
derivatives 155a–155e underwent smooth Br/Mg exchanges with sBu2Mg in the presence of DMPU 
(1.00 equiv)146 within 2 h at −20 °C, generating the diarylmagnesium reagents 156a–156e. After 
allylation, addition to benzaldehyde or transmetalation with ZnCl2 followed by Pd-catalyzed Negishi 
cross-coupling with 4-iodoanisole, the corresponding products (157a–157e) were obtained in 55–98% 
yield (entries 1–5). Under similar conditions, the dibromofuran 155f led within 90 min at −20 °C to the 
di(bromofuryl)magnesium species 156f, which furnished, after allylation with methallyl bromide, the 
alkylated furan 157f in 51% yield (entry 6). More electron-poor thiophenes 155g–155i reacted 
quantitatively with 151a solely, providing the magnesiated thiophenes 156g–156i. After acylation or 
cross-coupling with 4-iodoanisole, the functionalized thiophenes 157g–157i were isolated in 63–91% 
yield (entries 7–9). Analogously, the bromoquinolines 155j–155k and bromoisoquinoline 155l 
underwent complete Br/Mg exchange upon treatment with 151a (25 °C, 60 min). The corresponding 
diheteroarylmagnesium compound (156j–156l) were smoothly engaged in a Pd-catalyzed cross-
coupling with (E)-1-iodooct-1-ene or a Cu-catalyzed allylation with 3-bromocyclohexene, producing 
the functionalized (iso)quinolines 157ja–157jb and 157k–157l in 70–79% yield (entries 10–13). 
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Table 5: Reaction of various aryl- and heteroaryl- bromides with sBu2Mg (151a), followed by trapping 







Product, yield [%][b] 
1[c] 
 












156d (–20, 120)   157d: 55 
5[c] 
 




156f (–20, 90)   157f: 51 
7  
156g (–20, 45)   157g: 91 
8  
156h (–20, 45)   157h: 63 
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9  




156j (25, 60)  
 
157ja: 78 















[a] See Experimental Part (p. 154–163) for detailed electrophilic trappings. [b] Isolated yield of 
analytically pure product. [c] DMPU (1.00 equiv) was used. [d] A 97:3 ratio of the regioisomers 
was obtained. 
 
2.4 Optimization and Scope of the I/Mg Exchange on Alkenyl Iodides 
We further studied the reactivity of the exchange reagents with alkenyl iodides in toluene (Table 6). 
First, we treated (E)-1-iodooct-1-ene (158a) with the previously described sBuMgOR·LiOR (R = 2-
ethylhexyl, 134a) and sBu2Mg·2LiOR (134b) in toluene at 0 °C for 60 min, which both led to a total 
decomposition of 158a (entries 1–2). In an attempt to achieve a full exchange reaction, we mixed 158a 
with 151a under various conditions. Thus, treatment of 158a with 151a at 0 °C led after 60 min to 159a 
(Y = alkenyl) in 6% yield (entry 3). However, using sBu2Mg (151a, 0.60 equiv) in the presence of 
DMPU (1.00 equiv)146 led to a complete magnesiation of 158a after 60 min at 0 °C, affording 159a (Y 
= alkenyl) in 99% yield (entry 4). 
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Table 6: Screening of the I/Mg exchange on (E)-1-iodooct-1-ene (158a). 
 
Entry Exchange reagent (equiv)[a] Yield [%][b] 
1 sBuMgOR·LiOR (134a, 1.20 equiv) 0 
2 sBu2Mg·2LiOR (134b, 0.60 equiv) 0 
3 sBu2Mg (151a, 0.60 equiv) 6 
4 sBu2Mg (151a, 0.60 equiv) + DMPU (1.00 equiv) 99 
[a] R = 2-ethylhexyl, these reactions were carried out at a concentration of 0.50 . All reagents were 
displayed accordingly to their stoichiometry and not their actual structure. [b] Calibrated yields determined 
by GC-analysis of reaction aliquots quenched with water. 0% yield indicates that full decomposition was 
observed. 
The newly formed dialkenylmagnesium reagent 159a smoothly reacted in toluene with ethyl 2-
(bromomethyl)acrylate in the presence of copper to provide the allylated (E)-alkene 160a in 82% yield 
(Scheme 45). 
 
Scheme 45: Reaction of various alkenyl iodides with sBu2Mg (151a) in the presence of DMPU, 
followed by electrophilic functionalization.148 
The exchange on (Z)-1-iodohept-1-ene (158b) followed by allylation proceeded with retention of the 
configuration, affording the (Z)-alkene 160b in 66% yield and Z/E = 99:1. In addition, the protected 
allylic alcohol 158c underwent retentive I/Mg exchange with 151a within 60 min at 0 °C, providing the 
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(Z)-dialkenyl magnesium species 159c (Z/E = 99:1). On the one hand, when 159c reacted with DMF, 
the unsaturated aldehyde was fully isomerized to its (E)-isomer, providing 160ca in 53% yield. On the 
other hand, an allylation with allyl bromide generated the Z-alkene 160cb in 73% yield. Finally, the 
(Z)-alkene 158d and E-alkene 158e furnished after thioalkylation the corresponding alkenes 160d and 
160e with retention of configuration in 70–82% yield. 
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3 Preparation of Polyfunctional Arylzinc Organometallics in Toluene via 
Halogen/Zinc Exchange Reactions 
3.1 Introduction 
Organozinc reagents represent key intermediates in organic synthesis as they are mild and they tolerate 
many functional groups. For that reason, they widely participate in transition-metal-catalyzed C-C bond 
forming reactions.149 Especially, (hetero)aryl zinc halides have been readily used for accessing complex 
organic molecules.150 Organozinc compounds can be generated by directed insertion of zinc powder to 
organic halides27b,28a,30,151 but also by directed metalation using TMP-zinc bases.94,96,105 Halogen/zinc 
exchange using lithium organozincates of type R3ZnLi or R4ZnLi2 have also been reported.152 
Moreover, a Li(acac)-catalyzed I/Zn exchange has been performed on (hetero)aryl iodides using 
pyrophoric and light sensitive iPr2Zn in NMP.77a Unfortunately, the corresponding less expensive aryl 
or heteroaryl bromides are not reactive enough to be used as substitutes. The exchange reagent 
iPrMgCl·LiCl (turbo-Grignard) has been extensively used to prepare related organomagnesium species, 
since it allows high reaction rates for the Br/Mg exchange reaction.55a This exchange can be further 
accelerated by using a stronger donor such as a lithium alkoxide (ROLi; R = 2-ethylhexyl) instead of 
LiCl.71 This exchange could even be performed in the industrially friendly solvent toluene. Herein, we 
report a new I/Zn exchange and firstly, a Br/Zn exchange using a bimetallic exchange reagent of type 
sBu2Zn·2LiOR (161), which allows the preparation of a wide range of polyfunctional (hetero)arylzinc 
reagents.123,153 
 
149 a) E. Negishi, Acc. Chem. Res. 1982, 15, 340; b) P. Knochel, R. D. Singer, Chem. Rev. 1993, 93, 2117; c) P. 
Knochel, N. Millot, A. L. Rodriguez, C. E. Tucker, in Preparation and Applications of Functionalized Organozinc 
Compounds. Organic Reactions. Vol. 58, Wiley-VCH, Weinheim, 2004, 417; d) E. Negishi, Angew. Chem. Int. 
Ed. 2011, 50, 6738; e) Metal-Catalyzed Cross-Coupling Reactions, Second Edition (Eds.: A. de Meijere, F. 
Diederich), Wiley-VCH, Weinheim, 2008; f) Y.-H. Chen, M. Ellwart, V. Malakhov, P. Knochel, Synthesis 2017, 
49, 3215. 
150 a) T. J. Greshock, K. P. Moore, R. T. McClain, A. Bellomo, C. K. Chung, S. D. Dreher, P. S. Kutchukian, Z. 
Peng, I. W. Davies, P. Vachal, M. Ellwart, S. M. Manolikakes, P. Knochel, P. G. Nantermet, Angew. Chem. Int. 
Ed. 2016, 55, 13714; b) Y. H. Chen, M. Ellwart, G. Toupalas, Y. Ebe, P. Knochel, Angew. Chem. Int. Ed. 2017, 
56, 4612; c) Y. H. Chen, C. P. Tüllmann, M. Ellwart, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 9236. 
151 a) C. Y. Liu, X. Wang, T. Furuyama, S. Yasuike, A. Muranaka, K. Morokuma, M. Uchiyama, Chem. Eur. J. 
2010, 16, 1780; b) R. D. Rieke, Science 1989, 246, 1260; c) R. D. Rieke, M. V. Hanson, Tetrahedron 1997, 53, 
1925. 
152 a) M. Uchiyama, T. Furuyama, M. Kobayashi, Y. Matsumoto, K. Tanaka, J. Am. Chem. Soc. 2006, 128, 8404; 
b) T. Furuyama, M. Yonehara, S. Arimoto, M. Kobayashi, Y. Matsumoto, M. Uchiyama, Chem. Eur. J. 2008, 14, 
10348; c) L. Melzig, C. R. Diène, C. J. Rohbogner, P. Knochel, Org. Lett. 2011, 13, 3174; d) D. Tilly, F. 
Chevallier, F. Mongin, P. C. Gros, Chem. Rev. 2014, 114, 1207. 
153 The compounds 166d–166g,166j,166q,166s–166u, 169c–169d,169l–169q and 170a–170m were prepared by 
Dr. M. Balkenhohl and Dr. D.S. Ziegler and will be shown for the sake of completeness. See: M. Balkenhohl, 
Dissertation, 2019, LMU München. 
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3.2 Optimization and Scope of the I/Zn Exchange on Aryl and Heteroaryl Iodides 
Thus, we have prepared several zinc alkoxides ROZnEt·ROH of type 162 by treating Et2Zn (25 °C, 2 h) 
with various alcohols (2.00 equiv, 163) in toluene.154 These zinc alkoxides (162) further reacted with 
sBuLi (2.00 equiv, in cyclohexane) within 2 h at 25 °C to generate the bimetallic reagent tentatively 
represented as sBu2Zn·2LiOR (161). Removal of the solvents and further redissolution in toluene 
provided a light-yellow solution of 161 (c = 0.80–1.20 M in toluene; Scheme 46) which can be stored 
at 25 °C over months without significant loss of reactivity. 
 
Scheme 46: Preparation of bimetallic exchange reagents of type 161. 
First, the complex sBu2Zn·2LiOR (R = 2-octyl; 161a) reacted in toluene155  with 3-iodoanisole (164a) 
within 30 min at 25 °C, producing bis-anisylzinc (165a) in 23% yield, as determined by GC-analysis of 
reaction aliquots (Table 7, entry 1). 
Table 7: Optimization of the reaction conditions for the I/Zn exchange using dialkylzinc reagents of 
type 161. 
 
Entry sBu2Zn·2LiOR (161) Time (min) Yield [%][a] 
1  30 23 




4 161c 1 99 
[a] Yield of 165a determined by GC-analysis of reaction aliquots quenched with water. 
 
 
154 a) R. L. Geerts, J. C. Huffman, K. G. Caulton, Inorg. Chem. 1986, 25, 1803; b) S. C. Goel, M. Y. Chiang, W. 
E. Buhro, Inorg. Chem. 1990, 29, 4646; c) K. Merz, S. Block, R. Schoenen, M. Driess, Dalton Trans. 2003, 3365. 
155 A solvent screening showed, that the halogen/zinc exchange can not only be performed in hydrocarbons such 
as toluene or hexane, but also in other industrially friendly ethereal solvents such as 2-methyl-THF or MTBE. 
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The use of alcohols bearing N-coordination sites further improved the I/Zn exchange.70 Indeed, the 
complex 161b (R = -CH2CH2N(Et)2) led to the diarylzinc 165a in 95% yield (entry 2). A great 
improvement was made by using an alcohol bearing a second N-coordination site. Thus, the new reagent 
161c (R = -CH2CH2N(CH3)CH2CH2N(CH3)2) led to the formation of 165a in 99% yield (entry 3). In 
fact, after 1 min reaction time, the I/Zn exchange was already complete (entry 4). The resulting bis-
anisylzinc reagent 165a reacted with allyl bromide in the presence of CuI (20 mol%) to give the 
allylated arene 166a in 67% yield (Scheme 47). Transmetalation of 165a to copper using CuI (0.60 
equiv) followed by addition of 4-chlorobenzoyl chloride provided the acylated anisole 166b in 86% 
yield. 
 
Scheme 47: Reaction of various aryl iodides with sBu2Zn·2LiOR (161c), followed by electrophilic 
functionalization. 
B. RESULTS AND DISCUSSION    53 
When the zinc species 165a was mixed with ethyl 4-iodobenzoate, Pd(OAc)2 (3 mol%), and SPhos (6 
mol%),156 a palladium-catalyzed Negishi cross-coupling157 took place, leading to the biaryl 166c in 76% 
yield. 4-Iodobenzotrifluoride underwent a smooth I/Zn exchange using 161c, leading to the 
corresponding diarylzinc reagent 165b. Reaction of 165b with ethyl 2-(bromomethyl)acrylate or a 
palladium-catalyzed cross-coupling with 4-iodothioanisole gave functionalized arenes 166d–166e in 
48–67% yield (Scheme 47). TBS- or TIPS-protected iodophenols were treated with 161c and the 
resulting zinc organometallic was allylated or acylated, providing 166f–166g in 61–83% yield. The zinc 
reagent obtained from sterically demanding 2-iodo-1,3-dimethylbenzene was quenched with ethyl 2-
(bromomethyl)acrylate and 4-fluorobenzoyl chloride to give the 2-substituted m-xylenes 166h–166i in 
67–80% yield. Various electron-poor aryl iodides bearing ester or nitrile groups readily reacted with 
161c and quenching of the zinc reagent of type 165 with various electrophiles gave products 166j–166p 
in 59–98% yield. Exchange on an aryl iodide bearing a triazine moiety, followed by allylation, gave 
166q in 72% yield. Next, the diaryl zinc species generated from 4-iodobenzophenone was allylated, 
providing ketone 166r in 83% yield. Also, the I/Zn exchange could also be extended to nitro-substituted 
aryl iodides. In this case, pTol2Zn·2LiOR (167) gave the best result.158 Hence, the milder exchange 
reagent pTol2Zn·2LiOR (167, R = -CH2CH2N(CH3)CH2CH2N(CH3)2) was prepared by mixing the 
akoxide 162c with ptolyllithium (2.00 equiv).159 Treatment of 2,4-dinitroiodobenzene or 3-iodo-4-
nitrobenzonitrile with 167 (0.60 equiv) at –15 °C for 15 min, followed by a copper-mediated allylation 
reaction, afforded nitroarenes 166s–166t in 71–79% yield. For converting an iodo-benzaldehyde to the 
corresponding zinc species, a short screening showed, that the best exchange reagent was 
tBu2Zn·2LiOR (168). Thus, the alkoxide 162c was treated with tBuLi (2.00 equiv) and the resulting 
less nucleophilic reagent tBu2Zn·2LiOR (168, R = -CH2CH2N(CH3)CH2CH2N(CH3)2) was obtained as 
a 1.00 M solution in toluene. Reaction of 5-iodo-veratraldehyde with 168 (0.80 equiv, 0 °C, 10 min) 
afforded a diarylzinc organometallic of type 165, which, after allylation, provided the vanillin derivative 
166u in 48% yield (Scheme 47). 
Various aryl- and heteroaryl iodides reacted smoothly with 161c, to give a range of functionalized bis-
arylzinc organometallics. Thus, bis-thienylzinc either reacted with 3-bromocyclohexene or 2-
bromobenzoyl chloride to provide 169a–169b in 61–71% yield (Scheme 48). Benzyl-protected 3-
iodopyrazole reacted with 161c to give, after allylation, 169c in 80% yield. Also, various iodopyridines, 
-pyrimidines and -quinoline were converted into the corresponding zinc reagents using 161c and 
quenched with several acid chlorides and allyl bromides, producing 169d–169l in 72–96% yield. The 
 
156 a) R. A. Altman, S. L. Buchwald, Nat. Protoc. 2007, 2, 3115; b) T. E. Barder, S. D. Walker, J. R. Martinelli, 
S. L. Buchwald, J. Am. Chem. Soc. 2005, 127, 4685. 
157 a) A. O. King, N. Okukado, E. Negishi, J. Chem. Soc., Chem. Commun. 1977, 683; b) D. Haas, J. M. 
Hammann, R. Greiner, P. Knochel, ACS Catal. 2016, 6, 1540. 
158 When 2,4-dinitroiodobenzene was treated with 161c, decomposition of the starting material was observed. 
159 pTolyllithium was prepared by a direct lithium insertion to 4-chlorotoluene, see: C. G. Screttas, B. R. Steele, 
M. Micha-Screttas, G. A. Heropoulos, Org. Lett. 2012, 14, 5680. 
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organometallic obtained from an iodoquinoline underwent a copper-mediated 1,4-addition to methyl 
vinyl ketone in the presence of TMSCl. Subsequent enol ether cleavage using TBAF (1.10 equiv, 25 °C, 
1 h) gave ketone 169m in 56% yield over two steps. Reaction of more complex iodinated N-heterocycles 
namely pyrazolone, uracil or 5,6-dihydropyridone gave the expected bis-zinc reagents of type 165, 
which, after allylation or acylation provided 169n–169q in 74–85% yield.160 4-Iodofuraldehyde was 
treated with tBu2Zn·2LiOR (168) and the resulting zinc reagent reacted with 3-bromocyclohexene in 
the presence of CuI to give the furfural derivative 169r in 66% yield (Scheme 48). 
 





160 Due to poor solubility of the aryl iodides, the reactions leading to 169g,169j,169k,169n–169q were performed 
in THF. 
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3.3 The Br/Zn Exchange on Aryl and Heteroaryl Bromides 
The impressive reactivity of these bimetallic exchange reagents led us to examine the Br/Zn exchange 
reaction. Thus, treatment of 4-bromobenzonitrile with 161c (0.80 equiv) at 25 °C for 5 h in toluene, 
provided the desired bis-arylzinc of type 165, which, after quenching with iodine, gave 4-
iodobenzonitrile (170a) in 77% yield (Scheme 49). Reaction of the same zinc reagent with 4-
iodoanisole under palladium-catalysis gave the desired biaryl 170b in 64% yield.161 Allylation, 
acylation and cross-coupling of the zinc reagents obtained from 2-bromobenzonitrile and 2-
bromobenzotrifluoride gave 170c–170e in 63–67% yield. Various bromoarenes bearing e.g. an ester 
functional group underwent a smooth Br/Zn exchange, which, after allylation or cross-coupling, 
produced the arenes 170f–170i in 60–79% yield. Additionally, bromopyridines and a bromoquinoline 
were treated with 161c. Allylation of the resulting zinc reagents gave the functionalized heteroarenes 
170j–170l in 61–70% yield. Finally, 2-bromobenzothiazole was mixed with 161c and the obtained 
metal species reacted with iodine to give 170m in 75% yield (Scheme 49). 
 
Scheme 49: Reaction of various aryl bromides with sBu2Zn·2LiOR (161c), followed by electrophilic 
functionalization. 
 
161 Prior to the addition of the catalyst system and aryl iodide, TMSCl (0.80 equiv, 0 °C, 10 min) was added in 
order to quench the excess of alkoxide. 
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4 Regioselective Iodine/Zinc Exchange for the Selective Functionalization 
of Polyiodinated Arenes and Heterocycles in Toluene 
4.1 Introduction 
The regioselective functionalization of polyhalogenated arenes and heteroarenes61h,126a-c,162 is an 
excellent method for the preparation of various functionalized halogenated aromatics and heterocycles 
of interest as agrochemicals, pharmaceuticals or new organic materials.8,125 The functionalization of 
halogenated (hetero)arenes was best performed by their conversion to organometallics followed by 
various quenching reactions with electrophiles.1a-b Organozinc intermediates were usually preferred 
over organolithium and organomagnesium species as they tolerate most functional groups.1c,132,149c,e,163 
The selective zinc dust insertion in the presence of LiCl on dihalogenated (hetero)arenes led to such 
organometallic species with remarkable regioselectivities.28a,30,146b Although regioselective iodine or 
bromine/magnesium-exchanges have been reported in THF55a,67,68,128,164 and more recently in non-polar 
solvents such as toluene,141b,c no selective I/Zn exchanges on polyiodoarenes have been described yet.165 
Recently, we have reported that reagents of the type sBu2Zn·2LiOR (R = (CH2)2N(CH3)(CH2)2N(CH3)2; 
161c, 0.60–1.00   in toluene) allowed iodine/zinc exchanges in toluene, displaying a good functional 
group tolerance.142 
Herein, we report fast and highly regioselective I/Zn exchanges on various polyiodo-arenes and -
heteroarenes using pTol2Zn·2LiOR (R = (CH2)2N(CH3)(CH2)2N(CH3)2; 167, 0.60–1.00  in toluene), 
which was readily prepared from pTolLi (2.00 equiv), ROH (R = (CH2)2N(CH3)(CH2)2N(CH3)2, 2.00 
equiv) and Et2Zn (1.00 equiv) in toluene (Scheme 50).142 
 
Scheme 50: Preparation of pTol2Zn·2LiOR (167) in toluene. 
 
162 a) S. Schröter, C. Stock, T. Bach, Tetrahedron 2005, 61, 2245; b) C. Y. Legault, Y. Garcia, C. A. Merlic, K. 
N. Houk, J. Am. Chem. Soc. 2007, 129, 12664; c) S. T. Keaveney, G. Kundu, F. Schoenebeck, Angew. Chem. Int. 
Ed. 2018, 57, 12573. 
163 P. Knochel, H. Leuser, L.-Z. Cong, S. Perrone, F. F. Kneisel In Handbook of Functionalized Organometallics, 
Wiley-VCH, Weinheim, 2008. 
164 a) O. Baron, P. Knochel, Angew. Chem. Int. Ed. 2005, 44, 3133; b) S. Bruña, A. R. Kennedy, M. Fairley, C. T. 
O’Hara, Chem. Eur. J. 2021, 27, 4134. 
165 a) T. D. Blümke, T. Klatt, K. Koszinowski, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9926; b) M. 
Balkenhohl, P. Knochel, Chem. Eur. J. 2020, 26, 3688. 
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4.2 Optimization and Scope of the Regioselective I/Zn Exchange on Polyiodinated Arenes and 
Heteroarenes in Toluene 
In preliminary experiments, we have studied the I/Zn exchange on ethyl 3,5-diiodo-2-
(tosyloxy)benzoate (171a) in toluene (Table 8). First, the diiodoarene 171a was treated with 0.60 equiv 
of sBu2Zn·2LiOR (R = (CH2)2N(CH3)(CH2)2N(CH3)2; 161c)142 in toluene at 0 °C for 20 min, generating 
regioselectively the organozinc species 172a in 63% yield (Table 8, entry 1).166 
Table 8: Screening of the I/Zn exchange on ethyl 3,5-diiodo-2-(tosyloxy)benzoate (171a). 
 
Entry Exchange reagent[a] Regioselectivity [%][b] Yield [%][b] 
1 sBu2Zn·2LiOR (161c) 99 63 
2 pTol2Zn·2LiOR (167) 99 99 
[a] These reactions were carried out at 0.50 . All organometallic reagents were displayed 
accordingly to their stoichiometry and not their actual structure. [b] Yield and 
regioselectivity were determined by GC-analysis of reaction aliquots quenched with water. 
As arylmetal reagents have proven to tolerate more functional groups,147 the dialkylzinc reagent 161c 
was replaced by the diarylzinc exchange reagent pTol2Zn·2LiOR (R = (CH2)2N(CH3)(CH2)2N(CH3)2; 
167). Thus, treatment of the diiodoarene 171a with 167 at 0 °C led after 20 min to the diarylzinc 172a 
in 99% yield (Table 8, entry 2). After a Cu-catalyzed allylation of 172a with methallyl bromide, the 
functionalized tosylate 173a was isolated in 61% yield (Scheme 51). Similarly, 2,4,6-triiodoanisole 
(171b) regioselectively underwent complete I/Zn exchange upon treatment with 167 (0 °C, 20 min). 
The corresponding diarylzinc (172b) was smoothly allylated, producing the allylated product 173b in 
93% yield. Analogously, the diiodinated anisole 171c–171d were both converted into the corresponding 
organozinc compounds (172c–172d), which gave after copper-catalyzed (CuI, 0.10 equiv) reaction with 
methallyl bromide the nitrile and ester 173c–173d in 76–84% yield. In addition, the benzylic ethers 
171e–171g led to the corresponding zincated aryl iodides 172e–172g, which furnished after trapping 
with allyl bromide or 3-bromocyclohexene the iodinated products 173e–173g in 57–88% yield.  Also, 
when reacted with the bis-tolylzinc reagent 167, the phosphoramide 171h generated the corresponding 
diorganozinc species 172h. After allylation, the polyfunctionalized arene 173h was obtained in 62% 
 
166 37% of the corresponding carboxylic acid were obtained after hydrolysis. 
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yield. Next, the two carbamates 171i–171j successfully afforded the corresponding organozinc species 
(172i–172j), which furnished after allylation the products 173i–173j in 71–89% yield. Pivalate 
derivatives 171k–171l were also tolerated and produced after I/Zn exchange and allylation with ethyl 
2-(bromomethyl)acrylate the esters 173k–173l in 49–77% yield. The 2-methoxyethylether 171m 
underwent smooth exchange to generate the organozinc 172m. It reacted with 3-bromocyclohexene in 
the presence of a copper catalyst to yield 173m in 75% yield. Additionally, the para-methoxybenzyl 
derivatives 171n–171p were subjected to the same conditions, leading after allylation to the iodinated 
products 173n–173p in 75–96% yield. The dimethylcarbamothioic acid derivative 171q was 
furthermore successfully used and produced after allylation 173q in 57% yield. Afterwards, the 
triiodoaryl ether 171r reacted with 167 to give the corresponding diarylzinc (172r). This species 
smoothly reacted with 3-bromocyclohexene furnishing 173r in 74% yield. Finally, the thioether 171s 
was successfully converted to the corresponding organozinc reagent (172s) which provided after 
allylation the diiodoarene 173s in 54% yield. 
 
Scheme 51: Zincation of various polyiodinated aromatics with pTol2Zn·2LiOR (167), followed by a 
copper-catalyzed allylation. 
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Extending further the scope of this regioselective I/Zn exchange reaction, ethyl 2,3,5-triiodobenzoate 
(171t) led to the regioselective formation of 172t (Scheme 52). After transmetallation with CuI and 
acylation with 4-chlorobenzoyl chloride (3.00 equiv), the ketone 173t was isolated in 56% yield. To 
our delight, the I/Zn exchange could be extended to 1,4-diiodo-2-nitrobenzene (171u), which resulted 
in the regioselective generation of the diorganozinc 172u. After a copper-catalyzed reaction with allyl 
bromide, the allylated aryl iodide bearing a nitro group 173u was obtained in 74% yield. 
 
Scheme 52: Reaction of various polyiodinated aromatics with pTol2Zn·2LiOR (167), followed by a 
copper-catalyzed allylation or acylation. 
The extension to iodinated heterocycles (174a–174e) was then evaluated (Scheme 53). Thus, the 
tosylated diiodoquinoline 174a underwent a selective I/Zn exchange with 167 at 0 °C within 20 min. 
The resulting diarylzinc (175a) was allylated with allyl bromide in the presence of CuI (10 mol%) and 
the desired product 176a was isolated in 54% yield. Similarly, the carbamate 174b was converted into 
the corresponding diheteroarylzinc species (175b), which provided after allylation the allylated 
iodoquinoline 176b in 63% yield. In addition, the triiodomethoxypyridine 174c successfully generated 
the organometallic 175c upon addition of 167. After allylation with 3-bromocyclohexene, 175c gave 
the allylated pyridine 176c in 76% yield. 2,5-Diiodopyridine (174d) regioselectively led to the 
corresponding zincated heterocycle (175d) using diarylzinc reagent 167. After transmetallation to 
copper (0.60 equiv) and reaction with 4-chlorobenzoyl chloride (3.00 equiv) or Cu-catalyzed (CuI, 0.10 
equiv) allylation with methallyl bromide, the ketone 176da and allylated pyridine 176db were obtained 
in 67–72% yield. Finally, the scope of this I/Zn exchange was extended to the diiodopyrimidine 174e. 
Thus, after mixing the diiodouracil derivative 174e with 167 for 20 min at 0 °C, the zincated pyrimidine 
175e was formed. After allylation with allyl bromide, the iodopyrimidine 176e was obtained in 73% 
yield. 
B. RESULTS AND DISCUSSION    60 
 
Scheme 53: Reaction of various polyiodinated heteroaromatics with pTol2Zn·2LiOR (167), followed 
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5 Iron-Catalyzed Cross-Coupling of Functionalized Benzylmanganese 
Halides with Alkenyl Iodides, Bromides and Triflates 
5.1 Introduction 
Transition-metal catalyzed cross-couplings are of great importance for generating C─C bonds with 
diverse electrophiles.110b Although palladium- and nickel-catalyzed cross-couplings167 are amongst the 
most versatile, tolerating various functionalities on both electrophiles and nucleophiles, these metals 
have drawbacks including high prices for palladium168 and acute toxicity in the case of nickel.169 
Alternative metal-catalyses have been developed and include the use of copper,170 iron171  or cobalt.172 
Organomagnesium111a and organozinc157b reagents have mostly been used as organometallic reaction 
partners.173 Pioneered by Cahiez, organomanganese reagents have proven to be remarkable 
nucleophiles in various cross-coupling reactions, including those catalyzed by iron salts.16,118a,171b 
Unfortunately, these reactions often required the use of N-methylpyrrolidinone (NMP)174,175 and 
exhibited a limited functional group tolerance. The low price and toxicity of these metals being 
considered, such cross-coupling methodologies represent attractive alternatives compared to organo-
boronic esters which may have genotoxic properties.176 
We have recently described an effective preparation of functionalized benzylic manganese reagents of 
type 177 starting from benzylic chlorides of type 178.109b,118d,177 Herein, we report an iron-catalyzed 
cross-coupling of functionalized benzylic manganese reagents (177) with alkenyl iodides, bromides and 
triflates of type 179 providing a range of polyfunctionalized alkenes of type 180 (Scheme 54). 
 
167 a) Cross-Coupling Reactions. A Practical Guide (Eds.: N. Miyaura), Springer, Berlin, 2002; b) 
Organotransition Metal Chemistry (Ed.: J. F. Hartwig), University Science Books: Sausalito, CA, 2010; c) R. 
Jana, T. P. Pathak, M. S. Sigman, Chem. Rev. 2011, 111, 1417; d) V. B. Phapale, D. J. Cárdenas, Chem. Soc. Rev. 
2009, 38, 1598. 
168 FeCl2 ca. 332 €/mol, PdCl2 ca. 6164 €/mol; prices retrieved from Alfa Aesar in August 2019. 
169 a) LD50(FeCl2, rat oral) = 900 mg/kg; LD50(NiCl2, rat oral) = 186 mg/kg; b) K. S. Egorova, V. P. Ananikov, 
Angew. Chem. Int. Ed. 2016, 55, 12150. 
170 S. Thapa, B. Shrestha, S. K. Gurung, R. Giri, Org. Biomol. Chem. 2015, 13, 4816. 
171 a) G. Cahiez, A. Moyeux, J. Cossy, Adv. Synth. Catal. 2015, 357, 1983; b) A. Fürstner, A. Leitner, M. Méndez, 
H. Krause, J. Am. Chem. Soc. 2002, 124, 13856; c) R. B. Bedford, P. B. Brenner, In Iron Catalysis II (Eds.: E. 
Bauer), Springer, Berlin, 2015; d) I. Bauer, H.-J. Knölker, Chem. Rev. 2015, 115, 3170. 
172 a) G. Cahiez, A. Moyeux, Chem. Rev. 2010, 110, 1435; b) C. Gosmini, J.-M. Bégouin, A. Moncomble, Chem. 
Commun. 2008, 3221. 
173 K. Groll, T. D. Blümke, A. Unsinn, D. Haas, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 11157. 
174 a) G. Cahiez, H. Avedissian, Synthesis 1998, 1199; b) Reprotoxic Category 2, R61, Official Journal of the 
European Union, December 31, 2008, European regulation No. 1272/2008. 
175 For a recent report on the role of NMP in Fe-catalyzed coupling methodologies, see: S. B. Muñoz III, S. L. 
Daifuku, J. D. Sears, T. M. Baker, S. H. Carpenter, W. W. Brennessel, M. L. Neidig, Angew. Chem. Int. Ed. 2018, 
57, 6496. 
176 a) M. R. O’Donovan, C. D. Mee, S. Fenner, A. Teasdale, D. H. Phillips, Mutat. Res. 2011, 724, 1; b) M. M. 
Hansen, R. A. Jolly, R. J. Linder, Org. Process Res. Dev. 2015, 19, 1507. 
177 A. D. Benischke, A. Desaintjean, T. Juli, G. Cahiez, P. Knochel, Synthesis 2017, 49, 5396. 
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Scheme 54: Preparation of benzylic manganese reagents[a] by in situ transmetalation followed by iron-
catalyzed cross-couplings with alkenyl iodides, bromides and triflates. 
5.2 Optimization and Scope of the Iron-Catalyzed Cross-Coupling of Functionalized 
Benzylmanganese Halides with Alkenwl Iodides, Bromides and Triflates 
In preliminary experiments, we have prepared various benzylic organometallics derived from 3-
methoxybenzyl chloride (178a). Thus, the benzylic manganese reagent 177a was conveniently prepared 
by treating 178a (1.00 equiv) in THF at –5 °C with magnesium turnings (2.40 equiv) and MnCl2·2LiCl 
(1.30 equiv) for 1 h. Titration178 with iodine led to a yield for 177a of 78%. We also prepared the 
corresponding benzylic magnesium (181; 48% yield) and zinc (182; 42% yield) chlorides.179 
In the absence of any iron-catalyst, the cross-coupling of 177a with (E)-1-iodooctene (179a; 25 °C, 1 
h) produced the desired cross-coupling product 180a in 65% yield (Table 9, entry 1). Under these 
conditions, 181 and 182 gave lower yields (respectively 47% and 14%). Although the cross-coupling 
performed with FeBr2 gave a moderate yield of 63%, the use of Fe(acac)2, Fe(acac)3 or FeBr3 afforded 
180a in 74–80% yield (entries 2–5). Using FeCl3 proved to be even more effective as the yield increased 
to 96% (entry 6). Our best result was obtained with FeCl2 as catalyst, producing 180a in 97% yield. 
Moreover, the use of 99.99% pure FeCl2 similarly gave 180a in 98% yield, showing that it is unlikely 
that metal impurities are responsible for this catalysis (entries 7–8). 
 
 
178 A. Krasovskiy, P. Knochel, Synthesis 2006, 890. 
179 For more details, see the Experimental Part (p. 249). 
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Table 9: Catalyst screening of the reaction between the benzylic manganese chloride 177a[a] and (E)-
1-iodooctene (179a). 
 
Entry Catalyst (10 mol%) Yield [%][b] 
1 none 65 
2 FeBr2 63 
3 Fe(acac)2 75 
4 Fe(acac)3 74 
5 FeBr3 80 
6 FeCl3 96 
7 FeCl2 (99.5% purity) 97 
8 FeCl2 (99.99% purity) 98 
[a] For clarity reasons, the magnesium salt has been 
omitted. [b] Yield of analytically pure product. 
We noticed that the reprotoxic cosolvent NMP174,175 did not positively influence the reaction.179 
However, the amount of FeCl2 could be reduced to 2.5 mol% without significantly decresing the 
yield.179 We also observed that the benzylic magnesium and zinc species (181 and 182) were less 
efficient reagents and reacted with 179a in the presence of 10 mol% FeCl2 (25 °C, 1 h) to give 180a in 
66–68% yield. 
Furthermore, the cross-couplings of 177a with (2-bromovinyl)trimethylsilane (179b; Z/E = 10:90) gave 
the olefin 180b in 92% yield with retention of stereochemistry (Z/E = 6:94) whereas the yield without 
iron salt was of 0% (Table 10, entry 1). When the electron-rich 4-(methylthio)benzylmanganese 
chloride (177b) was mixed with (1-bromovinyl)trimethylsilane (179c), alkenylsilane 180c was 
generated in 92% yield and no product was observed without iron catalyst (entry 2). Benzylmanganese 
chloride (177c) underwent smooth cross-couplings with 179a and (E)-1-bromo-2-(2-iodovinyl)benzene 
(179d) to afford E-alkenes 180d and 180e in 77% and 87% yield. In comparison, 7% and 52% were 
obtained without catalyst (entries 3–4). Also, 4-(tert-butyl)benzylmanganese chloride (177d) reacted 
with 2,2-diphenylvinyl trifluoromethanesulfonate (179e) to give 180f in 95% yield (entry 5). 
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Table 10: Iron-catalyzed cross-couplings of benzylmanganese reagents (177a–177k)[a] with alkenyl 
iodides, bromides and triflates (179a–179k).[b] 
 
Entry Benzylic manganese reagent Electrophile Product, yield [%]
[c] 
1 177a  179b: Z/E = 10:90 
 
180b: 92 (0)[d] 
Z/E = 6:94 
2 177b  
179c 
 
180c: 92 (0)[d] 
3 177c  179a: Z/E = 1:99 
 
180d: 77 (7)[d] 
Z/E = 1:99 
4 177c  
179d: Z/E = 1:99 
 
180e: 87 (52)[d] 
Z/E = 1:99 
5 177d  
179e  180f: 95 (74)[d] 
6 177e  
179f: Z/E = 1:99 
 
180g: 79 (0)[d] 





180h: 57 (8)[d] 
8 177f  
179h 
 
180i: 84 (0)[d] 
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9 177g  179a: Z/E = 1:99 
 
180j: 94 (0)[d] 
Z/E = 1:99 
10 177h  
179i 
 
180k: 87 (7)[d] 
11 177i  
179j: Z/E = 99:1 
 
180l: 98 (21)[d] 
Z/E = 99:1 
12 177j  
179k: Z/E = 99:1 
 
180m: 98 (58)[d] 
Z/E = 99:1 
13 177k  
179e  180n: 43 (20)[d] 
14 177k  
179k: Z/E = 99:1 
 
180o: 53 (12)[d] 
Z/E = 99:1 
[a] For clarity reasons, the magnesium salt has been omitted. [b] Reaction time: 1 h for iodides, 
12 h for bromides and triflates. [c] Isolated yield of analytically pure product. [d] In parentheses, 
yield obtained without catalyst. [e] For this reaction, 1.00 equiv of 177e were used. 
Very interestingly, 4-isopropylbenzylmanganese chloride (177e) reacted with the acid-sensitive (E)-1-
bromo-3,3-diethoxyprop-1-ene (179f) and 1,2-dibromocyclopent-1-ene (179g, 1.00 equiv of 177e) to 
provide the acetal 180g (Z/E = 1:99) and the bromopentene derivative 180h in 79% and 57% yield. The 
reaction without FeCl2 gave almost no product (0–8%, entries 6–7). Electron-deficient fluorine-
containing benzylmanganese reagents (177f–177h) also reacted with various cross-coupling partners 
(179a,179h–179i) producing 180i–180k in 84–94% yield (0–7% were obtained without FeCl2, entries 
8–10). The analogous chlorine-containing benzylmanganese species (177i–177j) reacted with the 
functionalized alkenyl halides (Z)-4-(2-bromovinyl)benzonitrile (179j) and (Z)-1-(2-iodovinyl)-4-
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(trifluoromethyl)benzene (179k) to yield 98% of 180l and 180m (21% and 58% were obtained without 
any catalyst, entries 11–12). Finally, 4-bromobenzylmanganese chloride (177k) reacted with the 
alkenyl triflate 179e and iodostyrene 179k produced the expected alkenes 180n and 180o in 43–53% 
yield (12–20% were obtained without FeCl2, entries 13–14). Generally, we have observed that alkenyl 
bromides and electron-poor benzylmanganese reagents only gave traces of product in the absence of 
FeCl2. 
Table 11: Iron-catalyzed cross-couplings of benzylmanganese reagents (177a–177b,177d–177j)[a] with 
iodoacrylates (179l–179n). 
 
Entry Benzylic manganese reagent Electrophile Product, yield [%]
[b] 
1 177a  
179l: Z/E = 99:1  180p: 98 (73)[c] 
Z/E = 99:1 
2 177b  
179l: Z/E = 99:1 
 
180q: 78 
Z/E = 99:1 
3 177d  179m: Z/E = 1:99 
 
180r: 55 (44)[c] 
Z/E = 1:99 
4 177e  
179n: Z/E = 99:1 
 
180s: 78, Z/E = 99:1 
(60, Z/E = 44:56)[c] 
5 177f  
179l: Z/E = 99:1 
 
180t: 97 
Z/E = 99:1 
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6 177f 
 
179m: Z/E = 1:99 
 
180u: 66 (41)[c] 
Z/E = 1:99 
7 177g  
179l: Z/E = 99:1 
 
180v: 71 
Z/E = 99:1 
8 177g  
179n: Z/E = 99:1 
 
180w: 69, Z/E = 99:1 
(83, Z/E = 67:33)[c] 
9 177h  
179l: Z/E = 99:1 
 
180x: 50 
Z/E = 99:1 
10 177i  
179l: Z/E = 99:1 
 
180y: 50 
Z/E = 99:1 
11 177j  
179l: Z/E = 99:1 
 
180z: 73 
Z/E = 99:1 
[a] For clarity reasons, the magnesium salt has been omitted. [b] Isolated yield of analytically 
pure product. [c] In parentheses, yield obtained without catalyst. 
These benzylic manganese species also undergo cross-couplings with iodoacrylate derivatives (179l–
179n). Thus, the benzylic manganese chloride 177a reacted with ethyl (Z)-3-iodoacrylate (179l) to 
provide the Z-acrylate 180p in 98% yield (73% were obtained without catalysis). In the same conditions, 
4-(methylthio)benzylmanganese chloride (177b) afforded the acrylate 180q in 78% yield (Table 11, 
entries 1–2). Moreover, 4-alkylated benzylic manganese chlorides 177d–177e respectively reacted with 
(E)-3-iodoacrylate (179m) and ethyl (Z)-3-iodobut-2-enoate (179n) to give the acrylates 180r and 180s 
in 55% and 78% yield, whereas the reactions without FeCl2 gave 44% and 60% yield (Z/E = 44:56, 
entries 3–4). Also, 2-fluorobenzylman-ganese chloride (177f) reacted with both Z and E isomers of 
ethyl-3-iodoacrylate (179l–179m) to yield the corresponding Z and E acrylates 180t in 97% and 180u 
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in 66% yield (41% were obtained without catalysis, entries 5–6). The two other fluorine-containing 
benzylic manganese species 177g–177h also underwent smooth cross-couplings with 179l,179n to 
yield 50–71% of 180v–180x (180w: 83%, Z/E = 67:33 were obtained without FeCl2; entries 7–9). The 
chloro-substituted benzylic manganese species 177i–177j were treated with 179l and 10 mol% FeCl2 
to give the Z-acrylates 180y–180z in 50–73% yield (entries 10–11).180 
  
 
180 Interestingly, partial isomerization of the double bond was observed when reactions of unsymmetrically 
substituted substrates were carried out without FeCl2. 
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6 Iron-Catalyzed Cross-Coupling of Functionalized Bis-(aryl)manganese 
Nucleophiles with Alkenyl Halides 
6.1 Introduction 
Transition-metal catalyzed cross-couplings are widely used in the development and production of 
pharmaceutical compounds.181 Since they tolerate a great variety of functionalities on both coupling 
partners, palladium-catalyzed and nickel-catalyzed cross-couplings are the most versatile ones.167c-d,182 
Yet, these metals have drawbacks such as toxicity169 and high prices in the case of palladium.168 That is 
one of the reasons why copper,170 iron,171 or cobalt172a have been developed as alternative metal-
catalysts. 
Pioneered by Cahiez,16 organomanganese species often considerably reduce the amount of side 
reactions such as homo-coupling109a,183 and have proven to be excellent nucleophiles in various types of 
reactions,109a,184 including cross-couplings.118a Organomanganese compounds thus constitute an 
interesting alternative to usual cross-coupling partners such as organomagnesium,111a organozinc,157b 
and organo-boronic esters, which may have genotoxic properties.176 
Recently, we have developed a two-step preparation of functionalized bis-(aryl)manganese reagents by 
oxidative insertion of magnesium into the C-Br bond of aryl bromides, which is followed by a 
transmetalation with MnCl2·2LiCl.177 Herein, we wish to report an effective one-pot preparation of 
those functionalized bis-(aryl)manganese reagents (Ar2Mn·2MgX2·4LiCl, denoted as Ar2Mn (181), 
Scheme 55) starting from aryl bromides, which are followed by an iron-catalyzed cross-coupling of 181 
with alkenyl iodides and bromides, and provide a range of polyfunctionalized alkenes (184, Scheme 
55). These bis-(aryl)manganese reagents are generally stable at 25 °C for several hours, which makes 
them suitable reagents for mild cross-coupling reactions.185 
 
181 Applications of Transition Metal Catalysis in Drug Discovery and Development: An Industrial Perspective 
(Eds.: M. L. Crawley, B. M. Trost), John Wiley & Sons: New Jersey, 2012. 
182 a) N. Miyaura, Org. Process Res. Dev. 2003, 7, 1084; b) J. F. Hartwig, Angew. Chem. Int. Ed. 2010, 49, 7622. 
183 D. Haas, J. M. Hammann, A. Moyeux, G. Cahiez, P. Knochel, Synlett 2015, 26, 1515. 
184 a) G. Cahiez, A. Masuda, D. Bernard, J. F. Normant, Tetrahedront Lett. 1976, 36 ,3155; b) G. Friour, A. 
Alexakis, G. Cahiez, J. F. Normant, Tetrahedron 1984, 40, 683; c) T. Kauffmann, M. Bisling, Tetrahedron Lett. 
1984, 25, 293; d) G. Cahiez, M. Alami, Tetrahedron Lett. 1986, 27, 569; e) G. Cahiez, M. Alami, Tetrahedron 
Lett. 1989, 30, 3541; f) G. Cahiez, M. Alami, J. Organomet. Chem. 1990, 397, 291. 
185 G. Cahiez, O. Gager, F. Lecomte, Org. Lett. 2008, 10, 5255. 
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Scheme 55: One-pot preparation of bis-(aryl)manganese reagents by in situ transmetalation followed 
by iron-catalyzed cross-couplings with alkenyl iodides and bromides. 
6.2 Optimization and Scope of the Iron-Catalyzed Cross-Coupling of Functionalized Bis-
(aryl)manganese Nucleophiles with Alkenyl Halides 
In preliminary experiments, the bis-(aryl)manganese reagent 181a was conveniently prepared by 
treating 4-bromoanisole (182a, 1.00 equiv) in THF at –5 °C with magnesium turnings and LiCl (2.40 
equiv) in the presence of MnCl2 (0.60 equiv) within 1 h. Titration178 with iodine led to a yield for 181a 
of 87%. 
Table 12: Catalyst screening of the reaction between the bis-(aryl)manganese reagent 181a and (Z)-
ethyl 3-iodoacrylate (183a). 
 
Entry Catalyst (10 mol%) Yield [%][a] 
1 none 60[b] 
2 FeBr2 42 
3 FeCl3 54 
4 FeBr3 57 
5 FeCl2 64 
6 Fe(acac)2 67 
7 Fe(acac)3 (>99% purity) 79 
[a] Yield of analytically pure product. [b] A Z/E = 50:50 
mixture of 184a was obtained. 
In the absence of any iron catalyst, the cross-coupling of 181a with (Z)-ethyl 3-iodoacrylate (183a; 25 
°C, 1 h) produced a Z/E = 50:50 mixture of the desired cross-coupling product 184a in 60% yield (Table 
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12, entry 1). Although the cross-coupling performed with FeBr2 gave a moderate yield of 42%, the use 
of FeCl3, FeBr3, or FeCl2 afforded the E isomer of 184a in 54–64% yield (entries 2–5). Using Fe(acac)2 
proved to be more effective since the yield increased to 67% (entry 6). Our best result was obtained 
with Fe(acac)3 (>99% purity) as a catalyst, producing the E isomer of 184a in a 79% yield (entry 7). 
Table 13: Iron-catalyzed couplings of bis-(aryl)manganese (181a–181g)[a] with alkenyl electrophiles 
(183a–183e). 
 
Entry Ar2Mn Electrophile Product, yield [%][b] 
1 181a  
183b: Z/E = 10:90 
 
184b: 98, Z/E = 1:99  
 (24, Z/E = 20:80)[c] 
2 181b  
183a: Z/E = 99:1 
 
184c: 69, Z/E = 1:99  
 (58, Z/E = 69:31)[c] 
3 181c  
183b: Z/E = 10:90 
 
184d: 80, Z/E = 1:99  
 (8, Z/E = 1:99)[c] 
4 181c  
183a: Z/E = 99:1 
 
184e: 57, Z/E = 1:99  
 (66, Z/E = 72:28)[c] 
5 181c  
183c: Z/E = 18:82 
 
184f: 82, Z/E = 1:99  
 (80, Z/E = 53:47)[c] 
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6 181c  
183d: Z/E = 1:99  184g: 87, Z/E = 9:91  
 (77, Z/E = 4:96)[c] 
7 181d  
183a: Z/E = 99:1 
 
184h: 77, Z/E = 1:99  
 (74, Z/E = 81:19)[c] 
8 181e  
183a: Z/E = 99:1 
 
184i: 64, Z/E = 1:99  
 (51, Z/E = 57:43)[c] 
9 181f  
183b: Z/E = 10:90 
 
184j: 78, Z/E = 1:99  
 (39, Z/E = 20:80)[c] 
10 181f  
183a: Z/E = 99:1 
 
184k: 84, Z/E = 1:99  
 (48, Z/E = 99:1)[c] 
11 181g  
183b: Z/E = 10:90 
 
184l:[d] 20, Z/E = 21:79 
91, Z/E = 5:95[e] 
 (traces, Z/E = 50:50)[c] 
12 181d  
183e: Z/E = 98:2  184m: 74, Z/E = 98:2  
 (19, Z/E = 73:27)[c] 
13 181e  
183e: Z/E = 98:2 
 
184n: 66, Z/E = 70:30  
 (41, Z/E = 72:28)[c] 
[a] For clarity reasons, the magnesium salt has been omitted. [b] Yield of analytically pure 
product. [c] In parentheses, yield and Z/E ratio obtained without catalysis. [d] Yields determined 
by GC and 1H-NMR. [e] After 18 h. 
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Furthermore, the cross-coupling of 181a with (2-bromovinyl)trimethylsilane (183b; Z/E = 10:90) gave 
the olefin 184b in 98% yield with complete E-selectivity (Z/E = 1:99) whereas the yield without iron 
salt was 24% (Z/E = 20:80, Table 13, entry 1). When the electron-rich bis-(3,4-
dimethoxyphenyl)manganese (181b) was mixed with 183a, the E-acrylate 184c was generated in 69% 
yield and a Z/E = 69:31 mixture of products was obtained in 58% yield without an iron catalyst (entry 
2). The tri-substituted bis-(3,4,5-trimethoxyphenyl)manganese (181c) underwent smooth cross-
coupling with 183b to afford the E-alkene 184d in 80% (8% were obtained without a catalyst, entry 3). 
Additionally, 181c reacted with 183a and 2-bromostyrene (183c; Z/E = 18:82) to give the acrylate 184e 
and 184f (Z/E = 1:99) in 57% and 82% yield whereas 66% (Z/E = 72:28) and 80% (Z/E = 53:47) were 
respectively obtained without a catalyst (entries 4–5). In the last experiment, 181c reacted with (E)-1-
iodooctene (183d) to provide the alkene 184g in 87% yield (Z/E = 9:91) when 77% yield (Z/E = 4:96) 
was obtained without a catalyst (entry 6). Furthermore, bis-(4-(trifluoromethoxy)phenyl)manganese 
(181d) reacted with 183a to provide the acrylate 184h (Z/E = 1:99) in 77% yield (entry 7). The reaction 
without Fe(acac)3 gave a similar yield but a mix of the two isomers (74%, Z/E = 81:19, entry 7). The 
silicon-containing bis-(aryl)manganese reagent 181e could also react with 183a, which produces 184i 
(Z/E = 1:99) in 64% yield (51%, Z/E = 57:43 were obtained without Fe(acac)3, entry 8). Some good 
yields could be achieved in the absence of the iron catalyst (entries 2, 4–8), which could be attributed 
to the catalytic activity of the manganese(II) itself. For example, manganese salts proved to efficiently 
catalyze several couplings of organomagnesium reagents with alkenyl electrophiles in the past.185 The 
bis-benzo[d][1,3]dioxol-5-ylmanganese (181f) also reacted with 183a and 183b to yield the E-alkenes 
184j and 184k in 78–84% yield (entries 9–10). The bulkier bis-mesitylmanganese 181g reacted with 
183b to afford 184l with a small 20% yield (91% after 18 h, entry 11). This method also proved to 
tolerate nitriles, since 4-(2-bromovinyl)benzonitrile 183e (Z/E = 98:2) could be used as a coupling 
partner with 181d and 181e in good yields (entries 12–13). 
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7 Summary 
In this thesis, several challenges in the field of organometallic chemistry have been dealt with. First, the 
use of the highly reactive exchange reagents of type sBu2Mg·2LiOR (R = 2-ethylhexyl) to perform 
regioselective Br/Mg exchanges on a plethora of polyhalogenated (hetero)arenes offered a versatile 
method for the generation of highly functionalized halogenated building blocks. The fact that this type 
of reagents was utilized in apolar solvants such as toluene avoided any solvent coordination and 
displayed interesting regioselectivities by proximity effect. Moreover, it triggered a total 
regioselectivity switch on dibromo-pyridines and -quinoline when the substrate was prevented from 
coordinating to the exchange reagent by adding PMDTA. Although never being observed in any case 
before, a preference for a Br/Mg over an I/Mg exchange on 2-bromo-4-iodoanisole derivatives was 
discovered using nBu2Mg·2LiOR. Next, reagents of the type R2Mg (R = sBu, Mes) were successfully 
used to generate di(hetero)aryl magnesium species bearing sensitive functional groups such as a 
triazene, an ester or a nitro group via I/Mg- and Br/Mg- exchange reactions in apolar solvents. The 
methodology was extended to alkenyl iodides to provide the first dialkenyl magnesium reagents in 
apolar solvents. Furthermore, a lithium alkoxide complexed dialkylzinc reagent was developed for a 
solvent independent halogen/zinc exchange. These reagents of type 1R2Zn·2LiOR allowed not only the 
exchange of aryl iodides in solvents such as THF or toluene, but also the first bromine/zinc exchange 
using dialkylzinc reagents. Additionally, highly sensitive functional groups such as ketones, aldehydes 
or nitro groups were tolerated by these new reagents. Also, a regioselective version of those I/Zn 
exchanges was developed on polyiodinated (hetero)arenes, furnishing iodinated (hetero)aryl zincs. 
Many iodinated building blocks bearing sensitive functional groups were obtained. Next, an iron-
catalyzed cross-coupling of functionalized benzylic manganese chlorides – which were prepared in a 
one-pot manner – with alkenyl iodides, bromides and triflates provided a greener alternative to usual 
transition-metal-catalyzed carbon-carbon bond-forming coupling methodologies for accessing various 
di-, tri- and tetra-substituted alkenes with total retention of stereochemistry. Sensitive functional groups 
such as nitriles or esters were tolerated, which resulted in the acquisition of highly functionalized 
alkenes. Finally, owing to the development of a new one-pot reaction, an extension of the last method 
to bis-(aryl)manganese species allowed the preparation of alkenes through an iron-catalyzed cross-
coupling with alkenyl halides. 
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7.1 Regioselective Bromine/Magnesium Exchange for the Selective Functionalization of 
Polyhalogenated Arenes and Heterocycles 
Regioselective Br/Mg exchanges of polybromo(hetero)arenes using reagents of the type R2Mg·2LiOR1 
(R = sBu, nBu; R1 = 2-ethylhexyl) in toluene have been reported. In some cases, a regioselectivity 
switch of the exchange could be achieved by adding a chelating ligand like PMDTA. These interesting 
selectivites which cannot be reached using turbo-Grignard reagents allowed for the first time a 
preference for a Br/Mg over an I/Mg exchange on some 2-bromo-4-iodoanisole derivatives (Scheme 
56). 
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7.2 Preparation of Functionalized Diorganomagnesium Reagents in Toluene via Bromine or 
Iodine/Magnesium Exchange Reactions 
Various polyfunctionalized iodo- and bromo(hetero)arenes underwent efficient halogen/magnesium 
exchange upon addition of R2Mg (R = sBu, Mes) in toluene under mild reaction conditions. The 
resulting di(hetero)arylmagnesium reagents, which tolerated functions like a nitro or triazene group, 
reacted smoothly with electrophiles via cross-couplings, allylations, acylations, and addition to 
aldehydes or ketones. The method was successfully extended to a retentive I/Mg exchange on alkenyl 
iodides to provide reactive alkenylmagnesium species in toluene (Scheme 57). 
 
Scheme 57: Examples of Halogen/Magnesium exchanges on sensitive (hetero)aryl halides using 
R2Mg (R = sBu, Mes). 
 
  
B. RESULTS AND DISCUSSION    77 
7.3 Preparation of Polyfunctional Arylzinc Organometallics in Toluene via Halogen/Zinc 
Exchange Reactions 
New bimetallic reagents of type 1R2Zn·2LiOR for the I/Zn and Br/Zn exchange reactions have been 
developed. Thanks to the mild nature of organozinc compounds, several highly sensitive functional 
groups including triazines, ketones, aldehydes or nitro groups could be tolerated. Thus, quenching of 
the formed diarylzinc species with various electrophiles allowed the preparation of a plethora of 
functionalized (hetero)arenes. Additionally, the exchange could not only be performed in hydrocarbons 
such as toluene or hexane, but also in ethereal solvents including THF, 2-methyl-THF or MTBE 
(Scheme 58). 
 
Scheme 58: The halogen/zinc exchange using dialkylzinc reagents complexed with lithium alkoxides 
of type 1R2Zn·2LiOR. 
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7.4 Regioselective Iodine/Zinc Exchange for the Selective Functionalization of Polyiodinated 
Arenes and Heterocycles in Toluene 
Various polyiodo-arenes and –heteroarenes underwent efficient and regioselective I/Zn exchanges upon 
addition of the bimetallic combination pTol2Zn·2LiOR (R = (CH2)2N(Me)(CH2)2NMe2) in toluene 
under mild reaction conditions. The resulting iodo-substituted diorganozinc reagents reacted effectively 
with electrophiles such as allyl bromides and acyl chlorides (Scheme 59). 
 
Scheme 59: Regioselective iodine/zinc exchange on polyiodo(hetero)arenes using pTol2Zn·2LiOR. 
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7.5 Iron-Catalyzed Cross-Coupling of Functionalized Benzylmanganese Halides with Alkenyl 
Iodides, Bromides and Triflates 
Starting from benzylic chlorides, various functionalized benzylic manganese species have been readily 
prepared by insertion of magnesium in the presence of MnCl2·2LiCl in THF under convenient 
conditions. These benzylic manganese reagents smoothly reacted with various functionalized alkenyl 
iodides, bromides, triflates and iodoacrylates in the presence of a catalytic amount of FeCl2 at room 
temperature. Di-, tri- or tetra-substituted alkenes were formed with a good functional group tolerance. 
Aryl halides were for instance tolerated and can serve as a handle for further functionalization (Scheme 
60). 
 
Scheme 60: Generation of benzylic manganese reagents via Mg insertion and in situ transmetalation in 
the presence of MnCl2·2LiCl, followed by Fe-catalyzed cross-couplings with alkenyl iodides, bromides, 
triflates and iodoacrylates with retention of stereochemistry. 
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7.6 Iron-Catalyzed Cross-Coupling of Functionalized Bis-(aryl)manganese Nucleophiles with 
Alkenyl Halides 
Various substituted bis-(aryl)manganese species were prepared from aryl bromides by a new one-pot 
insertion of magnesium turnings in the presence of LiCl and in situ transmetalation with MnCl2 in THF 
at −5 °C within 2 h. These bis-(aryl)manganese reagents underwent smooth iron-catalyzed cross-
couplings using 10 mol% Fe(acac)3 with various functionalized alkenyl iodides and bromides in 1 h at 
25 °C.Various alkenes were formed with a good functional group tolerance (Scheme 61). 
 
Scheme 61: Generation of bis-(aryl)manganese reagents via Mg insertion and in situ transmetalation in 
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1 General Considerations 
 
All reactions were carried out under argon or nitrogen atmosphere in glassware dried with a heat gun 
(650 °C) under high vacuum (<1 mbar). Syringes which were used to transfer anhydrous solvents or 
reagents were purged thrice with argon or nitrogen prior to use. Indicated yields are isolated yields of 
compounds estimated to be >95% pure as determined by 1H-NMR (25 °C) and capillary GC. Unless 
otherwise indicated, all reagents were obtained from commercial sources. 
1.1 Solvents 
Solvents were dried according to standard procedures by distillation over drying agents as stated below 
and stored under argon. Otherwise, they were obtained from commercial sources and used without 
further purification.  
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under nitrogen 
and then stored over molecular sieves. 
Toluene was continuously refluxed and freshly distilled from sodium under nitrogen and stored over 
molecular sieves. 
CH2Cl2 (DCM), N,N′-Dimethylpropyleneurea (DMPU), MeCN, Me2NCHO (DMF), MTBE and 
NMP were distilled from CaH2 and stored over molecular sieves. 
Et2O was predried over calcium hydride and dried with the solvent purification system SPS-400-2 from 
Innovative Technologies Inc. 
TMEDA and PMDTA were freshly distilled from calcium hydride under nitrogen. 
Solvents for column chromatography were distilled on a rotary evaporator prior to use. 
1.2 Reagents 
All reagents were obtained from commercial sources and used without further purification unless 
otherwise stated. Liquid aldehydes and acyl chlorides were distilled prior to use. 
nBuLi, sBuLi, tBuLi solutions in hexane were purchased from Albemarle and the concentrations were 
titrated with N-benzylbenzamide in THF at –20 °C (–40 °C for sBuLi).186 
pTolyllithium (pTolLi): According to a literature procedure,159 lithium granulas (306 mg, 44 mmol) 
were placed in a dry and argon-flushed Schlenk-flask and cooled to 0 °C. Then, a solution of 4-
 
186 A. F. Burchat, J. M. Chong, N. Nielsen, J. Organomet. Chem. 1997, 542, 281. 
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chlorotoluene (2.37 mL, 20 mmol) in dry Et2O (20 mL) was added dropwise over 40 min and stirred 
for 2 hours at the same temperature. A concentration of 0.80-1.00 M was obtained. The solution was 
filtered twice prior to use and was titrated with N-benzylbenzamide in THF at 0 °C.186 
MesLi solution in ether: MesBr (20.00 mmol) was diluted in ether (40 mL) and tBuli (44.0 mmol) in 
hexane was added dropwise at −60 °C. After 1 h, the solution was titrated with N-benzylbenzamide at 
0 °C.186 
sBuMgCl and MesMgCl solution in diethyl ether were purchased from Sigma Aldrich and were titrated 
with I2 in a 0.50 M LiCl solution in THF at 25 °C.178  
iPrMgCl·LiCl solution in THF was obtained from Albemarle and the concentration was determind by 
iodometric titration.178 
nBu2Mg solution in hexane was purchased from Albemarle and titrated with I2 in a 0.50 M LiCl solution 
in THF at 0 °C.178 
Magnesium-2-ethylhexanolate was purchased from Albemarle and the concentration was determined 
by acidimetric titration with 4-(phenylazo)-diphenylamine and CF3CO2H (TFA) in toluene at 0 °C. 
Et2Zn: Either a Commerially available Et2Zn (purchased from Sigma Aldrich, 15 wt.% (= 1.11 M) in 
toluene) was used or Et2Zn (100 mmol) was dissolved in dry toluene (100 mL) and titrated against I2 
in a 0.50 M LiCl solution in THF at 0 °C. Both Et2Zn reagents were suitable for the performed reactions. 
1.00 M CuCN·2LiCl solution in THF: CuCN (80.0 mmol, 7.17 g) and LiCl (160 mmol, 6.77 g) were 
dried in a Schlenk-flask under vacuum at 140 °C for 12 h. After cooling, dry THF (80 mL) was added 
and stirring continued until the salts were dissolved.130 
1.00 M ZnCl2 solution in THF: ZnCl2 (100 mmol, 13.6 g) was dried in a Schlenk-flask under vacuum 
at 140 °C for 5 h. After cooling, 100 mL dry THF were added and stirring was continued until the salt 
was dissolved.  
1.00 M MnCl2·2LiCl solution in THF: A dry and argon-flushed 250 mL Schlenk-flask, equipped with 
a magnetic stirring bar and a rubber septum, was charged with LiCl (8.48 g, 200 mmol), heated to 450 
°C under high vacuum and after cooling to room temperature under vacuum furthermore vigorously 
stirred at 160 °C for 3 h. Subsequently, MnCl2 (12.6 g, 100 mmol) was added under argon at room 
temperature and the reaction mixture as heated to 160 °C for 3 h under high vacuum. After cooling to 
room temperature, the flask as charged with freshly distilled THF (100 mL) and the mixture was stirred 
for 48 h at 25 °C. The resulting MnCl2·2LiCl (1.00 M in THF) solution appeared as a light brown liquid.  
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0.50 M LiCl solution in THF: LiCl (5.00 mmol) was dried in vacuo using a heatgun (400 °C) for 10 
min. After cooling to room tempetature, dry THF (10 mL) was added and the mixture stirred until the 
salt was dissolved completely. 
2-((2-(Dimethylamino)ethyl)(methyl)amino)ethane-1-ol: The alcohol was distilled in vacuo from 
CaH2 (29 mbar, 95 °C) and stored under argon in a Schlenk-flask. 
1.3 Chromatography 
Flash column chromatography was performed using silica gel 60 (0.040–0.063 mm, 230–400 mesh 
ASTM) from Merck. 
Thin layer chromatography was performed using aluminum plates covered with SiO2 (Merck 60, 
F-254). The chromatograms were examined under 254 nm UV irradiation. When necessary, a staining 
of the TLC plate was performed with a PMA solution (10 g of PMA dissolved in 100 mL absolute 
ethanol) followed by heating with a heat gun. 
1.4 Analytical Data 
NMR spectra were recorded on VARIAN Mercury 200, BRUKER AXR 300, VARIAN VXR 400 S 
and BRUKER AMX 600 instruments in CDCl3 unless otherwise stated. Chemical shifts are reported as 
δ-values in parts per million (ppm) relative to the residual solvent peak CDCl3 (δH: 7.26; δC: 77.16), 
(CD3)2SO (δH: 2.50; δC: 39.52). Abbreviations for signal coupling are as follows: s, singlet; d, doublet; 
t, triplet; q, quartet; m, multiplet. If not otherwise noted, the coupling constants given are H-H-coupling 
constants for proton signals and C-F-coupling constants for carbon signals. 
High Resolution Mass Spectroscopy (HRMS) electron impact ionization (EI) and low resolution (MS) 
spectra were recorded on a FINNIGAN MAT 95Q instrument. EI was conducted with an electron 
energy of 70 eV. Electrospray ionization (ESI) spectra were recorded on a FINNIGAN LTQ FTICR 
instrument.  
Gas chromatography (GC) was performed on machines of the types Hewlett-Packard 6890 or 5890 
Series II (Hewlett Packard, 5% phenylmethylpolysiloxane; length: 10 m, diameter: 0.25 mm; film 
thickness: 0.25 μm). The detection was accomplished using a flame ionization detector.  
Infrared spectra (IR) were recorded from 4500 cm−1 to 650 cm−1 on a PERKIN ELMER Spectrum 
BX-59343 instrument. For detection a SMITHS DETECTION DuraSamplIR II Diamond ATR sensor 
was used. Samples were measured neat. The absorption bands are reported in wavenumbers (cm−1). 
Melting points (M.p.) were determined on a BÜCHI B-540 apparatus and are uncorrected. 
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2 Regioselective Bromine/Magnesium Exchange for the Selective 
Functionalization of Polyhalogenated Arenes and Heterocycles 
2.1 Preparation and Titration of Reagents of Type 1RMgOR·LiOR and1R2Mg·2LiOR 
Preparation of sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu (134a):71 
 
Method A: 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with nBu2Mg (0.66 M in hexane, 15.0 mL, 9.90 mmol) and the reaction mixture was cooled to 0 °C. 
Then, 2-ethylhexanol (3.10 mL, 19.8 mmol) was added dropwise. After 12 h a gelatinous solution was 
obtained. To the reaction mixture sBuLi (1.21 M in hexane, 8.18 mL, 9.9 mmol) was added dropwise. 
After the addition was complete, the reaction mixture was allowed to warm to room temperature for 2 
h. The solvents were removed under vaccum affording a lightly yellow foam. Freshly distilled toluene 
(9 mL) was added under vigourous stirring at 0 °C. The freshly prepared 
sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu was titrated prior to use at 0 °C by iodometric titration.178 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Mg[OCH2CH(Et)Bu]2 (0.85 M in heptane, 15.0 mL, 12.8 mmol)187 and was cooled to 0 °C. Then, 
sBuLi (1.21 M in hexane, 10.6 mL, 12.8 mmol) was added dropwise. After the addition was complete, 
the reaction mixture was allowed to warm to room temperature for 2 h. The solvents were removed 
under vaccum affording a lightly yellow foam. Freshly distilled toluene (9 mL) was added under 
vigourous stirring at 0 °C. The prepared sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu was titrated prior 
to use at 0 °C by iodometric titration.178 The sBuMgOCH2CH(Et)Bu·LiOCH2CH(Et)Bu concentration 
of the resulting clear solution was 1.00–1.50 M. 
 
Preparation of sBu2Mg·2LiOCH2CH(Et)Bu (134b):71 
 
Method A: 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with nBu2Mg (0.66 M in hexane, 15.0 mL, 9.90 mmol) and the reaction mixture was cooled to 0 °C. 
 
187 This magnesium alkoxide solution (0.94 M in nheptane) is commercially available from Albemarle, Frankfurt: 
U. Wietelmann, U. Emmel, J. Roeder, M. Steinbild, K. Papstein (Albemarle), WO-2010146122, 2010. 
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Then, 2-ethylhexanol (3.10 mL, 19.8 mmol) was added dropwise. After 12 h a gelatinous solution was 
obtained. To the reaction mixture sBuLi (1.21 M in hexane, 16.36 mL, 19.8 mmol) was added dropwise. 
After the addition was complete, the reaction mixture was allowed to warm to room temperature for 2 
h. The solvents were removed under vaccum affording a lightly yellow foam. Freshly distilled toluene 
(9 mL) was added under vigourous stirring at 0 °C. The prepared sBu2Mg·2LiOCH2CH(Et)Bu was 
titrated prior to use at 0 °C by iodometric titration.178 The sBu2Mg·2LiOCH2CH(Et)Bu concentration 
of the resulting clear solution was 0.60–0.85 M. 
 
Method B: 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Mg[OCH2CH(Et)Bu]2 (0.85 M in heptane, 15.0 mL, 12.8 mmol)187 and was cooled to 0 °C. Then, 
sBuLi (1.21 M in hexane, 21.2 mL, 25.6 mmol) was added dropwise. After the addition was complete, 
the reaction mixture was allowed to warm to room temperature for 2 h. The solvents were removed 
under vaccum affording a lightly yellow foam. Freshly distilled toluene (9 mL) was added under 
vigourous stirring at 0 °C. The freshly prepared sBu2Mg·2LiOCH2CH(Et)Bu was titrated prior to use 
at 0 °C by iodometric titration.178 The sBu2Mg·2LiOCH2CH(Et)Bu concentration of the resulting clear 
solution was 0.60–0.85 M. 
 
Note 1: Analogous reagents tBu2Mg·2LiOR and nBu2Mg·2LiOR (134c) were prepared following the 
same procedures using tBuLi or nBuLi instead of sBuLi and gave similar concentrations. 
Note 2: All reagents should be storred at –20 °C and used within 2 weeks. 
 
Titration Using Iodine178 
A dry-flask was charged with accurately weighed I2 (128 mg, 0.504 mmol), fitted with a rubber septum, 
and flushed with argon. THF (2 mL) was added and stirring was started. After the iodine was completely 
dissolved, the resulting brown solution was cooled to 0 °C in an ice bath and the organomagnesium 
reagent was added dropwise via a 1.00-mL syringe (0.01-mL graduations) until the brown color 
disappeared. The amount consumed contains 1.00 equiv of the organometallic reagent relative to iodine 
in the case of monoorganometallic reagents and 0.50 equiv for diorganometallic reagents. 
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2.2 Typical Procedure 
Typical Procedure 1: Preparation of Di(hetero)arylmagnesium Alkoxides via a Bromine/Magnesium-
Exchange Followed by Electrophilic Functionalization 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with the corresponding (hetero)aryl bromide (1.00 equiv) and dissolved in dry toluene (0.50 M or 0.05 
M, specified for every single procedure). When needed, N,N,N’,N’’,N’’-pentamethyldiethylenetriamine 
(PMDTA, 0.60 equiv, specified for every single procedure) was added. Then, the exchange reagent 
1R2Mg·2LiOR (R = 2-ethylhexyl, 1R = sBu for 134b or nBu for 134c, 0.60 equiv) was added dropwise 
at the specified temperature and the reaction stirred for the indicated time. The completion of the 
bromine/magnesium exchange was checked by GC-analysis of reaction aliquots quenched with a sat. 
aq. NH4Cl solution, using undecane as internal standard. Subsequent reactions with electrophiles were 
carried out under the indicated conditions. After complete conversion, the mixture was quenched with 
a sat. aq. NH4Cl solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 
30 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
The crude product was purified by flash chromatography on silica gel using the appropriate eluent. 
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2.3 Starting Materials 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 2,4-dibromophenol (1.00 g, 3.97 mmol) and DMF (10 mL) and was cooled to 0 °C. NaH (60%, 
191 mg, 4.76 mmol) was slowly added at 0 °C and the reaction mixture was stirred for 30 min. 1-
Chloro-2-methoxyethane (451 mg, 4.76 mmol) was then added at 0 °C and the reaction mixture was 
stirred at 100 °C overnight. The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted 
with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column 
chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.43) to give the product 135b (1.22 g, 3.94 mmol, 
99% yield) as a brown oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.66 (d, J = 2.4 Hz, 1H), 7.35 (dd, J = 8.8, 2.4 Hz, 1H), 6.80 
(d, J = 8.8 Hz, 1H), 4.31 – 3.99 (m, 2H), 3.86 – 3.74 (m, 2H), 3.47 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 154.8, 135.7, 131.3, 114.9, 113.4, 70.9, 69.4, 59.7. 
IR (ATR, cm-1) ṽ = 2926, 2879, 1579, 1474, 1449, 1382, 1369, 1283, 1264, 1246, 1197, 1150, 1127, 
1097, 1083, 1057, 1041, 926, 866, 798, 696, 677. 
MS (EI, 70 eV, %) m/z = 312 (48), 310 (97), 308 (50), 254 (47), 252 (100), 251 (12), 250 (53), 225 
(16), 223 (33), 221 (17), 156 (13), 154 (13), 145 (10), 143 (10), 75 (11), 63 (12), 59 (64).  
HRMS (EI, 70 eV) m/z: calc. for C9H10Br2O2: 307.9048; found: 307.9041. 
 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 2,4-dibromophenol (5.04 g, 20.0 mmol), DMF (10 mL) and K2CO3 (3.32 g, 24.0 mmol) and stirred 
for 5 min. Allyl bromide (2.42 g, 20.0 mmol) was slowly added and the reaction mixture was stirred 
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overnight. The mixture was diluted with water (100 mL) and extracted with hexanes (3 x 100 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
product was purified via silica plug (isohexane) to give the product 135c (4.87 g, 16.7 mmol, 84% yield) 
as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.67 (d, J = 2.4 Hz, 1H), 7.35 (dd, J = 8.8, 2.4 Hz, 1H), 6.76 
(d, J = 8.8 Hz, 1H), 6.04 (ddt, J = 17.3, 10.2, 5.0 Hz, 1H), 5.47 (dq, J = 17.3, 1.7 Hz, 1H), 5.32 (dq, J = 
10.6, 1.5 Hz, 1H), 4.59 (dt, J = 5.0, 1.6 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 154.4, 135.7, 132.3, 131.3, 118.2, 114.8, 113.3 (2C), 70.0. 
 
The spectra matched those of the literature.188 
 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with iPrMgCl·LiCl (7.9 mL, 8.70 mmol) and was cooled to –50 °C. 1,2,4-Tribromobenzene (2.50 g, 
7.90 mmol) was added at –50 °C and the reaction mixture was stirred for 2 h. The completion of the 
bromine/magnesium exchange was checked by GC-analysis of reaction aliquots quenched with water, 
using undecane as internal standard. Trimethylsilyl chloride (2.0 mL, 15.8 mmol) was then added at –
20 °C and the reaction mixture was allowed to warm to room temperature overnight. After complete 
conversion, the mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 
mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column chromatography 
(isohexane, Rf = 0.90) to give the product 139c (2.08 g, 6.75 mmol, 85% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.40 (d, J = 2.5 Hz, 1H), 7.28 (s, 1H), 7.19 (dd, J = 8.4, 2.5 Hz, 
1H), 0.30 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 144.2, 138.7, 134.5, 133.7, 128.9, 121.6, –0.6. 
IR (ATR, cm-1) ṽ = 2954, 2899, 1560, 1541, 1535, 1438, 1407, 1355, 1260, 1249, 1136, 1102, 1084, 
1045, 1024, 1013, 886, 837, 810, 761, 751, 703, 690, 661. 
 
188 W. Lasek, M. Makosza, Synthesis 1993, 780. 
C. EXPERIMENTAL PART    90 
 
MS (EI, 70 eV, %) m/z = 308 (12), 295 (50), 293 (100), 291 (52), 213 (23), 211 (28), 171 (13), 169 
(13), 149 (27), 131 (50), 105 (22).  
HRMS (EI, 70 eV) m/z: calc. for C9H12Br2Si: 305.9075; found: 305.9066. 
 




A dry and argon flushed round-bottomed-flask, equipped with a magnetic stirring bar, was charged with 
diisopropylamine (2.18 mL, 15.5 mmol) and freshly distilled THF (45 mL). The mixture was cooled to 
–78 °C and nBuLi (6.62 mL, 14.1 mmol) was slowly added. The reaction mixture was stirred for 10 
min then cooled to 0 °C for 5 min. Then, 2,5-dibromo-3-fluoropyridine (135g, 3.6 g, 14.1 mmol, 
dissolved in 10 mL THF) was slowly added at –78 °C and the mixture was stirred for 1 h. After 
completion of the deprotonation, 1,1,2-trichloro-1,2,2-trifluoroethane (2.51 mL, 21.2 mmol) was slowly 
added at –78 °C. The reaction mixture was allowed to warm to room temperature overnight. The mixture 
was then quenched with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 mL) and extracted 
with ethyl acetate (3 x 30 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified via column chromatography (isohexane, Rf = 
0.28) to give the product 143e (2.67 g, 9.23 mmol, 65% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.38 (s, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.1 (d, J = 265.7 Hz), 147.0 (d, J = 6.6 Hz), 132.8 (d, J = 
17.9 Hz), 129.0 (d, J = 23.8 Hz), 121.4 (d, J = 4.5 Hz). 
19F-NMR (377 MHz, CDCl3, ppm)  = –107.3. 
IR (ATR, cm-1) ṽ = 1540, 1418, 1394, 1280, 1212, 1190, 1121, 1102, 907, 891, 807, 784. 
MS (EI, 70 eV, %) m/z = 293 (12), 291 (70), 289 (100), 287 (42), 212 (16), 210 (64), 208 (49), 131 
(21), 129 (62), 94 (11).  
HRMS (EI, 70 eV) m/z: calc. for C5HBr2ClFN: 288.8128; found: 288.8124. 
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Under air, 1-bromo-2-methoxy-4-methylbenzene (3.00 g, 14.9 mmol), (diacetoxy)iodobenzene (2.64 g, 
8.21 mmol) and finely crushed iodine (2.08 g, 8.21 mmol) were suspended in a mixture of acetic acid 
(30 mL) and acetic anhydride (15 mL). Then, H2SO4 (96% aq., 0.762 mL, 14.9 mmol) was added 
dropwise to start the reaction (exothermic addition), and then more slowly to avoid going over 40 °C. 
After coming back to room temperature, the mixture was diluted with DCM and the phases were 
separated. The organic phase was washed with water and then stirred vigorously with a 1.00 M NaOH 
solution in an Erlenmeyer-flask in order to quench the remaining AcOH/Ac2O. Only then a 0.10 M 
Na2S2O3 solution was added to quench the remaining iodine. The organic phase was dried and the 
solvent removed under reduced pressure. Then, the iodobenzene by-product was removed under 
vacuum. Recrystallization from MeOH (reflux to –18 °C) afforded the product 148b (3.90 g, 11.9 mmol, 
80% yield) as white crystals. 
 
M.p. (°C): 108-110. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.89 (s, 1H), 6.79 (s, 1H), 3.87 (s, 3H), 2.39 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.1, 141.9 (d, J = 18.7 Hz), 113.4, 109.4, 89.5, 56.4, 28.2. 
IR (ATR, cm-1) ṽ = 2934, 1577, 1557, 1484, 1471, 1457, 1438, 1357, 1282, 1248, 1189, 1172, 1049, 
878, 842. 
MS (EI, 70 eV, %) m/z = 328 (99), 326 (100), 313 (30), 311 (31), 283 (10), 204 (17), 158 (12), 156 
(11), 77 (15).  
HRMS (EI, 70 eV) m/z: calc. for C8H8BrIO: 325.8803; found: 325.8799. 
  
 
189 Procedure from: Q. Dherbassy, J.-P. Djukic, J. Wencel-Delord, F. Colobert, Angew. Chem. Int. Ed. 2018, 57, 
4668. 
C. EXPERIMENTAL PART    92 
 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 3-isopropylphenol (2.74 mL, 20.0 mmol) and DCM (35 mL) and was cooled down to 0 °C. Br2 
(1.05 mL, 20.4 mmol, in 17 mL DCM) was slowly added at 0 °C and the reaction mixture was allowed 
to warm to room temperature overnight. The mixture was quenched with a 0.10 M Na2S2O3 solution 
and extracted with DCM (3 x 30 mL). The combined organic extracts were dried over Na2SO4, filtered 
and concentrated in vacuo. The crude product was purified via column chromatography 
(isohexane:ethyl acetate = 99:1, Rf = 0.15) to give the product (1.70 g, 7.90 mmol, 40% yield) as a 
yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.35 (d, J = 8.2 Hz, 1H), 6.90 (d, J = 2.1 Hz, 1H), 6.69 (dd, J 
= 8.3, 2.1 Hz, 1H), 5.44 (s, 1H), 2.84 (p, J = 6.9 Hz, 1H), 1.22 (d, J = 6.9 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.1, 150.9, 131.7, 120.3, 114.2, 107.2, 33.9, 23.9. 
IR (ATR, cm-1) ṽ = 3508, 2962, 1595, 1573, 1482, 1461, 1439, 1420, 1346, 1306, 1289, 1254, 1202, 
1178, 1142, 1024, 941, 870, 806. 
MS (EI, 70 eV, %) m/z = 216 (39), 214 (39), 201 (90), 199 (91), 120 (100), 91 (17). 
HRMS (EI, 70 eV) m/z: calc. for C9H11BrO: 213.9993; found: 213.9987. 
 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 2-bromo-5-isopropylphenol (1.70 g, 7.90 mmol) and DMF (20 mL) and was cooled down to 0 °C. 
NaH (60%, 382 mg, 9.50 mmol) was slowly added at 0 °C and the reaction solution was stirred for 30 
min. Methyl iodide (0.76 mL, 11.9 mmol) was then added at 0 °C and the reaction was allowed to warm 
to room temperature overnight. The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), 
diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts 
 
190 Adapted procedure from: L. Shu, P. Wang, W. Liu, C. Gu, Org. Process Res. Dev. 2012, 16, 1866. 
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were dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column 
chromatography (isohexane, Rf = 0.33) to give the product (1.52 g, 6.63 mmol, 84% yield) as a yellow 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.43 (d, J = 8.1 Hz, 1H), 6.76 (d, J = 1.9 Hz, 1H), 6.72 (dd, J 
= 8.1, 2.0 Hz, 1H), 3.90 (s, 3H), 2.88 (p, J = 6.9 Hz, 1H), 1.24 (d, J = 6.9 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 155.8, 150.1, 133.1, 119.9, 110.6, 108.6, 56.2, 34.3, 24.1. 
IR (ATR, cm-1) ṽ = 2961, 2938, 1590, 1577, 1482, 1464, 1410, 1286, 1259, 1197, 1059, 1045, 1025, 
852, 812. 
MS (EI, 70 eV, %) m/z = 230 (33), 228 (34), 215 (79), 213 (80), 149 (17), 134 (100), 119 (19), 91 
(18). 
HRMS (EI, 70 eV) m/z: calc. for C10H13BrO: 228.0150; found: 228.0143. 
 




Under air, 1-bromo-2-methoxy-4-isopropylbenzene (1.51 g, 6.60 mmol), (diacetoxy)iodobenzene (1.20 
g, 3.73 mmol) and finely crushed iodine (936 mg, 3.73 mmol) were suspended in a mixture of acetic 
acid (13 mL) and acetic anhydride (6 mL). Then, H2SO4 (96% aq., 0.330 mL, 6.71 mmol) was added 
dropwise to start the reaction (exothermic addition), and then more slowly to avoid going over 40 °C. 
After coming back to room temperature, the mixture was diluted with DCM and the phases were 
separated. The organic phase was washed with water and then stirred vigorously with a 1.00 M NaOH 
solution in an Erlenmeyer-flask in order to quench the remaining AcOH/Ac2O. Only then a 0.10 M 
Na2S2O3 solution was added to quench the remaining iodine. The organic phase was dried and the 
solvent removed under reduced pressure. Then, the iodobenzene by-product was removed under 
vacuum. Recrystallization from MeOH (reflux to –18 °C) afforded the product 148c (1.06 g, 2.99 mmol, 
45% yield) as yellow crystals. 
 
M.p. (°C): 46-48. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.92 (s, 1H), 6.77 (s, 1H), 3.89 (s, 3H), 3.13 (p, J = 6.8 Hz, 
1H), 1.22 (d, J = 6.8 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.6, 151.2, 142.2, 109.9, 109.5, 89.3, 56.3, 38.2, 23.2. 
IR (ATR, cm-1) ṽ = 2962, 1576, 1469, 1440, 1386, 1361, 1338, 1244, 1083, 1047. 
C. EXPERIMENTAL PART    94 
 
MS (EI, 70 eV, %) m/z = 356 (48), 354 (49), 341 (40), 339 (41), 245 (11), 215 (10), 214 (96), 213 
(10), 212 (100), 171 (17), 169 (17), 148 (12), 147 (10), 133 (18), 127 (29), 118 (11), 117 (15), 115 (21), 
105 (23), 103 (22), 102 (12), 91 (12), 90 (19), 89 (36), 77 (21), 63 (10). 
HRMS (EI, 70 eV) m/z: calc. for C10H12BrIO: 353.9116; found: 353.9110. 
 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with butane-1-thiol (4.28 mL, 40.0 mmol), DCM (50 mL), water (25 mL) and iodine (5.58 g, 22 mmol) 
and stirred at room temperature for 30 min. The mixture was extracted with DCM (3 x 30 mL). The 
combined organic extracts were washed with water and dried over Na2SO4, filtered and concentrated in 
vacuo. The resulting solution of dibutyl disulfide was mixed with sodium benzenesulfinate (10.5 g, 64.0 
mmol), iodine (10.1 g, 40 mmol) and DCM (50 mL) and stirred for 22 h at room temperature. Then, a 
0.10 M Na2S2O3 solution was added to quench the excess of iodine. The organic phase was washed and 
dried and the solvent removed under reduced pressure to afford S-butyl benzenesulfonothioate (8.77 g, 
38.1 mmol, 95% yield) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.10 – 7.81 (m, 2H), 7.69 – 7.60 (m, 1H), 7.60 – 7.50 (m, 2H), 
3.00 (t, J = 7.4 Hz, 2H), 1.57 (tt, J = 8.8, 6.9 Hz, 2H), 1.32 (dq, J = 14.6, 7.3 Hz, 2H), 0.84 (t, J = 7.4 
Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 145.0, 133.7, 129.4, 127.1, 35.9, 30.7, 21.8, 13.5. 
IR (ATR, cm-1) ṽ = 2960, 2874, 1465, 1458, 1447, 1322, 1307, 1292, 1139, 1099, 1077, 1023, 999, 
754, 714, 685, 670. 
MS (EI, 70 eV, %) m/z = 141 (19), 125 (18), 97 (13), 89 (56), 77 (100), 55 (39). 
HRMS (EI, 70 eV) m/z: calc. for C10H14O2S2: 230.0435; found: 230.0507. 
  
 
191 Adapted procedure from: K. Fujiki, N. Tanifuji, Y. Sasaki, T. Yokoyama, Synthesis 2002, 343. 
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2.4 Additional Results and Screening Tables 
Complete table of optimization for Scheme 37 
 
Table 14: Screening of the regioselective Br/Mg exchange on 2,5-dibromo-3-methylthiophene 
(139a). 
 






1 iPrMgCl·LiCl[f] 60 80:20 99[a] 
2 sBuMgOR·LiOR (134a) 30 76:24 40[b] 
3 134a·TMEDA 30 99:1 66[b] 
4 sBu2Mg·2LiOR (134b) 5 90:10 99[c] 
5 tBu2Mg·2LiOR 5 70:30 99[c] 
6 nBu2Mg·2LiOR (134c) 5 84:16 99[c] 
7 134b·TMEDA 5 96:4 99[c] 
8[g] 134b·PMDTA 5 99:1 99[c] 
[a] Y = Cl·LiCl. [b] Y = OR·LiOR. [c] Y = thienyl·2LiOR(·ligand). [d] R = 2-
ethylhexyl, these reactions were carried out at 0.50  using 1.20 equiv of 
alkylmagnesium species. Reagents are displayed accordingly to their 
stoichiometry and not their actual structure. [e] Conversion determined by GC-
analysis of reaction aliquots after aqueous quench. [f] Reaction performed in 
THF at −20 °C. [g] When performed in THF, a ratio 140a:141a = 71:29 and a 
conversion of 53% were obtained. 
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Complete table of optimization for Table 2 
 
Table 15: Br/Mg exchange on 2,5-dibromopyridine (143a) using various exchange reagents. 
 
Entry Exchange reagent[d] Solvent Time (min) Ratio 144a:145a Conv. [%][e] 
1 iPrMgCl·LiCl THF 120 99:1 94[a] 
2 sBuMgOR·LiOR (134a) toluene 60 1:99 20[b] 
3 sBu2Mg·2LiOR (134b) toluene 30 1:99 99[c] 
4 134a·TMEDA toluene 60 99:1 81[b] 
5 134b·PMDTA toluene 30 99:1 99[c] 
[a] Y = Cl·LiCl. [b] Y = OR·LiOR(·TMEDA). [c] Y = pyridyl·2LiOR(·PMDTA). [d] R = 2-ethylhexyl, 
these reactions were carried out at 0.50  using 1.20 equiv of alkylmagnesium species. Reagents are 
displayed accordingly to their stoichiometry and not their actual structure. [e] Conversion determined by 
GC-analysis of reaction aliquots after aqueous quench. 
 
Note: The addition of 12-crown-4 (2.40 equiv)192 had the same effect as a chelating ligand, producing 
a majority of 144a (144a:145a = 90:10) with 57% of conversion. 
  
 
192 For literature about 12-crown-4, a specific lithium cation ionophore, see: a) C. J. Pedersen, J. Am. Chem. Soc. 
1967, 89, 2495; b) C. J. Pedersen, J. Am. Chem. Soc. 1967, 89, 7017; c) F. A. L. Anet, J. Krane, J. Dale, K. 
Daasvatn, P. O. Kristiansen, Acta Chem. Scand. 1973, 27, 3395; d) A. Pullman, C. Giessner-Prettre, Y. V. 
Kruglyak, Chem. Phys. Lett. 1975, 35, 156. 
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Optimization Br/Mg vs. I/Mg exchanges 
 
Table 16: Br/Mg exchange in the presence of an iodine on 2-bromo-4-iodoanisole (148a). 
 






1 iPrMgCl.LiCl 60 99:1 81[a] 
2 sBu2Mg·2LiOR (134b) 30 24:76 99[b] 
3[f] nBu2Mg·2LiOR (134c) 30 20:80 99[b] (71) 
4  134c·PMDTA 30 99:1 99[b] 
[a] Y = Cl·LiCl. [b] Y = anisyl·2LiOR(·ligand). [c] R = 2-ethylhexyl, reactions were 
carried out at 0.05 M and −10 °C using 1.20 equiv of alkylmagnesium species. 
Reagents are displayed accordingly to their stoichiometry and not their actual 
structure. [d] A mixture of 2-bromoanisole and 4-bromoanisole was obtained by 
halogen dance when the reactions were done at 25 °C. An increase in concentration 
(0.5 M in toluene) hampered the selectivity. [e] Conversion determined by GC-
analysis of reaction aliquots after aqueous quench. Isolated yield in parenthesis. [f] 
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Additional results Br/Mg vs. I/Mg exchanges 
 
 
Scheme 62: Selective Br/Mg exchange with 2-bromo-4-iodoanisole (148a) followed by allylation[a] 
reaction: comparison with iPrMgCl·LiCl. 
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2.5 Preparation of Compounds 138 to 150 




Compound 138a was prepared via TP1 using 2,4-dibromoanisole (135a, 133 mg, 0.50 mmol) and dry 
toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added at 25 °C. After stirring 
at 25 °C for 5 min, CuCN·2LiCl (1.00  in THF, 50 µL, 50 µmol) and allyl bromide (34 µL, 0.40 
mmol) were added at 0 °C and the reaction mixture was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane, Rf = 0.43) to 
give the product 138a (65 mg, 286 µmol, 72% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.29 (dd, J = 8.6, 2.6 Hz, 1H), 7.26 – 7.21 (m, 1H), 6.72 (d, J 
= 8.6 Hz, 1H), 5.95 (ddt, J = 15.7, 11.2, 6.6 Hz, 1H), 5.09 (s, 1H), 5.06 (dt, J = 5.6, 1.8 Hz, 1H), 3.81 
(s, 3H), 3.34 (dt, J = 6.6, 1.6 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.5, 136.1, 132.5, 131.1, 130.0, 116.3, 112.8, 112.0, 55.7, 
34.0. 
IR (ATR, cm-1) ṽ = 2938, 2836, 1638, 1592, 1488, 1463, 1440, 1432, 1401, 1322, 1304, 1278, 1243, 
1172, 1135, 1127, 1032, 996, 917, 861, 804. 
MS (EI, 70 eV, %) m/z = 228 (45), 226 (46), 199 (24), 197 (26), 148 (11), 147 (100), 132 (84), 131 
(70), 119 (17), 118 (91), 117 (12), 115 (36), 104 (11), 103 (18), 91 (73), 90 (12), 89 (13), 77 (12). 
HRMS (EI, 70 eV) m/z: calc. for C10H11BrO: 225.9993; found: 225.9978. 
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Compound 138b was prepared via TP1 using 2,4-dibromo-1-(2-methoxyethoxy)benzene (135b, 
155 mg, 0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was 
added at 25 °C. After stirring at 25 °C for 5 min, S-methyl methanesulfonothioate (51 mg, 0.40 mmol) 
was added and the reaction mixture was allowed to stir at room temperature overnight. After work-up, 
the crude product was purified via column chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.44) 
to give the product 138b (86 mg, 310 µmol, 78% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.23 – 7.11 (m, 2H), 6.70 (d, J = 8.2 Hz, 1H), 4.18 – 4.11 (m, 
2H), 3.90 – 3.68 (m, 2H), 3.46 (s, 3H), 2.41 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 154.6, 130.6, 128.2, 128.0, 114.0, 113.1, 71.0, 68.8, 59.6, 14.6. 
IR (ATR, cm-1) ṽ = 2923, 2879, 1573, 1472, 1450, 1438, 1382, 1368, 1300, 1266, 1238, 1198, 1128, 
1087, 1074, 1050, 1033, 924, 854, 799, 733, 713. 
MS (EI, 70 eV, %) m/z = 278 (20), 276 (20), 220 (100), 218 (99), 205 (16), 203 (16), 138 (14). 
HRMS (EI, 70 eV) m/z: calc. for C10H13BrO2S: 275.9820; found: 275.9813. 
 




Compound 138c was prepared via TP1 using 1-(allyloxy)-2,4-dibromobenzene (135c, 146 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added 
at 25 °C. After stirring at 25 °C for 5 min, N-methoxy-N-methylacetamide (41 mg, 0.40 mmol) was 
added and the reaction mixture was allowed to warm to room temperature overnight. After work-up, 
the crude product was purified via column chromatography (isohexane:ethyl acetate = 98:2, Rf = 0.27) 
to give the product 138c (65 mg, 255 µmol, 64% yield) as a white solid. 
 
M.p. (°C): 56-58. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.83 (d, J = 2.6 Hz, 1H), 7.51 (dd, J = 8.8, 2.6 Hz, 1H), 6.84 
(d, J = 8.8 Hz, 1H), 6.06 (ddt, J = 17.3, 10.6, 5.4 Hz, 1H), 5.42 (dq, J = 17.3, 1.5 Hz, 1H), 5.34 (dq, J = 
10.5, 1.3 Hz, 1H), 4.62 (dt, J = 5.3, 1.5 Hz, 2H), 2.62 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 198.5, 157.0, 136.1, 133.2, 132.3, 130.2, 118.8, 114.9, 113.5, 
69.9, 32.0. 
IR (ATR, cm-1) ṽ = 3093, 2931, 1660, 1628, 1588, 1566, 1481, 1460, 1423, 1409, 1398, 1369, 1352, 
1296, 1280, 1233, 1223, 1153, 1064, 1021, 1002, 992, 976, 931, 906, 816, 655. 
MS (EI, 70 eV, %) m/z = 241 (38), 239 (41), 213 (20), 211 (21), 201 (96), 199 (100), 160 (16), 132 
(32), 131 (17), 129 (15), 78 (15). 
HRMS (EI, 70 eV) m/z: calc. for C11H11BrO2: 253.9942; found: 253.9937. 
 




Compound 138d was prepared via TP1 using 2,4,6-tribromoanisole (135d, 172 mg, 0.50 mmol) and 
dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added at 25 °C. After 
stirring at 25 °C for 5 min, CuCN·2LiCl (1.00  in THF, 50 µL, 50 µmol) and 3-bromo-2-methylprop-
1-ene (40 µL, 0.40 mmol) were added at 0 °C and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane, Rf = 0.39) to give the product 138d (111 mg, 347 µmol, 87% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.56 (d, J = 2.4 Hz, 1H), 7.31 – 7.14 (m, 1H), 4.89 (s, 1H), 4.67 
(s, 1H), 3.79 (s, 3H), 3.35 (s, 2H), 1.72 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 154.9, 143.7, 136.8, 133.9, 132.8, 118.4, 117.2, 113.2, 61.2, 
38.2, 22.6. 
IR (ATR, cm-1) ṽ = 2938, 1652, 1576, 1553, 1461, 1438, 1417, 1393, 1375, 1276, 1251, 1220, 1147, 
1001, 895, 859, 810, 805, 753, 667. 
MS (EI, 70 eV, %) m/z = 322 (15), 320 (32), 318 (17), 241 (12), 239 (13), 226 (34), 225 (13), 224 
(31), 212 (11), 211 (21), 210 (12), 209 (22), 198 (10), 196 (12), 161 (10), 160 (69), 159 (19), 155 (14), 
146 (12), 145 (100), 144 (11), 129 (21), 128 (31), 117 (28), 116 (11), 115 (69), 102 (14), 91 (18), 89 
(26), 76 (10), 75 (16). 
HRMS (EI, 70 eV) m/z: calc. for C11H12Br2O: 317.9255; found: 317.9243. 
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Compound 138ea was prepared via TP1 using 3,5-dibromo-2-methoxypyridine (135e, 133 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added 
at 25 °C. After stirring at 25 °C for 5 min, CuCN·2LiCl (1.00  in THF, 50 µL, 50 µmol) and 3-bromo-
2-methylprop-1-ene (40 µL, 0.40 mmol) were added at 0 °C and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 96:4, Rf = 0.50) to give the product 138ea (78 mg, 
322 µmol, 81% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.06 (d, J = 2.5 Hz, 1H), 7.47 (dt, J = 2.6, 0.7 Hz, 1H), 4.95 – 
4.79 (m, 1H), 4.67 (dd, J = 2.1, 1.0 Hz, 1H), 3.91 (s, 3H), 3.24 (s, 2H), 1.71 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 161.3, 145.1, 142.9, 140.5, 124.7, 113.0, 111.8, 53.9, 37.4, 
22.5. 
IR (ATR, cm-1) ṽ = 2976, 2950, 1653, 1578, 1569, 1560, 1465, 1414, 1390, 1376, 1308, 1247, 1154, 
1138, 1020, 893, 752. 
MS (EI, 70 eV, %) m/z = 243 (99), 242 (59), 241 (100), 240 (61), 228 (78), 226 (79), 214 (50), 212 
(71), 210 (74), 200 (65), 198 (96), 196 (30), 188 (72), 186 (74), 172 (28), 170 (27), 147 (54), 146 (86), 
130 (42), 129 (32), 119 (72), 118 (70), 117 (28), 91 (27). 
HRMS (EI, 70 eV) m/z: calc. for C10H12BrNO: 241.0102; found: 241.0097. 
 




Compound 138eb was prepared via TP1 using 3,5-dibromo-2-methoxypyridine (135e, 133 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added 
at 25 °C. After stirring at 25 °C for 5 min, (4-chlorophenyl)(cyclopropyl)methanone (72 mg, 0.40 mmol) 
was added and the reaction solution was allowed to warm to room temperature overnight. After work-
up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 95:5, Rf = 
0.28) to give the product 138eb (100 mg, 271 µmol, 68% yield) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 8.16 (q, J = 2.4 Hz, 2H), 7.44 – 6.93 (m, 4H), 3.87 (d, J = 1.0 
Hz, 1H), 3.73 (s, 3H), 1.45 (ddtd, J = 8.2, 6.5, 5.5, 1.1 Hz, 1H), 0.66 – 0.50 (m, 3H), 0.46 (ddt, J = 7.9, 
5.4, 2.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.7, 146.4, 144.6, 138.8, 133.0, 131.0, 128.1, 127.2, 112.4, 
75.3, 54.0, 20.3, 1.9, 1.6. 
IR (ATR, cm-1) ṽ = 3546, 3011, 2952, 1578, 1564, 1489, 1461, 1409, 1381, 1331, 1294, 1242, 1202, 
1175, 1154, 1146, 1120, 1105, 1092, 1014, 985, 970, 942, 927, 899, 882, 871, 833, 806, 758, 734, 720, 
681. 
MS (EI, 70 eV, %) m/z = 343 (10), 341 (42), 339 (33), 216 (98), 214 (100), 139 (21). 
HRMS (EI, 70 eV) m/z: calc. for C16H15BrClNO2: 366.9975; found: 366.9971. 
 




Compound 138ec was prepared via TP1 using 3,5-dibromo-2-methoxypyridine (135e, 133 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added 
at 25 °C. After stirring at 25 °C for 5 min, ZnCl2 (1.00  in THF, 0.65 mL, 0.65 mmol), Pd(OAc)2 (5 
mg, 4 mol%), SPhos (17 mg, 8 mol%) and 4-iodobenzonitrile (92 mg, 0.40 mmol) were added and the 
reaction mixture was stirred at room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.74) to give the product 138ec 
(61 mg, 211 µmol, 53% yield) as a white solid. 
 
M.p. (°C): 155-157. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.25 (d, J = 2.4 Hz, 1H), 7.75 – 7.70 (m, 3H), 7.68 – 7.62 (m, 
2H), 3.96 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.6, 147.6, 140.9, 140.2, 132.3, 130.0, 124.4, 118.8, 112.2, 
111.9, 54.3. 
IR (ATR, cm-1) ṽ = 2955, 2226, 1742, 1608, 1566, 1463, 1415, 1395, 1299, 1245, 1220, 1032, 1017, 
1006, 843, 772. 
MS (EI, 70 eV, %) m/z = 290 (30), 289 (100), 288 (32), 287 (99), 273 (14), 271 (30), 269 (15), 259 
(12), 208 (15), 207 (13), 194 (22), 180 (50), 179 (54), 178 (13), 166 (30), 165 (29), 152 (20), 151 (20), 
140 (16), 139 (58), 138 (34), 125 (14), 88 (13), 86 (15). 
HRMS (EI, 70 eV) m/z: calc. for C13H9BrN2O: 287.9898; found: 287.9901. 
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Compound 138f was prepared via TP1 using 2,5-dibromo-3-chloropyridine (135f, 136 mg, 0.50 mmol) 
and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added at –20 °C. 
After stirring at –20 °C for 30 min, S-methyl methanesulfonothioate (51 mg, 0.40 mmol) was added 
and the reaction solution was allowed to warm to room temperature overnight. After work-up, the crude 
product was purified via column chromatography (isohexane, Rf = 0.31) to give the product 138f 
(57 mg, 239 µmol, 60% yield) as a white solid. 
 
M.p. (°C): 65-67. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.41 (d, J = 2.1 Hz, 1H), 7.68 (d, J = 2.0 Hz, 1H), 2.53 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 157.1, 148.0, 137.7, 129.4, 114.8, 13.7. 
IR (ATR, cm-1) ṽ = 3037, 2924, 1548, 1415, 1351, 1220, 1210, 1150, 1105, 1036, 900, 894, 812, 718. 
MS (EI, 70 eV, %) m/z = 241 (18), 239 (72), 238 (30), 237 (56), 236 (24), 208 (13), 206 (54), 204 
(100), 202 (98), 194 (12), 193 (18), 191 (14), 125 (14), 112 (26). 
HRMS (EI, 70 eV) m/z: calc. for C6H5BrClNS: 236.9015; found: 236.9010. 
 




Compound 138g was prepared via TP1 using 2,5-dibromo-3-fluoropyridine (135g, 128 mg, 0.50 mmol) 
and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added at –20 °C. 
After stirring at –20 °C for 30 min, N-methoxy-N-methylthiophene-2-carboxamide (69 mg, 0.40 mmol) 
was added and the reaction solution was allowed to warm to room temperature overnight. After work-
up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 97:3, Rf = 
0.20) to give the product 138g (75 mg, 262 µmol, 66% yield) as a yellow solid. 
 
M.p. (°C): 134-136. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.60 (dd, J = 1.8, 0.9 Hz, 1H), 7.98 (dd, J = 3.9, 1.2 Hz, 1H), 
7.88 – 7.70 (m, 2H), 7.17 (dd, J = 4.9, 3.9 Hz, 1H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 181.3 (d, J = 4.6 Hz), 158.0 (d, J = 277.1 Hz), 145.6 (d, J = 
5.3 Hz), 141.5 (d, J = 8.4 Hz), 141.2, 136.7, 136.5, 128.6 (d, J = 21.4 Hz), 128.2, 123.7 (d, J = 3.4 Hz). 
19F-NMR (377 MHz, CDCl3, ppm)  = –117.6. 
IR (ATR, cm-1) ṽ = 3109, 3097, 3068, 2924, 1656, 1634, 1572, 1514, 1442, 1436, 1408, 1396, 1353, 
1307, 1234, 1218, 1199, 1134, 1082, 1050, 909, 882, 868, 862, 826, 782, 729, 716, 679, 660. 
MS (EI, 70 eV, %) m/z = 259 (62), 257 (60), 111 (100). 
HRMS (EI, 70 eV) m/z: calc. for C10H5BrFNOS: 284.9259; found: 284.9250. 
 




Compound 138aa was prepared via TP1 using 2,4-dibromoanisole (135a, 266 mg, 1.00 mmol) and dry 
toluene (2.0 mL). Then, sBu2Mg·2LiOR (134b, 0.76 mL, 0.60 mmol) was added at 25 °C. After stirring 
at 25 °C for 5 min, CuCN·2LiCl (1.00  in THF, 100 µL, 100 µmol) and 2-fluorobenzoyl chloride 
(0.36 mL, 3.00 mmol) were added at 0 °C and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 95:5, Rf = 0.18) to give the product 138aa (233 mg, 754 µmol, 75% yield) 
as a white solid. 
 
M.p. (°C): 57-59. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.71 (td, J = 7.5, 1.9 Hz, 1H), 7.64 (d, J = 2.6 Hz, 1H), 7.57 
(dd, J = 8.8, 2.6 Hz, 1H), 7.51 (dddd, J = 8.3, 7.2, 5.0, 1.9 Hz, 1H), 7.23 (td, J = 7.5, 1.1 Hz, 1H), 7.06 
(ddd, J = 10.7, 8.3, 1.1 Hz, 1H), 6.84 (d, J = 8.8 Hz, 1H), 3.66 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 191.1, 161.3 (d, J = 255.5 Hz), 157.5 (d, J = 1.7 Hz), 135.7, 
134.1 (d, J = 8.8 Hz), 132.8 (d, J = 0.7 Hz), 131.4 (d, J = 1.2 Hz), 131.0 (d, J = 2.1 Hz), 127.8 (d, J = 
11.8 Hz), 124.3 (d, J = 3.6 Hz), 116.1 (d, J = 22.3 Hz), 113.5, 113.1, 56.0. 
19F-NMR (377 MHz, CDCl3, ppm)  = –112.3. 
IR (ATR, cm-1) ṽ = 2939, 1655, 1610, 1591, 1576, 1482, 1454, 1396, 1301, 1271, 1255, 1238, 1215, 
1181, 1162, 1152, 1126, 1101, 1023, 954, 832, 813, 790, 758. 
MS (EI, 70 eV, %) m/z = 310 (37), 308 (39), 293 (40), 291 (29), 215 (72), 213 (92), 212 (91), 201 
(71), 199 (76), 123 (100).  
HRMS (EI, 70 eV) m/z: calc. for C14H10BrFO2: 307.9848; found: 307.9843. 
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Synthesis of 2-bromo-9H-xanthen-9-one (138ab) 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with (5-bromo-2-methoxyphenyl)(2-fluorophenyl)methanone (138aa, 106 mg, 0.34 mmol) and 
dissolved in dry DCM (1.0 mL). Then, BBr3 (1.00  in DCM, 0.68 mL, 0.68 mmol) was added dropwise 
at –78 °C and the reaction solution was allowed to warm to room temperature overnight. The mixture 
was quenched with water (10 mL) and extracted with ether (3 x 30 mL). The combined organic extracts 
were dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.44) to give the product (5-bromo-2-
hydroxyphenyl)(2-fluorophenyl)methanone (98 mg, 332 µmol, 98% yield) as a yellow solid. 
 
M.p. (°C): 88-90. 
1H-NMR (400 MHz, CDCl3, ppm)  = 11.89 (s, 1H), 7.63 – 7.54 (m, 2H), 7.51 (t, J = 2.7 Hz, 1H), 
7.47 (ddd, J = 8.5, 6.6, 1.8 Hz, 1H), 7.32 (td, J = 7.5, 1.0 Hz, 1H), 7.23 (ddd, J = 9.5, 8.4, 1.0 Hz, 1H), 
6.98 (d, J = 8.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 197.8, 162.1, 159.3 (d, J = 252.2 Hz), 139.8, 135.3 (d, J = 2.6 
Hz), 133.6 (d, J = 8.3 Hz), 130.0 (d, J = 2.7 Hz), 125.8 (d, J = 15.5 Hz), 124.7 (d, J = 3.6 Hz), 121.1, 
120.6, 116.7 (d, J = 21.3 Hz), 110.8. 
19F-NMR (377 MHz, CDCl3, ppm)  = –111.9. 
IR (ATR, cm-1) ṽ = 3072, 1629, 1613, 1583, 1485, 1464, 1452, 1400, 1330, 1293, 1268, 1238, 1212, 
1159, 1149, 1122, 1100, 1084, 951, 944, 838, 829, 816, 792, 759, 720. 
MS (EI, 70 eV, %) m/z = 296 (37), 295 (96), 294 (39), 293 (100), 277 (37), 276 (31), 275 (32), 274 
(32), 201 (34), 200 (47), 199 (35), 198 (42), 172 (28), 170 (29), 145 (17), 143 (18), 123 (72).  
HRMS (EI, 70 eV) m/z: calc. for C13H8BrFO2: 293.9692; found: 293.9693. 
  
 
193 Adapted procedure from: J. F. W. McOmie, D. E. West, Org. Synth. 1969, 49, 50. 
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A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with (5-bromo-2-hydroxyphenyl)(2-fluorophenyl)methanone (88 mg, 0.30 mmol), K2CO3 (83 mg, 0.60 
mmol) and dry acetone (3.0 mL). Then, the tube was sealed and stirred at 50 °C for 4 h. The mixture 
was quenched with water (10 mL) and extracted with ether (3 x 30 mL). The combined organic extracts 
were dried over Na2SO4, filtered and concentrated in vacuo to give the product 138ab (81 mg, 
294 µmol, 98% yield) as an off-white solid. 
 
M.p. (°C): 146-148. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.45 (d, J = 2.4 Hz, 1H), 8.33 (dd, J = 8.0, 1.8 Hz, 1H), 7.80 
(dd, J = 8.9, 2.5 Hz, 1H), 7.75 (ddd, J = 8.7, 7.1, 1.8 Hz, 1H), 7.50 (dd, J = 8.5, 1.1 Hz, 1H), 7.44 – 7.36 
(m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 176.2, 156.2, 155.1, 137.8, 135.4, 129.4, 127.0, 124.4, 123.3, 
121.7, 120.2, 118.2, 117.2. 
IR (ATR, cm-1) ṽ = 3077, 2925, 1663, 1616, 1606, 1472, 1458, 1439, 1424, 1337, 1315, 1266, 1216, 
1170, 1153, 1132, 1108, 882, 843, 824, 756, 718, 680, 672. 
MS (EI, 70 eV, %) m/z = 277 (14), 276 (98), 275 (17), 274 (100), 248 (19), 246 (20), 195 (27), 139 
(78). 
HRMS (EI, 70 eV) m/z: calc. for C13H7BrO2: 273.9629; found: 273.9625. 
 




Compound 142a was prepared via TP1 using 2,5-dibromo-3-methylthiophene (139a, 128 mg, 
0.50 mmol), dry toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 
0.36 mL, 0.30 mmol) was added at 25 °C. After stirring at 25 °C for 5 min, 3-methoxybenzaldehyde 
(55 mg, 0.40 mmol) was added and the reaction solution was allowed to stir at room temperature 
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overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 9:1, Rf = 0.25) to give the product 142a (100 mg, 319 µmol, 80% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.36 – 7.19 (m, 1H), 7.05 – 6.94 (m, 2H), 6.85 (ddd, J = 8.3, 
2.5, 1.1 Hz, 1H), 6.61 – 6.47 (m, 1H), 5.86 (d, J = 3.7 Hz, 1H), 3.81 (s, 3H), 2.39 (dd, J = 3.9, 0.9 Hz, 
1H), 2.10 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.9, 147.1, 144.2, 136.9, 129.9, 126.9, 118.7, 113.8, 111.8, 
109.5, 72.6, 55.4, 15.4. 
IR (ATR, cm-1) ṽ = 2975, 1608, 1600, 1587, 1489, 1464, 1455, 1436, 1316, 1281, 1263, 1256, 1156, 
1131, 1094, 1082, 1050, 1020, 765. 
MS (EI, 70 eV, %) m/z = 314 (18), 312 (18), 234 (13), 233 (100), 207 (14), 205 (37), 203 (23), 201 
(14), 190 (11), 178 (14), 176 (14), 173 (11), 172 (83), 157 (15), 135 (83), 129 (16), 128 (17), 125 (17), 
115 (11), 109 (16), 98 (24), 97 (35), 94 (11), 92 (12), 77 (20). 
HRMS (EI, 70 eV) m/z: calc. for C13H13BrO2S: 311.9820; found: 311.9813. 
 




Compound 142b was prepared via TP1 using 2,4,5-tribromo-3-methylthiophene (139b, 167 mg, 
0.50 mmol), dry toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 
0.36 mL, 0.30 mmol) was added at 25 °C. After stirring at 25 °C for 5 min, bis(4-
(dimethylamino)phenyl)methanone (107 mg, 0.40 mmol) was added and the reaction solution was 
allowed to stir at room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.41) to give the product 142b (128 mg, 244 µmol, 
61% yield) as a blue oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.22 – 7.10 (m, 4H), 6.73 – 6.52 (m, 4H), 3.73 (s, 1H), 2.95 (s, 
12H), 2.18 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 150.0, 147.4, 137.8, 133.0, 128.7, 111.5, 110.0, 108.3, 79.7, 
40.6, 16.2. 
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IR (ATR, cm-1) ṽ = 2918, 1610, 1585, 1543, 1518, 1481, 1443, 1369, 1321, 1286, 1269, 1228, 1188, 
1171, 1129, 1115, 1063, 1022, 945, 819, 754. 
MS (EI, 70 eV, %) m/z = 526 (39), 525 (17), 524 (63), 523 (11), 522 (35), 510 (21), 509 (49), 508 
(43), 507 (84), 506 (23), 505 (44), 444 (23), 442 (17), 430 (16), 429 (21), 428 (16), 427 (18), 404 (14), 
364 (11), 349 (10), 348 (12), 347 (20), 331 (11), 308 (16), 306 (12), 283 (16), 270 (18), 269 (74), 268 
(26), 253 (16), 241 (10), 149 (10), 148 (100), 121 (18), 120 (16), 44 (30). 
HRMS (EI, 70 eV) m/z: calc. for C22H24Br2N2OS: 521.9976; found: 521.9969. 
 




Compound 142c was prepared via TP1 using (2,5-dibromophenyl)trimethylsilane (139c, 154 mg, 
0.50 mmol), dry toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 
0.36 mL, 0.30 mmol) was added at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  
in THF, 50 µL, 50 µmol) and allyl bromide (34 µL, 0.40 mmol) were added and the reaction mixture 
was allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane, Rf = 0.80) to give the product 142c (89 mg, 331 µmol, 83% yield) 
as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.45 (d, J = 8.1 Hz, 1H), 7.24 (d, J = 2.4 Hz, 1H), 7.03 (dd, J 
= 8.1, 2.4 Hz, 1H), 6.03 – 5.84 (m, 1H), 5.17 – 5.02 (m, 2H), 3.34 (dt, J = 6.8, 1.5 Hz, 2H), 0.39 (s, 
9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 141.1, 138.3, 137.1, 136.5, 132.8, 131.2, 128.1, 116.3, 39.8, –
0.4. 
IR (ATR, cm-1) ṽ = 2954, 2899, 1456, 1447, 1436, 1380, 1262, 1250, 1140, 1109, 1016, 992, 914, 871, 
839, 814, 761, 690. 
MS (EI, 70 eV, %) m/z = 273 (12), 271 (12), 268 (10), 256 (10), 255 (100), 254 (10), 253 (99), 191 
(11), 173 (44), 171 (13), 163 (29), 145 (86), 139 (10), 137 (11), 133 (10), 131 (27), 129 (34), 128 (10), 
115 (13), 91 (12), 75 (10). 
HRMS (EI, 70 eV) m/z: calc. for C12H17BrSi: 268.0283; found: 268.0277. 
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Compound 142d was prepared via TP1 using 1,4-dibromo-2-methylbenzene (139d, 125 mg, 
0.50 mmol), dry toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 
0.36 mL, 0.30 mmol) was added at 25 °C. After stirring at 25 °C for 5 min, CuCN·2LiCl (1.00  in 
THF, 50 µL, 50 µmol) and 3-bromocyclohexene (46 µL, 0.40 mmol) were added at 0 °C and the 
reaction mixture was allowed to warm to room temperature overnight. After work-up, the crude product 
was purified via column chromatography (isohexane, Rf = 0.71) to give the product 142d (66 mg, 
263 µmol, 66% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.44 (d, J = 8.2 Hz, 1H), 7.08 (d, J = 2.2 Hz, 1H), 6.90 (dd, J 
= 8.2, 2.3 Hz, 1H), 5.90 (dtd, J = 9.8, 3.7, 2.3 Hz, 1H), 5.71 – 5.58 (m, 1H), 3.33 (ddt, J = 8.3, 5.5, 2.8 
Hz, 1H), 2.38 (s, 3H), 2.08 (ddq, J = 6.8, 3.6, 2.0, 1.5 Hz, 2H), 2.03 – 1.95 (m, 1H), 1.79 – 1.68 (m, 
1H), 1.67 – 1.56 (m, 1H), 1.53 – 1.46 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 146.1, 137.7, 132.2, 130.4, 129.8, 128.8, 127.0, 122.3, 41.4, 
32.7, 25.1, 23.1, 21.2. 
IR (ATR, cm-1) ṽ = 2929, 2860, 1653, 1477, 1446, 1436, 1027, 892, 878, 814, 756. 
MS (EI, 70 eV, %) m/z = 252 (41), 250 (42), 171 (51), 156 (23), 144 (10), 143 (100), 142 (11), 141 
(26), 129 (28), 128 (76), 115 (32), 105 (24), 79 (12). 
HRMS (EI, 70 eV) m/z: calc. for C13H15Br: 250.0357; found: 250.0350. 
 




Compound 146a was prepared via TP1 using 2,5-dibromopyridine (143a, 119 mg, 0.50 mmol), dry 
toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) 
was added at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  in THF, 50 µL, 50 µmol) 
and 3-bromocyclohexene (46 µL, 0.40 mmol) were added and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
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chromatography (isohexane:diethyl ether = 10:0.05, Rf = 0.15) to give the product 146a (69 mg, 
290 µmol, 72% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.23 (t, J = 1.7 Hz, 1H), 7.40 (d, J = 1.6 Hz, 2H), 5.96 (dtd, J 
= 9.9, 3.7, 2.3 Hz, 1H), 5.68 – 5.48 (m, 1H), 3.40 (ddt, J = 8.2, 5.5, 2.8 Hz, 1H), 2.09 (dddd, J = 8.9, 
5.4, 4.2, 2.6 Hz, 2H), 2.06 – 1.94 (m, 1H), 1.77 – 1.67 (m, 1H), 1.67 – 1.57 (m, 1H), 1.50 (dddd, J = 
13.1, 10.1, 8.1, 3.1 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.9, 141.3, 139.6, 138.2, 130.1, 128.2, 127.9, 38.8, 32.4, 
24.9, 20.8. 
IR (ATR, cm-1) ṽ = 2927, 2868, 2857, 1670, 1606, 1574, 1560, 1453, 1430, 1377, 1355, 1346, 1260, 
1190, 1088, 1022, 830. 
MS (EI, 70 eV, %) m/z = 240 (12), 239 (93), 238 (29), 237 (100), 236 (17), 224 (31), 222 (32), 211 
(27), 210 (39), 209 (31), 208 (33), 183 (10), 158 (24), 143 (17), 130 (70), 129 (12), 128 (15), 117 (23), 
116 (15), 104 (14), 103 (19), 89 (11), 79 (10), 77 (26), 51 (13), 41 (10).  
HRMS (EI, 70 eV) m/z: calc. for C11H12BrN: 237.0153; found: 237.0148. 
 




Compound 146b was prepared via TP1 using 2,5-dibromo-3-methylpyridine (143b, 251 mg, 
1.00 mmol), dry toluene (2.0 mL) and PMDTA (0.13 mL, 0.60 mmol). Then, sBu2Mg·2LiOR (134b, 
0.71 mL, 0.60 mmol) was added at –20 °C. After stirring at –20 °C for 30 min, S-butyl 
benzenesulfonothioate (184 mg, 0.80 mmol) was added and the reaction mixture was allowed to warm 
to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:diethyl ether = 98:2, Rf = 0.20) to give the product 146b (181 mg, 
696 µmol, 87% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.11 (d, J = 2.4 Hz, 1H), 7.67 – 7.40 (m, 1H), 3.04 – 2.72 (m, 
2H), 2.35 (s, 3H), 1.66 – 1.55 (m, 2H), 1.49 – 1.38 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 147.2, 142.0, 139.4, 135.2, 133.6, 33.6, 31.2, 22.0, 21.9, 13.7. 
IR (ATR, cm-1) ṽ = 2957, 2929, 2872, 1534, 1453, 1436, 1397, 1383, 1376, 1124, 1047, 718, 685. 
MS (EI, 70 eV, %) m/z = 261 (11), 259 (10), 232 (34), 230 (35), 228 (13), 226 (16), 219 (99), 218 
(17), 217 (100), 216 (18), 214 (15), 212 (15), 205 (83), 204 (25), 203 (82), 202 (24), 201 (14), 199 (14), 
186 (32), 184 (32), 173 (10), 172 (13), 171 (10), 170 (13), 161 (20), 159 (19).  
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HRMS (EI, 70 eV) m/z: calc. for C10H14BrNS: 259.0030; found: 259.0023. 
 




Compound 146c was prepared via TP1 using 2,5-dibromo-4-methylpyridine (143c, 126 mg, 
0.50 mmol), dry toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 
0.36 mL, 0.30 mmol) was added at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  
in THF, 50 µL, 50 µmol) and 3-bromocyclohexene (46 µL, 0.40 mmol) were added and the reaction 
solution was allowed to warm to room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane:diethyl ether = 99:1, Rf = 0.11) to give the product 
146c (99 mg, 393 µmol, 98% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.10 (s, 1H), 7.24 (s, 1H), 5.96 (dtd, J = 10.0, 3.7, 2.4 Hz, 1H), 
5.60 (dq, J = 9.9, 2.3 Hz, 1H), 3.53 (ddt, J = 8.2, 5.6, 2.8 Hz, 1H), 2.31 (s, 3H), 2.13 – 2.05 (m, 2H), 
2.00 – 1.90 (m, 1H), 1.76 – 1.65 (m, 1H), 1.64 – 1.55 (m, 1H), 1.45 (dddd, J = 12.9, 9.8, 7.7, 3.1 Hz, 
1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.7, 148.1, 139.7, 139.2, 129.9, 129.0, 128.2, 35.7, 30.2, 
24.9, 20.7, 18.7. 
IR (ATR, cm-1) ṽ = 2926, 2857, 2836, 1579, 1545, 1465, 1446, 1349, 1341, 1293, 1154, 1142, 1086, 
983, 893, 883, 864, 784, 723. 
MS (EI, 70 eV, %) m/z = 253 (72), 252 (13), 251 (74), 250 (14), 238 (36), 225 (32), 224 (96), 223 
(30), 222 (100), 210 (20), 209 (11), 208 (20), 187 (12), 185 (12), 172 (36), 157 (22), 156 (14), 144 (84), 
143 (17), 142 (16), 131 (16), 130 (16), 128 (16), 115 (23), 77 (11). 
HRMS (EI, 70 eV) m/z: calc. for C12H14BrN: 251.0310; found: 251.0305. 
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Compound 146d was prepared via TP1 using 2,5-dibromo-6-methylpyridine (143d, 126 mg, 
0.50 mmol), dry toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 
0.36 mL, 0.30 mmol) was added at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  
in THF, 50 µL, 50 µmol) and 3-bromo-2-methylprop-1-ene (40 µL, 0.40 mmol) were added and the 
reaction mixture was allowed to warm to room temperature overnight. After work-up, the crude product 
was purified via column chromatography (isohexane:diethyl ether = 99:1, Rf = 0.11) to give the product 
146d (84 mg, 371 µmol, 93% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CD3CN, ppm)  = 7.36 (d, J = 8.0 Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 4.84 (s, 
1H), 4.49 (s, 1H), 3.29 (s, 2H), 2.41 (s, 3H), 1.71 (s, 3H). 
13C-NMR (101 MHz, CD3CN, ppm)  = 159.8, 144.3, 141.3, 139.0, 133.7, 126.2, 112.5, 40.5, 22.6, 
22.0. 
IR (ATR, cm-1) ṽ = 2954, 2926, 1651, 1576, 1558, 1435, 1168, 1126, 893, 881, 811. 
MS (EI, 70 eV, %) m/z = 226 (99), 224 (100), 212 (52), 211 (11), 210 (54), 209 (11), 187 (35), 185 
(35), 145 (22), 144 (16), 131 (19), 130 (15). 
HRMS (EI, 70 eV) m/z: calc. for C10H12NBr: 225.0153; found: 225.0067. 
 




Compound 146e was prepared via TP1 using 2,5-dibromo-4-chloro-3-fluoropyridine (143e, 116 mg, 
0.40 mmol), dry toluene (0.8 mL) and PMDTA (52 µL, 0.24 mmol). Then, sBu2Mg·2LiOR (134b, 
0.29 mL, 0.24 mmol) was added at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  
in THF, 40 µL, 40 µmol) and allyl bromide (28 µL, 0.32 mmol) were added and the reaction solution 
was allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane, Rf = 0.15) to give the product 146e (58 mg, 232 µmol, 72% yield) 
as a yellowish oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 8.06 (s, 1H), 5.91 (ddt, J = 16.7, 10.1, 6.4 Hz, 1H), 5.39 – 4.92 
(m, 2H), 3.49 (dt, J = 6.4, 1.6 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.6 (d, J = 260.8 Hz), 145.7 (d, J = 6.5 Hz), 135.6 (d, J = 
2.8 Hz), 133.0, 131.7, 128.0 (d, J = 23.8 Hz), 118.4, 34.3 (d, J = 1.5 Hz). 
19F-NMR (377 MHz, CDCl3, ppm)  = –113.2. 
IR (ATR, cm-1) ṽ = 1640, 1570, 1443, 1400, 1207, 992, 923, 789. 
MS (EI, 70 eV, %) m/z = 253 (13), 252 (24), 251 (56), 250 (100), 249 (42), 248 (76), 216 (12), 215 
(15), 214 (13), 213 (15), 169 (10), 168 (13), 135 (41), 134 (23), 107 (14). 
HRMS (EI, 70 eV) m/z: calc. for C8H6BrClFN: 248.9356; found: 248.9353. 
 




Compound 146f was prepared via TP1 using 2,4-dibromopyridine (143f, 119 mg, 0.50 mmol), dry 
toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) 
was added at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  in THF, 50 µL, 50 µmol) 
and 3-bromo-2-methylprop-1-ene (40 µL, 0.40 mmol) were added and the reaction mixture was allowed 
to warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 97:3, Rf = 0.18) to give the product 146f (54 mg, 255 µmol, 
64% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.26 (d, J = 5.0 Hz, 1H), 7.33 (s, 1H), 7.09 (d, J = 5.0 Hz, 1H), 
4.90 (s, 1H), 4.76 (s, 1H), 3.27 (s, 2H), 1.66 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.1, 150.0, 142.5, 142.4, 128.5, 123.6, 114.2, 43.6, 22.2. 
IR (ATR, cm-1) ṽ = 2974, 2937, 2912, 1650, 1587, 1541, 1463, 1446, 1436, 1378, 1207, 1117, 1079, 
987, 897, 874, 850, 806, 734, 706, 693. 
MS (EI, 70 eV, %) m/z = 133 (10), 132 (100), 117 (29), 57 (13), 55 (10), 43 (13), 41 (14), 38 (12).  
HRMS (EI, 70 eV) m/z: calc. for C9H10BrN: 210.9997; found: 210.9983. 
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Compound 146g was prepared via TP1 using 2,4-dibromoquinoline (143g, 144 mg, 0.50 mmol), dry 
toluene (1.0 mL) and PMDTA (63 µL, 0.30 mmol). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) 
was added at –20 °C. After stirring at –20 °C for 30 min, S-butyl benzenesulfonothioate (92 mg, 
0.40 mmol) was added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane, Rf = 0.15) to 
give the product 146g (68 mg, 230 µmol, 57% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.02 (ddd, J = 32.3, 8.5, 1.0 Hz, 2H), 7.71 (ddd, J = 8.4, 6.9, 
1.4 Hz, 1H), 7.55 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H), 7.22 (s, 1H), 3.09 (t, J = 7.3 Hz, 2H), 1.89 – 1.75 (m, 
2H), 1.56 (dq, J = 14.6, 7.4 Hz, 2H), 1.01 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.2, 147.6, 141.6, 130.9, 129.3, 126.8, 125.4, 123.7, 119.1, 
31.0, 30.0, 22.3, 13.8. 
IR (ATR, cm-1) ṽ = 2965, 2955, 2925, 1560, 1545, 1492, 1464, 1455, 1394, 1382, 1261, 1253, 1147, 
1101, 829, 763, 701. 
MS (EI, 70 eV, %) m/z = 268 (43), 266 (44), 255 (91), 254 (40), 253 (91), 252 (29), 250 (34), 248 
(37), 241 (99), 239 (100), 236 (10), 234 (11), 208 (44), 207 (11), 206 (37), 160 (22), 159 (38), 128 (28), 
127 (64), 116 (10).  
HRMS (EI, 70 eV) m/z: calc. for C13H14BrNS: 295.0030; found: 295.0022. 
 




Compound 147a was prepared via TP1 using 2,5-dibromopyridine (143a, 119 mg, 0.50 mmol) and dry 
toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added at –20 °C. After 
stirring at –20 °C for 30 min, benzaldehyde (42 µL, 0.40 mmol) was added and the reaction solution 
was allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 8:2, Rf = 0.28) to give  the product 147a (78 mg, 
295 µmol, 74% yield) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 8.64 (d, J = 2.0 Hz, 1H), 7.78 (dd, J = 8.4, 2.3 Hz, 1H), 7.41 – 
7.27 (m, 5H), 7.13 (dt, J = 8.5, 0.7 Hz, 1H), 5.78 (s, 1H), 4.70 (s, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.8, 148.8, 142.5, 140.1, 128.9, 128.3, 127.1, 122.9, 119.5, 
74.9. 
IR (ATR, cm-1) ṽ = 3313, 3286, 1466, 1453, 1366, 1091, 1055, 1026, 1009, 764, 700. 
MS (EI, 70 eV, %) m/z = 265 (55), 264 (25), 263 (56), 262 (22), 188 (22), 186 (25), 166 (15), 160 
(16), 159 (33), 158 (32), 157 (34), 156 (17), 154 (10), 107 (18), 105 (29), 91 (16), 79 (62), 78 (40), 77 
(100), 76 (22), 52 (11), 51 (54), 50 (24). 
HRMS (EI, 70 eV) m/z: calc. for C12H10BrNO: 262.9946; found: 262.9943. 
 




Compound 147b was prepared via TP1 using 2,5-dibromo-3-methylpyridine (143b, 126 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added 
at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  in THF, 50 µL, 50 µmol) and allyl 
bromide (34 µL, 0.40 mmol) were added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 98:2, Rf = 0.19) to give the product 147b (63 mg, 297 µmol, 74% yield) as 
a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.43 (d, J = 2.3 Hz, 1H), 7.57 (d, J = 1.9 Hz, 1H), 5.99 (ddt, J 
= 16.7, 10.1, 6.4 Hz, 1H), 5.19 – 4.88 (m, 2H), 3.52 (dt, J = 6.4, 1.6 Hz, 2H), 2.28 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.9, 147.8, 140.1, 134.5, 133.6, 118.3, 116.7, 39.9, 18.6. 
IR (ATR, cm-1) ṽ = 2978, 2925, 1637, 1558, 1458, 1438, 1420, 1393, 1237, 1152, 1136, 1129, 1110, 
995, 908, 890, 882, 728, 667. 
MS (EI, 70 eV, %) m/z = 212 (98), 210 (100), 131 (35), 130 (15). 
HRMS (EI, 70 eV) m/z: calc. for C9H10BrN: 210.9997; found: 210.9990. 
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Compound 147c was prepared via TP1 using 2,5-dibromo-4-methylpyridine (143c, 126 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added 
at –20 °C. After stirring at –20 °C for 30 min, N-methoxy-N-methylcyclohexanecarboxamide (69 mg, 
0.40 mmol) was added and the reaction  mixture was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 
99:1, Rf = 0.28) to give the product 147c (59 mg, 209 µmol, 52% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.67 (s, 1H), 7.87 (s, 1H), 3.79 (ddt, J = 11.2, 7.7, 3.3 Hz, 1H), 
2.44 (s, 3H), 1.93 – 1.77 (m, 4H), 1.52 – 1.32 (m, 4H), 1.30 – 1.07 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 204.7, 151.6, 150.6, 148.1, 127.6, 124.7, 44.1, 29.0, 26.1, 25.8, 
22.5. 
IR (ATR, cm-1) ṽ = 2926, 2853, 1692, 1583, 1449, 1385, 1309, 1256, 1240, 1165, 1058, 1046, 1031, 
1006, 987, 898, 779. 
MS (EI, 70 eV, %) m/z = 283 (17), 281 (19), 255 (16), 253 (17), 240 (14), 238 (14), 226 (14), 224 
(15), 200 (22), 198 (22), 187 (41), 186 (11), 185 (44), 173 (99), 172 (22), 171 (100), 170 (23), 92 (15), 
91 (10), 90 (11). 
HRMS (EI, 70 eV) m/z: calc. for C13H16BrNO: 281.0415; found: 281.0409. 
 




Compound 147d was prepared via TP1 using 2,5-dibromo-6-methylpyridine (143d, 126 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added 
at –20 °C. After stirring at –20 °C for 30 min, N-methoxy-N-methylacetamide (41 mg, 0.40 mmol) was 
added and the reaction mixture was allowed to warm to room temperature overnight. After work-up, 
the crude product was purified via column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.39) 
to give the product 147d (69 mg, 322 µmol, 81% yield) as a white solid. 
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M.p. (°C): 95-97. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.90 (d, J = 8.2 Hz, 1H), 7.70 (d, J = 8.2 Hz, 1H), 2.70 (s, 3H), 
2.67 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 199.8, 157.0, 151.7, 140.6, 126.0, 120.5, 25.8, 25.2. 
IR (ATR, cm-1) ṽ = 3066, 2919, 1692, 1656, 1567, 1554, 1430, 1392, 1385, 1357, 1297, 1248, 1209, 
1129, 1110, 1032, 984, 957, 835, 755, 695, 668. 
MS (EI, 70 eV, %) m/z = 215 (50), 213 (53), 190 (11), 188 (12), 187 (96), 185 (100), 173 (71), 171 
(72), 170 (52), 145 (15), 143 (15), 92 (40), 91 (23), 90 (19), 65 (12), 63 (12), 43 (12). 
HRMS (EI, 70 eV) m/z: calc. for C8H8BrNO: 212.9789; found: 212.9785. 
 




Compound 147e was prepared via TP1 using 2,5-dibromo-4-chloro-3-fluoropyridine (143e, 116 mg, 
0.40 mmol) and dry toluene (0.8 mL). Then, sBu2Mg·2LiOR (134b, 0.29 mL, 0.24 mmol) was added 
at –20 °C. After stirring at –20 °C for 30 min, CuCN·2LiCl (1.00  in THF, 40 µL, 40 µmol) and allyl 
bromide (28 µL, 0.32 mmol) were added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane, Rf = 0.15) to give the product 147e (67 mg, 267 µmol, 84% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.50 (s, 1H), 6.00 (ddt, J = 16.9, 10.1, 6.7 Hz, 1H), 5.33 – 5.05 
(m, 2H), 3.61 (ddt, J = 6.6, 2.8, 1.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.9 (d, J = 263.7 Hz), 148.0 (d, J = 16.1 Hz), 147.0 (d, J = 
6.6 Hz), 133.1 (d, J = 1.4 Hz), 131.5 (d, J = 17.4 Hz), 119.4 (d, J = 4.3 Hz), 118.0, 36.3 (d, J = 2.3 Hz). 
19F-NMR (377 MHz, CDCl3, ppm)  = –122.1. 
IR (ATR, cm-1) ṽ = 1641, 1572, 1540, 1440, 1401, 1188, 993, 946, 919, 900, 855, 768, 704. 
MS (EI, 70 eV, %) m/z = 253 (13), 252 (24), 251 (56), 250 (100), 249 (42), 248 (76), 216 (12), 215 
(15), 214 (13), 213 (15), 169 (10), 168 (13), 135 (41), 134 (23), 107 (14). 
HRMS (EI, 70 eV) m/z: calc. for C8H6BrClFN: 248.9356; found: 248.9353. 
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Compound 147f was prepared via TP1 using 2,4-dibromopyridine (143f, 119 mg, 0.50 mmol) and dry 
toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added at –20 °C. After 
stirring at –20 °C for 30 min, dicyclopropyl ketone (44 mg, 0.40 mmol) was added and the reaction 
mixture was allowed to warm to room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.32) to give the product 
147f (74 mg, 276 µmol, 69% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.27 (d, J = 5.3 Hz, 1H), 7.71 (d, J = 1.4 Hz, 1H), 7.37 (dd, J 
= 5.4, 1.8 Hz, 1H), 4.70 (s, 1H), 1.13 (tt, J = 8.3, 5.3 Hz, 2H), 0.67 (dtd, J = 9.6, 5.6, 4.2 Hz, 2H), 0.48 
(dddd, J = 9.2, 8.3, 5.9, 4.2 Hz, 2H), 0.32 (dtd, J = 9.7, 5.6, 4.3 Hz, 2H), 0.26 – 0.16 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.3, 147.7, 133.7, 125.6, 123.6, 71.8, 20.1, 1.6, –0.6. 
 IR (ATR, cm-1) ṽ = 3400, 3008, 1573, 1551, 1459, 1400, 1377, 1343, 1283, 1234, 1201, 1183, 1133, 
1104, 1091, 1037, 1024, 1014, 926, 913, 874, 850, 820, 787, 739, 681. 
MS (EI, 70 eV, %) m/z = 245 (11), 233 (79), 232 (13), 231 (100), 228 (18), 214 (11), 212 (14), 199 
(16), 197 (11), 186 (12), 184 (15), 173 (15), 171 (12), 160 (14), 159 (13), 158 (35), 157 (14), 156 (31), 
111 (44), 78 (17), 77 (10), 71 (10), 69 (13), 57 (23), 55 (15), 44 (13), 43 (44), 41 (37). 
HRMS (EI, 70 eV) m/z: calc. for C12H14BrNO: 267.0259; found: 267.0253. 
 




Compound 147g was prepared via TP1 using 2,4-dibromoquinoline (143g, 144 mg, 0.50 mmol) and 
dry toluene (1.0 mL). Then, sBu2Mg·2LiOR (134b, 0.36 mL, 0.30 mmol) was added at –20 °C. After 
stirring at –20 °C for 30 min, S-butyl benzenesulfonothioate (92 mg, 0.40 mmol) was added and the 
reaction solution was allowed to warm to room temperature overnight. After work-up, the crude product 
was purified via column chromatography (isohexane, Rf = 0.15) to give the product 147g (92 mg, 
311 µmol, 78% yield) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 8.12 – 8.02 (m, 1H), 7.91 (d, J = 8.4 Hz, 1H), 7.67 (ddd, J = 
8.4, 6.9, 1.4 Hz, 1H), 7.52 (s, 1H), 7.49 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H), 3.40 – 3.16 (m, 2H), 1.76 (tt, J 
= 8.6, 6.8 Hz, 2H), 1.52 (h, J = 7.4 Hz, 2H), 0.99 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.9, 148.8, 133.0, 130.6, 128.5, 126.9, 126.3, 125.5, 124.5, 
31.5, 29.8, 22.2, 13.9. 
IR (ATR, cm-1) ṽ = 2956, 2928, 2871, 1612, 1574, 1542, 1485, 1464, 1455, 1385, 1365, 1270, 1250, 
1203, 1144, 1091, 863, 853, 814, 755, 690. 
MS (EI, 70 eV, %) m/z = 268 (43), 266 (44), 255 (91), 254 (40), 253 (91), 252 (29), 250 (34), 248 
(37), 241 (99), 239 (100), 236 (10), 234 (11), 208 (44), 207 (11), 206 (37), 160 (22), 159 (38), 128 (28), 
127 (64), 116 (10).  
HRMS (EI, 70 eV) m/z: calc. for C13H14BrNS: 295.0030; found: 295.0022. 
 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with 4-bromo-2-iodoanisole (148a, 313 mg, 1.00 mmol) and dissolved in dry THF (2.0 mL). Then, 
iPrMgCl·LiCl (1.0 mL, 1.20 mmol) was added dropwise at room temperature and the reaction was 
stirred for 15 min. The completion of the iodine/magnesium exchange was checked by GC-analysis of 
reaction aliquots quenched with water, using undecane as internal standard. CuCN·2LiCl (1.00  in 
THF, 100 µL, 100 µmol) and 3-bromocyclohexene (0.09 mL, 0.80 mmol) were then added at 0 °C and 
the reaction solution was allowed to warm to room temperature overnight. The mixture was quenched 
with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 
x 30 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
The crude product was purified via column chromatography (isohexane, Rf = 0.20) to give the product 
149 (181 mg, 677 µmol, 85% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.39 (d, J = 2.2 Hz, 1H), 7.11 (dd, J = 8.4, 2.2 Hz, 1H), 6.83 
(d, J = 8.4 Hz, 1H), 5.89 (dtd, J = 9.9, 3.7, 2.3 Hz, 1H), 5.74 – 5.54 (m, 1H), 3.87 (s, 3H), 3.33 (ddp, J 
= 8.2, 5.5, 2.8 Hz, 1H), 2.08 (dddd, J = 9.0, 7.7, 4.3, 2.1 Hz, 2H), 2.02 – 1.92 (m, 1H), 1.76 – 1.67 (m, 
1H), 1.67 – 1.42 (m, 2H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 154.2, 140.5, 132.6, 129.8, 128.9, 127.8, 111.9, 111.5, 56.4, 
40.8, 32.8, 25.1, 21.1. 
IR (ATR, cm-1) ṽ = 2921, 2854, 1589, 1480, 1451, 1438, 1201, 1023, 767. 
MS (EI, 70 eV, %) m/z = 268 (64), 266 (67), 188 (12), 187 (84), 172 (28), 160 (12), 159 (100), 158 
(21), 146 (11), 145 (22), 144 (73), 141 (10), 131 (16), 129 (15), 128 (36), 121 (41), 116 (15), 115 (36).  
HRMS (EI, 70 eV) m/z: calc. for C13H15BrO: 266.0306; found: 266.0301. 
 




Compound 150a was prepared via TP1 using 2-bromo-4-iodoanisole (148a, 125 mg, 0.40 mmol) and 
dry toluene (8.0 mL). Then, nBu2Mg·2LiOR (134c, 0.32 mL, 0.28 mmol) was added at –10 °C. After 
stirring at –10 °C for 30 min, CuCN·2LiCl (1.00  in THF, 40 µL, 40 µmol) as well as 3-
bromocyclohexene (37 µL, 0.32 mmol) were added at –10 °C and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane, Rf = 0.45) to give the product 150a (65 mg, 207 µmol, 65% yield) as a 
colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.46 (dd, J = 8.5, 2.3 Hz, 1H), 7.42 (d, J = 2.3 Hz, 1H), 6.62 
(d, J = 8.5 Hz, 1H), 5.93 (dtd, J = 9.9, 3.7, 2.3 Hz, 1H), 5.74 – 5.48 (m, 1H), 3.80 (s, 3H), 3.76 (ddt, J 
= 8.4, 5.6, 2.8 Hz, 1H), 2.07 (dtt, J = 9.4, 3.7, 2.2 Hz, 2H), 1.97 (dddd, J = 12.8, 7.3, 5.6, 3.1 Hz, 1H), 
1.71 – 1.57 (m, 2H), 1.45 (dddd, J = 12.7, 9.4, 7.4, 3.5 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.9, 137.5, 137.3, 135.8, 129.5, 129.3, 112.7, 83.2, 55.6, 
34.2, 30.1, 25.2, 20.9. 
IR (ATR, cm-1) ṽ = 2934, 2831, 1639, 1592, 1485, 1468, 1447, 1431, 1406, 1326, 1304, 1279, 1241, 
1174, 1138, 1124, 1038, 991, 912, 869, 801. 
MS (EI, 70 eV, %) m/z = 315 (13), 314 (100), 299 (12), 281 (21), 260 (27), 258 (12), 225 (25), 207 
(61), 191 (12), 187 (25), 172 (20), 159 (32), 158 (11), 157 (12), 153 (11), 144 (75), 131 (17), 129 (14), 
128 (36), 127 (16), 121 (19), 118 (14), 116 (12), 115 (56), 91 (12), 89 (12). 
HRMS (EI, 70 eV) m/z: calc. for C13H15IO: 314.0168; found: 314.0162. 
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Compound 150b was prepared via TP1 using 1-bromo-5-iodo-4-methyl-2-methoxybenzene (148b, 
164 mg, 0.50 mmol) and dry toluene (10 mL). Then, nBu2Mg·2LiOR (134c, 0.38 mL, 0.30 mmol) was 
added at –10 °C. After stirring at –10 °C for 30 min, dicyclohexyl ketone (78 mg, 0.40 mmol) was 
added and the reaction solution was allowed to warm to room temperature overnight. After work-up, 
the crude product was purified via column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.22) 
to give the product 150b (140 mg, 316 µmol, 79%) as a colorless oil. 
 
1H-NMR (400 MHz, DMSO-d6, ppm)  = 7.50 (s, 1H), 6.55 (s, 1H), 3.82 (s, 1H), 2.14 (p, J = 1.9 Hz, 
6H), 1.95 (s, 2H), 1.77 (t, J = 11.3 Hz, 2H), 1.28 (ddd, J = 50.8, 27.4, 12.5 Hz, 7H), 1.05 – 0.90 (m, 
2H), 0.89 – 0.66 (m, 4H), 0.66 – 0.47 (m, 3H), 0.46 – 0.26 (m, 2H). 
13C-NMR (101 MHz, DMSO-d6, ppm)  = 156.7, 139.5, 132.2, 113.8, 90.0, 80.1, 55.3, 43.2, 27.9, 
27.0, 26.8, 26.4, 26.3. 
IR (ATR, cm-1) ṽ = 3481, 3437, 2251, 2123, 1053, 1024, 1005, 821, 758. 
MS (EI, 70 eV, %) m/z = 360 (15), 359 (100), 214 (36), 83 (10).  
HRMS (EI, 70 eV) m/z: calc. for C21H31IO2: 442.1369; found: 442.1363. 
 




Compound 150c was prepared via TP1 using 1-bromo-5-iodo-4-isopropyl-2-methoxybenzene (148c, 
178 mg, 0.50 mmol) and dry toluene (10 mL). Then, nBu2Mg·2LiOR (134c, 0.38 mL, 0.30 mmol) was 
added at –10 °C. After stirring at –10 °C for 30 min, N-methoxy-N-methyl-4-
(trifluoromethyl)benzamide (93 mg, 0.40 mmol) was added and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.27) to give the product 150c (147 mg, 
328 µmol, 82% yield) as a yellowish oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.88 (dt, J = 7.9, 0.8 Hz, 2H), 7.82 (s, 1H), 7.75 – 7.66 (m, 2H), 
6.87 (s, 1H), 3.70 (s, 3H), 3.22 (h, J = 6.8 Hz, 1H), 1.28 (d, J = 6.8 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 193.7, 158.4, 155.6, 140.7, 140.2, 134.2 (q, J = 32.5 Hz), 130.0, 
127.8, 125.4 (q, J = 3.7 Hz), 123.8 (q, J = 272.7 Hz), 109.5, 89.6, 55.7, 38.7, 23.0. 
19F-NMR (377 MHz, CDCl3, ppm)  = –63.0. 
IR (ATR, cm-1) ṽ = 2964, 1667, 1594, 1463, 1410, 1390, 1373, 1340, 1324, 1311, 1277, 1252, 1233, 
1168, 1129, 1108, 1066, 1034, 1017, 955, 857, 778. 
MS (EI, 70 eV, %) m/z = 449 (18), 448 (97), 431 (40), 430 (11), 379 (21), 306 (12), 304 (58), 303 
(100), 290 (10), 289 (40), 245 (12), 176 (10), 173 (88), 165 (12), 161 (63), 147 (15), 145 (68).  
HRMS (EI, 70 eV) m/z: calc. for C18H16F3IO2: 448.0147; found: 448.0144. 
 




Compound 149’ was prepared via TP1 using 3'-bromo-4'-methoxy-1,2,3,4-tetrahydro-1,1'-biphenyl 
(149, 50 mg, 187 µmol) and dry toluene (0.4 mL). Then, sBu2Mg·2LiOR (134b, 0.13 mL, 0.11 mmol) 
was added at 25 °C. After stirring at 25 °C for 10 min, CuCN·2LiCl (1.00  in THF, 19 µL, 19 µmol) 
and allyl bromide (13 µL, 150 µmol) were added at 0 °C and the reaction mixture was allowed to warm 
to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane, Rf = 0.15) to give the product 149’ (26 mg, 114 µmol, 76% yield) as a 
colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.05 (dd, J = 8.3, 2.3 Hz, 1H), 7.00 (d, J = 2.3 Hz, 1H), 6.81 
(d, J = 8.3 Hz, 1H), 6.02 (ddt, J = 16.8, 10.0, 6.6 Hz, 1H), 5.92 – 5.81 (m, 1H), 5.77 – 5.60 (m, 1H), 
5.12 – 5.00 (m, 2H), 3.82 (s, 3H), 3.39 (dd, J = 6.6, 1.6 Hz, 2H), 3.35 (ddt, J = 8.2, 5.5, 2.8 Hz, 1H), 
2.16 – 2.05 (m, 2H), 2.00 (dddd, J = 15.1, 7.8, 3.9, 2.0 Hz, 1H), 1.75 (dtq, J = 11.7, 4.6, 2.2, 1.6 Hz, 
1H), 1.70 – 1.47 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 155.7, 138.7, 137.3, 130.8, 129.4, 128.4, 128.2, 126.3, 115.4, 
110.3, 55.6, 41.2, 34.5, 32.9, 25.3, 21.5. 
IR (ATR, cm-1) ṽ = 2930, 2835, 1638, 1608, 1499, 1464, 1443, 1421, 1295, 1248, 1182, 1130, 1034, 
996, 911, 811. 
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MS (EI, 70 eV, %) m/z = 228 (44), 188 (14), 187 (100), 172 (10), 159 (48), 145 (14), 144 (39), 141 
(13), 129 (11), 128 (17), 121 (32), 115 (17), 79 (10).  
HRMS (EI, 70 eV) m/z: calc. for C16H20O: 228.1514; found: 228.1508. 
 




Compound 150a’ was prepared via TP1 using 5'-iodo-2'-methoxy-1,2,3,4-tetrahydro-1,1'-biphenyl 
(150a, 30 mg, 97 µmol), dry toluene (0.3 mL) and PMDTA (10 µL, 45 µmol). Then, sBu2Mg·2LiOR 
(134b, 0.06 mL, 58 µmol) was added at 25 °C. After stirring at 25 °C for 10 min, CuCN·2LiCl (1.00  
in THF, 10 µL, 10 µmol) and allyl bromide (7 µL, 78 µmol) were added at 0 °C and the reaction was 
allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane, Rf = 0.20) to give the product 150a’ (16 mg, 70.1 µmol, 90% 
yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.00 (dq, J = 5.2, 2.3 Hz, 2H), 6.87 – 6.72 (m, 1H), 6.08 – 5.83 
(m, 2H), 5.66 (dq, J = 10.2, 2.4 Hz, 1H), 5.13 – 4.89 (m, 2H), 3.82 (s, 4H), 3.32 (dt, J = 6.7, 1.5 Hz, 
2H), 2.17 – 2.03 (m, 2H), 2.02 – 1.93 (m, 1H), 1.78 – 1.58 (m, 2H), 1.55 – 1.40 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 155.4, 138.2, 134.6, 131.8, 130.5, 128.9, 128.5, 126.8, 115.4, 
110.4, 55.6, 39.7, 34.4, 30.4, 25.3, 21.3. 
IR (ATR, cm-1) ṽ = 2930, 2858, 2835, 2359, 1684, 1654, 1497, 1464, 1458, 1446, 1437, 1244, 1117, 
1033, 810. 
MS (EI, 70 eV, %) m/z = 229 (17), 228 (100), 213 (14), 187 (70), 185 (14), 174 (20), 172 (28), 171 
(31), 159 (87), 158 (16), 157 (16), 155 (14), 153 (23), 152 (19), 147 (27), 145 (17), 144 (76), 141 (37), 
131 (30), 129 (32), 128 (58), 121 (30), 115 (75), 91 (36), 79 (16), 77 (19). 
HRMS (EI, 70 eV) m/z: calc. for C16H20O: 228.1514; found: 228.1508. 
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3 Preparation of Functionalized Diorganomagnesium Reagents in Toluene 
via Bromine or Iodine/Magnesium Exchange Reactions 
3.1 Preparation and Titration of Reagents of Type R2Mg 
Preparation of sBu2Mg 
 
A dry and argon-flushed Schlenk-flask equipped with a stirring bar and a septum, was charged with 
sBuMgCl (10.2 mL, 20 mmol, 1.95 M in Et2O, 1.00 equiv). Then sBuLi (12.8 mL, 20 mmol, 1.56 M in 
cyclohexane, 1.00 equiv) was added at room temperature under vigorous stirring. The resulting 
suspension was stirred for 2 h at room temperature. The solvents were removed under vacuum followed 
by addition of dry toluene (40 mL). The resulting suspension was vigorously stirred and allowed to 
settle overnight. The colourless solution was carefully transferred by cannula using a syringe filter to 
obtain sBu2Mg (0.43-0.48 M, 96% yield) in toluene. 
 
 
 Preparation of Mes2Mg 
 
A dry and argon-flushed Schlenk-flask equipped with a stirring bar and a septum, was charged with 
MesMgCl (23.5 mL, 20 mmol, 0.85 M in Et2O, 1.00 equiv). Then MesLi (13.3 mL, 20 mmol, 1.50 M in 
Et2O, 1.00 equiv) was added at −60 °C under vigorous stirring. The resulting suspension was stirred at 
−20 °C overnight. The solvents were removed under vacuum followed by addition of dry toluene (30 
mL). The resulting suspension was vigorously stirred and allowed to settle overnight. The solution was 
carefully transferred by cannula using a syringe filter to obtain Mes2Mg (0.55-0.65 M, 80% yield) in 
toluene. 
 
Both reagents were titrated against I2 in a 0.50 M LiCl solution in THF. 
 
Note: All reagents should be storred at −20 °C and used within 2 weeks. 
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3.2 Typical Procedure 
Typical Procedure 2: Preparation of Diorganomagnesium Species by Halide/Magnesium Exchange 
Followed by Electrophilic Functionalization 
 
A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with the corresponding (hetero)aryl or alkenyl halide (1.00 equiv) and dissolved in dry toluene at the 
indicated concentration. When necessary, DMPU was added (detailed for each compound thereafter). 
Then, the exchange reagent R2Mg (R = sBu, 151a; R = Mes, 151b 0.60-0.70 equiv) was added dropwise 
at the indicated temperature and the reaction stirred for the indicated time. Subsequent reactions with 
electrophiles were carried out under the indicated conditions. The mixture was then quenched with a 
sat. aq. NH4Cl solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 
30 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. 
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3.3 Preparation of Compounds 152 to 160 




A dry and argon-flushed 25 mL Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with 4-hydroxy-3,5-diiodobenzonitrile (740 mg, 2.00 mmol) and DMF (5 mL) and was cooled 
down to 0 °C. NaH (60%, 88 mg, 2.20 mmol) was slowly added at 0 °C and the reaction solution was 
stirred for 30 min. Methyl iodide (0.15 mL, 2.40 mmol) was then added at 0 °C and the reaction was 
allowed to warm to room temperature overnight. The mixture was quenched with a sat. aq. NH4Cl 
solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
product was purified via column chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.51) to give 
152h (756 mg, 1.96 mmol, 98% yield) as a white solid. 
 
M.p. (°C): 140-142. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.05 (s, 2H), 3.91 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.2, 143.2, 115.5, 111.8, 90.9, 61.1. 
IR (ATR, cm-1) ṽ = 2922, 2231, 1408, 978, 717. 
MS (EI, 70 eV, %) m/z = 386 (9), 385 (100), 371 (3), 370 (43), 342 (6), 244 (4), 243 (64), 228 (6), 164 
(4), 127 (14), 101 (5), 100 (4), 88 (20). 
HRMS (EI, 70 eV) m/z: calc. C8H5I2NO: 384.8460; found: 384.8456. 
 




A dry and argon-flushed 25 mL Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with ethyl 4-hydroxy-3,5-diiodobenzoate (834 mg, 2.00 mmol) and DMF (5 mL) and was 
cooled down to 0 °C. K2CO3 (304 mg, 2.20 mmol) was added at 0 °C and the reaction solution was 
stirred for 30 min. Methyl iodide (0.15 mL, 2.40 mmol) was then added at 0 °C and the reaction was 
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allowed to warm to room temperature overnight. The mixture was quenched with a sat. aq. NH4Cl 
solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
product was purified via column chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.65) to give 
the product 152i (858 mg, 1.98 mmol, 98% yield) as a white solid. 
 
M.p. (°C): 97-99. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.42 (s, 2H), 4.36 (q, J = 7.1 Hz, 2H), 3.90 (s, 3H), 1.39 (t, J = 
7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.5, 162.6, 141.3, 129.8, 90.2, 61.8, 60.9, 14.4. 
IR (ATR, cm-1) ṽ = 2978, 1711, 1271, 1259, 995. 
MS (EI, 70 eV, %) m/z = 433 (11), 432 (100), 404 (88), 389 (11), 387 (77), 344 (10), 305 (13), 290 
(10), 287 (9), 262 (19), 245 (31), 231 (9), 229 (9), 218 (9), 217 (11), 189 (16), 178 (9). 
HRMS (EI, 70 eV) m/z: calc. C10H10I2O3: 431.8719; found: 431.8713. 
 




A dry and argon-flushed two-neck 250 mL Schlenk-flask equipped with a magnetic stirring bar, a 
septum and a reflux condenser was charged with 1,3,5-tribromobenzene (4.40 g, 14.0 mmol), KI (24.0 
g, 145 mmol), Ni powder (3.20 g, 54.5 mmol), I2 (30.0 g, 118 mmol) and anhydrous DMF (75 mL). 
The mixture was refluxed under argon at 187 °C for 8 h. After cooling, the solution was washed with 
3% aqueous HCl (150 mL) and extracted with DCM (3 x 75 mL). The combined DCM phase was 
washed with brine (3 x 100 mL) and dried over MgSO4. The solvent was evaporated and the crude 
product was purified via column chromatography (isohexane, Rf = 0.69) to give a white solid (5.15 g) 
which was subjected to a second cycle under the same conditions to yield after recrystallization from 
isohexane 152q (5.04 g, 11.1 mmol, 79% yield) as a white solid. 
 
M.p. (°C): 168-170. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.00 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 144.5, 95.4. 
IR (ATR, cm-1) ṽ = 1531, 1393, 846, 733, 699, 657. 
 
194 Adapted procedure from: S. Deng, J. Zhi, X. Zhang, Q. Wu, Y. Ding, A. Hu, Angew. Chem. Int. Ed. 2014, 53, 
14144; Angew. Chem. 2014, 127, 14368. 
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MS (EI, 70 eV, %) m/z = 456 (100), 329 (24), 202 (17), 75 (59), 74 (39).  
HRMS (EI, 70 eV) m/z: calc. for C6H3I3: 455.7369; found 455.7369. 
 




A dry and argon-flushed 100 mL Schlenk-flask was charged with 4-iodoaniline (1.00 g, 4.60 mmol), 
water (16 mL), conc. HCl (1.6 mL) and MeCN (38 mL). The mixture was cooled to 0 °C. A solution of 
NaNO2 (347 mg, 5.00 mmol) in water (2 mL) was added drop by drop and the mixture was stirred for 
45 min at 0 °C. Then, the mixture was transferred to a flask containing K2CO3 (2.15 g, 15.5 mmol) and 
pyrrolidine (0.76 mL, 9.20 mmol) in 25 mL H2O at 0 °C. The reaction was allowed to warm to room 
temperature and stirred for another 2 h before being extracted with EtOAc (3 x 100 mL). After 
extraction, the organic phase was dried over MgSO4. The solvent was evaporated and the crude product 
was purified via column chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.32) to give 152r (1.04 
g, 3.50 mmol, 76% yield) as a yellow solid. 
 
M.p. (°C): 104-106. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.69 – 7.52 (m, 2H), 7.23 – 7.09 (m, 2H), 3.77 (s, 4H), 2.20 – 
1.90 (m, 4H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.2, 137.9, 122.5, 89.2, 23.9 (2C). 
IR (ATR, cm-1) ṽ = 2966, 2872, 1420, 1391, 1316, 826. 
MS (EI, 70 eV, %) m/z = 231 (100), 203 (62), 76 (18).  











195 Adapted procedure from: K. Erden, İ. Savaş, C. Dengiz, Tetrahedron Letters 2019, 60, 1982. 
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A cold mixture of conc. HNO3 (1.9 mL) and conc. H2SO4 (2.7 mL) was added slowly to a solution of 
ethyl 4-iodobenzoate (2.75 g, 10.0 mmol) dissolved in conc. H2SO4 (5 mL) within 30 min under 
vigorous stirring. Upon completion of the addition, the solution was allowed to warm to ambient 
temperature and stirring was continued overnight. The reaction mixture was then poured onto ice (100 
g). The solid was filtrated, taken up in ethyl acetate (100 mL) and washed with sat. aq. NaHCO3 (100 
mL), dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column 
chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.39) to give the product 152t (2.40 g, 7.40 
mmol, 75% yield) as a yellow solid. 
 
M.p. (°C): 88-90. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.44 (d, J = 2.0 Hz, 1H), 8.14 (d, J = 8.2 Hz, 1H), 7.89 (dd, J 
= 8.2, 2.0 Hz, 1H), 4.42 (q, J = 7.1 Hz, 2H), 1.41 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.2, 153.3, 142.5, 133.6, 132.1, 126.2, 92.2, 62.3, 14.4. 
IR (ATR, cm-1) ṽ = 2981, 1713, 1533, 1284, 1237. 
MS (EI, 70 eV, %) m/z = 321 (22), 293 (100), 277 (10), 276 (58), 247 (15), 230 (28), 229 (8), 201 
(11), 191 (12), 136 (21), 103 (22), 75 (14), 92 (9), 75 (14). 
HRMS (EI, 70 eV) m/z: calc. C9H8INO4: 320.9498; found: 320.9492. 
 




nBuLi in hexanes (4.33 mL, 1.50 m, 6.50 mmol) was added to a solution of 2,2,6,6-
tetramethylpiperidine (1.10 mL, 6.50 mmol) in THF (10 mL) inside a dry and argon-flushed 100 mL 
Schlenk-flask at −20 °C. After stirring for 30 min, the solution was cooled to −78 °C and a solution of 
3-bromobenzonitrile (980 mg, 5.44 mmol) in THF (6 mL) was added dropwise while maintaining the 
temperature below −70 °C. After 2 h, a 1.00 M solution of ZnCl2 in THF (1.20 mL, 6.50 mmol) was 
added dropwise and the reaction solution was allowed to stir for an additional 30 min. Bromine (0.42 
 
196 Adapted procedure from: K. Menzel, E. L. Fisher, L. DiMichele, D. E. Frantz, T. D. Nelson, M. H. Kress, J. 
Org. Chem. 2006, 71, 2188. 
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mL, 8.10 mmol) was added dropwise while keeping the temperature below −50 °C. The reaction was 
monitored by GC and the completed reaction was allowed to warm to 25 °C and quenched with H2O 
after 1 h. The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 
mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column chromatography 
(isohexane:ethyl acetate = 90:10, Rf = 0.38) to give the product 155e (970 mg, 3.74 mmol, 69% yield) 
as a white solid. 
 
M.p. (°C): 115-117. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.85 (dd, J = 8.1, 1.5 Hz, 1H), 7.62 (dd, J = 7.8, 1.5 Hz, 1H), 
7.30 (t, J = 7.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 137.9, 133.2, 128.8, 128.2, 126.9, 118.1, 117.0. 
IR (ATR, cm-1) ṽ = 3071, 2230, 1441, 1406, 783. 
MS (EI, 70 eV, %) m/z = 264 (4), 263 (49), 262 (7), 261 (100), 260 (4), 259 (52), 210 (22), 208 (23), 
101 (5), 100 (16), 99 (5), 75 (7), 74 (4), 50 (4). 
HRMS (EI, 70 eV) m/z: calc. C7H3Br2N: 258.8632; found: 258.8627. 
 




A two-neck 250 mL Schlenk-flask equipped with a magnetic stirring bar, a septum and a reflux 
condenser was charged with 3,4-dibromofuran-2-carboxylic acid (2.50 g, 9.40 mmol) and ethanol (50 
mL). Conc. H2SO4 (2 mL) was added and the mixture was heated under reflux overnight. The reaction 
mixture was quenched with a saturated aqueous sodium bicarbonate solution until neutral pH and 
extracted with ethyl acetate (3 x 60 mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated in vacuo. The crude product was purified via column chromatography 
(isohexane:ethyl acetate = 90:10, Rf = 0.58) to give 155f (689 mg, 2.32 mmol, 25% yield) as a white 
solid. 
 
M.p. (°C): 62-64. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.17 (s, 1H), 4.36 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 157.1, 146.3, 128.4, 121.9, 103.9, 61.8, 14.4. 
IR (ATR, cm-1) ṽ = 2983, 1723, 1479, 1292, 1179, 982, 730. 
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MS (EI, 70 eV, %) m/z = 299 (12), 298 (26), 296 (13), 272 (47), 270 (100), 268 (52), 255 (32), 254 
(18), 253 (64), 251 (34), 228 (17), 226 (34), 224 (17), 199 (24), 197 (53), 195 (25), 175 (12), 119 (15), 
118 (37), 117 (14), 116 (37). 
HRMS (EI, 70 eV) m/z: calc. C7H6Br2O3: 295.8684; found: 295.8676. 
 




A dry and argon-flushed 50 mL Schlenk-flask was charged with BH3·SMe2 (5.00 M in ether, 2.12 mL, 
10.6 mmol). Cyclohexene (2.14 mL, 21.1 mmol) was added drop by drop over 10 min at 0 °C. After 
stirring at this temperature for 5 min, the reaction was allowed to warm to room temperature and was 
further stirred for 1 h. The reaction was cooled to 0 °C, and 1-iodo-hept-1-yne (2.22 g, 10.0 mmol) was 
added drop by drop over a 10 min period. The reaction was further stirred for 30 min and the ice bath 
was then removed. The reaction was stirred 1 h at room temperature and cooled again to 0 °C. Glacial 
acetic acid (4 mL) was added slowly and the mixture was extracted with diethyl ether (3 x 100 mL). 
After extraction, the organic phase was dried over MgSO4. The solvent was evaporated and the crude 
product was purified via column chromatography (isohexane, Rf = 0.85) to give 158b (1.20 g, 5.40 
mmol, 54% yield) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.34 – 6.01 (m, 2H), 2.13 (dtd, J = 7.5, 5.3, 1.5 Hz, 2H), 1.51 
– 1.38 (m, 2H), 1.38 – 1.26 (m, 4H), 0.98 – 0.78 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 141.7, 82.3, 34.8, 31.5, 27.8, 22.7, 14.2. 
IR (ATR, cm-1) ṽ = 3011, 1713, 1466, 1071, 728, 665. 
MS (EI, 70 eV, %) m/z = 224 (19), 167 (45), 154 (100), 97 (74), 69 (31), 55 (69).  
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A dry and argon-flushed 100 mL Schlenk-flask equipped with a thermometer charged with ethyl cis-3-
iodoacrylate (3.39 g, 15.0 mmol) and DCM (30 mL) was cooled to −78 °C. DIBAL-H (1.00 M in DCM, 
15 mL, 15.0 mmol) was slowly added so that the temperature of the reaction mixture did not exceed 
−75 °C. After stirring at −78 °C for 30 min, hexylmagnesium bromide (16.5 mmol) was added dropwise 
at −70 °C. The reaction was allowed to warm to room temperature and stirred overnight. 1.00 M HCl 
(30 mL) was added dropwise at −5 °C and the mixture was warmed to room temperature. After 
extraction with diethyl ether (3 x 30 mL), the organic phase was dried over MgSO4. The solvent was 
evaporated and the crude product was purified via column chromatography (isohexane:ethyl acetate = 
9:1, Rf = 0.30) to give the product (3.48 g, 13.0 mmol, 87% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.33 (dd, J = 7.6, 0.9 Hz, 1H), 6.24 (t, J = 7.6 Hz, 1H), 4.40 
(tdd, J = 7.3, 5.9, 0.9 Hz, 1H), 1.76 – 1.60 (m, 2H), 1.61 – 1.50 (m, 1H), 1.48 – 1.17 (m, 8H), 0.96 – 
0.74 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 143.6, 82.5, 74.6, 36.1, 31.9, 29.4, 25.1, 22.7, 14.3. 
IR (ATR, cm-1) ṽ = 2924, 2854, 1456, 1377, 1171. 
MS (EI, 70 eV, %) m/z = 183 (100), 81 (11).  
HRMS (EI, 70 eV) m/z: calc. for C3H4OI: 182.9307; found 182.9301. 
 




A dry and argon-flushed 25 mL Schlenk-flask charged with (Z)-1-iodonon-1-en-3-ol (402 mg, 1.50 
mmol), imidazole (255 mg, 3.80 mmol) and DMF (5 mL) was cooled to 0 °C. TBDMSCl (271 mg, 1.80 
mmol) was slowly added and the reaction was allowed to warm to room temperature and stirred 
overnight. A saturated aqueous solution of NH4Cl (30 mL) was added and the mixture was extracted 
with EtOAc (3 x 30 mL). The organic phase was washed with Brine (3 x 100 mL) and dried over 
MgSO4. The solvent was evaporated and the crude product was purified via column chromatography 
 
198 Adapted procedure from: I. Marek, C. Meyer, J.-F. Normant, Organic Syntheses 1997, 74, 194. 
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(isohexane:ethyl acetate = 99:1, Rf = 0.78) to give 158c (540 mg, 1.47 mmol, 98% yield) as a colorless 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.26 – 6.06 (m, 2H), 4.33 (dtd, J = 7.6, 5.1, 1.3 Hz, 1H), 1.53 
– 1.36 (m, 3H), 1.32 – 1.20 (m, 7H), 0.99 – 0.82 (m, 12H), 0.09 (s, 3H), 0.05 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 145.0, 79.7, 75.6, 37.0, 32.0, 29.4, 26.0, 25.1, 22.8, 18.3, 14.3, 
–4.1, –4.6. 
IR (ATR, cm-1) ṽ = 2928, 1251, 1087, 836, 776. 
MS (EI, 70 eV, %) m/z = 325 (100), 241 (34), 185 (44), 113 (33), 85 (31), 75 (60).  
HRMS (EI, 70 eV) m/z: calc. for C14H28OISi: 367.0954; found 367.0947. 
 




A dry and argon-flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was charged 
with butane-1-thiol (4.28 mL, 40.0 mmol), DCM (50 mL), water (25 mL) and iodine (5.58 g, 22.0 
mmol) and stirred at room temperature for 30 min. The mixture was extracted with DCM (3 x 30 mL). 
The combined organic extracts were washed with water and dried over Na2SO4, filtered and 
concentrated in vacuo. The resulting solution of dibutyl-disulfide was mixed with sodium 
benzenesulfinate (10.5 g, 64.0 mmol), iodine (10.1 g, 40.0 mmol) and DCM (50 mL) and stirred for 22 
h at room temperature. Then, a 0.10 M Na2S2O3 solution was added to quench the remaining iodine. The 
organic phase was washed and dried and the solvent removed under reduced pressure to afford S-butyl 
benzenesulfonothioate (8.77 g, 38.1 mmol, 95% yield) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.10 – 7.81 (m, 2H), 7.69 – 7.60 (m, 1H), 7.60 – 7.50 (m, 2H), 
3.00 (t, J = 7.4 Hz, 2H), 1.57 (tt, J = 8.8, 6.9 Hz, 2H), 1.32 (dq, J = 14.6, 7.3 Hz, 2H), 0.84 (t, J = 7.4 
Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 145.0, 133.7, 129.4, 127.1, 35.9, 30.7, 21.8, 13.5. 
IR (ATR, cm-1) ṽ = 2960, 1458, 1292, 1139, 1077, 999, 670. 
MS (EI, 70 eV, %) m/z = 141 (19), 125 (18), 97 (13), 89 (56), 77 (100), 55 (39). 
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Allylated benzonitrile 154aa was prepared via TP2 using 2-iodobenzonitrile (115 mg, 0.50 mmol) and 
dry toluene (5.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 °C. After stirring 
at −78 °C for 10 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 3-bromocyclohexene (47 µL, 
0.40 mmol) were added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 
60:40, Rf = 0.29) to give the product 154aa (90 mg, 491 µmol, 98% yield) as an orange oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.61 (dd, J = 7.7, 1.4 Hz, 1H), 7.52 (td, J = 7.7, 1.5 Hz, 1H), 
7.36 (dd, J = 8.0, 1.2 Hz, 1H), 7.28 (td, J = 7.6, 1.2 Hz, 1H), 6.04 – 5.94 (m, 1H), 5.63 (dd, J = 10.1, 
2.5 Hz, 1H), 3.86 (ddt, J = 8.3, 5.6, 2.8 Hz, 1H), 2.19 – 2.05 (m, 3H), 1.75 – 1.61 (m, 2H), 1.57 – 1.47 
(m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 150.4, 133.0, 132.9, 130.1, 128.4, 128.1, 126.7, 118.2, 112.1, 
40.2, 31.7, 24.9, 21.0. 
IR (ATR, cm-1) ṽ = 2931, 1633, 1570, 1445, 1046. 
MS (EI, 70 eV, %) m/z = 183 (18), 182 (100), 168 (24), 167 (27), 166 (15), 165 (45), 154 (31), 140 
(15), 115 (23). 
HRMS (EI, 70 eV) m/z: calc. C13H13N: 183.1048; found: 183.1040. 
 




Ester 154ab was prepared via TP2 using 2-iodobenzonitrile (115 mg, 0.50 mmol) and dry toluene (5.0 
mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 °C. After stirring at −78 °C for 10 
min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and ethyl 2-(bromomethyl)acrylate (83 µL, 0.60 
mmol) were added and the reaction solution was allowed to warm to room temperature overnight. After 
work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 80:20, 
Rf = 0.35) to give the product 154ab (88 mg, 409 µmol, 88% yield) as a yellow oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.63 (dd, J = 7.8, 1.4 Hz, 1H), 7.51 (td, J = 7.7, 1.5 Hz, 1H), 
7.40 – 7.35 (m, 1H), 7.31 (td, J = 7.6, 1.2 Hz, 1H), 6.32 (d, J = 1.0 Hz, 1H), 5.57 (d, J = 1.3 Hz, 1H), 
4.18 (q, J = 7.1 Hz, 2H), 3.86 (s, 2H), 1.25 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 142.7, 138.2, 133.0, 132.8, 130.3, 127.7, 127.1, 118.0, 
113.1, 61.1, 36.6, 14.2. 
IR (ATR, cm-1) ṽ = 2981, 2224, 1712, 1137, 761. 
MS (EI, 70 eV, %) m/z = 187 (20), 170 (9), 169 (14), 143 (10), 142 (28), 141 (100), 140 (32), 115 
(30), 114 (19). 
HRMS (EI, 70 eV) m/z: calc. C13H13NO2: 215.0946; found: 215.0941. 
 




Biaryl 154ac was prepared via TP2 using 2-iodobenzonitrile (115 mg, 0.50 mmol) and dry toluene (5.0 
mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 °C. After stirring at –78 °C for 10 
min, ZnCl2 (1.00 M in THF, 0.65 mL, 0.65 mmol), Pd(OAc)2 (5 mg, 4 mol%), SPhos (17 mg, 8 mol%) 
and 4-iodoanisole (93 mg, 0.40 mmol) were added and the reaction mixture was stirred at room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 90:10, Rf = 0.30) to give the product 154ac (61 mg, 291 µmol, 73% yield) 
as a white solid. 
 
M.p. (°C): 84-86. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.74 (dd, J = 7.7, 1.4 Hz, 1H), 7.62 (td, J = 7.7, 1.4 Hz, 1H), 
7.55 – 7.47 (m, 3H), 7.40 (td, J = 7.6, 1.2 Hz, 1H), 7.04 – 6.99 (m, 2H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.2, 145.3, 133.9, 132.9, 130.6, 130.1, 130.0, 127.2, 119.2, 
114.3, 111.2, 55.5. 
IR (ATR, cm-1) ṽ = 2922, 2222, 1608, 1478, 1246, 763. 
MS (EI, 70 eV, %) m/z = 210 (15), 209 (100), 194 (12), 167 (7), 166 (47), 140 (27), 139 (13), 113 (7), 
63 (8), 42 (6). 
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Tertiary alcohol 154ad was prepared via TP2 using 2-iodobenzonitrile (115 mg, 0.50 mmol) and dry 
toluene (5.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 °C. After stirring at 
−78 °C for 10 min, cyclobutyl(phenyl)methanone (91 µL, 0.60 mmol) were added and the reaction 
solution was stirred at room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 80:20, Rf = 0.34) to give the product 154ad (72 mg, 
273 µmol, 55% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.60 – 7.52 (m, 2H), 7.51 – 7.43 (m, 2H), 7.38 – 7.20 (m, 5H), 
3.39 (dt, J = 16.6, 8.5 Hz, 1H), 2.26 (s, 1H), 2.08 – 1.96 (m, 3H), 1.94 – 1.84 (m, 1H), 1.83 – 1.73 (m, 
1H), 1.72 – 1.64 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.4, 145.2, 132.0, 128.6, 128.5, 127.7, 127.1, 126.5, 126.3, 
119.1, 110.6, 78.5, 43.8, 23.3, 22.3, 17.2. 
IR (ATR, cm-1) ṽ = 2938, 2168, 1724, 906, 730. 
MS (EI, 70 eV, %) m/z = 209 (15), 208 (100), 190 (2), 130 (80), 105 (5), 102 (2), 77 (3). 
HRMS (EI, 70 eV) m/z: calc. for C18H17NO: 263.1310; found: 263.1308. 
 




Biaryl 154b was prepared via TP2 using 3-iodobenzonitrile (115 mg, 0.50 mmol) and dry toluene (2.0 
mL). Then, sBu2Mg (151a, 0.38 mL, 0.30 mmol) was added at −78 °C. After stirring at −78 °C for 10 
min, ZnCl2 (1.00 M in THF, 0.65 mL, 0.65 mmol), Pd(OAc)2 (5 mg, 4 mol%), SPhos (17 mg, 8 mol%) 
and ethyl 4-iodobenzoate (67 µL, 0.40 mmol) were added and the reaction mixture was stirred at room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 90:10, Rf = 0.30) to give the product 154b (72 mg, 286 µmol, 72% yield) as 
a white solid. 
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M.p. (°C): 89-91. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.19 – 8.11 (m, 2H), 7.90 (t, J = 1.7 Hz, 1H), 7.84 (dt, J = 7.7, 
1.4 Hz, 1H), 7.68 (dt, J = 7.8, 1.4 Hz, 1H), 7.65 – 7.61 (m, 2H), 7.58 (t, J = 7.8 Hz, 1H), 4.41 (q, J = 
7.1 Hz, 2H), 1.42 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 143.1, 141.5, 131.7, 131.6, 131.0, 130.5, 129.9, 127.2, 
118.7, 113.3, 61.3, 14.5. 
IR (ATR, cm-1) ṽ = 2981, 1710, 1273, 1103, 767. 
MS (EI, 70 eV, %) m/z = 252 (5), 251 (28), 224 (5), 223 (30), 207 (15), 206 (100), 179 (5), 178 (23), 
177 (28), 176 (5), 152 (9), 151 (26), 150 (9), 75 (6), 51 (5). 
HRMS (EI, 70 eV) m/z: calc. C16H13NO2: 251.0946; found: 251.0934. 
 




Biaryl 154c was prepared via TP2 using 4-iodobenzonitrile (115 mg, 0.50 mmol) and dry toluene (2.0 
mL). Then, sBu2Mg (151a, 0.38 mL, 0.30 mmol) was added at −78 °C. After stirring at −78 °C for 10 
min, ZnCl2 (1.00 M in THF, 0.65 mL, 0.65 mmol), Pd(OAc)2 (5 mg, 4 mol%), SPhos (17 mg, 8 mol%) 
and ethyl 4-iodobenzoate (67 µL, 0.40 mmol) were added and the reaction mixture was stirred at room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 90:10, Rf = 0.23) to give the product 154c (70 mg, 278 µmol, 70% yield) as 
a white solid. 
 
M.p. (°C): 118-120. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.18 – 8.12 (m, 2H), 7.78 – 7.70 (m, 4H), 7.67 – 7.63 (m, 2H), 
4.41 (q, J = 7.1 Hz, 2H), 1.42 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 144.6, 143.4, 132.9, 130.7, 130.5, 128.1, 127.3, 118.8, 
111.9, 61.4, 14.5. 
IR (ATR, cm-1) ṽ = 2987, 2223, 1707, 1098, 771. 
MS (EI, 70 eV, %) m/z = 251 (88), 223 (83), 207 (42), 206 (100), 178 (58), 177 (71), 152 (16), 151 
(64), 150 (18). 
HRMS (EI, 70 eV) m/z: calc. C16H13NO2: 251.0946; found: 251.0944. 
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Diaryl ketone 154d was prepared via TP2 using 4-bromo-2-iodobenzonitrile (154 mg, 0.50 mmol) and 
dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.38 mL, 0.30 mmol) was added at −78 °C. After stirring 
at −78 °C for 10 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 4-chlorobenzoyl chloride (77 
µL, 0.60 mmol) were added and the reaction solution was allowed to warm at −20 °C and was stirred 
at this temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.23) to give the product 154d (121 mg, 
380 µmol, 76% yield) as a white solid. 
 
M.p. (°C): 171-173. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.82 (dd, J = 8.2, 2.0 Hz, 1H), 7.78 – 7.73 (m, 3H), 7.70 (d, J 
= 8.3 Hz, 1H), 7.54 – 7.49 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 191.2, 142.7, 141.2, 135.3, 134.9, 133.8, 133.0, 131.8, 129.5, 
127.7, 116.4, 110.7. 
IR (ATR, cm-1) ṽ = 2922, 1665, 1580, 1286, 941. 
MS (EI, 70 eV, %) m/z = 287 (7), 286 (47), 285 (8), 284 (49), 242 (7), 240 (22), 141 (33), 140 (7), 139 
(100), 111 (14), 100 (7), 75 (11). 
HRMS (EI, 70 eV) m/z: calc. for C14H7BrClNO: 318.9400; found: 318.9393. 
 




Ester 154e was prepared via TP2 using ethyl 2-iodobenzoate (138 mg, 0.50 mmol) and dry toluene (0.8 
mL). Then, sBu2Mg (151a, 0.38 mL, 0.30 mmol) was added at −78 °C. After stirring at −78 °C for 15 
min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and methallyl bromide (60 µL, 0.60 mmol) were 
added and the reaction solution was allowed to warm to room temperature overnight. After work-up, 
the crude product was purified via column chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.15) 
to give the product 154e (94 mg, 459 µmol, 92% yield) as a pale yellow oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.86 (dd, J = 7.8, 1.5 Hz, 1H), 7.43 (td, J = 7.5, 1.5 Hz, 1H), 
7.35 – 7.18 (m, 2H), 4.78 (dq, J = 2.4, 1.3 Hz, 1H), 4.45 (tt, J = 1.6, 0.8 Hz, 1H), 4.33 (q, J = 7.1 Hz, 
2H), 3.71 (s, 2H), 1.74 (dd, J = 1.4, 0.8 Hz, 3H), 1.37 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 168.0, 145.5, 140.9, 131.7, 131.5, 130.9, 130.5, 126.3, 111.6, 
61.0, 41.9, 23.0, 14.4. 
IR (ATR, cm-1) ṽ = 2925, 1717, 1253, 1076, 740. 
MS (EI, 70 eV, %) m/z = 189 (100), 161 (85), 159 (56), 158 (57), 157 (25), 143 (20), 131 (51), 130 
(25), 129 (74), 128 (26), 115 (51), 91 (29).  
HRMS (EI, 70 eV) m/z: calc. for C13H16O2: 204.1150; found 204.1144. 
 




Ketone 154fa was prepared via TP2 using 2-fluoro-3-iodopyridine (112 mg, 0.50 mmol) and dry 
toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 °C. After stirring at 
−78 °C for 15 min, CuCN·2LiCl (1.00 M in THF, 0.30 mL, 0.30 mmol) and 4-chlorobenzoyl chloride 
(77 µL, 0.60 mmol) were added and the reaction solution was allowed to warm to room temperqture 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 90:10, Rf = 0.15) to give the product 154fa (86 mg, 365 µmol, 73% yield) as a white solid. 
 
M.p. (°C): 93-95. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.44 (d, J = 4.3 Hz, 1H), 8.05 (ddd, J = 9.2, 7.4, 2.0 Hz, 1H), 
7.82 – 7.72 (m, 2H), 7.54 – 7.44 (m, 2H), 7.38 (ddd, J = 7.0, 4.8, 1.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 190.7 (d, J = 4.8 Hz), 161.3, 158.9, 150.9 (d, J = 14.9 Hz), 
142.0 (d, J = 3.3 Hz), 135.0, 131.1 (d, J = 1.3 Hz), 129.2, 122.0 (d, J = 4.7 Hz), 121.3 (d, J = 30.1 Hz). 
19F-NMR (377 MHz, CDCl3, ppm)  = –62.4. 
IR (ATR, cm-1) ṽ = 2921, 1656, 1090, 848, 772. 
MS (EI, 70 eV, %) m/z = 237 (5), 235 (16), 141 (33), 140 (8), 139 (100), 124 (7), 111 (9), 96 (5), 75 
(6). 
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Tertiary alcohol 154fb was prepared via TP2 using 2-fluoro-3-iodopyridine (112 mg, 0.50 mmol), dry 
THF (48 µL, 0.60 mmol) and dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was 
added at −78 °C. After stirring at −78 °C for 15 min, adamantone previously dissolved in 0.2 mL of 
toluene (150 mg, 1.00 mmol) was added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 60:40, Rf = 0.32) to give the product 154fb (91 mg, 368 µmol, 74% yield) 
as a white solid. 
 
M.p. (°C): 110-113. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.17 – 8.05 (m, 1H), 7.89 (ddd, J = 10.4, 7.6, 1.9 Hz, 1H), 7.19 
(ddd, J = 7.7, 4.8, 2.1 Hz, 1H), 2.65 (s, 2H), 2.42 (d, J = 12.5 Hz, 2H), 2.13 (d, J = 2.8 Hz, 1H), 1.93 – 
1.78 (m, 4H), 1.76 – 1.63 (m, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 161.8 (d, J = 241.3 Hz), 146.2 (d, J = 16.1 Hz), 139.4 (d, J = 
5.5 Hz), 127.8 (d, J = 24.2 Hz), 121.4 (d, J = 4.2 Hz), 75.8 (d, J = 5.1 Hz), 37.6, 35.6, 35.5, 35.1, 32.9, 
27.2, 26.7. 
19F-NMR (377 MHz, CDCl3, ppm)  = –62.0. 
IR (ATR, cm-1) ṽ = 2915, 1596, 1242, 1103, 968, 808. 
MS (EI, 70 eV, %) m/z = 230 (16), 229 (100), 204 (11), 187 (40), 186 (11), 175 (12), 152 (15), 151 
(19), 151 (15), 150 (16), 140 (20), 136 (20), 127 (11), 124 (11), 124 (25), 93 (15), 91 (14), 81 (12), 79 
(18). 
HRMS (EI, 70 eV) m/z: calc. for C15H18FNO: 247.1372; found: 247.1369. 
 




Ketone 154g was prepared via TP2 using 2,6-dichloro-4-iodopyridine (137 mg, 0.50 mmol) and dry 
toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 °C. After stirring at 
−78 °C for 15 min, CuCN·2LiCl (1.00 M in THF, 0.30 mL, 0.30 mmol) and benzoyl chloride (70 µL, 
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0.60 mmol) were added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 
90:10, Rf = 0.46) to give the product 154g (95 mg, 377 µmol, 75% yield) as a white solid. 
 
M.p. (°C): 85-87. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.85 – 7.77 (m, 2H), 7.73 – 7.66 (m, 1H), 7.59 – 7.49 (m, 4H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 192.3, 151.4, 149.9, 135.1, 134.4, 130.2, 129.1, 122.5. 
IR (ATR, cm-1) ṽ = 3079, 1657, 1280, 1165, 661. 
MS (EI, 70 eV, %) m/z = 251 (12), 216 (3), 146 (3), 110 (4), 106 (8), 105 (100), 77 (25). 
HRMS (EI, 70 eV) m/z: calc. for C12H7Cl2NO: 250.9905; found: 250.9894. 
 




Iodoanisole 154h was prepared via TP2 using 3,5-diiodo-4-methoxybenzonitrile (152h, 192 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 °C. 
After stirring at −78 °C for 15 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and methallyl 
bromide (60 µL, 0.60 mmol) were added and the reaction solution was allowed to warm to −20 °C and 
stirred at this temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.54) to give the product 154h (80 mg, 
255 µmol, 51% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.95 (d, J = 2.0 Hz, 1H), 7.56 – 7.37 (m, 1H), 4.93 (tt, J = 1.7, 
0.9 Hz, 1H), 4.66 (tq, J = 1.4, 0.7 Hz, 1H), 3.81 (s, 3H), 3.40 (s, 2H), 1.72 (t, J = 1.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 162.2, 143.2, 141.3, 135.5, 135.0, 117.3, 113.9, 110.0, 92.5, 
61.5, 38.4, 22.6. 
IR (ATR, cm-1) ṽ = 2940, 2359, 1464, 1265, 994. 
MS (EI, 70 eV, %) m/z = 313 (86), 284 (35), 186 (45), 171 (100), 170 (64), 157 (65), 156 (93), 144 
(26), 143 (35), 140 (26), 115 (60). 
HRMS (EI, 70 eV) m/z: calc. for C12H12INO: 312.9964; found: 312.9964. 
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Alcohol 154i was prepared via TP2 using ethyl 3,5-diiodo-4-methoxybenzoate (152i, 215 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −78 
°C. After stirring at −78 °C for 15 min, benzaldehyde (0.69 µL, 0.60 mmol) was added and the reaction 
solution was allowed to warm to room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane:ethyl acetate = 80:20, Rf = 0.12) to give the product 
154i (109 mg, 265 µmol, 53% yield) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.41 (d, J = 2.1 Hz, 1H), 8.18 (d, J = 2.1 Hz, 1H), 7.39 – 7.32 
(m, 4H), 7.30 – 7.27 (m, 1H), 6.09 (d, J = 4.8 Hz, 1H), 4.36 (qd, J = 7.1, 1.2 Hz, 2H), 3.62 (s, 3H), 2.57 
(d, J = 5.1 Hz, 1H), 1.38 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.9, 160.9, 143.0, 140.7, 138.5, 129.9, 128.8, 128.5, 128.1, 
126.8, 91.4, 72.1, 61.6, 61.5, 14.5. 
IR (ATR, cm-1) ṽ = 3439, 1715, 1275, 1144, 700. 
MS (EI, 70 eV, %) m/z = 412 (31), 398 (17), 397 (100), 394 (11), 367 (12), 349 (14), 347 (27), 333 
(11), 319 (35), 291 (15), 194 (20), 165 (12), 152 (13). 
HRMS (EI, 70 eV) m/z: calc. for C17H17IO4: 412.0172; found: 412.0167. 
 




Allylated anisole 154ja was prepared via TP2 using 4-iodoanisole (94 mg, 0.40 mmol), dry THF (39 
µL, 0.48 mmol) and dry toluene (0.8 mL). Then, sBu2Mg (151a, 0.58 mL, 0.28 mmol) was added at 25 
°C. After stirring at 25 °C for 30 min, CuCN·2LiCl (1.00 M in THF, 40 µL, 40 µmol) and 3-
bromocyclohexene (55 µL, 0.48 mmol) were added at 0 °C and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane, Rf = 0.29) to give the product 154ja (59 mg, 312 µmol, 78% yield) as a 
yellow oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.16 – 7.12 (m, 2H), 7.00 – 6.64 (m, 2H), 5.87 (dtd, J = 9.9, 
3.6, 2.3 Hz, 1H), 5.69 (dq, J = 10.2, 2.5 Hz, 1H), 3.79 (s, 3H), 3.36 (ddt, J = 8.2, 5.6, 2.8 Hz, 1H), 2.11 
– 2.04 (m, 2H), 2.02 – 1.94 (m, 1H), 1.72 (dddd, J = 11.7, 6.6, 4.8, 2.2 Hz, 1H), 1.61 (dddd, J = 12.2, 
6.9, 3.6, 1.5 Hz, 1H), 1.52 (dddd, J = 13.1, 10.6, 8.0, 2.6 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.0, 138.9, 130.6, 128.8, 128.3, 113.8, 55.4, 41.1, 32.9, 25.2, 
21.3. 
IR (ATR, cm-1) ṽ = 2931, 1510, 1245, 1035, 827. 
MS (EI, 70 eV, %) m/z = 188 (52), 160 (25), 111 (33), 109 (25), 97 (72), 95 (34), 85 (36), 83 (54), 81 
(32), 71 (54), 69 (52), 57 (100), 56 (30), 55 (52), 43 (63), 41 (34). 
HRMS (EI, 70 eV) m/z: calc. for C13H16O: 188.1201; found: 188.1199. 
 




Alcohol 154jb was prepared via TP2 using 4-iodoanisole (94 mg, 0.40 mmol), dry THF (39 µL, 0.48 
mmol) and dry toluene (0.8 mL). Then, sBu2Mg (151a, 0.58 mL, 0.28 mmol) was added at 25 °C. After 
stirring at 25 °C for 30 min, (4-chlorophenyl)(cyclopropyl)methanone (87 mg, 0.48 mmol) was added 
and the reaction solution was stirred at room temperature overnight. After work-up, the crude product 
was purified via column chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.29) to give the product 
154jb (73 mg, 253 µmol, 63% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.38 – 7.29 (m, 4H), 7.29 – 7.21 (m, 2H), 6.88 – 6.79 (m, 2H), 
3.78 (s, 3H), 1.81 (s, 1H), 1.54 (tt, J = 8.2, 5.4 Hz, 1H), 0.73 – 0.56 (m, 1H), 0.56 – 0.47 (m, 1H), 0.43 
(dddd, J = 9.1, 6.6, 5.2, 3.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.9, 146.1, 139.1, 132.8, 128.3 (2C), 128.1, 113.5, 55.4, 
21.8, 2.3, 1.5. 
IR (ATR, cm-1) ṽ = 3490, 3004, 1509, 1248, 825. 
MS (EI, 70 eV, %) m/z = 262 (20), 260 (60), 247 (15), 141 (25), 139 (76), 135 (38), 121 (100), 77 
(12). 
HRMS (EI, 70 eV) m/z: calc. for C17H17ClO2: 288.0917; found: 288.0911. 
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Biaryl 154ka was prepared via TP2 using 3-iodoanisole (94 mg, 0.40 mmol), dry THF (39 µL, 0.48 
mmol) and dry toluene (0.8 mL). Then, sBu2Mg (151a, 0.58 mL, 0.28 mmol) was added at 25 °C. After 
stirring at 25 °C for 30 min, ZnCl2 (1.00 M in THF, 0.52 mL, 0.52 mmol), Pd(OAc)2 (4 mg, 4 mol%), 
SPhos (13 mg, 8 mol%) and 4-iodobenzonitrile (73 mg, 0.32 mmol)  were added and the reaction 
solution was stirred at room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 98:2, Rf = 0.21) to give the product 154ka (59 mg, 
282 µmol, 88% yield) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.83 – 7.61 (m, 4H), 7.40 (t, J = 7.9 Hz, 1H), 7.17 (ddd, J = 
7.6, 1.8, 0.9 Hz, 1H), 7.10 (t, J = 2.1 Hz, 1H), 6.97 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.2, 145.6, 140.7, 132.7, 130.3, 127.9, 119.8, 119.1, 114.0, 
113.2, 111.1, 55.5. 
IR (ATR, cm-1) ṽ = 2226, 1603, 1480, 1296, 1215, 836. 
MS (EI, 70 eV, %) m/z = 210 (15), 209 (100), 180 (38), 179 (82), 178 (28), 166 (25), 151 (10), 140 
(36), 139 (14). 
HRMS (EI, 70 eV) m/z: calc. for C14H11NO: 209.0841; found: 209.0832. 
 




Ketone 154kb was prepared via TP2 using 3-iodoanisole (94 mg, 0.40 mmol), dry THF (39 µL, 0.48 
mmol) and dry toluene (0.8 mL). Then, sBu2Mg (151a, 0.58 mL, 0.28 mmol) was added at 25 °C. After 
stirring at 25 °C for 30 min, CuCN·2LiCl (1.00 M in THF, 0.24 mL, 0.24 mmol) and 2-fluorobenzoyl 
chloride (76 mg, 0.48 mmol) were added at 0 °C and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 98:2, Rf = 0.24) to give the product 154kb (55 mg, 239 µmol, 60% yield) as 
a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.56 – 7.47 (m, 2H), 7.44 – 7.42 (m, 1H), 7.39 – 7.32 (m, 2H), 
7.26 (td, J = 7.6, 1.1 Hz, 1H), 7.19 – 7.11 (m, 2H), 3.86 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 193.4, 160.2 (d, J = 252.4 Hz), 159.8, 138.8, 133.2 (d, J = 8.4 
Hz), 130.8 (d, J = 2.9 Hz), 129.6, 127.2 (d, J = 14.8 Hz), 124.3 (d, J = 3.6 Hz), 123.1 (d, J = 1.5 Hz), 
120.2, 116.4 (d, J = 21.7 Hz), 113.7, 55.6. 
19F-NMR (377 MHz, CDCl3, ppm)  = –111.4. 
IR (ATR, cm-1) ṽ = 1664, 1482, 1450, 1295, 753. 
MS (EI, 70 eV, %) m/z = 230 (59), 210 (14), 199 (19), 135 (100), 123 (67), 107 (32), 95 (11), 77 (22). 
HRMS (EI, 70 eV) m/z: calc. for C14H11FO2: 230.0743; found: 230.0736. 
 




Alcohol 154kc was prepared via TP2 using 3-iodoanisole (94 mg, 0.40 mmol), dry THF (39 µL, 0.48 
mmol) and dry toluene (0.8 mL). Then, sBu2Mg (151a, 0.58 mL, 0.28 mmol) was added at 25 °C. After 
stirring at 25 °C for 30 min, (4-fluorophenyl)(cyclopropyl)methanone (79 mg, 0.48 mmol) was added 
and the reaction solution was stirred at room temperature overnight. After work-up, the crude product 
was purified via column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.18) to give the product 
154kc (102 mg, 375 µmol, 94% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, DMSO-d6, ppm)  = 7.57 – 7.33 (m, 2H), 7.20 (t, J = 7.9 Hz, 1H), 7.13 – 7.06 
(m, 2H), 6.99 – 6.90 (m, 2H), 6.77 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 5.26 (s, 1H), 3.71 (s, 3H), 1.96 – 1.45 
(m, 1H), 0.43 (dddd, J = 15.2, 6.8, 3.8, 1.8 Hz, 4H). 
13C-NMR (101 MHz, DMSO-d6, ppm)  = 160.8 (d, J = 242.3 Hz), 158.7, 150.2, 144.8 (d, J = 3.0 Hz), 
128.7, 128.4 (d, J = 8.0 Hz), 119.0, 114.2 (d, J = 21.0 Hz), 112.7, 111.2, 74.7, 54.9, 21.3, 1.4 (2C). 
19F-NMR (377 MHz, DMSO-d6, ppm)  = –117.0. 
IR (ATR, cm-1) ṽ = 3490, 3004, 1506, 1221, 777. 
MS (EI, 70 eV, %) m/z = 245 (11), 244 (64), 183 (10), 136 (36), 135 (14), 123 (100), 108 (11), 95 
(10). 
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Secondary alcohol 154l was prepared via TP2 using 2-iodoanisole (234 mg, 1.00 mmol), dry THF (100 
µL, 1.20 mmol) and dry toluene (2.0 mL). Then, sBu2Mg (151a, 1.46 mL, 0.70 mmol) was added at 25 
°C. After stirring at 25 °C for 30 min, 2,4-dichlorobenzaldehyde (263 mg, 1.50 mmol) was added and 
the reaction solution was stirred at room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.28) to give the product 
154l (211 mg, 745 µmol, 75% yield) as a white solid. 
 
M.p. (°C): 92-94. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.53 (d, J = 8.4 Hz, 1H), 7.38 (d, J = 2.1 Hz, 1H), 7.32 – 7.27 
(m, 2H), 7.09 – 6.77 (m, 3H), 6.38 (s, 1H), 3.88 (s, 3H), 3.03 (s, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 157.1, 138.7, 133.7, 133.6, 130.0, 129.6, 129.4, 129.2, 127.7, 
127.3, 120.9, 110.7, 68.4, 55.6. 
IR (ATR, cm-1) ṽ = 3368, 1463, 1241, 1022, 749. 
MS (EI, 70 eV, %) m/z = 284 (28), 282 (51), 229 (31), 173 (34), 137 (37), 135 (52), 109 (100), 107 
(29), 77 (36). 
HRMS (EI, 70 eV) m/z: calc. for C14H12Cl2O2: 282.0214; found: 282.0206. 
 




Diaryl 154m was prepared via TP2 using tert-butyl(4-iodophenoxy)dimethylsilane (134 mg, 
0.40 mmol), dry THF (39 µL, 0.48 mmol) and dry toluene (0.8 mL). Then, sBu2Mg (151a, 0.58 mL, 
0.28 mmol) was added at 25 °C. After stirring at 25 °C for 30 min, ZnCl2 (1.00 M in THF, 0.52 mL, 
0.52 mmol), Pd(OAc)2 (4 mg, 4 mol%), SPhos (13 mg, 8 mol%) and 4-iodoanisole (75 mg, 0.32 mmol) 
were added and the reaction solution was stirred at room temperature overnight. After work-up, the 
crude product was purified via column chromatography (isohexane:toluene = 70:30, Rf = 0.49) to give 
the product 154m (65 mg, 207 µmol, 65% yield) as a white solid. 
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M.p. (°C): 84-86. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.68 – 7.35 (m, 4H), 7.02 – 6.76 (m, 4H), 3.84 (s, 3H), 1.00 (s, 
9H), 0.22 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.8, 154.9, 134.1, 133.7, 127.9, 127.8, 120.4, 114.2, 55.5, 
25.9, 18.4, –4.2. 
IR (ATR, cm-1) ṽ = 2926, 2364, 1502, 1251, 822. 
MS (EI, 70 eV, %) m/z = 314 (66), 258 (34), 257 (100), 71 (19), 57 (29), 43 (35). 
HRMS (EI, 70 eV) m/z: calc. for C19H26SiO2: 314.1702; found: 314.1701. 
 




Alcohol 154n was prepared via TP2using 2-bromo-4-iodo-1-methylbenzene (119 mg, 0.40 mmol), dry 
THF (39 µL, 0.48 mmol) and dry toluene (0.8 mL). Then, sBu2Mg (151a, 0.58 mL, 0.28 mmol) was 
added at 25 °C. After stirring at 25 °C for 30 min, (4-fluorophenyl)(cyclopropyl)methanone (79 mg, 
0.48 mmol) was added and the reaction solution was stirred at room temperature overnight. After work-
up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 9:1, Rf = 
0.46) to give the product 154n (71 mg, 212 µmol, 53% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.63 (d, J = 1.8 Hz, 1H), 7.47 – 7.34 (m, 2H), 7.24 – 7.11 (m, 
2H), 7.05 – 6.93 (m, 2H), 2.37 (s, 3H), 1.83 (s, 1H), 1.56 (tt, J = 8.3, 5.4 Hz, 1H), 0.72 – 0.55 (m, 2H), 
0.45 (dd, J = 5.4, 1.8 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 162.1 (d, J = 246.1 Hz), 146.8, 142.7 (d, J = 3.3 Hz), 136.8, 
130.7, 130.5, 128.7 (d, J = 8.0 Hz), 125.9, 124.8, 115.0 (d, J = 21.2 Hz), 76.4, 22.7, 21.8, 2.1, 1.9. 
19F-NMR (377 MHz, CDCl3, ppm)  = –115.6. 
IR (ATR, cm-1) ṽ = 3467, 1506, 1225, 1159, 836. 
MS (EI, 70 eV, %) m/z = 308 (49), 306 (50), 295 (11), 293 (11), 199 (37), 197 (20), 184 (10), 183 
(17), 136 (26), 123 (100). 
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Iodobenzene 154oa was prepared via TP2 using 1,3-diiodobenzene (165 mg, 0.50 mmol), DMPU (60 
µL, 0.50 mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at 
−20 °C. After stirring at −20 °C for 60 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and allyl 
bromide (52 µL, 0.60 mmol) were added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane, Rf = 0.60) to give the product 154oa (79 mg, 324 µmol, 65% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.84 – 7.50 (m, 2H), 7.27 – 7.15 (m, 1H), 7.11 – 6.87 (m, 1H), 
5.92 (ddt, J = 15.8, 11.0, 6.7 Hz, 1H), 5.11 (t, J = 1.5 Hz, 1H), 5.08 (dq, J = 7.6, 1.6 Hz, 1H), 3.33 (dt, 
J = 6.7, 1.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 142.6, 137.7, 136.7, 135.3, 130.3, 128.0, 116.7, 94.7, 39.8. 
IR (ATR, cm-1) ṽ = 2923, 1710, 1456, 1259, 1024. 
MS (EI, 70 eV, %) m/z = 244 (33), 118 (10), 117 (100), 115 (82), 91 (14).  
HRMS (EI, 70 eV) m/z: calc. for C9H9I: 243.9749; found 243.9744. 
 




Secondary alcohol 154ob was prepared via TP2 using 1,3-diiodobenzene (165 mg, 0.50 mmol), DMPU 
(60 µL, 0.50 mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added 
at −20 °C. After stirring at −20 °C for 60 min, 4-fluorobenzaldehyde (0.69 µL, 0.60 mmol) was added 
and the reaction solution was allowed to warm to room temperature overnight. After work-up, the crude 
product was purified via column chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.17) to give 
the product 154ob (120 mg, 366 µmol, 73% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.74 (t, J = 1.8 Hz, 1H), 7.61 (dt, J = 7.8, 1.4 Hz, 1H), 7.36 – 
7.27 (m, 3H), 7.10 – 6.99 (m, 3H), 5.76 (d, J = 3.0 Hz, 1H), 2.23 (d, J = 3.4 Hz, 1H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 162.4 (d, J = 246.4 Hz), 146.0, 139.1 (d, J = 3.2 Hz), 136.9, 
135.4, 130.4, 128.4 (d, J = 8.2 Hz), 125.8, 115.7 (d, J = 21.6 Hz), 94.7, 75.0. 
19F-NMR (377 MHz, CDCl3, ppm)  = –114.3. 
IR (ATR, cm-1) ṽ = 3341, 1506, 1221, 905, 727. 
MS (EI, 70 eV, %) m/z = 328 (15), 231 (92), 204 (19), 203 (11), 201 (11), 183 (22), 125 (14), 123 
(100), 97 (19), 78 (11), 77 (15), 76 (11). 
HRMS (EI, 70 eV) m/z: calc. for C13H10FIO: 327.9760; found: 327.9755. 
 




Ester 154pa was prepared via TP2 using 1,2-diiodobenzene (165 mg, 0.50 mmol), DMPU (60 µL, 0.50 
mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −20 °C. 
After stirring at −20 °C for 60 min, ethyl cyanoformate (59 µL, 0.60 mmol) was added and the reaction 
solution was allowed to warm to room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.31) to give the product 
154pa (62 mg, 225 µmol, 45% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.97 (dd, J = 8.0, 1.2 Hz, 1H), 7.78 (dd, J = 7.8, 1.7 Hz, 1H), 
7.39 (td, J = 7.6, 1.2 Hz, 1H), 7.13 (td, J = 7.7, 1.7 Hz, 1H), 4.39 (q, J = 7.1 Hz, 2H), 1.40 (t, J = 7.1 
Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.7, 141.3, 135.5, 132.6, 130.9, 128.0, 94.1, 61.8, 14.3. 
IR (ATR, cm-1) ṽ = 2979, 1725, 1288, 1250, 741. 
MS (EI, 70 eV, %) m/z = 276 (24), 248 (33), 231 (100), 203 (30), 127 (11), 76 (37), 50 (14). 
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Iodobenzene 154pb was prepared via TP2 using 1,2-diiodobenzene (165 mg, 0.50 mmol), DMPU (60 
µL, 0.50 mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at 
−20 °C. After stirring at −20 °C for 60 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 3-
bromocyclohexene (69 µL, 0.60 mmol) were added and the reaction solution was allowed to warm to 
room temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane, Rf = 0.79) to give the product 154pb (91 mg, 320 µmol, 64% yield) as a red oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.83 (dd, J = 7.9, 1.3 Hz, 1H), 7.36 – 7.13 (m, 2H), 6.89 (td, J 
= 7.5, 1.9 Hz, 1H), 5.96 (dtd, J = 9.9, 3.7, 2.3 Hz, 1H), 5.65 (dq, J = 10.2, 2.5 Hz, 1H), 3.69 (ddp, J = 
8.3, 5.5, 2.8 Hz, 1H), 2.08 (tqd, J = 8.7, 6.1, 3.4 Hz, 3H), 1.79 – 1.60 (m, 2H), 1.41 (dddd, J = 13.1, 9.9, 
7.8, 3.4 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 148.3, 139.6, 129.7, 129.2, 128.7, 128.4, 128.0, 101.3, 45.9, 
30.6, 25.2, 20.9. 
IR (ATR, cm-1) ṽ = 2928, 1460, 1432, 1009, 750. 
MS (EI, 70 eV, %) m/z = 284 (100), 230 (27), 142 (20), 141 (23), 129 (92), 128 (70), 116 (23), 115 
(37).  
HRMS (EI, 70 eV) m/z: calc. for C12H13I: 284.0062; found 284.0057. 
 




Diiodobenzene 154q was prepared via TP2 using 1,3,5-triiodobenzene (152q, 228 mg, 0.50 mmol), 
DMPU (60 µL, 0.50 mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was 
added at −20 °C. After stirring at −20 °C for 60 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) 
and methallyl bromide (60 µL, 0.60 mmol) were added and the reaction solution was allowed to warm 
to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane, Rf = 0.75) to give the product 154q (126 mg, 328 µmol, 66% yield) as a 
colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 8.07 – 7.81 (m, 1H), 7.50 (d, J = 1.5 Hz, 2H), 4.86 (t, J = 1.7 
Hz, 1H), 4.74 (dd, J = 2.1, 1.1 Hz, 1H), 3.19 (s, 2H), 1.66 (t, J = 1.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 144.1, 143.6, 143.0, 137.3, 113.4, 94.9, 43.8, 22.1. 
IR (ATR, cm-1) ṽ = 2907, 1572, 1539, 1416, 895, 707. 
MS (EI, 70 eV, %) m/z = 384 (12), 257 (18), 226 (19), 196 (14), 194 (18), 165 (12), 130 (26), 129 
(15), 115 (21), 57 (26), 55 (10), 45 (100), 44 (40), 43 (17), 41 (15).  
HRMS (EI, 70 eV) m/z: calc. for C10H10I2: 383.8872; found 383.8875. 
 




Triazene 154r was prepared via TP2 using 1-((4-iodophenyl)diazenyl)pyrrolidine (152r, 90 mg, 
0.30 mmol), DMPU (36 µL, 0.30 mmol) and dry toluene (0.60 mL). Then, Mes2Mg (151b, 0.28 mL, 
0.18 mmol) was added at −20 °C. After stirring at −20 °C for 1 h, CuCN·2LiCl (1.00 M in THF, 30 µL, 
30 µmol) and allyl bromide (31 µL, 0.36 mmol) were added and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 97:3, Rf = 0.25) to give the product 154r (51 mg, 237 µmol, 
79% yield) as a yellowish solid. 
 
M.p. (°C): 50-52. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.56 – 7.31 (m, 2H), 7.20 – 6.98 (m, 2H), 5.98 (ddt, J = 16.8, 
10.1, 6.6 Hz, 1H), 5.21 – 4.89 (m, 2H), 3.78 (s, 4H), 3.37 (dd, J = 6.7, 1.6 Hz, 2H), 2.39 – 1.49 (m, 4H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.9, 137.9, 137.0, 129.2, 120.5, 115.6, 39.9, 24.0 (2C). 
IR (ATR, cm-1) ṽ = 2973, 2870, 1430, 1404, 1319. 
MS (EI, 70 eV, %) m/z = 207 (20), 145 (74), 117 (16), 115 (100), 91 (33).  
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Nitrobenzene 154s was prepared via TP2 using 1-iodo-2-nitrobenzene (125 mg, 0.50 mmol), DMPU 
(0.25 mL, 2.00 mmol) and dry toluene (0.50 mL). Then, Mes2Mg (151b, 0.46 mL, 0.30 mmol) was 
added at −50 °C. After stirring at −50 °C for 1 h, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 3-
bromocyclohexene (46 µL, 0.40 mmol) were added and the reaction solution was allowed to warm to 
−20 °C and stirred at this temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 97:3, Rf = 0.25) to give the product 154s (58 mg, 
284 µmol, 71% yield) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.78 (dd, J = 8.1, 1.4 Hz, 1H), 7.53 (td, J = 7.6, 1.4 Hz, 1H), 
7.45 (dd, J = 7.9, 1.6 Hz, 1H), 7.33 (ddd, J = 8.7, 7.2, 1.6 Hz, 1H), 6.04 – 5.92 (m, 1H), 5.65 – 5.53 (m, 
1H), 3.95 (ddt, J = 8.4, 5.6, 2.8 Hz, 1H), 2.26 – 2.16 (m, 1H), 2.11 (ddq, J = 6.9, 3.8, 2.0, 1.4 Hz, 2H), 
1.81 – 1.60 (m, 2H), 1.58 – 1.47 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.9, 140.7, 132.6, 130.4, 129.8, 129.0, 127.0, 124.2, 36.9, 
31.8, 25.0, 21.3. 
IR (ATR, cm-1) ṽ = 2928, 1672, 1564, 1233, 758. 
MS (EI, 70 eV, %) m/z = 186 (60), 169 (12), 168 (93), 167 (58), 158 (66), 156 (21), 153 (17), 152 
(16), 147 (13), 146 (63), 143 (39), 141 (20), 132 (18), 130 (100), 129 (14), 128 (54), 117 (20), 115 (55), 
105 (13), 91 (17), 77 (20). 
HRMS (EI, 70 eV) m/z: calc. for C12H13NO2: 203.0946; found: 203.0894. 
 




Nitrobenzene 154t was prepared via TP2 using ethyl 4-iodo-3-nitrobenzoate (152t, 160 mg, 
0.50 mmol), DMPU (0.25 mL, 2.0 mmol) and dry toluene (1.0 mL). Then, Mes2Mg (151b, 0.46 mL, 
0.30 mmol) was added at −70 °C. After stirring at −70 °C for 1 h, CuI (13 mg, 10 mol%) and methallyl 
bromide (40 µL, 0.40 mmol) were added and the reaction solution was allowed to warm to −20 °C and 
stirred at this temperature overnight. After work-up, the crude product was purified via column 
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chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.46) to give the product 154t (60 mg, 
240 µmol, 60% yield) as a red oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.54 (d, J = 1.8 Hz, 1H), 8.18 (dd, J = 8.0, 1.8 Hz, 1H), 7.45 
(d, J = 8.0 Hz, 1H), 4.89 – 4.85 (s, 1H), 4.54 – 4.49 (s, 1H), 4.42 (q, J = 7.1 Hz, 2H), 3.69 (s, 2H),1.75 
(s, 3H), 1.42 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.6, 142.6, 139.2, 133.4, 132.7, 130.3, 125.9, 113.4, 100.1, 
61.9, 40.7, 23.0, 14.4. 
IR (ATR, cm-1) ṽ = 2980, 1720, 1532, 1261, 727. 
MS (EI, 70 eV, %) m/z = 219 (54), 204 (31), 203 (60), 191 (35), 188 (16), 176 (16), 175 (29), 174 
(53), 172 (17), 163 (21), 162 (17), 158 (100), 146 (23), 144 (28), 130 (52), 128 (16), 118 (40), 117 (18), 
115 (18). 
HRMS (EI, 70 eV) m/z: calc. for C13H15NO4: 249.1001; found: 249.0998. 
 




Benzonitrile 157a was prepared via TP2 using 4-bromo-2,6-difluorobenzonitrile (108 mg, 0.50 mmol), 
DMPU (60 µL, 0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was 
added at −20 °C. After stirring at −20 °C for 2 h, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 
methallyl bromide (60 µL, 0.60 mmol) were added and the reaction solution was allowed to warm to 
room temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 90:10, Rf = 0.54) to give the product 157a (95 mg, 492 µmol, 98% yield) as 
a pale yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.91 (s, 1H), 6.89 (s, 1H), 4.96 – 4.92 (s, 1H), 4.80 – 4.76 (s, 
1H), 3.36 (s, 2H), 1.67 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.5 (d, J = 4.9 Hz), 161.9 (d, J = 4.9 Hz), 150.2 (t, J = 9.2 
Hz), 142.1, 114.7, 112.7 (d, J = 3.4 Hz), 112.5 (d, J = 3.3 Hz), 109.5, 90.2 (t, J = 19.4 Hz), 44.8 (t, J = 
1.8 Hz), 22.1. 
19F-NMR (377 MHz, CDCl3, ppm)  = –104.5. 
IR (ATR, cm-1) ṽ = 2924, 1632, 1442, 1044, 904. 
MS (EI, 70 eV, %) m/z = 194 (13), 193 (85), 192 (17), 179 (12), 178 (100), 176 (13), 165 (13), 153 
(14), 152 (41), 125 (10). 
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HRMS (EI, 70 eV) m/z: calc. for C11H9F2N: 193.0703; found: 193.0690. 
 




Benzonitrile 157b was prepared via TP2 using 4-bromo-2-fluorobenzonitrile (99 mg, 0.50 mmol), 
DMPU (60 µL, 0.50 mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was 
added at −20 °C. After stirring at −20 °C for 2 h, benzaldehyde (0.61 µL, 0.60 mmol) was added and 
the reaction solution was allowed to warm to room temperature overnight. After work-up, the crude 
product was purified via column chromatography (isohexane:ethyl acetate = 60:40, Rf = 0.46) to give 
the product 157b (70 mg, 308 µmol, 62% yield) as pale yellow solid. 
 
M.p. (°C): 54-56. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.56 (dd, J = 8.1, 6.5 Hz, 1H), 7.40 – 7.30 (m, 6H), 7.28 – 7.24 
(m, 1H), 5.84 (d, J = 2.8 Hz, 1H), 2.44 (d, J = 3.0 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.40 (d, J = 259.3 Hz), 152.3 (d, J = 7.2 Hz), 142.4, 133.5, 
129.2, 128.8, 126.9, 122.7 (d, J = 3.3 Hz), 114.4, 114.2 (d, J = 5.2 Hz), 100.1 (d, J = 15.7 Hz), 75.4 (d, 
J = 1.7 Hz). 
19F-NMR (377 MHz, CDCl3, ppm)  = –105.9. 
IR (ATR, cm-1) ṽ = 3438, 2237, 1620, 1427, 906, 726. 
MS (EI, 70 eV, %) m/z = 227 (13), 226 (8), 208 (18), 207 (8), 190 (8), 148 (77), 122 (42), 121 (18), 
107 (12), 106 (8), 105 (100), 100 (12), 79 (66), 78 (17), 77 (46). 
HRMS (EI, 70 eV) m/z: calc. for C14H10FNO: 227.0746; found: 227.0741. 
 




Benzonitrile 157c was prepared via TP2 using 2-bromobenzonitrile (91 mg, 0.50 mmol), DMPU (60 
µL, 0.50 mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at 
−20 °C. After stirring at −20 °C for 2 h, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 3-
bromocyclohexene (47 µL, 0.40 mmol) were added and the reaction solution was allowed to warm to 
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room temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 98:2, Rf = 0.36) to give the product 157c (58 mg, 317 µmol, 79% yield) as a 
pale yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.61 (dd, J = 7.7, 1.4 Hz, 1H), 7.52 (td, J = 7.7, 1.5 Hz, 1H), 
7.36 (dd, J = 8.0, 1.2 Hz, 1H), 7.28 (td, J = 7.6, 1.2 Hz, 1H), 6.04 – 5.94 (m, 1H), 5.63 (dd, J = 10.1, 
2.5 Hz, 1H), 3.86 (ddt, J = 8.3, 5.6, 2.8 Hz, 1H), 2.19 – 2.05 (m, 3H), 1.75 – 1.61 (m, 2H), 1.57 – 1.47 
(m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 150.4, 133.0, 132.9, 130.1, 128.4, 128.1, 126.7, 118.2, 112.1, 
40.2, 31.7, 24.9, 21.0. 
IR (ATR, cm-1) ṽ = 2931, 1633, 1570, 1445, 1046. 
MS (EI, 70 eV, %) m/z = 183 (40), 182 (100), 168 (22), 167 (26), 166 (19), 165 (43), 154 (27), 140 
(13), 128 (12), 115 (19). 
HRMS (EI, 70 eV) m/z: calc. for C13H13N: 183.1048; found 183.1040. 
 




Diaryl 157d was prepared via TP2 using 4-bromobenzonitrile (91 mg, 0.50 mmol), DMPU (60 µL, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −20 
°C. After stirring at −20 °C for 2 h, ZnCl2 (1.00 M in THF, 0.65 mL, 0.65 mmol), Pd(OAc)2 (5 mg, 4 
mol%), SPhos (17 mg, 8 mol%) and 4-iodoanisole (94 mg, 0.40 mmol) were added and the reaction 
mixture was stirred at room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 96:4, Rf = 0.25) to give the product 157d (47 mg, 
220 µmol, 55% yield) as a white solid. 
 
M.p. (°C): 107-109. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.79 – 7.59 (m, 4H), 7.57 – 7.43 (m, 2H), 7.09 – 6.84 (m, 2H), 
3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.3, 145.4, 132.7, 131.6, 128.5, 127.2, 119.2, 114.7, 110.2, 
55.5. 
IR (ATR, cm-1) ṽ = 2224, 1605, 1494, 1036, 822, 753. 
MS (EI, 70 eV, %) m/z = 210 (15), 209 (100), 194 (59), 166 (62), 140 (31), 139 (12).  
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HRMS (EI, 70 eV) m/z: calc. for C14H11ON: 209.0841; found 209.0835. 
 




Benzonitrile 157e was prepared via TP2 using 2,3-dibromobenzonitrile (155e, 131 mg, 0.50 mmol), 
DMPU (60 µL, 0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was 
added at −20 °C. After stirring at −20 °C for 2 h, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 
methallyl bromide (60 µL, 0.60 mmol) were added and the reaction solution was allowed to warm to 
−20 °C and was stirred at this temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.52) to give the product 157e (100 mg, 
425 µmol, 85% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.80 (dd, J = 8.1, 1.3 Hz, 1H), 7.62 (dd, J = 7.7, 1.3 Hz, 1H), 
7.20 (t, J = 7.9 Hz, 1H), 4.87 (s, 1H), 4.34 (s, 1H), 3.70 (s, 2H), 1.86 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 143.1, 141.4, 137.6, 132.2, 128.3, 126.4, 117.5, 115.4, 112.5, 
42.5, 23.3. 
IR (ATR, cm-1) ṽ = 2225, 1439, 1116, 891, 784, 723. 
MS (EI, 70 eV, %) m/z = 237 (31), 236 (28), 235 (31), 234 (29), 156 (100), 155 (17), 154 (18), 129 
(88), 128 (46), 116 (25), 115 (19). 
HRMS (EI, 70 eV) m/z: calc. for C11H10BrN: 234.9997; found: 234.9992. 
 




Furan 157f was prepared via TP2 using ethyl 3,4-dibromofuran-2-carboxylate (155f, 148 mg, 
0.50 mmol), DMPU (60 µL, 0.50 mmol) and dry toluene (0.50 mL). Then, sBu2Mg (151a, 0.63 mL, 
0.30 mmol) was added at −20 °C. After stirring at −20 °C for 90 min, CuCN·2LiCl (1.00 M in THF, 50 
µL, 50 µmol) and methallyl bromide (40 µL, 0.40 mmol) were added and the reaction solution was 
allowed to warm to −20 °C and was stirred at this temperature overnight. After work-up, the crude 
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product was purified via column chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.51) to give 
the product 157f (55 mg, 202 µmol, 51% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.13 (s, 1H), 4.86 (s, 1H), 4.74 (s, 1H), 4.34 (q, J = 7.1 Hz, 
2H), 3.42 (s, 2H), 1.75 (t, J = 1.1 Hz, 3H), 1.36 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.2, 155.3, 143.5, 140.1, 121.1, 113.4, 99.3, 61.3, 35.0, 22.4, 
14.5. 
IR (ATR, cm-1) ṽ = 1720, 1303, 1181, 906, 729. 
MS (EI, 70 eV, %) m/z = 275 (100), 272 (99), 259 (25), 257 (26), 246 (18), 244 (18), 229 (33), 227 
(34), 205 (39), 203 (40), 201 (46), 199 (43), 173 (29), 171 (20), 150 (19), 120 (77), 119 (31), 92 (28), 
91 (61). 
HRMS (EI, 70 eV) m/z: calc. for C11H13BrO3: 272.0048; found: 272.0041. 
 




Thiophene 157g was prepared via TP2 using 3-bromothiophene-2-carbonitrile (94 mg, 0.50 mmol) and 
dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −20 °C. After stirring 
at −20 °C for 45 min, CuCN·2LiCl (1.00 M in THF, 0.30 mL, 0.30 mmol) and 4-chlorobenzoyl chloride 
(77 µL, 0.60 mmol) were added and the reaction solution was allowed to warm to room temperature 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 60:40, Rf = 0.49) to give the product 157g (113 mg, 456 µmol, 91% yield) as a light yellow 
solid. 
 
M.p. (°C): 71-73. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.83 – 7.77 (m, 2H), 7.67 (d, J = 5.1 Hz, 1H), 7.54 – 7.48 (m, 
2H), 7.39 (d, J = 5.1 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 187.5, 147.9, 141.0, 135.3, 132.4, 131.6, 129.8, 129.6, 114.0, 
113.0. 
IR (ATR, cm-1) ṽ = 2220, 1656, 1264, 1089, 863, 725. 
MS (EI, 70 eV, %) m/z = 247 (9), 219 (7), 213 (12), 212 (100), 184 (6), 141 (23), 139 (77), 136 (33), 
110 (11), 75 (9). 
HRMS (EI, 70 eV) m/z: calc. for C12H6ClNOS: 246.9859; found: 246.9853. 
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Ketone 157h was prepared via TP2 using 3,4-dibromothiophene (121 mg, 0.50 mmol) and dry toluene 
(1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −20 °C. After stirring at −20 °C for 
45 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and cyclopropanecarbonyl chloride (92 µL, 
1.00 mmol) were added and the reaction solution was stirred at this temperature overnight. After work-
up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 60:40, Rf = 
0.74) to give the product 157h (72 mg, 313 µmol, 63% yield) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.04 (d, J = 3.5 Hz, 1H), 7.33 (d, J = 3.5 Hz, 1H), 2.62 – 2.53 
(m, 1H), 1.25 (dt, J = 6.9, 3.4 Hz, 2H), 1.07 – 1.01 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 195.1, 140.3, 132.6, 125.6, 109.7, 19.8, 12.2. 
IR (ATR, cm-1) ṽ = 3105, 1664, 1416, 1052, 931, 727. 
MS (EI, 70 eV, %) m/z = 232 (4), 230 (4), 193 (4), 192 (5), 191 (100), 190 (5), 189 (98), 150 (6), 82 
(13). 
HRMS (EI, 70 eV) m/z: calc. for C8H7BrOS: 229.9401; found: 229.9396. 
 




Thiophene 157i was prepared via TP2 using ethyl 5-bromothiophene-2-carboxylate (118 mg, 
0.50 mmol) and dry toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at −40 
°C. After stirring at −40 °C for 45 min, ZnCl2 (1.00 M in THF, 0.65 mL, 0.65 mmol), Pd(OAc)2 (5 mg, 
4 mol%), SPhos (17 mg, 8 mol%) and 4-iodoanisole (93 mg, 0.40 mmol) were added and the reaction 
mixture was stirred at room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 90:10, Rf = 0.32) to give the product 157i (75 mg, 
282 µmol, 72% yield) as a white solid. 
 
M.p. (°C): 71-73. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.73 (d, J = 3.9 Hz, 1H), 7.61 – 7.53 (m, 2H), 7.18 (d, J = 3.9 
Hz, 1H), 6.97 – 6.90 (m, 2H), 4.36 (q, J = 7.1 Hz, 2H), 3.84 (s, 3H), 1.39 (t, J = 7.1 Hz, 3H). 
C. EXPERIMENTAL PART    160 
 
13C-NMR (101 MHz, CDCl3, ppm)  = 162.5, 160.3, 151.3, 134.4, 131.6, 127.6, 126.4, 122.7, 114.6, 
61.2, 55.5, 14.5. 
IR (ATR, cm-1) ṽ = 2930, 1697, 1446, 1252, 1091, 749. 
MS (EI, 70 eV, %) m/z = 263 (15), 262 (100), 235 (12), 234 (94), 220 (10), 219 (84), 217 (50), 191 
(42), 190 (36), 189 (13), 175 (16), 163 (11), 145 (57), 102 (14). 
HRMS (EI, 70 eV) m/z: calc. for C14H14O3S: 262.0664; found: 262.0659. 
 




Quinoline 157ja was prepared via TP2 using 2-bromoquinoline (105 mg, 0.50 mmol) and dry toluene 
(1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at 25 °C. After stirring at 25 °C for 60 
min, ZnCl2 (1.00 M in THF, 0.65 mL, 0.65 mmol), Pd(OAc)2 (5 mg, 4 mol%), SPhos (17 mg, 8 mol%) 
and trans-1-Iodo-1-octene (95 mg, 0.40 mmol) were added and the reaction mixture was stirred at room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 90:10, Rf = 0.51) to give the product 157ja (75 mg, 313 µmol, 78% yield) as 
an orange oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.07 (d, J = 8.6 Hz, 1H), 8.02 (d, J = 8.5 Hz, 1H), 7.75 (d, J = 
8.3 Hz, 1H), 7.67 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.53 (d, J = 8.6 Hz, 1H), 7.51 – 7.40 (m, 1H), 6.83 
(dt, J = 16.0, 6.7 Hz, 1H), 6.71 (d, J = 15.9 Hz, 1H), 2.39 – 2.28 (m, 2H), 1.60 – 1.51 (m, 2H), 1.41 – 
1.29 (m, 6H), 0.90 (t, J = 6.7 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.7, 148.2, 138.2, 136.3, 131.1, 129.6, 129.2, 127.6, 127.3, 
125.9, 118.8, 33.2, 31.9, 29.1, 29.0, 22.8, 14.3. 
IR (ATR, cm-1) ṽ = 2923, 1596, 1502, 966, 749. 
MS (EI, 70 eV, %) m/z = 238 (15), 210 (43), 196 (20), 183 (12), 182 (84), 180 (18), 168 (77), 167 
(100), 166 (12), 156 (26), 143 (20). 
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Quinoline 157jb was prepared via TP2 using 2-bromoquinoline (105 mg, 0.50 mmol) and dry toluene 
(1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at 25 °C. After stirring at 25 °C for 60 
min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 3-bromocyclohexene (47 µL, 0.40 mmol) were 
added at 0 °C and the reaction solution was cooled down to −20 °C and was stirred at this temperature 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 80:20, Rf = 0.62) to give the product 157jb (59 mg, 280 µmol, 70% yield) as a brown oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.09 (d, J = 8.7 Hz, 1H), 8.06 (d, J = 8.3 Hz, 1H), 7.78 (dd, J 
= 8.1, 1.4 Hz, 1H), 7.68 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.49 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.37 (d, J 
= 8.5 Hz, 1H), 6.03 – 5.94 (m, 1H), 5.92 – 5.84 (m, 1H), 3.84 – 3.75 (m, 1H), 2.22 – 2.13 (m, 3H), 1.88 
– 1.81 (m, 1H), 1.78 – 1.69 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.0, 147.9, 136.6, 129.5, 129.3, 129.1, 128.7, 127.6, 127.1, 
125.9, 120.3, 45.4, 30.9, 25.2, 21.6. 
IR (ATR, cm-1) ṽ = 2931, 1661, 1595, 1502, 819, 754. 
MS (EI, 70 eV, %) m/z = 210 (11), 209 (82), 208 (100), 206 (11), 194 (61), 193 (16), 192 (10), 180 
(52), 167 (24), 143 (14), 128 (11). 
HRMS (EI, 70 eV) m/z: calc. for C15H15N: 209.1204; found: 209.1200. 
 




Bromoquinoline 157k was prepared via TP2 using 2,4-dibromoquinoline (143 mg, 0.50 mmol) and dry 
toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at 25 °C. After stirring at 25 
°C for 60 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 3-bromocyclohexene (69 µL, 0.50 
mmol) were added at 0 °C and the reaction solution was cooled down to −20 °C and was stirred at this 
temperature overnight. After work-up, the crude product was purified via column chromatography 
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(isohexane:ethyl acetate = 80:20, Rf = 0.68) to give the product 157k (97:3, 102 mg, 355 µmol, 71% 
yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.14 (dd, J = 8.4, 1.4 Hz, 1H), 8.05 (d, J = 8.5 Hz, 1H), 7.73 
(ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.65 (s, 1H), 7.58 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H), 6.05 – 5.98 (m, 1H), 
5.89 – 5.83 (m, 1H), 3.82 – 3.72 (m, 1H), 2.22 – 2.13 (m, 3H), 1.88 – 1.80 (m, 1H), 1.80 – 1.69 (m, 
2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.0, 148.6, 134.5, 130.4, 130.0, 129.5, 128.0, 127.2, 126.7, 
126.6, 124.2, 45.0, 30.8, 25.1, 21.5. 
IR (ATR, cm-1) ṽ = 2930, 1663, 1575, 1491, 762. 
MS (EI, 70 eV, %) m/z = 289 (44), 288 (55), 287 (45), 286 (79), 274 (40), 272 (41), 260 (97), 258 
(100), 223 (41), 221 (42), 208 (43), 204 (35), 179 (30), 178 (32), 167 (31). 
HRMS (EI, 70 eV) m/z: calc. for C15H14BrN: 287.0310; found: 287.0307. 
 




Isoquinoline 157l was prepared via TP2 using 1,4-dibromoisoquinoline (143 mg, 0.50 mmol) and dry 
toluene (1.0 mL). Then, sBu2Mg (151a, 0.63 mL, 0.30 mmol) was added at 25 °C. After stirring at 25 
°C for 60 min, CuCN·2LiCl (1.00 M in THF, 50 µL, 50 µmol) and 3-bromocyclohexene (69 µL, 0.50 
mmol) were added at 0 °C and the reaction solution was cooled down to −20 °C and was stirred at this 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 80:20, Rf = 0.70) to give the product 157l (114 mg, 397 µmol, 79% yield) as 
a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.68 (s, 1H), 8.23 (d, J = 8.5 Hz, 1H), 8.19 (d, J = 8.4 Hz, 1H), 
7.77 (ddd, J = 8.3, 6.8, 1.2 Hz, 1H), 7.65 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H), 6.05 – 5.99 (m, 1H), 5.93 – 
5.87 (m, 1H), 4.44 – 4.37 (m, 1H), 2.27 – 2.10 (m, 3H), 1.94 – 1.74 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.4, 143.9, 135.2, 131.1, 128.8, 128.7, 128.0, 127.9, 127.0, 
125.4, 118.1, 40.2, 30.4, 25.0, 22.1. 
IR (ATR, cm-1) ṽ = 2928, 1671, 1233, 903, 760, 722. 
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MS (EI, 70 eV, %) m/z = 288 (17), 286 (18), 261 (11), 260 (98), 258 (100), 223 (18), 221 (18), 179 
(18), 166 (15). 
HRMS (EI, 70 eV) m/z: calc. for C15H14BrN: 287.0310; found: 287.0308. 
 




Alkene 160a was prepared via TP2 using (E)-1-iodooct-1-ene (95 mg, 0.40 mmol), DMPU (48 µL, 
0.40 mmol) and dry toluene (0.40 mL). Then, sBu2Mg (151a, 0.50 mL, 0.24 mmol) was added at 0 °C. 
After stirring at 0 °C for 1 h, CuCN·2LiCl (1.00 M in THF, 40 µL, 40 µmol) and ethyl 2-
(bromomethyl)acrylate (44 µL, 0.32 mmol) were added and the reaction solution was allowed to warm 
to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.16) to give the product 160a (59 mg, 263 µmol, 
82% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.15 (q, J = 1.1 Hz, 1H), 5.53 (d, J = 1.6 Hz, 1H), 5.50 – 5.38 
(m, 2H), 4.20 (q, J = 7.1 Hz, 2H), 3.12 – 2.72 (m, 2H), 2.01 (q, J = 6.7 Hz, 2H), 1.48 – 1.15 (m, 11H), 
1.01 – 0.72 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.3, 140.3, 133.5, 126.4, 124.8, 60.8, 34.9, 32.7, 31.9, 29.5, 
29.0, 22.8, 14.4, 14.3. 
IR (ATR, cm-1) ṽ = 2926, 1720, 1465, 1190, 1025. 
MS (EI, 70 eV, %) m/z = 149 (20), 139 (57), 121 (19), 111 (100), 107 (18), 95 (34), 94 (18), 93 (50), 
91 (19), 81 (43), 79 (60), 77 (19), 67 (48).  
HRMS (EI, 70 eV) m/z: calc. for C14H24O2: 224.1776; found 224.1767. 
 




Alkene 160b was prepared via TP2 using (Z)-1-iodohept-1-ene (158b, 90 mg, 0.40 mmol), DMPU (48 
µL, 0.40 mmol) and dry toluene (0.40 mL). Then, sBu2Mg (151a, 0.50 mL, 0.24 mmol) was added at 0 
°C. After stirring at 0 °C for 1 h, CuCN·2LiCl (1.00 M in THF, 40 µL, 40 µmol) and 3-
bromocyclohexene (37 µL, 0.32 mmol) were added and the reaction solution was allowed to warm to 
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room temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane, Rf = 0.72) to give the product 160b (38 mg, 213 µmol, 66% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 5.70 (dtd, J = 9.9, 3.7, 2.3 Hz, 1H), 5.45 (dq, J = 10.0, 2.4 Hz, 
1H), 5.39 – 5.30 (m, 1H), 5.23 (ddt, J = 10.9, 9.5, 1.6 Hz, 1H), 3.06 (ddq, J = 11.1, 5.4, 2.6 Hz, 1H), 
2.06 (qd, J = 7.2, 1.5 Hz, 2H), 1.98 (dtt, J = 9.5, 5.0, 2.7 Hz, 2H), 1.74 (dtd, J = 9.7, 5.7, 5.1, 2.1 Hz, 
2H), 1.56 (tdd, J = 12.5, 7.3, 3.6 Hz, 2H), 1.40 – 1.19 (m, 6H), 0.91 – 0.86 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 134.1, 130.9, 129.5, 127.3, 34.0, 31.7, 29.8, 29.7, 27.5, 25.0, 
22.7, 21.3, 14.2. 
IR (ATR, cm-1) ṽ = 3017, 3010, 3003, 1684, 1456, 668. 
MS (EI, 70 eV, %) m/z = 135 (21), 107 (20), 94 (26), 93 (21), 91 (20), 81 (25), 80 (23), 79 (100), 77 
(13). 
HRMS (EI, 70 eV) m/z: calc. for C13H22: 178.1722; found 178.1714. 
 




Michael acceptor 160ca was prepared via TP2 using (Z)-tert-butyl((1-iodonon-1-en-3-
yl)oxy)dimethylsilane (158c, 147 mg, 0.40 mmol), DMPU (48 µL, 0.40 mmol) and dry toluene (0.40 
mL). Then, sBu2Mg (151a, 0.50 mL, 0.24 mmol) was added at 0 °C. After stirring at 0 °C for 1 h, DMF 
(25 µL, 0.32 mmol) was added and the reaction solution was allowed to warm to room temperature 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 99:1, Rf = 0.35) to give the product 160ca (48 mg, 169 µmol, 53% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 9.57 (d, J = 8.0 Hz, 1H), 6.80 (dd, J = 15.5, 4.6 Hz, 1H), 6.26 
(ddd, J = 15.5, 8.0, 1.6 Hz, 1H), 4.40 (tdd, J = 6.1, 4.5, 1.6 Hz, 1H), 1.71 – 1.46 (m, 2H), 1.40 – 1.17 
(m, 8H), 0.91 (s, 9H), 0.89 – 0.86 (m, 3H), 0.06 (s, 3H), 0.03 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 193.9, 160.5, 130.8, 71.8, 37.3, 31.9, 29.4, 25.9, 24.9, 22.7, 
18.3, 14.2, –4.5, –4.8. 
IR (ATR, cm-1) ṽ = 2929, 2857, 1699, 1095, 836. 
MS (EI, 70 eV, %) m/z = 227 (54), 199 (26), 143 (37), 131 (13), 129 (100), 75 (100), 73 (35). 
HRMS (EI, 70 eV) m/z: calc. for C16H32O2Si: 284.2172; found 284.2534. 
 
 
C. EXPERIMENTAL PART    165 
 




Alkene 160cb was prepared via TP2 using (Z)-tert-butyl((1-iodonon-1-en-3-yl)oxy)dimethylsilane 
(158c, 147 mg, 0.40 mmol), DMPU (48 µL, 0.40 mmol) and dry toluene (0.40 mL). Then, sBu2Mg 
(151a, 0.50 mL, 0.24 mmol) was added at 0 °C. After stirring at 0 °C for 1 h, CuCN·2LiCl (1.00 M in 
THF, 40 µL, 40 µmol) and allyl bromide (28 µL, 0.32 mmol) were added at 0 °C and the reaction 
solution was allowed to warm to room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane, Rf = 0.48) to give the product 160cb (69 mg, 
233 µmol, 73% yield) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 5.80 (ddt, J = 16.6, 10.1, 6.2 Hz, 1H), 5.42 (ddt, J = 11.3, 8.4, 
1.5 Hz, 1H), 5.34 (dtd, J = 11.0, 7.3, 1.0 Hz, 1H), 5.05 (dq, J = 17.1, 1.7 Hz, 1H), 5.00 (dq, J = 10.1, 
1.6 Hz, 1H), 4.47 – 4.33 (m, 1H), 2.86 – 2.75 (m, 2H), 1.52 (ddd, J = 12.8, 6.0, 3.3 Hz, 1H), 1.40 – 1.32 
(m, 2H), 1.28 (dq, J = 13.9, 5.3, 4.5 Hz, 7H), 0.91 – 0.86 (m, 12H), 0.04 (s, 3H), 0.03 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 136.7, 135.5, 125.8, 115.2, 68.8, 38.6, 32.3, 32.1, 29.4, 26.0, 
25.5, 22.8, 18.4, 14.3, –4.1, –4.6. 
IR (ATR, cm-1) ṽ = 2927, 1251, 1071, 833, 773. 
MS (EI, 70 eV, %) m/z = 240 (3), 239 (23), 221 (3), 211 (25), 75 (100).  
HRMS (EI, 70 eV) m/z: calc. for C17H33OSi: 281.2301; found 281.2291. 
 




Alkene 160d was prepared via TP2 using (Z)-1-(2-iodovinyl)-4-(trifluoromethyl)benzene (119 mg, 
0.40 mmol), DMPU (48 µL, 0.40 mmol) and dry toluene (0.40 mL). Then, sBu2Mg (151a, 0.50 mL, 
0.24 mmol) was added at 0 °C. After stirring at 0 °C for 1 h, S-butyl benzenesulfonothioate (74 mg, 
0.32 mmol) was added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane, Rf = 0.41) to 
give the product 160d (68 mg, 261 µmol, 82% yield) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.68 – 7.50 (m, 4H), 6.43 (dd, J = 11.0, 2.6 Hz, 2H), 2.82 (t, J 
= 7.4 Hz, 2H), 1.82 – 1.61 (m, 2H), 1.46 (dq, J = 14.6, 7.4 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 140.6 (q, J = 1.3 Hz), 131.1, 128.7, 128.2 (q, J = 32.4 Hz), 
125.3 (q, J = 3.9 Hz), 124.4 (q, J = 271.8 Hz), 123.8, 35.9, 32.4, 21.8, 13.8. 
19F-NMR (377 MHz, CDCl3, ppm)  = –62.5. 
IR (ATR, cm-1) ṽ = 2959, 1319, 1112, 1066, 838. 
MS (EI, 70 eV, %) m/z = 260 (74), 204 (47), 183 (36), 135 (100), 134 (18).  
HRMS (EI, 70 eV) m/z: calc. for C13H15F3S: 260.0847; found 260.0841. 
 




Alkene 160e was prepared via TP2 using (E)-1-bromo-2-(2-iodovinyl)benzene (124 mg, 0.40 mmol), 
DMPU (48 µL, 0.40 mmol) and dry toluene (0.40 mL). Then, sBu2Mg (151a, 0.50 mL, 0.24 mmol) was 
added at 0 °C. After stirring at 0 °C for 1 h, S-methyl methanethiosulfonate (33 µL, 0.32 mmol) was 
added and the reaction solution was allowed to warm to room temperature overnight. After work-up, 
the crude product was purified via column chromatography (isohexane, Rf = 0.45) to give the product 
160e (51 mg, 223 µmol, 70% yield) as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.53 (dd, J = 8.1, 1.3 Hz, 1H), 7.43 (dd, J = 7.8, 1.6 Hz, 1H), 
7.23 (dd, J = 7.7, 1.3 Hz, 1H), 7.04 (td, J = 7.7, 1.7 Hz, 1H), 6.80 (d, J = 15.3 Hz, 1H), 6.61 (d, J = 15.4 
Hz, 1H), 2.43 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 136.9, 133.1, 129.2, 128.0, 127.7, 126.2, 123.0, 122.7, 14.8. 
IR (ATR, cm-1) ṽ = 2916, 1588, 1432, 1020, 927, 740. 
MS (EI, 70 eV, %) m/z = 149 (92), 134 (100).  
HRMS (EI, 70 eV) m/z: calc. for C9H9BrS: 227.9608; found 227.9601. 
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4 Preparation of Polyfunctional Arylzinc Organometallics in Toluene via 
Halogen/Zinc Exchange Reactions 
4.1 Screening Tables 
Variation of the alkoxide residue 
Table 17: I/Zn exchange on 3-iodoanisole with sBu2Zn·2LiOR in function of the nature of R. 
 














[a] Yield determined by GC-analysis of water quenched reaction aliquots. 
 
Reaction time screening 
Table 18: Reaction time of the I/Zn exchange on 3-iodoanisole with sBu2Zn·2LiOR. 
 
Entry time (min) GC Conv. [%][a] 
1 0.5 93 
2 1 99 
3 60 99 
[a] Yield determined by GC-analysis of water quenched reaction aliquots. 
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Variation of the alkyl residue 
Table 19: I/Zn exchange on 3-iodoanisole with 1R2Zn·2LiOR in function of the nature of 1R. 
 
Entry 1R GC Conv. [%][a] 
1 nBu 80 
2 sBu 99 
3 tBu 89 




Table 20: I/Zn exchange on 3-iodoanisole with sBu2Zn·2LiOR in function of the solvent. 
 
Entry Solvent 
GC Yield [%][a] 
hydrolysis iodolysis 
1 Et2O 99 91 
2 THF 99 87 
3 2-MeTHF 99 85 
4 Dioxane 99 86 
5 MTBE 99 89 
6 Acetone 9 0 
7 MeCN 99 36 
8 DMF 99 31 
9 Ethyl acetate 99 19 
10 1,2-Dichloroethane 99 80 
11 Chlorobenzene 99 60 
12 Toluene 99 86 
13 Hexane 99 90 
[a] Yield determined by GC-analysis of water quenched reaction aliquots. 
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4.2 Preparation and Titration of Reagents of Type 1R2Zn·2LiOR 
 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Et2Zn (1.11 M in toluene, 9.01 mL, 10.0 mmol) and the reaction mixture was cooled to –40 °C. 
Then, 2-((2-(dimethylamino)ethyl)(methyl)amino)ethane-1-ol (2.925 g, 20.0 mmol) was added 
dropwise and the reaction stirred for 2 h. Then, the reaction mixture was cooled to –40 °C and nBuLi 
(2.40 M in hexane, 8.33 mL, 20.0 mmol) added dropwise. After the addition was complete, the reaction 
mixture was allowed to warm to room temperature and stir for 2 h. The solvents were removed in vacuo 
affording a light yellow oil. Freshly distilled toluene was added under vigorous stirring until the residue 
was dissolved (6-8 mL). The prepared nBu2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 was titrated prior to 
use at 0 °C by iodometric titration. The nBu2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 concentration of the 








A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Et2Zn (1.11 M in toluene, 9.01 mL, 10.0 mmol) and the reaction mixture was cooled to –40 °C. 
Then, 2-((2-(dimethylamino)ethyl)(methyl)amino)ethane-1-ol (2.925 g, 20.0 mmol) was added 
dropwise and the reaction stirred for 2 h. Then, the reaction mixture was cooled to –0 °C and sBuLi 
(1.32 M in cyclohexane, 15.15 mL, 20.0 mmol) added dropwise. After the addition was complete, the 
reaction mixture was allowed to warm to room temperature and stir for 2 h. The solvents were removed 
in vacuo affording a light-yellow oil. Freshly distilled toluene was added under vigorous stirring until 
the residue was dissolved (6-8 mL). The prepared sBu2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 was 
titrated prior to use at 0 °C by iodometric titration. The sBu2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 
concentration of the resulting clear solution was 0.80–1.20 M. 
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A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Et2Zn (1.11 M in toluene, 9.01 mL, 10.0 mmol) and the reaction mixture was cooled to –40 °C. 
Then, 2-((2-(dimethylamino)ethyl)(methyl)amino)ethane-1-ol (2.925 g, 20.0 mmol) was added 
dropwise and the reaction stirred for 2 h. Then, the reaction mixture was cooled to –40 °C and pTolLi 
(0.98 M in Et2O, 20.4 mL, 20.0 mmol) added dropwise. After the addition was complete, the reaction 
mixture was allowed to warm to room temperature and stir for 2 h. The solvents were removed in vacuo 
affording a light-yellow oil. Freshly distilled toluene was added under vigorous stirring until the residue 
was dissolved (6-8 mL). The prepared pTol2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 was titrated prior to 
use at 0 °C by iodometric titration. The pTol2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 concentration of the 









A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Et2Zn (1.11 M in toluene, 9.01 mL, 10.0 mmol) and the reaction mixture was cooled to –40 °C. 
Then, 2-((2-(dimethylamino)ethyl)(methyl)amino)ethane-1-ol (2.925 g, 20.0 mmol) was added 
dropwise and the reaction stirred for 2 h. Then, the reaction mixture was cooled to –40 °C and tBuLi 
(1.93 M in pentane, 10.36 mL, 20.0 mmol) added dropwise. After the addition was complete, the 
reaction mixture was allowed to warm to room temperature and stir for 2 h. The solvents were removed 
in vacuo affording a light-yellow oil. Freshly distilled toluene was added under vigorous stirring until 
the residue was dissolved (6-8 mL). The prepared tBu2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 was titrated 
prior to use at 0 °C by iodometric titration. The tBu2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 concentration 
of the resulting clear solution was 0.60–1.00 M. 
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Titration Using Iodine178 
 
A dry flask was charged with accurately weighed I2 (128 mg, 0.504 mmol), fitted with a rubber septum, 
and flushed with argon. THF (2 mL) was added and stirring was started. After the iodine was completely 
dissolved, the resulting brown solution was cooled to 0 °C in an ice bath and the organozinc reagent 
was added dropwise via a 1.00-mL syringe (0.01-mL graduations) until the brown color disappeared. 
The obtained concentration needs to be divided by 2 to obtain the concentration of the dialkyl zinc 
species. 
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4.3 Typical Procedures 
 
Typical Procedure 3: Preparation of Diarylzinc Alkoxides via an Iodine/Zinc Exchange Followed by 
Electrophilic Functionalization 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with the corresponding aryl halide (1.00 equiv) and dissolved in dry toluene (0.50 M): Then, the 
exchange reagent R2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 (161c, 167 or 168) (0.60–0.80 equiv) was 
added dropwise and the reaction stirred for 10 minutes unless otherwise stated. The completion of the 
halogen-zinc exchange was checked by GC-analysis of reaction aliquots quenched with water, using 
undecane as internal standard. Subsequent reactions with electrophiles were carried out under the 
indicated conditions. After complete conversion, the mixture was quenched with a sat. aq. NH4Cl 
solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. If the crude 




Typical Procedure 4: Preparation of Diarylzinc Alkoxides via a Bromine/Zinc Exchange Followed by 
Electrophilic Functionalization 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with the corresponding aryl halide (1.00 equiv) and dissolved in dry toluene (1.00 M): Then, 
sBu2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 (161c, 0.80 equiv) was added dropwise and the reaction 
stirred for 5 hours. The completion of the halogen-zinc exchange was checked by GC-analysis of 
reaction aliquots quenched with water, using undecane as internal standard. Subsequent reactions with 
electrophiles were carried out under the indicated conditions. After complete conversion, the mixture 
was quenched with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 mL) and extracted with 
ethyl acetate (3 x 30 mL). The combined organic extracts were dried over Na2SO4, filtered and 
concentrated in vacuo. If the crude product needed purification, it was purified by flash chromatography 
on silica gel using the appropriate eluent. 
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4.4 Preparation of Compounds 166 to 170 




Anisole 166a was prepared via TP3 using 3-iodoanisole (59 mg, 0.25 mmol) and sBu2Zn·2LiOR (161c, 
0.20 mL, 0.15 mmol). After the exchange was complete, the reaction was cooled to 0 °C and CuI 
(10 mg, 0.05 mmol) was added. After stirring at 0 °C for 30 min, allyl bromide (0.03 mL, 0.38 mmol) 
was added and the reaction stirred for 2 h at the same temperature. After work-up, the crude product 
was purified via column chromatography (pentane:ethyl acetate = 10:0.2) to give 166a (29 mg, 
196 µmol, 78%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.25 – 7.20 (m, 1H), 6.83 – 6.74 (m, 3H), 5.98 (m, 1H), 5.14 – 
5.06 (m, 2H), 3.81 (s, 3H), 3.38 (dt, J = 6.6, 1.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.8, 141.8, 137.4, 129.5, 121.1, 116.1, 114.4, 111.5, 55.3, 
40.4. 
 
The spectra matched those of the literature.199 
 




Arene 166b was prepared via TP3 using 1-iodo-3-methoxybenzene (59 mg, 0.25 mmol) and 
sBu2Zn·2LiOR (161c, 0.20 mL, 0.15 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (29 mg, 0.15 mmol) was added. After stirring at 0 °C for 30 min,  
4-chlorobenzoyl chloride (131 mg, 0.75 mmol) was added and the reaction stirred for 2 h at room 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 100:2) to give 166b (53 mg, 215 µmol, 86%) as a colorless oil. 
 
 
199 X. Cheng, M. Prehm, M. K. Das, J. Kain, U. Baumeister, S. Diele, D. Leine, A. Blume, C. Tschierske, J. Am. 
Chem. Soc. 2003, 125, 10977. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.79 – 7.73 (m, 2H), 7.50 – 7.43 (m, 2H), 7.39 (m, 1H), 7.31 
(m, 2H), 7.14 (m, 1H), 3.86 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 195.5, 159.8, 139.1, 138.6, 136.0, 131.6, 129.5, 128.8, 122.8, 
119.2, 114.3, 55.6. 
IR (ATR, cm-1) ṽ = 3016, 1658, 1595, 1584, 1569, 1485, 1464, 1449, 1426, 1399, 1301, 1287, 1273, 
1215, 1175, 1138, 1090, 1049, 1040, 1015, 981, 968, 948, 845, 745, 703, 682, 667. 
MS (EI, 70 eV, %) m/z = 246 (18), 211 (15), 141 (44), 139 (100), 135 (76), 92 (22), 77 (13), 75 (23), 
63 (11). 
HRMS (EI, 70 eV) m/z: calc. for C14H11ClO2: 246.0448; found: 246.0443. 
 




Biaryl 166c was prepared via TP3 using 1-iodo-3-methoxybenzene (59 mg, 0.25 mmol) and 
sBu2Zn·2LiOR (161c, 0.20 mL, 0.15 mmol). After the exchange was complete, Pd(OAc)2 (3 mg, 
10 µmol), SPhos (8 mg, 20 µmol) and ethyl 4-iodobenzoate (55 mg, 0.20 mmol) were added and the 
reaction stirred for 2 h at room temperature. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 98:2) to give 166c (39 mg, 152 µmol, 76%) as a light yellow 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.14 – 8.08 (m, 2H), 7.68 – 7.62 (m, 2H), 7.38 (t, J = 7.9 Hz, 
1H), 7.21 (ddd, J = 7.7, 1.7, 1.0 Hz, 1H), 7.15 (t, J = 2.1 Hz, 1H), 6.94 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 
4.40 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 1.42 (t, J = 7.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.6, 160.1, 145.5, 141.7, 130.2, 130.1, 129.5, 127.2, 119.9, 
113.6, 113.2, 61.1, 55.5, 14.5. 
 
The spectra matched those of the literature.200 
  
 
200 M. Amatore, C. Gosmini, Angew. Chem. Int. Ed. 2008, 47, 2089. 
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Biaryl 166d was prepared via TP3 using 1-iodo-4-(trifluoromethoxy)benzene (139 mg, 0.48 mmol) and 
sBu2Zn·2LiOR (161c, 0.30 mL, 0.29 mmol). After the exchange was complete, Pd(OAc)2 (3 mg, 
14 µmol), SPhos (12 mg, 29 µmol) and 4-iodothioanisole (100 mg, 0.40 mmol) were added and the 
reaction stirred for 12 h at room temperature. After work-up, the crude product was purified via column 
chromatography (pentane:ethyl acetate = 10:0.04) to give 166d (55 mg, 193 µmol, 48%) as a colorless 
solid. 
 
M.p. (°C): 103-105. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.60 – 7.55 (m, 2H), 7.51 – 7.47 (m, 2H), 7.36 – 7.31 (m, 2H), 
7.30 – 7.26 (m, 2H), 2.53 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 148.7 (q, J = 2 Hz), 139.4, 138.4, 136.6, 128.2, 127.5, 127.0, 
121.4, 120.6 (q, J = 257 Hz), 15.9. 
IR (ATR, cm-1) ṽ = 2623, 1594, 1523, 1484, 1205, 1155, 1100, 805. 
MS (EI, 70 eV, %) m/z = 284 (100), 269 (42), 236 (10), 184 (9), 139 (14). 
HRMS (EI, 70 eV) m/z: calc. for C14H11F3OS: 284.0483; found: 284.0475. 
 




Arene 166e was prepared via TP3 using 1-iodo-4-(trifluoromethoxy)benzene (139 mg, 0.48 mmol) and 
sBu2Zn·2LiOR (161c, 0.30 mL, 0.29 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (19 mg, 0.1 mmol) was added. After stirring at 0 °C for 30 min, ethyl 2-
(bromomethyl)acrylate (139 mg, 0.72 mmol) was added and the reaction stirred for 12 h at room 
temperature. After work-up, the crude product was purified via column chromatography (pentane:ethyl 
acetate = 1000:1 to 9:1) to give 166e (88 mg, 321 µmol, 67%) as a colorless oil. The product was 
detected by GC-analysis. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.25 – 7.19 (m, 2H), 7.16 – 7.11 (m, 2H), 6.25 (q, J = 0.9 Hz, 
1H), 5.49 (q, J = 1.4 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.63 (d, J = 1.2 Hz, 2H), 1.26 (t, J = 7.1 Hz, 
3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.8, 147.9, 140.0, 137.7, 130.4, 126.5, 121.1, 61.0, 37.6, 
14.3. 
IR (ATR, cm-1) ṽ = 2984, 2932, 1716, 1634, 1508, 1257, 1222, 1196, 1161, 1021, 950, 813. 
MS (EI, 70 eV, %) m/z = 274 (25), 229 (12), 201 (24), 200 (100), 199 (17), 161 (11), 131 (15), 115 
(47), 103 (15). 
HRMS (EI, 70 eV) m/z: calc. for C13H13F3O3: 274.0817; found: 274.0811. 
 




Arene 166f was prepared via TP3 using tert-butyl(4-iodophenoxy)dimethylsilane (154 mg, 0.46 mmol) 
and sBu2Zn·2LiOR (161c, 0.29 mL, 0.28 mmol). After the exchange was complete, the reaction was 
cooled to 0 °C and CuI (53 mg, 0.28 mmol) was added. After stirring at 0 °C for 30 min, 
cyclopropanecarbonyl chloride (0.13 mL, 1.38 mmol) was added and the reaction stirred for 12 h at 
room temperature. After work-up, the crude product was purified via column chromatography 
(pentane:ethyl acetate = 10:0.5) to give 166f (77 mg, 279 µmol, 61%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.98 – 7.92 (m, 2H), 6.92 – 6.86 (m, 2H), 2.63 (tt, J = 7.8, 4.5 
Hz, 1H), 1.20 (dt, J = 4.5, 3.4 Hz, 2H), 0.99 (s, 11H), 0.23 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 199.4, 160.2, 131.7, 130.3, 120.0, 25.7, 18.4, 16.8, 11.4, –4.2. 
IR (ATR, cm-1) ṽ = 3008, 2955, 2930, 2858, 1664, 1599, 1508, 1415, 1272, 1257, 1225, 1164, 994, 
910, 840, 782. 
MS (EI, 70 eV, %) m/z = 277 (100). 
HRMS (EI, 70 eV) m/z: calc. for C16H25O2Si: 277.1624; found: 277,1620. 
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Arene 166g was prepared via TP3 using (2-iodophenoxy)triisopropylsilane (376 mg, 1.00 mmol) and 
sBu2Zn·2LiOR (161c, 0.62 mL, 0.60 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (38 mg, 0.2 mmol) was added. After stirring at 0 °C for 30 min, ethyl 2-
(bromomethyl)acrylate (289 mg, 1.50 mmol) was added and the reaction stirred for 12 h at room 
temperature. After work-up, the crude product was purified via column chromatography (pentane:ethyl 
acetate = 10:0.5) to give 166g (300 mg, 827 µmol, 83%) as a colorless oil.  
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.09 (dd, J = 8.2, 6.5 Hz, 2H), 6.87 (td, J = 7.4, 1.2 Hz, 1H), 
6.80 (dt, J = 7.3, 1.1 Hz, 1H), 6.20 (q, J = 1.4 Hz, 1H), 5.22 (q, J = 1.7 Hz, 1H), 4.22 (q, J = 7.1 Hz, 
2H), 3.64 (t, J = 1.6 Hz, 2H), 1.34 – 1.23 (m, 6H), 1.08 (d, J = 7.3 Hz, 18H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.4, 154.2, 139.7, 131.0, 128.9, 127.6, 125.5, 120.8, 118.1, 
60.7, 32.6, 18.2, 14.4, 13.2. 
IR (ATR, cm-1) ṽ = 2945, 2867, 1718, 1491, 1453, 1265, 1132, 1108, 910, 755, 683. 
MS (EI, 70 eV, %) m/z = 319 (100), 291 (33), 175 (23), 161 (24), 159 (17), 149 (18), 131 (35), 115 
(18), 103 (46), 89 (14), 75 (55), 61 (11). 
HRMS (EI, 70 eV) m/z: calc. for C18H27O3Si: 319.1729; found: 319.1725. 
 




Arene 166h was prepared via TP3 using 2-iodo-1,3-dimethylbenzene (116 mg, 0.50 mmol) and 
sBu2Zn·2LiOR (161c, 0.28 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (19 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, ethyl 2-
(bromomethyl)acrylate (145 mg, 0.75 mmol) was added and the reaction stirred for 2 h at room 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 99:1) to give 166h (73 mg, 0.33 mmol, 67%) as a light yellow oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.05 (q, J = 5.5 Hz, 3H), 6.12 (q, J = 1.8 Hz, 1H), 4.91 (q, J = 
2.0 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 3.63 (t, J = 2.1 Hz, 2H), 2.22 (s, 6H), 1.36 (t, J = 7.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.5, 138.2, 137.2, 135.2, 128.2, 126.6, 124.1, 61.0, 31.3, 
19.9, 14.4. 
IR (ATR, cm-1) ṽ = 2978, 2962, 2934, 2872, 1712, 1632, 1469, 1445, 1402, 1389, 1378, 1367, 1339, 
1299, 1274, 1249, 1171, 1128, 1095, 1026, 960, 941, 868, 817, 767. 
MS (EI, 70 eV, %) m/z = 157 (12), 145 (27), 144 (68), 143 (33), 130 (32), 129 (100), 128 (53), 127 
(11), 117 (13), 115 (35), 105 (41), 91 (16), 77 (10). 
HRMS (EI, 70 eV) m/z: calc. for C14H18O2: 218.1307; found: 218.1300. 
 




Arene 166i was prepared via TP3 using 2-iodo-1,3-dimethylbenzene (162 mg, 0.70 mmol) and 
sBu2Zn·2LiOR (161c, 0.51 mL, 0.42 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (80 mg, 0.42 mmol) was added. After stirring at 0 °C for 30 min,  
4-fluorobenzoyl chloride (333 mg, 2.10 mmol) was added and the reaction stirred for 2 h at room 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 99:1) to give 166i (128 mg, 0.56 mmol, 80%) as a light yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.86 (dd, J = 8.4, 5.5 Hz, 2H), 7.29 (d, J = 6.4 Hz, 1H), 7.19 – 
7.09 (m, 4H), 2.15 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 199.0, 166.3 (d, J = 256.0 Hz), 139.4, 134.2, 133.6 (d, J = 2.9 
Hz), 132.2 (d, J = 9.5 Hz), 129.0, 127.8, 116.2 (d, J = 22.0 Hz), 19.5. 
IR (ATR, cm-1) ṽ = 2955, 2924, 2870, 2855, 1734, 1717, 1700, 1670, 1635, 1592, 1558, 1550, 1539, 
1520, 1502, 1461, 1423, 1408, 1380, 1319, 1303, 1293, 1268, 1237, 1225, 1157, 1143, 1093, 1034, 
1012, 970, 926, 876, 848, 816, 769, 760, 731, 700, 687, 668, 664, 657. 
MS (EI, 70 eV, %) m/z = 228 (29), 227 (100), 213 (62), 212 (35), 211 (17), 210 (42), 207 (10), 196 
(14), 193 (12), 183 (19), 133 (26), 123 (45), 105 (20), 95 (13), 79 (10), 77 (13). 
HRMS (EI, 70 eV) m/z: calc. for C15H13FO: 228.0950; found: 228.0944. 
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Arene 166j was prepared via TP3 using 2,4-dichloro-1-iodobenzene (273 mg, 1.00 mmol) and 
sBu2Zn·2LiOR (161c, 0.85 mL, 0.60 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (38 mg, 0.20 mmol) was added. After stirring at 0 °C for 30 min, 3-bromocyclohexene 
(0.17 mL, 1.50 mmol) was added and the reaction stirred for 12 h at room temperature. After work-up, 
the crude product was purified via column chromatography (pentane:ethyl acetate = 1000:1) to give 
166j (202 mg, 889 µmol, 89%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.36 (dd, J = 1.7, 0.8 Hz, 1H), 7.22 – 7.17 (m, 2H), 5.98 (m, 
1H), 5.66 – 5.56 (m, 1H), 3.84 (m, 1H), 2.15 – 2.01 (m, 3H), 1.65 (m, 2H), 1.52 – 1.41 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 142.1, 134.4, 132.3, 130.2, 129.8, 129.2, 128.8, 127.0, 37.7, 
30.0, 25.1, 20.7. 
IR (ATR, cm-1) ṽ = 3020, 2928, 2858, 2834, 2360, 1587, 1557, 1468, 1378, 1101, 1052, 881, 865, 819, 
804, 728, 681, 670. 
MS (EI, 70 eV, %) m/z = 226 (57), 211 (23), 192 (41), 165 (32), 163 (100), 155 (20), 128 (55), 127 
(20). 
HRMS (EI, 70 eV) m/z: calc. for C12H12Cl2: 226.0316; found: 226.0311. 
 




Biaryl 166k was prepared via TP3 using 4-iodobenzonitrile (57 mg, 0.25 mmol) and sBu2Zn·2LiOR 
(161c, 0.22 mL, 0.15 mmol). After the exchange was complete, Pd(OAc)2 (3 mg, 10 µmol), SPhos 
(8 mg, 20 µmol) and 1-iodo-4-methoxybenzene (47 mg, 0.20 mmol) were added and the reaction stirred 
for 2 h at room temperature. After work-up, the crude product was purified via column chromatography 
(pentane:ethyl acetate = 9.5:0.5) to give 166k (37 mg, 177 µmol, 89%) as a colorless solid. 
 
M.p. (°C): 101-103. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.70 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.57 – 7.52 
(m, 2H), 7.04 – 6.98 (m, 2H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.3, 145.4, 132.7, 131.6, 128.5, 127.3, 119.3, 114.7, 110.2, 
55.6. 
IR (ATR, cm-1) ṽ = 2958, 2923, 2225, 1604, 1509, 1494, 1464, 1457, 1293, 1249, 1180, 1037, 822, 
730, 668. 
MS (EI, 70 eV, %) m/z = 209 (100), 194 (44), 166 (53), 140 (35), 139 (11). 
HRMS (EI, 70 eV) m/z: calc. for C14H11NO: 209.0841; found: 209.0836. 
 




Biaryl 166l was prepared via TP3 using 4-iodobenzonitrile (57 mg, 0.25 mmol) and sBu2Zn·2LiOR 
(161c, 0.22 mL, 0.15 mmol). After the exchange was complete, Pd(OAc)2 (3 mg, 10 µmol), SPhos 
(8 mg, 20 µmol) and ethyl 4-iodobenzoate (55 mg, 0.20 mmol) were added and the reaction stirred for 
2 h at room temperature. After work-up, the crude product was purified via column chromatography 
(pentane:ethyl acetate = 9.5:0.5) to give 166l (35 mg, 140 µmol, 70%) as a colorless solid. 
 
M.p. (°C): 114-116. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.18 – 8.12 (m, 2H), 7.76 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.5 
Hz, 2H), 7.68 – 7.63 (m, 2H), 4.41 (q, J = 7.1 Hz, 2H), 1.42 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 144.6, 143.4, 132.9, 130.7, 130.5, 128.1, 127.3, 118.8, 
111.9, 61.4, 14.5. 
IR (ATR, cm-1) ṽ = 2924, 2852, 2221, 1701, 1675, 1605, 1494, 1464, 1395, 1365, 1311, 1290, 1275, 
1208, 1180, 1116, 1101, 1020, 1005, 984, 972, 961, 906, 870, 847, 835, 794, 771, 728, 698, 668. 
MS (EI, 70 eV, %) m/z = 251 (16), 223 (50), 207 (14), 206 (100), 179 (17), 178 (26), 177 (36), 151 
(34), 150 (23). 
HRMS (EI, 70 eV) m/z: calc. for C16H13NO2: 251.0946; found: 251.0943. 
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Biaryl 166m was prepared via TP3 using ethyl 4-iodobenzoate (67 mg, 0.25 mmol) and sBu2Zn·2LiOR 
(161c, 0.22 mL, 0.15 mmol). After the exchange was complete, Pd(OAc)2 (3 mg, 10 µmol), SPhos 
(8 mg, 20 µmol) and 1-iodo-4-methoxybenzene (47 mg, 0.20 mmol) were added and the reaction stirred 
for 2 h at room temperature. After work-up, the crude product was purified via column chromatography 
(pentane:ethyl acetate = 9.8:0.2) to give 166m (30 mg, 117 µmol, 59%) as a light yellow solid. 
 
M.p. (°C): 101-103. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.11 – 8.06 (m, 2H), 7.65 – 7.55 (m, 4H), 7.03 – 6.97 (m, 2H), 
4.40 (q, J = 7.1 Hz, 2H), 3.86 (s, 3H), 1.41 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.7, 159.9, 145.2, 132.6, 130.2, 128.7, 128.5, 126.6, 114.5, 
61.1, 55.5, 14.5. 
IR (ATR, cm-1) ṽ = 2981, 2929, 1705, 1604, 1581, 1562, 1526, 1497, 1464, 1442, 1425, 1400, 1367, 
1310, 1275, 1248, 1181, 1109, 1103, 1038, 1024, 1015, 1001, 905, 862, 853, 828, 773, 761, 726, 702, 
668. 
MS (EI, 70 eV, %) m/z = 256 (80), 228 (52), 213 (22), 212 (14), 211 (100), 185 (20), 183 (22), 168 
(41), 157 (11), 152 (29), 140 (50), 139 (95). 
HRMS (EI, 70 eV) m/z: calc. for C16H16O3: 256.1099; found: 256.1095. 
 




Arene 166n was prepared via TP3 using 4-iodobenzonitrile (57 mg, 0.25 mmol) and sBu2Zn·2LiOR 
(161c, 0.20 mL, 0.15 mmol). After the exchange was complete, the reaction was cooled to 0 °C and CuI 
(10 mg, 0.15 mmol) was added. After stirring at 0 °C for 30 min, 3-bromocyclohexene (60 mg, 
0.38 mmol) was added and the reaction stirred for 2 h at room temperature. After work-up, the crude 
product was purified via column chromatography (pentane:ethyl acetate = 10:0.1) to give 166n (45 mg, 
246 µmol, 98%) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.58 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 6.00 – 5.91 
(m, 1H), 5.70 – 5.61 (m, 1H), 3.51 – 3.40 (m, 1H), 2.13 – 2.06 (m, 2H), 2.06 – 1.98 (m, 1H), 1.77 – 
1.57 (m, 2H), 1.56 – 1.45 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.4, 132.3, 129.8, 128.7, 128.6, 119.3, 109.9, 42.1, 32.4, 
25.0, 21.0. 
IR (ATR, cm-1) ṽ = 2924, 2884, 2854, 2226, 1606, 1502, 1445, 899, 882, 831, 795, 733, 720, 668. 
MS (EI, 70 eV, %) m/z = 183 (22), 182 (41), 179 (59), 178 (19), 169 (11), 168 (100), 167 (10), 155 
(52), 154 (74), 153 (21), 142 (18), 141 (12), 140 (43), 129 (25), 128 (26), 116 (17), 115 (47) 42 (37). 
HRMS (EI, 70 eV) m/z: calc. for C13H13N: 183.1048; found: 183.1042. 
 




Biaryl 166o was prepared via TP3 using 2-iodobenzonitrile (57 mg, 0.25 mmol) and sBu2Zn·2LiOR 
(161c, 0.22 mL, 0.15 mmol). After the exchange was complete, Pd(OAc)2 (3 mg, 10 µmol), SPhos 
(8 mg, 20 µmol) and 1-iodo-4-methoxybenzene (47 mg, 0.20 mmol) were added and the reaction stirred 
for 2 h at room temperature. After work-up, the crude product was purified via column chromatography 
(pentane:ethyl acetate = 9.5:0.5) to give 166o (32 mg, 153 µmol, 76%) as a light yellow solid. 
 
M.p. (°C): 83-85. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.74 (dd, J = 7.7, 1.4 Hz, 1H), 7.62 (td, J = 7.7, 1.4 Hz, 1H), 
7.50 (td, J = 8.3, 7.6, 1.7 Hz, 3H), 7.40 (td, J = 7.6, 1.3 Hz, 1H), 7.06 – 6.98 (m, 2H), 3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.2, 145.3, 133.9, 132.9, 130.6, 130.1, 130.0, 127.2, 119.2, 
114.3, 111.2, 55.5. 
IR (ATR, cm-1) ṽ = 2955, 2933, 2837, 2222, 1608, 1597, 1578, 1516, 1478, 1464, 1441, 1413, 1306, 
1293, 1269, 1246, 1179, 1115, 1108, 1047, 1033, 1016, 1000, 957, 833, 810, 762, 750, 733, 729, 720, 
680, 668. 
MS (EI, 70 eV, %) m/z = 209 (100), 194 (28), 167 (11), 166 (84), 140 (47), 139 (25), 113 (10). 
HRMS (EI, 70 eV) m/z: calc. for C14H11NO: 209.0841; found: 209.0835. 
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Biaryl 166p was prepared via TP3 using 2-iodobenzonitrile (57 mg, 0.25 mmol) and sBu2Zn·2LiOR 
(161c, 0.22 mL, 0.15 mmol). After the exchange was complete, Pd(OAc)2 (3 mg, 10 µmol), SPhos 
(8 mg, 20 µmol) and ethyl 4-iodobenzoate (55 mg, 0.20 mmol) were added and the reaction stirred for 
2 h at room temperature. After work-up, the crude product was purified via column chromatography 
(pentane:ethyl acetate = 9.8:0.2) to give 166p (44 mg, 175 µmol, 88%) as a light yellow solid. 
 
M.p. (°C): 119-121. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.2 – 8.1 (m, 2H), 7.8 (dd, J = 7.7, 1.4 Hz, 1H), 7.7 – 7.6 (m, 
3H), 7.5 (dd, J = 7.9, 1.2 Hz, 1H), 7.5 (td, J = 7.6, 1.3 Hz, 1H), 4.4 (q, J = 7.1 Hz, 2H), 1.4 (t, J = 7.1 
Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 144.5, 142.5, 134.0, 133.1, 130.8, 130.1, 130.1, 128.9, 
128.4, 118.5, 111.4, 61.3, 14.5. 
IR (ATR, cm-1) ṽ = 2960, 2920, 2909, 2224, 1709, 1608, 1594, 1479, 1464, 1443, 1406, 1392, 1367, 
1315, 1271, 1185, 1126, 1120, 1111, 1098, 1030, 1006, 962, 891, 860, 778, 763, 741, 722, 705. 
MS (EI, 70 eV, %) m/z = 223 (27), 207 (15), 206 (100), 179 (80), 178 (53), 177 (68), 169 (18), 151 
(70), 150 (60), 75 (13). 
HRMS (EI, 70 eV) m/z: calc. for C16H13NO2: 251.0946; found: 251.0941. 
 




Arene 166q was prepared via TP3 using 1-((4-iodophenyl)diazenyl)pyrrolidine (301 mg, 1.00 mmol) 
and sBu2Zn·2LiOR (161c, 0.58 mL, 0.60 mmol). After the exchange was complete, the reaction was 
cooled to 0 °C and CuI (38 mg, 0.20 mmol) was added. After stirring at 0 °C for 30 min, allyl bromide 
(0.13 mL, 1.50 mmol) was added and the reaction stirred for 12 h at room temperature. After work-up, 
the crude product was purified via column chromatography (pentane:ethyl acetate = 10:0.2) to give 
166q (166 mg, 771 µmol, 77%) as a light yellow solid. 
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M.p. (°C): 50-52. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.38 – 7.33 (m, 2H), 7.18 – 7.13 (m, 2H), 5.99 (m, 1H), 5.13 – 
5.02 (m, 2H), 3.79 (s, 4H), 3.38 (dt, J = 6.6, 1.6 Hz, 2H), 2.06 – 1.96 (m, 4H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.9, 137.9, 136.9, 129.1, 120.4, 115.6, 48.8, 39.9, 23.9. 
IR (ATR, cm-1) ṽ = 3025, 2986, 2972, 2921, 2874, 1500, 1427, 1404, 1347, 1319, 1261, 1154, 886, 
923, 849, 810, 689. 
MS (EI, 70 eV, %) m/z = 215 (9), 145 (92), 117 (7), 115 (100), 91 (29). 
HRMS (EI, 70 eV) m/z: calc. for C13H17N3: 215.1422; found: 215.1416. 
 




Arene 166r was prepared via TP3 using (4-iodophenyl)(phenyl)methanone (77 mg, 0.25 mmol) and 
sBu2Zn·2LiOR (161c, 0.18 mL, 0.15 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (29 mg, 0.15 mmol) was added. After stirring at 0 °C for 30 min, 2-bromobenzoyl 
chloride (165 mg, 0.75 mmol) was added and the reaction stirred for 2 h at room temperature. After 
work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 9.5:0.5) 
to give 166r (76 mg, 208 µmol, 83%) as a light yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.94 – 7.89 (m, 2H), 7.88 – 7.84 (m, 2H), 7.84 – 7.80 (m, 2H), 
7.70 – 7.66 (m, 1H), 7.65 – 7.59 (m, 1H), 7.54 – 7.47 (m, 2H), 7.47 – 7.43 (m, 1H), 7.43 – 7.37 (m, 
2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 196.0, 195.5, 141.9, 140.3, 138.9, 137.0, 133.5, 133.2, 131.7, 
130.3, 130.1, 130.1, 129.3, 128.6, 127.5, 119.7. 
IR (ATR, cm-1) ṽ = 1798, 1736, 1657, 1596, 1588, 1447, 1430, 1403, 1307, 1273, 1246, 1204, 1178, 
1159, 1072, 1060, 1047, 1027, 1016, 1000, 984, 939, 920, 864, 759, 748, 731, 711, 698, 660. 
MS (EI, 70 eV, %) m/z = 209 (50), 185 (74), 184 (98), 181 (19), 180 (24), 157 (13), 153 (15), 152 
(57), 151 (23), 150 (16), 105 (100), 77 (88), 76 (37), 75 (21). 
HRMS (EI, 70 eV) m/z: calc. for C20H13BrO2: 364.0099; found: 364.0094. 
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Arene 166s was prepared via TP3 using 1-iodo-2,4-dinitrobenzene (294 mg, 1.00 mmol) and 
pTol2Zn·2LiOR (167, 0.76 mL, 0.60 mmol) at –15 °C for 15 min. After the exchange was complete, 
CuI (38 mg, 0.20 mmol) and 3-bromocyclohexene (0.17 mL, 1.50 mmol) were added and the reaction 
stirred for 2 h at the same temperature. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 9.8:0.2) to give 166s (196 mg, 0.79 mmol, 79%) as a yellow 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.62 (d, J = 2.4 Hz, 1H), 8.38 – 8.31 (m, 1H), 7.69 (d, J = 8.7 
Hz, 1H), 6.10 – 6.01 (m, 1H), 5.57 (m, 1H), 4.02 (m, 1H), 2.27 – 2.18 (m, 1H), 2.17 – 2.10 (m, 2H), 
1.80 – 1.61 (m, 2H), 1.51 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.6, 147.9, 146.2, 131.9, 131.2, 127.3, 126.7, 119.8, 37.3, 
31.6, 24.8, 20.9. 
IR (ATR, cm-1) ṽ = 3105, 3025, 2930, 1603, 1526, 1447, 1341, 1065, 901, 834, 788, 743, 724, 661. 
MS (EI, 70 eV, %) m/z = 231 (56), 214 (32), 203 (32), 191 (94), 185 (61), 184 (51), 175 (35), 168 
(43), 167 (100), 166 (28), 157 (64), 156 (61), 155 (21), 154 (26), 153 (41), 152 (58), 145 (39), 139 (34), 
130 (31), 129 (24), 129 (38), 128 (77), 127 (30), 126 (23), 117 (27), 115 (96), 102 (28), 89 (36), 77 
(39). 
HRMS (EI, 70 eV) m/z: calc. for C12H12N2O4: 248.0797; found: 248.0746. 
 




Arene 166t was prepared via TP3 using 3-iodo-4-nitrobenzonitrile (132 mg, 0.48 mmol) and 
pTol2Zn·2LiOR (167, 0.42 mL, 0.29 mmol) at –15 °C for 15 min. After the exchange was complete, 
the reaction was cooled to –40 °C and CuI (19 mg, 0.10 mmol) and allyl bromide (0.06 mL, 0.72 mmol) 
were added and the reaction stirred for 30 min at the same temperature. After work-up, the crude product 
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was purified via column chromatography (pentane:ethyl acetate = 9:1) to give 166t (64 mg, 340 µmol, 
71%) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.21 (d, J = 1.8 Hz, 1H), 7.82 (dd, J = 8.1, 1.8 Hz, 1H), 7.62 – 
7.53 (m, 1H), 5.93 (m, 1H), 5.29 – 5.08 (m, 2H), 3.75 (dt, J = 6.5, 1.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.5, 140.4, 135.9, 133.5, 133.3, 128.5, 118.9, 116.7, 111.9, 
37.1. 
IR (ATR, cm-1) ṽ = 3058, 2983, 2236, 1616, 1531, 1412, 1352, 1195, 1074, 995, 922, 902, 845, 812, 
678. 
MS (EI, 70 eV, %) m/z = 187 (24), 171 (98), 154 (40), 143 (49), 142 (57), 141 (40), 140 (100), 129 
(55), 116 (82), 114 (32), 113 (36), 89 (40). 
HRMS (EI, 70 eV) m/z: calc. for C10H7N2O2: 187.0508; found: 187.0498. 
 




Arene 166u was prepared via TP3 using 3-iodo-4,5-dimethoxybenzaldehyde (115 mg, 0.394 mmol) 
and tBu2Zn·2LiOR (168, 0.35 mL, 0.24 mmol) at 0 °C for 10 min. After the exchange was complete, 
CuI (15 mg, 0.08 mmol) and 3-bromocyclohexene (0.07 mL, 0.59 mmol) were added and the reaction 
stirred for 30 min at the same temperature. After work-up, the crude product was purified via column 
chromatography (pentane:ethyl acetate = 9:1) to give 166u (47 mg, 191 µmol, 48%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 9.87 (s, 1H), 7.34 (dd, J = 13.0, 1.9 Hz, 2H), 5.96 (dtd, J = 9.9, 
3.7, 2.4 Hz, 1H), 5.65 – 5.57 (m, 1H), 3.97 – 3.78 (m, 7H), 2.18 – 1.95 (m, 3H), 1.78 – 1.59 (m, 2H), 
1.50 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 191.8, 153.3, 152.4, 140.7, 132.3, 129.6, 129.4, 125.7, 108.6, 
61.2, 56.0, 34.9, 31.2, 25.1, 21.3. 
IR (ATR, cm-1) ṽ = 3018, 2932, 2858, 2835, 2736, 1689, 1583, 1482, 1455, 1426, 1386, 1296, 1134, 
1086, 1002, 977, 859, 723, 670. 
MS (EI, 70 eV, %) m/z = 246 (100), 231 (42), 217 (31), 192 (28), 165 (22), 137 (17), 115 (15). 
HRMS (EI, 70 eV) m/z: calc. for C15H18O3: 246.1256; found: 246.1249. 
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Thiophene 169a was prepared via TP3 using 2-iodothiophene (106 mg, 0.50 mmol) and sBu2Zn·2LiOR 
(161c, 0.30 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled to 0 °C and CuI 
(19 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, 3-bromocyclohexene (121 mg, 
0.75 mmol) was added and the reaction stirred for 2 h at room temperature. After work-up, the crude 
product was purified via column chromatography (isohexane) to give 169a (58 mg, 353 µmol, 71%) as 
a light-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.15 (dd, J = 5.1, 1.2 Hz, 1H), 6.95 (dd, J = 5.1, 3.4 Hz, 1H), 
6.85 (dt, J = 3.5, 1.1 Hz, 1H), 5.92 – 5.77 (m, 2H), 3.77 – 3.66 (m, 1H), 2.19 – 2.02 (m, 3H), 1.84 – 
1.59 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 150.6, 129.8, 128.5, 126.7, 123.5, 123.1, 36.8, 32.6, 25.0, 20.8. 
IR (ATR, cm-1) ṽ = 3022, 2930, 2857, 2835, 1446, 1276, 1232, 1223, 896, 884, 876, 850, 821, 758, 
722, 690. 
MS (EI, 70 eV, %) m/z = 164 (100), 163 (16), 149 (40), 136 (32), 135 (92), 115 (10), 91 (12). 
HRMS (EI, 70 eV) m/z: calc. for C10H12S: 164.0660; found: 164.0654. 
 




Arene 169b was prepared via TP3 using 2-iodothiophene (106 mg, 0.50 mmol) and sBu2Zn·2LiOR 
(161c, 0.30 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled to 0 °C and CuI 
(57 mg, 0.30 mmol) was added. After stirring at 0 °C for 30 min, 2-bromobenzoyl chloride (329 mg, 
1.50 mmol) was added and the reaction stirred for 2 h at room temperature. After work-up, the crude 
product was purified via column chromatography (isohexane:ethyl acetate = 9.5:0.5) to give 169b 
(82 mg, 307 µmol, 61%) as a light yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.77 (dd, J = 4.9, 1.2 Hz, 1H), 7.68 – 7.63 (m, 1H), 7.45 – 7.38 
(m, 3H), 7.35 (ddd, J = 7.8, 6.1, 3.1 Hz, 1H), 7.12 (dd, J = 4.9, 3.8 Hz, 1H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 188.0, 143.6, 140.6, 136.2, 135.8, 133.5, 131.4, 128.9, 128.5, 
127.2, 119.6. 
IR (ATR, cm-1) ṽ = 1644, 1588, 1514, 1467, 1431, 1409, 1354, 1294, 1275, 1256, 1232, 1054, 1040, 
1030, 885, 844, 770, 741, 727, 685, 668. 
MS (EI, 70 eV, %) m/z = 187 (22), 185 (18), 183 (19), 115 (14), 111 (100), 76 (11), 75 (12). 
HRMS (EI, 70 eV) m/z: calc. for C11H7BrOS: 265.9401; found: 265.9393. 
 




Pyrazole 169c was prepared via TP3 using 1-benzyl-4-iodopyrazole (142 mg, 0.50 mmol) and 
sBu2Zn·2LiOR (161c, 0.38 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (19 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, 3-bromocyclohexene 
(0.09 mL, 0.75 mmol) was added and the reaction stirred for 2 h at room temperature. After work-up, 
the crude product was purified via column chromatography (pentane:ethyl acetate:triethylamine = 
9:1:0.1) to give 169c (95 mg, 0.40 mmol, 80%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.32 (s, 1H), 7.28 – 7.17 (m, 3H), 7.14 – 7.10 (m, 2H), 7.09 (s, 
1H), 5.71 – 5.59 (m, 2H), 5.17 (s, 2H), 3.27 – 3.23 (m, 1H), 1.97 – 1.84 (m, 3H), 1.67 – 1.41 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 138.3, 137.0, 130.3, 128.8, 128.0, 127.7, 127.6, 127.1, 127.1, 
56.1, 31.7, 31.6, 25.0, 20.8. 
IR (ATR, cm-1) ṽ = 2933, 1709, 1649, 1455, 1431, 1358, 1221, 1177, 1072, 996, 848, 714. 
MS (EI, 70 eV, %) m/z = 238 (48), 147 (17), 119 (29), 91 (100), 65 (16). 
HRMS (EI, 70 eV) m/z: calc. for C16H18N2: 238.1470; found: 238.1465. 
 




Pyridine 169d was prepared via TP3 using 2-fluoro-3-iodopyridine (118 mg, 0.53 mmol) and 
sBu2Zn·2LiOR (161c, 0.38 mL, 0.32 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (61 mg, 0.32 mmol) was added. After stirring at 0 °C for 30 min,  
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4-fluorobenzoyl chloride (0.19 mL, 1.59 mmol) was added and the reaction stirred for 12 h at room 
temperature. After work-up, the crude product was purified via column chromatography (pentane:ethyl 
acetate = 8:2) to give 169d (111 mg, 506 µmol, 96%) as a colorless solid. 
 
M.p. (°C): 77-78. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.41 (ddd, J = 4.9, 2.1, 1.1 Hz, 1H), 8.03 (ddd, J = 9.2, 7.4, 2.0 
Hz, 1H), 7.88 – 7.81 (m, 2H), 7.37 (ddd, J = 7.3, 4.9, 1.9 Hz, 1H), 7.20 – 7.12 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 190.2 (d, J = 5 Hz), 166.2 (d, J = 257 Hz), 156.0 (d, J = 243 
Hz), 150.6 (d, pJ = 15 Hz), 141.8 (d, J = 3 Hz), 132.9 (t, J = 3, 1 Hz), 132.4 (dd, J = 10, 1 Hz), 121.8 
(d, J = 5 Hz), 121.3 (d, J = 30 Hz), 116.0 (d, J = 22 Hz). 
IR (ATR, cm-1) ṽ = 3071, 2360, 2343, 1664, 1596, 1573, 1412, 1430, 1229, 1150, 930, 855, 772. 
MS (EI, 70 eV, %) m/z = 219 (28), 123 (12), 123 (100), 96 (5), 75 (6). 
HRMS (EI, 70 eV) m/z: calc. for C12H7F2NO: 219.0496; found: 219.0490. 
 




Pyridine 169e was prepared via TP3 using 4-chloro-3-iodo-2-methylpyridine (106 mg, 0.50 mmol) and 
sBu2Zn·2LiOR (161c, 0.30 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (57 mg, 0.30 mmol) was added. After stirring at 0 °C for 30 min, cyclohexanecarbonyl 
chloride (220 mg, 1.50 mmol) was added and the reaction stirred for 2 h at room temperature. After 
work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 9.6:0.4) 
to give 169e (85 mg, 0.36 mmol, 72%) as a light yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.34 (dd, J = 5.2, 0.7 Hz, 1H), 7.39 (d, J = 5.1 Hz, 1H), 3.61 – 
3.50 (m, 1H), 2.45 (s, 3H), 1.90 – 1.82 (m, 2H), 1.79 (ddd, J = 10.2, 4.2, 2.1 Hz, 2H), 1.74 – 1.66 (m, 
1H), 1.42 – 1.32 (m, 4H), 1.30 – 1.19 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 206.9, 156.0, 146.5, 146.2, 131.7, 126.0, 47.0, 28.3, 26.1, 25.7, 
15.5. 
IR (ATR, cm-1) ṽ = 2930, 2854, 1700, 1552, 1449, 1397, 1383, 1364, 1310, 1264, 1234, 1206, 1170, 
973, 833, 713. 
MS (EI, 70 eV, %) m/z = 194 (10), 154 (19), 141 (29), 129 (33), 128 (19), 127 (100), 126 (19), 92 
(100). 
HRMS (EI, 70 eV) m/z: calc. for C13H16ClNO: 237.0920; found: 237.0912. 
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Pyridine 169f was prepared via TP3 using 6-chloro-3-iodo-2-methylpyridine (127 mg, 0.50 mmol) and 
sBu2Zn·2LiOR (161c, 0.30 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (19 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, 3-bromo-2-
methylprop-1-ene (102 mg, 0.75 mmol) was added and the reaction stirred for 2 h at room temperature. 
After work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 
9.6:0.4) to give 169f (87 mg, 0.48 mmol, 96%) as a light yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.35 (d, J = 7.9 Hz, 1H), 7.09 (d, J = 8.0 Hz, 1H), 4.83 (p, J = 
1.3 Hz, 1H), 4.50 (tt, J = 1.6, 0.8 Hz, 1H), 3.25 (s, 2H), 2.45 (s, 3H), 1.70 (dd, J = 1.5, 0.8 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.3, 148.2, 142.7, 140.2, 131.9, 121.5, 112.7, 40.4, 22.7, 
22.1. 
IR (ATR, cm-1) ṽ = 2972, 2920, 2851, 1651, 1581, 1564, 1433, 1392, 1376, 1365, 1194, 1169, 1139, 
1109, 1033, 1018, 979, 921, 892, 838, 813, 785, 777, 670. 
MS (EI, 70 eV, %) m/z = 180 (21), 168 (32), 167 (10), 166 (100), 131 (29), 130 (16). 
HRMS (EI, 70 eV) m/z: calc. for C10H12ClN: 181.0658; found: 181.0650. 
 




Pyridine 169g was prepared via TP3 using 2,6-dichloro-4-iodopyridine (120 mg, 0.50 mmol) and 
sBu2Zn·2LiOR (161c, 0.36 mL, 0.30 mmol) in THF (1 mL). After the exchange was complete, the 
reaction was cooled to 0 °C and CuI (57 mg, 0.30 mmol) was added. After stirring at 0 °C for 30 min, 
4-fluorobenzoyl chloride (238 mg, 1.50 mmol) was added and the reaction stirred for 2 h at room 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 9.9:0.1) to give 169g (85 mg, 444 µmol, 89%) as a light yellow solid. 
 
M.p. (°C): 117-119. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.89 – 7.83 (m, 2H), 7.51 (s, 2H), 7.27 – 7.22 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 190.8, 166.5 (d, J = 258.0 Hz), 151.5, 149.7, 133.0 (d, J = 9.7 
Hz), 131.4 (d, J = 3.0 Hz), 122.3, 116.5 (d, J = 22.2 Hz). 
IR (ATR, cm-1) ṽ = 3079, 2926, 1668, 1594, 1578, 1533, 1504, 1467, 1412, 1360, 1303, 1274, 1230, 
1184, 1158, 1101, 1012, 993, 973, 964, 886, 847, 837, 814, 759, 718, 692. 
MS (EI, 70 eV, %) m/z = 269 (11), 123 (100), 95 (10). 
HRMS (EI, 70 eV) m/z: calc. for C12H6Cl2FNO: 268.9810; found: 268.9806. 
 




Pyridine 169h was prepared via TP3 using 2-bromo-5-iodopyridine (142 mg, 0.50 mmol) and 
sBu2Zn·2LiOR (161c, 0.30 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (57 mg, 0.30 mmol) was added. After stirring at 0 °C for 30 min,  
4-chlorobenzoyl chloride (263 mg, 1.50 mmol) was added and the reaction stirred for 2 h at room 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 9.5:0.5) to give 169h (126 mg, 425 µmol, 85%) as a colorless solid. 
 
M.p. (°C): 129-131. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.7 (dd, J = 2.5, 0.8 Hz, 1H), 8.0 (dd, J = 8.2, 2.5 Hz, 1H), 7.8 
– 7.7 (m, 2H), 7.7 (dd, J = 8.3, 0.7 Hz, 1H), 7.5 – 7.5 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 192.7, 151.3, 146.5, 140.2, 139.4, 134.8, 132.1, 131.4, 129.3, 
128.4. 
IR (ATR, cm-1) ṽ = 1665, 1588, 1574, 1357, 1304, 1291, 1276, 1215, 1087, 924, 850, 744, 681, 667. 
MS (EI, 70 eV, %) m/z = 262 (97), 260 (100), 186 (13), 184 (14), 158 (12), 156 (12), 141 (21), 139 
(74), 111 (11). 
HRMS (EI, 70 eV) m/z: calc. for C12H7BrClNO: 294.9400; found: 294.9395. 
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Pyrazole 169i was prepared via TP3 using 2-bromo-5-iodopyridine (142 mg, 0.50 mmol) and 
sBu2Zn·2LiOR (161c, 0.30 mL, 0.30 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (19 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min,  
3-bromo-2-methylprop-1-ene (102 mg, 0.75 mmol) was added and the reaction stirred for 2 h at room 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 9.5:0.5) to give 169i (98 mg, 0.46 mmol, 92%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.2 – 8.2 (m, 1H), 7.4 – 7.3 (m, 2H), 4.9 (t, J = 1.7 Hz, 1H), 
4.7 (dt, J = 2.2, 1.1 Hz, 1H), 3.3 (d, J = 1.2 Hz, 2H), 1.7 (t, J = 1.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 150.7, 143.5, 139.9, 139.2, 134.5, 127.8, 113.3, 40.9, 22.1. 
IR (ATR, cm-1) ṽ = 2965, 2928, 2360, 2342, 2336, 1578, 1560, 1454, 1378, 1087, 1024, 896, 802. 
MS (EI, 70 eV, %) m/z = 211 (43), 210 (92), 198 (91), 196 (94), 132 (34), 131 (13), 130 (21), 117 
(100), 116 (26), 91 (14). 
HRMS (EI, 70 eV) m/z: calc. for C9H10BrN: 210.9997; found: 210.9991. 
 




Pyrimidine 169j was prepared via TP3 using 4-chloro-5-iodo-2,6-dimethoxypyrimidine (150 mg, 
0.50 mmol) and sBu2Zn·2LiOR (161c, 0.36 mL, 0.30 mmol) in THF (1 mL). After the exchange was 
complete, the reaction was cooled to 0 °C and CuI (19 mg, 0.10 mmol) was added. After stirring at 0 
°C for 30 min, allyl bromide (91 mg, 0.75 mmol) was added and the reaction stirred for 2 h at room 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 9.5:0.5) to give 169j (101 mg, 0.47 mmol, 94%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 5.8 (ddt, J = 17.5, 9.7, 6.2 Hz, 1H), 5.1 – 5.0 (m, 2H), 4.0 (d, J 
= 5.6 Hz, 6H), 3.3 (dt, J = 6.2, 1.6 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 170.2, 162.8, 160.1, 133.5, 116.1, 110.8, 55.3, 55.0, 29.7. 
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IR (ATR, cm-1) ṽ = 2958, 1639, 1589, 1546, 1482, 1463, 1375, 1348, 1330, 1303, 1290, 1246, 1225, 
1202, 1181, 1082, 1031, 993, 946, 930, 915, 855, 813, 781. 
MS (EI, 70 eV, %) m/z = 214 (100), 213 (39), 201 (14), 199 (44), 187 (24), 185 (42), 184 (17), 179 
(46), 173 (16), 169 (11), 149 (10), 130 (16), 122 (13). 
HRMS (EI, 70 eV) m/z: calc. for C9H11ClN2O2: 214.0509; found: 214.0501. 
 




Pyrimidine 169k was prepared via TP3 using 4-chloro-5-iodo-2,6-dimethoxypyrimidine (150 mg, 
0.50 mmol) and sBu2Zn·2LiOR (161c, 0.36 mL, 0.30 mmol) in THF (1 mL). After the exchange was 
complete, the reaction was cooled to 0 °C and CuI (19 mg, 0.10 mmol) was added. After stirring at 0 
°C for 30 min, ethyl 2-(bromomethyl)acrylate (145 mg, 0.75 mmol) was added and the reaction stirred 
for 2 h at room temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 9.5:0.5) to give 169k (137 mg, 0.48 mmol, 96%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.2 (q, J = 1.6 Hz, 1H), 5.1 (td, J = 2.0, 0.9 Hz, 1H), 4.2 (q, J 
= 7.1 Hz, 2H), 4.0 (d, J = 13.5 Hz, 6H), 3.6 (t, J = 1.8 Hz, 2H), 1.3 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 170.6, 166.8, 163.2, 161.1, 136.7, 124.5, 109.6, 61.1, 55.4, 
55.0, 27.7, 14.4. 
IR (ATR, cm-1) ṽ = 2985, 1717, 1637, 1593, 1548, 1484, 1465, 1426, 1382, 1348, 1282, 1256, 1225, 
1199, 1174, 1135, 1083, 1033, 945, 782. 
MS (EI, 70 eV, %) m/z = 251 (56), 241 (13), 240 (16), 224 (11), 223 (100), 214 (28), 212 (87), 211 
(23), 203 (28), 197 (15), 187 (15), 183 (21), 177 (91). 
HRMS (EI, 70 eV) m/z: calc. for C12H15ClN2O4: 286.0720; found: 286.0713. 
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Quinoline 169l was prepared via TP3 using 3-fluoro-4-iodo-6-methoxyquinoline (155 mg, 0.51 mmol) 
and sBu2Zn·2LiOR (161c, 0.37 mL, 0.31 mmol) at 0 °C for 10 min. After the exchange was complete, 
CuI (19 mg, 0.09 mmol) was added. After stirring at 0 °C for 30 min, allyl bromide (0.07 mL, 
0.77 mmol) was added and the reaction stirred for 12 h at room temperature. After work-up, the crude 
product was purified via column chromatography (pentane:ethyl acetate = 9:1) to give 169l (102 mg, 
0.47 mmol, 92%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.61 (d, J = 1.2 Hz, 1H), 7.98 (d, J = 9.2 Hz, 1H), 7.31 – 7.27 
(m, 1H), 7.14 (d, J = 2.8 Hz, 1H), 5.97 (ddt, J = 17.2, 10.1, 6.0 Hz, 1H), 5.11 (dq, J = 10.1, 1.6 Hz, 1H), 
5.05 (dq, J = 17.0, 1.7 Hz, 1H), 3.90 (s, 3H), 3.77 (dq, J = 6.1, 1.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.6, 154.9 (d, J = 252.6 Hz), 141.6 (d, J = 2.5 Hz), 138.4 (d, 
J = 29.3 Hz), 133.7, 131.7, 129.3 (d, J = 3.6 Hz), 127.1 (d, J = 12.8 Hz), 120.5 (d, J = 2.7 Hz), 117.1, 
102.1 (d, J = 5.5 Hz), 55.6, 28.4 (d, J = 4.0 Hz). 
IR (ATR, cm-1) ṽ = 3081, 3007, 2938, 2831, 2360, 1620, 1506, 1468, 1360, 1320, 1263, 1216, 1136, 
1029, 908, 827, 784, 699, 674. 
MS (EI, 70 eV, %) m/z = 218 (100). 
HRMS (EI, 70 eV) m/z: calc. for C13H13FNO: 218.0981; found: 218.0974.  
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Enol intermediate was prepared via TP3 using 3-fluoro-4-iodo-6-methoxyquinoline (155 mg, 
0.51 mmol) and sBu2Zn·2LiOR (161c, 0.44 mL, 0.31 mmol) at 0 °C for 10 min. After the exchange 
was complete, CuI (19 mg, 0.09 mmol) was added. After stirring at 0 °C for 30 min, a solution of methyl 
vinyl ketone (0.13 mL, 0.53 mL) and TMSCl (0.28 mL, 2.15 mmol) was added and the reaction stirred 
for 12 h at room temperature. After work-up, the crude product was obtained as a yellow oil and used 
as is in the next step. 
 
Step 2: Synthesis of 169m 
 
The enol product from step 1 was dissolved in THF (2.5 mL) and TBAF (1.00 M in THF, 0.6 mL, 
0.6 mmol) added dropwise. The reaction was stirred at room temperature for 1 h. Then, a sat. aq. NH4Cl 
solution (10 mL) was added and the reaction mixture extracted with ethyl acetate (3 x 30 mL). After 
purification via column chromatography (pentane:ethyl acetate = 7:3) 169m (71 mg, 287 µmol, 56%) 
was obtained as a colorless solid over two steps. 
 
M.p. (°C): 61-63. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.56 (d, J = 1.3 Hz, 1H), 7.96 (d, J = 9.2 Hz, 1H), 7.29 (dd, J 
= 9.2, 2.7 Hz, 1H), 7.16 (d, J = 2.7 Hz, 1H), 3.92 (s, 3H), 3.28 (td, J = 8.3, 7.9, 1.8 Hz, 2H), 2.83 – 2.77 
(m, 2H), 2.17 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 206.9, 158.9, 155.1 (d, J = 252.2 Hz), 141.6 (d, J = 2.4 Hz), 
138.2 (d, J = 29.0 Hz), 131.9, 129.0 (d, J = 3.7 Hz), 128.8 (d, J = 12.7 Hz), 120.6 (d, J = 2.8 Hz), 101.6 
(d, J = 5.4 Hz), 55.7, 42.5 (d, J = 1.3 Hz), 30.0, 18.2 (d, J = 3.5 Hz). 
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IR (ATR, cm-1) ṽ = 3003, 2958, 2835, 1712, 1620, 1508, 1469, 1359, 1229, 1207, 1027, 907, 829, 788, 
731. 
MS (EI, 70 eV, %) m/z = 247 (100), 205 (11), 204 (91), 190 (60), 173 (19), 172 (20), 161 (11), 160 
(11). 
HRMS (EI, 70 eV) m/z: calc. for C14H14FNO2: 247.1009; found: 247.1003. 
 




Uracil 169n was prepared via TP3 using 5-iodo-1,3-dimethyluracil (137 mg, 0.515 mmol) and 
sBu2Zn·2LiOR (161c, 0.37 mL, 0.31 mmol) in THF (1 mL) at 0 °C for 10 min. After the exchange was 
complete, CuI (19 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, 3-bromocyclohexene 
(0.09 mL, 0.77 mmol) was added and the reaction stirred for 12 h at room temperature. After work-up, 
the crude product was purified via column chromatography (pentane:ethyl acetate:triethylamine = 
6:4:0.1) to give 169n (91 mg, 413 µmol, 80%) as a colorless solid. 
 
M.p. (°C): 79-82. 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.87 (d, J = 0.8 Hz, 1H), 5.93 (dtd, J = 9.8, 3.7, 2.1 Hz, 1H), 
5.49 (ddt, J = 10.1, 4.0, 2.2 Hz, 1H), 3.54 – 3.47 (m, 1H), 3.38 (s, 3H), 3.35 (s, 3H), 2.06 – 1.99 (m, 
2H), 1.97 – 1.87 (m, 1H), 1.59 (m, 1H), 1.55 – 1.42 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.4, 151.8, 139.9, 130.6, 127.6, 117.2, 37.1, 32.4, 28.3, 28.1, 
25.2, 19.5. 
IR (ATR, cm-1) ṽ = 3062, 3019, 2927, 2860, 2836, 1696, 1656, 1632, 1449, 1338, 1238, 1089, 784, 
756. 
MS (EI, 70 eV, %) m/z = 220 (90), 205 (43), 192 (13), 191 (41), 179 (19), 166 (100), 165 (23), 153 
(20), 148 (12), 134 (14), 107 (10). 
HRMS (EI, 70 eV) m/z: calc. for C12H16N2O2: 220.1212; found: 220.1205. 
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Uracil 169o was prepared via TP3 using 5-iodo-1,3-dimethyluracil (136 mg, 0.51 mmol) and 
sBu2Zn·2LiOR (161c, 0.44 mL, 0.31 mmol) in THF (1 mL) at 0 °C for 10 min. After the exchange was 
complete, CuI (58 mg, 0.31 mmol) was added. After stirring at 0 °C for 30 min, 2-thiophenecarbonyl 
chloride (0.17 mL, 1.53 mmol) was added and the reaction stirred for 12 h at room temperature. After 
work-up, the crude product was purified via column chromatography (pentane:ethyl acetate = 4:6) to 
give 169o (99 mg, 396 µmol, 77%) as a colorless solid. 
 
M.p. (°C): 193-196. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.88 (s, 1H), 7.78 (dd, J = 3.9, 1.1 Hz, 1H), 7.68 (dd, J = 5.0, 
1.2 Hz, 1H), 7.13 (dd, J = 4.9, 3.9 Hz, 1H), 3.51 (s, 3H), 3.41 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 181.8, 160.4, 151.2, 148.2, 143.5, 135.0, 134.8, 128.1, 113.5, 
37.9, 28.5. 
IR (ATR, cm-1) ṽ = 3105, 301, 2953, 1706, 1648, 1635, 1599, 1410, 1335, 1220, 1056, 794, 748, 670. 
MS (EI, 70 eV, %) m/z = 250 (61), 222 (21), 221 (100), 207 (15), 167 (27), 124 (11), 111 (58). 
HRMS (EI, 70 eV) m/z: calc. for C11H10N2O3S: 250.0412; found: 250.0409. 
 





Antipyrine 169p was prepared via TP3 using iodoantipyrine (145 mg, 0.46 mmol) and sBu2Zn·2LiOR 
(161c, 0.33 mL, 0.28 mmol) in THF (1 mL) at 0 °C for 10 min. After the exchange was complete, CuI 
(19 mg, 0.09 mmol) was added. After stirring at 0 °C for 30 min, ethyl 2-(bromomethyl)acrylate 
(134 mg, 0.69 mmol) was added and the reaction stirred for 12 h at room temperature. After work-up, 
the crude product was purified via column chromatography (pentane:ethyl acetate = 4:6) to give 169p 
(103 mg, 343 µmol, 74%) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.44 – 7.37 (m, 4H), 7.22 (ddt, J = 6.6, 5.7, 2.6 Hz, 1H), 6.22 
(q, J = 1.0 Hz, 1H), 5.71 (q, J = 1.5 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.30 (t, J = 1.2 Hz, 2H), 3.01 (s, 
3H), 2.21 (s, 3H), 1.28 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.1, 166.0, 154.4, 137.3, 135.5, 129.1, 126.3, 126.1, 123.4, 
107.6, 60.8, 36.4, 24.8, 14.3, 11.4. 
IR (ATR, cm-1) ṽ = 2982, 2906, 1713, 1667, 1595, 1496, 1292, 1254, 1025, 946, 757, 696. 
MS (EI, 70 eV, %) m/z = 300 (31), 299 (31), 271 (89), 255 (19), 254 (20), 227 (100), 226 (19), 208 
(18), 207 (29), 201 (19), 196 (18), 152 (22), 124 (18). 
HRMS (EI, 70 eV) m/z: calc. for C17H20N2O3: 300.1474; found: 300.1471. 
 




Morpholine 169q was prepared via TP3 using 1-(4-iodophenyl)-3-(piperidin-1-yl)-5,6-dihydropyridin-
2(1H)-one (76 mg, 0.20 mmol) and sBu2Zn·2LiOR (161c, 0.17 mL, 0.12 mmol) at 0 °C for 10 min. 
After the exchange was complete, CuI (8 mg, 0.04 mmol) was added. After stirring at 0 °C for 30 min, 
allyl bromide (0.03 mL, 0.30 mmol) was added and the reaction stirred for 2 h at room temperature. 
After work-up, the crude product was purified via column chromatography (pentane:ethyl acetate = 6:4) 
to give 169q (50 mg, 168 µmol, 85%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.37 – 7.26 (m, 4H), 6.09 – 5.97 (m, 1H), 5.71 (t, J = 4.7 Hz, 
1H), 5.21 – 5.11 (m, 2H), 3.93 – 3.88 (m, 4H), 3.85 (t, J = 6.7 Hz, 2H), 3.48 – 3.43 (m, 2H), 3.01 – 2.96 
(m, 4H), 2.60 – 2.52 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 161.5, 143.9, 141.0, 138.0, 137.3, 129.0, 125.1, 116.0, 114.2, 
66.9, 50.6, 48.7, 39.9, 23.5. 
IR (ATR, cm-1) ṽ = 2957, 2924, 2892, 2854, 2818, 1659, 1620, 1511, 1219, 1118, 924, 811, 782. 
MS (EI, 70 eV, %) m/z = 298 (5), 280 (100), 279 (29), 239 (34), 212 (55), 146 (39), 117 (18), 115 
(27). 
HRMS (EI, 70 eV) m/z: calc. for C19H24N2O: 298.1681; found: 298.1681. 
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Furane 169r was prepared via TP3 using 5-iodofuran-2-carbaldehyde (56 mg, 0.25 mmol) and 
tBu2Zn·2LiOR (168, 0.30 mL, 0.20 mmol) at 0 °C for 10 min. After the exchange was complete, CuI 
(10 mg, 0.05 mmol) and 3-bromocyclohexene (61 mg, 0.38 mmol) was added and the reaction stirred 
for 30 min at the same temperature. After work-up, the crude product was purified via column 
chromatography (pentane:ethyl acetate = 9.9:0.1) to give 169r (29 mg, 164 µmol, 66%) as a colorless 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 9.5 (s, 1H), 7.2 (d, J = 3.5 Hz, 1H), 6.2 (dd, J = 3.5, 0.8 Hz, 
1H), 6.0 – 5.9 (m, 1H), 5.8 – 5.7 (m, 1H), 3.6 – 3.5 (m, 1H), 2.1 – 2.0 (m, 3H), 1.9 – 1.8 (m, 1H), 1.7 – 
1.6 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 177.3, 166.5, 152.0, 130.3, 125.4, 108.5, 35.4, 27.9, 24.9, 20.3. 
IR (ATR, cm-1) ṽ = 2933, 2863, 2836, 1673, 1511, 1449, 1400, 1300, 1281, 1198, 1023, 966, 873, 803, 
764, 726. 
MS (EI, 70 eV, %) m/z = 176 (53), 161 (10), 148 (14), 147 (100), 119 (45), 91 (50). 
HRMS (EI, 70 eV) m/z: calc. for C11H12O2: 176.0837; found: 176.0830. 
 




Benzonitrile 170a was prepared via TP4 using 4-bromobenzonitrile (94 mg, 516 µmol) and 
sBu2Zn·2LiOR (161c, 0.55 mL, 413 µmol). After the exchange was complete, a solution of I2 (262 mg, 
1.03 mmol) in THF (2 mL) was added and the reaction stirred for 30 min. After work-up, the crude 
product was purified via column chromatography (isohexane:ethyl acetate = 9:1) to give 170a (91 mg, 
397 µmol, 77%) as a colorless solid. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.88 – 7.81 (m, 2H), 7.40 – 7.32 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 138.6, 133.3, 118.3, 111.8, 100.5. 
The spectra matched those of the literature.201 
 
201 Y.-H. Chen, M. Sun, P. Knochel, Angew. Chem. Int. Ed. 2009, 48, 2236. 
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Biaryl 170b was prepared via TP4 using 4-bromobenzonitrile (52 mg, 286 µmol) and sBu2Zn·2LiOR 
(161c, 0.305 mL, 229 µmol). After the exchange was complete, Pd(OAc)2 (2 mg, 9 µmol), SPhos 
(7 mg, 17 µmol) and 4-iodoanisole (53 mg, 0.23 mmol) were added and the reaction stirred for 12 h at 
room temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 9:1) to give 170b (31 mg, 148 µmol, 64%) as a colorless solid. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.72 – 7.61 (m, 4H), 7.57 – 7.50 (m, 2H), 7.04 – 6.97 (m, 2H), 
3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.3, 145.3, 132.7, 131.6, 128.5, 127.2, 119.3, 114.7, 110.2, 
55.5. 
 
The spectra matched those of the literature.202 
 




Benzonitrile 170c was prepared via TP4 using 2-bromobenzonitrile (89 mg, 0.49 mmol) and 
sBu2Zn·2LiOR (161c, 0.47 mL, 0.39 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (19 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, ethyl 2-
(bromomethyl)acrylate (171 mg, 0.74 mmol) was added and the reaction stirred for 2 h at the same 
temperature. After work-up, the crude product was purified via column chromatography (pentane:ethyl 
acetate = 7:3) to give 170c (66 mg, 0.31 mmol, 63%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.63 (ddd, J = 7.8, 1.5, 0.6 Hz, 1H), 7.51 (td, J = 7.7, 1.4 Hz, 
1H), 7.37 (ddd, J = 7.9, 1.2, 0.6 Hz, 1H), 7.32 (td, J = 7.6, 1.2 Hz, 1H), 6.33 (q, J = 0.9 Hz, 1H), 5.57 
(q, J = 1.3 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.86 (s, 2H), 1.25 (t, J = 7.1 Hz, 3H). 
 
202 S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9205. 
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13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 142.8, 138.3, 133.0, 132.9, 130.3, 127.6, 127.2, 118.0, 
113.1, 61.1, 36.7, 14.2. 
 
The spectra matched those of the literature.203 
 




Benzonitrile 170d was prepared via TP4 using 2-bromobenzonitrile (85 mg, 0.47 mmol) and 
sBu2Zn·2LiOR (161c, 0.48 mL, 0.38 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (71 mg, 0.38 mmol) was added. After stirring at 0 °C for 30 min, cyclopropanecarbonyl 
chloride (147 mg, 1.41 mmol) was added and the reaction stirred for 12 h at room temperature. After 
work-up, the crude product was purified via column chromatography (pentane:ethyl acetate = 7:3) to 
give 170d (54 mg, 315 µmol, 67%) as a colorless solid. 
 
M.p. (°C): 66-67. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.99 (dd, J = 7.9, 1.3 Hz, 1H), 7.79 (dd, J = 7.6, 1.4 Hz, 1H), 
7.71 (td, J = 7.7, 1.4 Hz, 1H), 7.62 (td, J = 7.6, 1.3 Hz, 1H), 2.59 (tt, J = 7.7, 4.5 Hz, 1H), 1.35 (p, J = 
3.8 Hz, 2H), 1.16 (dq, J = 7.4, 3.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 199.6, 141.5, 134.8, 132.7, 132.0, 129.3, 118.1, 110.8, 19.4, 
13.3. 
IR (ATR, cm-1) ṽ = 3076, 3006, 2220, 1673, 1590, 1571, 1486, 1383, 1223, 989, 871, 756. 
MS (EI, 70 eV, %) m/z = 170 (10), 143 (13), 130 (100), 115 (8), 75 (6). 




203 M. Ketels, M. A. Ganiek, N. Weidmann, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 12770. 
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Biaryl 170e was prepared via TP4 using 2-bromobenzonitrile (93 mg, 0.51 mmol) and sBu2Zn·2LiOR 
(161c, 0.49 mL, 0.41 mmol). After the exchange was complete, the reaction was cooled to 0 °C and 
TMSCl (0.05 mL, 0.41 mmol) added at 0 °C and stirred for 10 min. Then, Pd(OAc)2 (4 mg, 15 µmol), 
SPhos (13 mg, 31 µmol) and 4-tertbutyliodobenzene (107 mg, 0.41 mmol) were added and the reaction 
stirred for 12 h at room temperature. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 10:0.2) to give 170e (62 mg, 263 µmol, 64%) as a colorless 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.76 (ddd, J = 7.7, 1.4, 0.6 Hz, 1H), 7.63 (ddd, J = 7.5, 1.4 Hz, 
1H), 7.54 – 7.50 (m, 5H), 7.42 (td, J = 7.6, 1.3 Hz, 1H), 1.38 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.9, 145.6, 135.3, 133.9, 132.9, 130.2, 128.6, 127.4, 125.8, 
119.1, 111.2, 34.8, 31.4. 
 
The spectra matched those of the literature.204 
 




Arene 170f was prepared via TP4 using 1-bromo-2-(trifluoromethyl)benzene (238 mg, 1.06 mmol) and 
sBu2Zn·2LiOR (161c, 1.05 mL, 0.85 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuCN·2LiCl (1.00 M in THF, 0.21 mL, 0.21 mmol) was added. After stirring at 0 °C for 10 
min, 3-bromocyclohexene (0.18 mL, 1.59 mmol) was added and the reaction stirred for 2 h at the same 
temperature. After work-up, the crude product was purified via column chromatography 
(isohexane:diethyl ether = 1000:1) to give 170f (185 mg, 818 µmol, 77%) as a colorless oil. 
 
 
204 S. Sarkar, M. Jana, T. Narender, Eur. J. Org. Chem. 2013, 6491. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.61 (dd, J = 7.9, 1.3 Hz, 1H), 7.52 – 7.40 (m, 2H), 7.29 (t, J = 
7.6 Hz, 1H), 5.97 – 5.87 (m, 1H), 5.64 – 5.55 (m, 1H), 3.86 – 3.77 (m, 1H), 2.17 – 2.03 (m, 3H), 1.86 
– 1.76 (m, 1H), 1.74 – 1.61 (m, 1H), 1.53 – 1.41 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 145.8 (d, J = 1.5 Hz), 131.9, 130.0 (d, J = 29.3 Hz), 128.7, 
128.0 (q, J = 29.2 Hz), 126.2, 126.0, 125.7 (q, J = 5.9 Hz), 123.5, 37.9 (d, J = 2.0 Hz), 32.8, 25.0, 21.8. 
 
The spectra matched those of the literature.205 
 




Biaryl 170g was prepared via TP4 using 3-bromo-5-fluorobenzonitrile (193 mg, 0.97 mmol) and 
sBu2Zn·2LiOR (161c, 0.96 mL, 0.78 mmol). After the exchange was complete, Pd(OAc)2 (7 mg, 
29 µmol), SPhos (24 mg, 58 µmol) and 3-iodoanisole (159 mg, 0.68 mmol) were added and the reaction 
stirred for 12 h at room temperature. After work-up, the crude product was purified via column 
chromatography (pentane:ethyl acetate = 10:0.5) to give 170g (93 mg, 409 µmol, 60%) as a colorless 
solid. 
 
M.p. (°C): 109-110. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.7 (t, J = 1.5 Hz, 1H), 7.5 (ddd, J = 9.6, 2.5, 1.6 Hz, 1H), 7.4 
(t, J = 8.0 Hz, 1H), 7.3 (ddd, J = 7.7, 2.5, 1.4 Hz, 1H), 7.1 (ddd, J = 7.6, 1.8, 0.9 Hz, 1H), 7.1 (t, J = 2.1 
Hz, 1H), 7.0 (ddd, J = 8.3, 2.6, 0.9 Hz, 1H), 3.9 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 162.6 (d, J = 250.1 Hz), 160.3, 145.0 (d, J = 8.1 Hz), 139.2 (d, 
J = 2.1 Hz), 130.5, 126.9 (d, J = 3.2 Hz), 119.5, 119.1 (d, J = 21.8 Hz), 117.8 (d, J = 3.5 Hz), 117.7 (d, 
J = 24.8 Hz), 114.4, 114.2 (d, J = 10.0 Hz), 112.9, 55.5. 
IR (ATR, cm-1) ṽ = 3081, 2928, 2234, 1580, 1460, 1440, 1403, 1332, 1287, 1240, 1046, 966, 865, 776, 
685. 
MS (EI, 70 eV, %) m/z = 228 (15), 227 (100), 198 (49), 184 (26), 158 (29). 
HRMS (EI, 70 eV) m/z: calc. for C14H10FNO: 227.0746; found: 227.0740.  
 
205 L. Baker, T. Minehan, J. Org. Chem. 2004, 69, 3957. 
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Benzonitrile 170h was prepared via TP4 using 3-bromo-5-fluorobenzonitrile (222 mg, 1.03 mmol) and 
sBu2Zn·2LiOR (161c, 1.01 mL, 0.82 mmol) at 25 °C for 1 h. After the exchange was complete, the 
reaction was cooled to 0 °C and CuCN·2LiCl (1.00 M in THF, 0.21 mL, 0.21 mmol) and allyl bromide 
(0.13 mL, 1.53 mmol) was added and the reaction stirred for 1 h at the same temperature. After work-
up, the crude product was purified via column chromatography (pentane:ethyl acetate = 10:0.2) to give 
170h (144 mg, 811 µmol, 79%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.5 (d, J = 2.1 Hz, 1H), 7.4 (d, J = 8.4 Hz, 1H), 7.4 (dd, J = 
8.4, 2.1 Hz, 1H), 5.9 (ddt, J = 16.8, 10.1, 6.7 Hz, 1H), 5.2 – 5.0 (m, 2H), 3.4 – 3.4 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 139.8, 135.4, 134.6, 134.4, 134.0, 130.0, 117.8, 116.2, 113.3, 
39.0. 
IR (ATR, cm-1) ṽ = 3082, 2982, 2902, 2837, 1711, 1640, 1472, 1432, 1359, 1220, 1055, 994, 919, 829 
MS (EI, 70 eV, %) m/z = 179 (17), 177 (54), 150 (10), 143 (10), 142 (100), 141 (11), 140 (33), 115 
(70). 
HRMS (EI, 70 eV) m/z: calc. for C10H8ClN: 177.0345; found: 177.0338. 
 




Arene 170i was prepared via TP4 using ethyl 5-bromo-2-chlorobenzoate (130 mg, 0.49 mmol) and 
sBu2Zn·2LiOR (161c, 0.46 mL, 0.39 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (18 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, 3-bromocyclohexene 
(0.09 mL, 0.74 mmol) was added and the reaction stirred for 12 h at the same temperature. After work-
up, the crude product was purified via column chromatography (pentane:ethyl acetate = 10:0.05) to give 
170i (95 mg, 359 µmol, 73%) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.55 (d, J = 2.3 Hz, 1H), 7.29 (d, J = 8.3 Hz, 1H), 7.20 – 7.17 
(m, 1H), 5.90 – 5.82 (m, 1H), 5.61 – 5.55 (m, 1H), 4.33 (q, J = 7.2 Hz, 2H), 3.39 – 3.30 (m, 1H), 2.06 
– 1.98 (m, 2H), 1.98 – 1.90 (m, 1H), 1.69 – 1.59 (m, 1H), 1.59 – 1.49 (m, 1H), 1.49 – 1.39 (m, 1H), 
1.34 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 145.6, 131.9, 131.0, 130.9, 130.6, 130.5, 129.5, 129.1, 
61.7, 41.2, 32.5, 25.0, 21.0, 14.4. 
IR (ATR, cm-1) ṽ = 3020, 2981, 2930, 2858, 1731, 1472, 1294, 1251, 1189, 1118, 1045, 827. 
MS (EI, 70 eV, %) m/z = 264 (100), 219 (48), 191 (46), 183 (52), 163 (67), 129 (55), 128 (98), 115 
(50). 
HRMS (EI, 70 eV) m/z: calc. for C15H17ClO2: 264.0917; found: 264.0912. 
 




Quinoline 170j was prepared via TP4 using 3-bromoquinoline (100 mg, 0.48 mmol) and 
sBu2Zn·2LiOR (161c, 0.45 mL, 0.38 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (18 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, allyl bromide 
(0.07 mL, 0.72 mmol) was added and the reaction stirred for 2 h at the same temperature. After work-
up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 9:1) to give 
170j (57 mg, 337 µmol, 70%) as a light yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.77 (d, J = 2.2 Hz, 1H), 8.09 (dq, J = 8.4, 0.9 Hz, 1H), 7.92 
(dd, J = 2.2, 1.0 Hz, 1H), 7.76 (dd, J = 8.1, 1.5 Hz, 1H), 7.66 (ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.51 (ddd, 
J = 8.1, 6.9, 1.2 Hz, 1H), 6.11 – 5.95 (m, 1H), 5.21 – 5.09 (m, 2H), 3.62 – 3.53 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.1, 147.1, 136.2, 134.7, 132.7, 129.3, 128.9, 128.3, 127.5, 
126.8, 117.2, 37.5. 
 




206 D. Seomoon, P. H. Lee, J. Org. Chem. 2008, 73, 1165. 
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Pyridine 170k was prepared via TP4 using 2-bromopyridine (82 mg, 0.52 mmol) and sBu2Zn·2LiOR 
(161c, 0.56 mL, 0.42 mmol). After the exchange was complete, the reaction was cooled to 0 °C and CuI 
(18 mg, 0.10 mmol) was added. After stirring at 0 °C for 30 min, 3-bromocyclohexene (0.09 mL, 
0.78 mmol) was added and the reaction stirred for 12 h at room temperature. After work-up, the crude 
product was purified via column chromatography (isohexane:ethyl acetate = 9:1) to give 170k (51 mg, 
0.32 mmol, 62%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.53 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 7.59 (td, J = 7.6, 1.9 Hz, 
1H), 7.18 (dt, J = 7.9, 1.1 Hz, 1H), 7.09 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 5.96 – 5.89 (m, 1H), 5.81 – 5.75 
(m, 1H), 3.62 – 3.51 (m, 1H), 2.18 – 1.97 (m, 3H), 1.79 – 1.58 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 165.5, 149.4, 136.5, 129.1, 128.8, 121.9, 121.2, 44.1, 30.8, 
25.0, 21.2. 
IR (ATR, cm-1) ṽ = 3018, 2928, 2859, 2835, 2360, 1587, 1568, 1469, 1432, 1150, 880, 774, 749, 723, 
686. 
MS (EI, 70 eV, %) m/z = 159 (2), 158 (20), 144 (16), 131 (10), 130 (100), 117 (14). 
HRMS (EI, 70 eV) m/z: calc. for C11H13N: 159.1048; found: 159.1041. 
 




Pyridine 170l was prepared via TP4 using 3,5-dibromopyridine (235 mg, 1.00 mmol) and 
sBu2Zn·2LiOR (161c, 0.76 mL, 0.60 mmol). After the exchange was complete, the reaction was cooled 
to 0 °C and CuI (38 mg, 0.20 mmol) was added. After stirring at 0 °C for 30 min, allyl bromide 
(0.13 mL, 1.50 mmol) was added and the reaction stirred for 12 h at room temperature. After work-up, 
the crude product was purified via column chromatography (isohexane:ethyl acetate = 9.7:0.3) to give 
170l (120 mg, 0.61 mmol, 61%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.56 (d, J = 2.1 Hz, 1H), 8.40 (d, J = 1.5 Hz, 1H), 7.69 (t, J = 
2.0 Hz, 1H), 5.99 – 5.89 (m, 1H), 5.23 – 5.11 (m, 2H), 3.40 (d, J = 6.6 Hz, 2H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 148.7, 148.1, 138.8, 137.2, 135.2, 120.7, 117.7, 36.7. 
IR (ATR, cm-1) ṽ = 2923, 2356, 1640, 1580, 1555, 1421, 1096, 1022, 993, 921, 884, 851. 
MS (EI, 70 eV, %) m/z = 199 (36), 198 (99), 197 (36), 196 (100), 118 (39), 117 (84), 91 (23). 
HRMS (EI, 70 eV) m/z: calc. for C8H8BrN: 196.9840; found: 196.9833. 
 




Benzothiazole 170m was prepared via TP4 using 2-bromobenzothiazole (110 mg, 0.51 mmol) and 
sBu2Zn·2LiOR (161c, 0.55 mL, 41 mmol). After the exchange was complete, a solution of I2 (261 mg, 
1.02 mmol) in THF (2 mL) was added and the reaction stirred for 30 min. After work-up, the crude 
product was purified via column chromatography (isohexane:ethyl acetate = 9:1) to give 170m (100 mg, 
383 µmol, 75%) as a colorless solid. 
 
M.p. (°C): 79-80. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.06 – 8.00 (m, 1H), 7.87 – 7.81 (m, 1H), 7.48 – 7.34 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 154.3, 139.2, 126.5, 125.7, 122.7, 120.6, 105.9. 
IR (ATR, cm-1) ṽ = 3054, 3026, 2965, 2927, 2831, 1451, 1416, 1308, 1228, 951, 940, 750, 722.  
MS (EI, 70 eV, %) m/z = 260 (100), 134 (35), 90 (6). 
HRMS (EI, 70 eV) m/z: calc. for C7H4INS: 260.9109; found: 260.9103.  
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5 Regioselective Iodine/Zinc Exchange for the Selective Functionalization 
of Polyiodinated Arenes and Heterocycles in Toluene 
5.1 Preparation and Titration of pTol2Zn·2LiOR 




A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with Et2Zn (1.11 M in toluene, 9.01 mL, 10.0 mmol) and the reaction mixture was cooled to –40 °C. 
Then, 2-((2-(dimethylamino)ethyl)(methyl)amino)ethane-1-ol (2.925 g, 20.0 mmol) was added 
dropwise and the reaction stirred for 2 h at 25 °C. Then, the reaction mixture was cooled to –40 °C and 
pTolLi (0.98 M in Et2O, 20.4 mL, 20.0 mmol) added dropwise. After the addition was complete, the 
reaction mixture was allowed to warm to room temperature and stir for 2 h. The solvents were removed 
in vacuo affording a light yellow oil. Freshly distilled toluene was added under vigorous stirring until 
the residue was dissolved (6-8 mL). The prepared pTol2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 was 
titrated prior to use at 0 °C by iodometric titration. The pTol2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 
concentration of the resulting clear solution was 0.60-1.00 M. 
 
Titration Using Iodine178 
A dry flask was charged with accurately weighed I2 (128 mg, 0.504 mmol), fitted with a rubber septum, 
and flushed with argon. THF (2 mL) was added and stirring was started. After the iodine was completely 
dissolved, the resulting brown solution was cooled to 0 °C in an ice bath and the organomagnesium 
reagent was added dropwise via a 1.00-mL syringe (0.01-mL graduations) until the brown color 
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5.2 Typical Procedures 
Typical Procedure 5: Protection of Polyiodophenol Derivatives 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with the corresponding polyiodophenol (1.00 equiv) and dissolved in dry DMF (0.50 M). Then, NaH 
(60% dispersion in mineral oil, 1.10 equiv) was carefully added at 0 °C. After stirring at 0 °C for 30 
min, the corresponding electrophile (1.20 equiv) was added portionwise at 0 °C and the reaction solution 
was allowed to warm to room temperature overnight. The reaction was then quenched with a sat. aq. 
NH4Cl solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
product was purified by flash chromatography on silica gel using the appropriate eluent. 
 
Typical Procedure 6: Preparation of Di(hetero)arylzinc Alkoxides via an Iodine/Zinc Exchange 
Followed by Quenching with Allylic Bromides or Acyl Chlorides 
 
A dry and argon-flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with the corresponding (hetero)aryl polyiodide (1.0 equiv) and dissolved in dry toluene (0.50 M): Then, 
the exchange reagent pTol2Zn·2LiO(CH2)2N(Me)(CH2)2N(Me)2 (167) (0.60 equiv) was added dropwise 
at the indicated temperature and the reaction stirred for the indicated time. The completion of the 
iodine/zinc exchange was checked by GC-analysis of reaction aliquots quenched with water, using 
undecane as internal standard. Subsequent reactions with allylic bromides and acyl chlorides were 
carried out under the indicated conditions. After complete conversion, the mixture was quenched with 
a sat. aq. NH4Cl solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 
30 mL). The combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. If 
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5.3 Starting Materials 




Ethyl 2-hydroxy-3,5-diiodobenzoate (171a, 987 mg, 2.36 mmol) was dissolved in dry pyridine (10 mL). 
Tosyl chloride (541 mg, 2.83 mmol) was then added at 0 °C and the mixture was stirred at room 
temperature overnight. The mixture was quenched with a sat. aq. NH4Cl solution (1 0 mL), diluted with 
water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were dried 
over Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column 
chromatography (isohexane:ethyl acetate = 92:8, Rf = 0.21) to give the product 171a (610 mg, 1.07 
mmol, 45%) as a white solid. 
 
M.p. (°C): 107-109. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.16 (dd, J = 16.1, 2.2 Hz, 2H), 7.79 – 7.61 (m, 2H), 7.44 – 
7.31 (m, 2H), 4.37 (q, J = 7.1 Hz, 2H), 2.47 (s, 3H), 1.42 (t, J = 7.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.9, 150.8, 148.0, 146.3, 140.6, 133.5, 130.2, 130.1, 129.1, 
93.4, 91.9, 62.6, 22.0, 14.1. 
IR (ATR, cm-1) ṽ = 2980, 1721, 1380, 1272, 1174, 740. 
MS (EI, 70 eV, %) m/z = 372 (100), 281 (22), 245 (24), 225 (23), 207 (75), 189 (36), 155 (60), 139 
(30), 128 (62), 127 (84), 119 (37), 91 (88), 73 (24). 
HRMS (EI, 70 eV) m/z: calc. for C16H14I2O5S: 571.8651; found: 571.8667. 
 




Compound 171b was prepared via TP5 using 2,4,6-triiodophenol (2.41 g, 5.00 mmol), NaH (60% 
dispersion in mineral oil, 220 mg, 5.50 mmol) and dry DMF (10 mL).  After stirring at 0 °C for 30 min, 
MeI (852 mg, 6.00 mmol) was added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
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(isohexane:ethyl acetate = 99:1, Rf = 0.47) to give the product 171b (2.25 g, 4.63 mmol, 95%) as a 
white solid. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.04 (s, 2H), 3.83 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.2, 147.4, 91.8, 89.4, 60.9. 
 
The spectra matched those of the literature.207 
 




Compound 171c was prepared via TP5 using 2-hydroxy-3,5-diiodobenzonitrile (1.85 g, 5.00 mmol), 
NaH (60% dispersion in mineral oil, 220 mg, 5.50 mmol) and dry DMF (10 mL).  After stirring at 0 °C 
for 30 min, MeI (852 mg, 6.00 mmol) was added and the reaction solution was allowed to warm to 
room temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 99:1, Rf = 0.21) to give the product 171c (1.74 g, 4.52 mmol, 90%) as a 
yellowish solid. 
 
M.p. (°C): 150-152. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.29 (d, J = 2.1 Hz, 1H), 7.84 (d, J = 2.1 Hz, 1H), 4.05 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 161.7, 151.9, 142.1, 114.4, 107.9, 93.4, 86.9, 62.3. 
IR (ATR, cm-1) ṽ = 2923, 1465, 1412, 1246, 978, 753. 
MS (EI, 70 eV, %) m/z = 385 (100), 370 (39), 342 (14), 243 (54), 127 (34), 88 (28). 










207 D. Alberico, A. Rudolph, M. Lautens, J. Org. Chem. 2007, 72, 775. 
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3,5-Diiodosalicylic acid (3.90 g, 10.0 mmol) was dissolved in DMF (20 mL). KOH (1.68 g, 30 mmol) 
and MeI (1.9 mL) were added at 0 °C and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane, Rf = 0.57) to give the product 171d (3.73 g, 8.92 mmol, 89%) as a white solid. 
 
M.p. (°C): 83-85. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.24 (d, J = 2.2 Hz, 1H), 8.07 (d, J = 2.2 Hz, 1H), 3.92 (s, 3H), 
3.87 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.6, 156.1, 140.9, 132.2, 129.3, 126.0, 85.5, 62.7, 14.3. 
IR (ATR, cm-1) ṽ = 2944, 1728, 1410, 1273, 1206, 990. 
MS (EI, 70 eV, %) m/z = 418 (55), 389 (100), 387 (44), 386 (16), 385 (75), 372 (17), 357 (19), 343 
(71), 276 (17), 262 (28), 260 (18), 245 (50), 217 (71), 189 (34), 76 (11). 
HRMS (EI, 70 eV) m/z: calc. for C9H8I2O3: 417.8563; found: 417.8593. 
 




Compound 171e was prepared via TP5 using 2-hydroxy-3,5-diiodobenzonitrile (2.60 g, 7.00 mmol), 
NaH (60% dispersion in mineral oil, 308 mg, 7.70 mmol) and dry DMF (20 mL).  After stirring at 0 °C 
for 30 min, BnBr (1.32 g, 7.70 mmol) was added and the reaction solution was allowed to warm to 
room temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 99:1, Rf = 0.32) to give the product 171e (2.15 g, 4.7 mmol, 67%) as a white 
solid. 
 
M.p. (°C): 110-112. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.32 (d, J = 2.1 Hz, 1H), 7.86 (d, J = 2.1 Hz, 1H), 7.66 – 7.49 
(m, 2H), 7.48 – 7.32 (m, 3H), 5.20 (s, 3H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 160.3, 152.0, 142.1, 134.9, 129.2, 128.8, 114.4, 109.1, 94.2, 
87.4, 77.1, 29.9. 
IR (ATR, cm-1) ṽ = 3059, 2923, 2231, 1433, 1374, 1241. 
MS (EI, 70 eV, %) m/z = 91 (100). 
HRMS (EI, 70 eV) m/z: calc. for C14H9I2NO: 460.8773; found: 460.8771. 
 




Compound 171f was prepared via TP5 using 2,4,6-triiodophenol (3.30 g, 7.00 mmol), NaH (60% 
dispersion in mineral oil, 308 mg, 7.70 mmol) and dry DMF (20 mL).  After stirring at 0 °C for 30 min, 
BnBr (1.44 g, 8.40 mmol) was added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane, Rf = 0.38) to give the product 171f (2.68 g, 4.80 mmol, 68%) as a white solid. 
 
M.p. (°C): 120-122. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.10 (s, 2H), 7.73 – 7.54 (m, 2H), 7.48 – 7.36 (m, 3H), 4.98 (s, 
2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 157.7, 147.5, 135.9, 128.7 (3C), 92.4, 89.7, 74.7. 
IR (ATR, cm-1) ṽ = 2923, 1424, 1370, 1237, 963, 696. 
MS (EI, 70 eV, %) m/z = 435 (7), 343 (5), 189 (12), 91 (100). 
HRMS (EI, 70 eV) m/z: calc. for C13H9I3O: 561.7787; found: 561.7791. 
 




N,N’-dicyclohexylcarbodiimide (DCC, 8.00 g, 39 mmol) was dissolved in dry THF (50 mL) and added 
dropwise over 30 min to a stirred suspension of 3,5-diiodosalicylic acid (14.1 g, 36.1 mmol) and N,N-
 
208 Adapted procedure from: R. Kluger, V. De Stefano, J. Org. Chem. 2000, 65, 214. 
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dimethylaminopyridine (DMAP, 170 mg, 1.4 mmol) in tert-butyl alcohol (125 mL). The mixture was 
stirred at room temperature overnight and then concentrated. The residue was stirred in diethyl ether 
(50 mL), and oxalic acid (5.3 g, 5.9 mmol) was introduced in portions to decompose excess DCC and 
precipitate DMAP. The mixture was filtered, and the filtrate was washed with aq. NaHCO3 (0.30 M, 3 
x 40 mL) and dried over MgSO4. The solvent was evaporated and the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.70) to give the product (15.2 g, 
34.1 mmol, 94%) as a white solid. 
 
M.p. (°C): 137-139. 
1H-NMR (400 MHz, CDCl3, ppm)  = 11.92 (s, 1H), 8.14 (d, J = 2.2 Hz, 1H), 8.01 (d, J = 2.2 Hz, 
1H), 1.60 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 168.1, 160.4, 151.6, 138.7, 115.8, 87.0, 84.7, 80.6, 28.2. 
IR (ATR, cm-1) ṽ = 2976, 1675, 1430, 1327, 1158, 790. 
MS (EI, 70 eV, %) m/z = 390 (100), 373 (22), 372 (98), 57 (17). 
HRMS (EI, 70 eV) m/z: calc. for C11H12I2O3: 445.8876; found: 445.8862. 
 




Compound 171g was prepared via TP5 using tert-butyl 2-hydroxy-3,5-diiodobenzoate (1.12 g, 
2.50 mmol), NaH (60% dispersion in mineral oil, 110 mg, 2.75 mmol) and dry DMF (5 mL). After 
stirring at 0 °C for 30 min, BnBr (0. 33 mL, 3.00 mmol) was added and the reaction solution was 
allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.62) to give the product 171g (1.28 g, 
2.38 mmol, 95%) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.22 (d, J = 2.2 Hz, 1H), 7.94 (d, J = 2.2 Hz, 1H), 7.66 – 7.52 
(m, 2H), 7.49 – 7.32 (m, 3H), 5.03 (s, 2H), 1.54 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.4, 157.1, 150.0, 139.9, 136.5, 130.2, 128.5, 128.3, 128.3, 
95.7, 88.1, 82.9, 76.4, 28.2. 
IR (ATR, cm-1) ṽ = 2978, 1722, 1369, 1286, 1158. 
MS (EI, 70 eV, %) m/z = 480 (21), 91 (100). 
HRMS (EI, 70 eV) m/z: calc. for C18H18I2O3: 535.9345; found: 535.9616. 
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2-hydroxy-3,5-diiodobenzonitrile (1.85 g, 5.00 mmol) was dissolved in dry THF (15 mL). Et3N (0.83 
mL, 6.00 mmol), DMAP (61 mg, 0.50 mmol) and tetramethyl-phosphorodiamidic acid chloride (0.74 
mL, 5.00 mmol) were then added at 0 °C and the mixture was stirred at room temperature overnight. 
The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 mL) and 
extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were dried over Na2SO4, 
filtered and concentrated in vacuo. The crude product was purified via column chromatography (ethyl 
acetate, Rf = 0.20) to give the product 171h (1.38 g, 2.70 mmol, 55%) as an off-white solid. 
 
M.p. (°C): 194-196. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.33 (dd, J = 2.1, 0.7 Hz, 1H), 7.87 (dd, J = 2.1, 0.5 Hz, 1H), 
2.84 (s, 6H), 2.81 (s, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.6 (d, J = 6.8 Hz), 152.4 (d, J = 1.6 Hz), 142.3 (d, J = 1.7 
Hz), 114.4, 110.0 (d, J = 2.9 Hz), 93.0 (d, J = 4.0 Hz), 88.2 (d, J = 2.4 Hz), 37.3 (d, J = 4.7 Hz). 
IR (ATR, cm-1) ṽ = 2927, 2233, 1430, 1242, 995, 749. 
MS (EI, 70 eV, %) m/z = 398 (13), 378 (17), 135 (100). 
HRMS (EI, 70 eV) m/z: calc. for C11H14I2N3O2P: 504.8913; found: 504.8904. 
 




2,4,6-triiodophenol (2.36 g, 5.00 mmol) was dissolved in dry pyridine (5 mL) in a round bottom flask 
equipped with an air condenser and a stirring bar. DMAP (61 mg, 0.50 mmol) and diisopropyl 
carbamoyl chloride (818 mg, 5.00 mmol) were then added at 25 °C and the mixture was heated to reflux 
 
209 Adapted procedure from: J. Clayden, J. Chem. Soc., Perkin Trans. 1 2000, 3232. 
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for 2 days. The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 
mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column chromatography 
(isohexane:ethyl acetate = 98:2, Rf = 0.28) to give the product 171i (887 mg, 1.48 mmol, 30%) as a 
yellow solid. 
 
M.p. (°C): 126-128. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.06 (s, 2H), 4.29 (p, J = 6.8 Hz, 1H), 3.87 (p, J = 6.8 Hz, 1H), 
1.40 (d, J = 6.8 Hz, 6H), 1.35 (d, J = 6.8 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.3, 150.0, 146.9, 93.0, 90.7, 47.7, 46.8, 21.8, 20.6. 
IR (ATR, cm-1) ṽ = 2966, 1724, 1416, 1311, 1231. 
MS (EI, 70 eV, %) m/z = 472 (47), 345 (10), 218 (13), 189 (21), 128 (97), 86 (100), 43 (14). 
HRMS (EI, 70 eV) m/z: calc. for C13H16I3NO2: 598.8315; found: 598.8406. 
 




2-hydroxy-3,5-diiodobenzonitrile (927 mg, 2.50 mmol) was dissolved in dry pyridine (2.5 mL) in a 
round bottom flask equipped with an air condenser and a stirring bar. DMAP (30 mg, 0.25 mmol) and 
diisopropyl carbamoyl chloride (409 mg, 2.50 mmol) were then added at 25 °C and the mixture was 
heated to reflux for 2 days. The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted 
with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column 
chromatography (isohexane:ethyl acetate = 96:4, Rf = 0.18) to give the product 171j (1.03 g, 2.07 mmol, 
83%) as an off-white solid. 
 
M.p. (°C): 96-98. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.32 (d, J = 2.0 Hz, 1H), 7.88 (d, J = 2.0 Hz, 1H), 4.19 (p, J = 
6.8 Hz, 1H), 3.96 (p, J = 6.8 Hz, 1H), 1.40 (d, J = 6.9 Hz, 6H), 1.34 (d, J = 6.7 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 154.1, 151.3, 150.3, 141.2, 113.5, 111.0, 94.5, 89.3, 47.6, 47.5, 
21.6, 20.5. 
IR (ATR, cm-1) ṽ = 2971, 1725, 1419, 1311, 1136. 
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MS (EI, 70 eV, %) m/z = 371 (52), 128 (100), 86 (61), 43 (44). 
HRMS (EI, 70 eV) m/z: calc. for C14H16I2N2O2: 497.9301; found: 497.9305. 
 




2-hydroxy-3,5-diiodobenzonitrile (927 mg, 2.50 mmol) and Et3N (0.50 mL) were dissolved in dry THF 
(5.0 mL) in a round bottom flask. Pivaloyl chloride (0.31 mL, 2.50 mmol) was then added at 0 °C and 
the mixture was allowed to warm to room temperature overnight. The mixture was quenched with a sat. 
aq. NH4Cl solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). 
The combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
product was purified via column chromatography (isohexane:ethyl acetate = 98:2, Rf = 0.24) to give the 
product 171k (1.01 g, 2.21 mmol, 89%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.35 (d, J = 2.0 Hz, 1H), 7.91 (d, J = 2.0 Hz, 1H), 1.46 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 174.9, 153.4, 151.7, 141.4, 113.1, 110.2, 93.5, 90.0, 39.6, 27.3. 
IR (ATR, cm-1) ṽ = 2973, 1771, 1433, 1070, 1025. 
MS (EI, 70 eV, %) m/z = 371 (100), 342 (10), 243 (21), 127 (14), 88 (23), 57 (23), 41 (11). 
HRMS (EI, 70 eV) m/z: calc. for C12H11I2NO2: 454.8879; found: 454.8874. 
 




2,4,6-triiodophenol (2.36 g, 5.00 mmol) and Et3N (1 mL) were dissolved in dry THF (10 mL) in a round 
bottom flask. Pivaloyl chloride (0.62 mL, 5.00 mmol) was then added at 0 °C and the mixture was 
allowed to warm to room temperature overnight. The mixture was quenched with a sat. aq. NH4Cl 
solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
 
210 Adapted procedure from: M. H. Aukland, M. Šiaučiulis, A. West, G. J. P. Perry, D. J. Procter, Nat. Cat. 2020, 
3, 163. 
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product was purified via column chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.18) to give the 
product 171l (1.49 g, 2.68 mmol, 54%) as an off-white solid. 
 
M.p. (°C): 103-105. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.08 (s, 2H), 1.46 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 174.5, 151.9, 147.3, 91.8, 91.4, 39.7, 27.6. 
IR (ATR, cm-1) ṽ = 2971, 1768, 1539, 1421, 1080. 
MS (EI, 70 eV, %) m/z = 472 (100), 344 (18), 218 (11), 189 (36), 127 (16), 57 (17). 
HRMS (EI, 70 eV) m/z: calc. for C11H11I3O2: 555.7893; found: 555.7897. 
 




Compound 171m was prepared via TP5 using 2,4,6-triiodophenol (4.50 g, 9.50 mmol), NaH (60% 
dispersion in mineral oil, 456 mg, 11.40 mmol) and dry DMF (19 mL).  After stirring at 0 °C for 30 
min, 1-chloro-2-methoxyethane (1.05 mL, 11.40 mmol) was added and the reaction solution was 
allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane, Rf = 0.31) to give the product 171m (3.56 g, 6.72 mmol, 71%) as 
a yellow solid. 
 
M.p. (°C): 92-94. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.05 (s, 2H), 4.13 (dd, J = 5.4, 4.3 Hz, 2H), 3.87 (dd, J = 5.4, 
4.3 Hz, 2H), 3.49 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.1, 147.5, 92.1, 89.5, 72.2, 71.6, 59.4. 
IR (ATR, cm-1) ṽ = 2924, 1427, 1359, 1245, 1128. 
MS (EI, 70 eV, %) m/z = 530 (14), 472 (11), 62 (10), 59 (100). 
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Compound 171n was prepared via TP5 using 2-hydroxy-3,5-diiodobenzonitrile (464 mg, 1.25 mmol), 
NaH (60% dispersion in mineral oil, 55 mg, 1.38 mmol) and dry DMF (5 mL).  After stirring at 0 °C 
for 30 min, 4-methoxybenzyl chloride (0.19 mL, 1.38 mmol) was added and the reaction solution was 
allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.28) to give the product 171n (300 mg, 
0.61 mmol, 49%) as a pink solid. 
 
M.p. (°C): 126-128. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.31 (d, J = 2.1 Hz, 1H), 7.84 (d, J = 2.1 Hz, 1H), 7.60 – 7.39 
(m, 2H), 7.04 – 6.81 (m, 2H), 5.14 (s, 2H), 3.83 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.3 (2C), 151.9, 142.0, 131.1, 127.0, 114.5, 114.1, 109.3, 
94.4, 87.3, 76.9, 55.5. 
IR (ATR, cm-1) ṽ = 2932, 1611, 1514, 1436, 1239. 
MS (EI, 70 eV, %) m/z = 371 (16), 121 (100). 
HRMS (EI, 70 eV) m/z: calc. for C15H11I2NO2: 490.8879; found: 490.8867. 
 




Compound 171o was prepared via TP5 using tert-butyl 2-hydroxy-3,5-diiodobenzoate (1.12 g, 
2.50 mmol), NaH (60% dispersion in mineral oil, 110 mg, 2.75 mmol) and dry DMF (5 mL). After 
stirring at 0 °C for 30 min, PMBCl (0. 38 mL, 3.00 mmol) was added and the reaction solution was 
allowed to warm to room temperature overnight. After work-up, the crude product was purified via 
column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.46) to give the product 171o (937 mg, 
1.65 mmol, 66%) as a yellow oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 8.21 (d, J = 2.2 Hz, 1H), 7.93 (d, J = 2.2 Hz, 1H), 7.57 – 7.37 
(m, 2H), 7.07 – 6.70 (m, 2H), 4.96 (s, 2H), 3.83 (s, 3H), 1.56 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.4, 159.8, 157.2, 149.9, 139.9, 130.2, 130.2, 128.7, 113.9, 
95.9, 88.0, 82.9, 76.3, 55.4, 28.2. 
IR (ATR, cm-1) ṽ = 2974, 1721, 1514, 1244, 1158. 
MS (EI, 70 eV, %) m/z = 122 (19), 121 (100). 
HRMS (EI, 70 eV) m/z: calc. for C19H20I2O4: 565.9451; found: 565.9449. 
 




Compound 171p was prepared via TP5 using 2,4,6-triiodophenol (1.18 g, 2.50 mmol), NaH (60% 
dispersion in mineral oil, 110 mg, 2.75 mmol) and dry DMF (7 mL).  After stirring at 0 °C for 30 min, 
4-methoxybenzyl chloride (0.37 mL, 2.75 mmol) was added and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.42) to give the product 171p (1.28 g, 
2.16 mmol, 86%) as an off-white solid. 
 
M.p. (°C): 143-145. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.09 (s, 2H), 7.62 – 7.49 (m, 2H), 7.04 – 6.75 (m, 2H), 4.91 (s, 
2H), 3.84 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.1, 157.7, 147.5, 130.6, 128.0, 114.0, 92.6, 89.6, 74.6, 55.5. 
IR (ATR, cm-1) ṽ = 2927, 1514, 1427, 1234, 816. 
MS (EI, 70 eV, %) m/z = 472 (5), 122 (8), 121 (100), 78 (3), 77 (3), 62 (3). 
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Compound 171q was prepared via TP5 using 2,4,6-triiodophenol (1.42 g, 3.00 mmol), NaH (60% 
dispersion in mineral oil, 132 mg, 3.30 mmol) and dry DMF (5 mL). After stirring at 0 °C for 30 min, 
DMAP (18 mg, 0.15 mmol) and dimethylthiocarbamoyl chloride (445 mg, 3.60 mmol) were added and 
the reaction solution was allowed to warm to room temperature overnight. After work-up, the crude 
product was purified via column chromatography (isohexane:ethyl acetate = 9:1, Rf = 0.37) to give the 
product 171q (881 mg, 1.58 mmol, 53%) as an orange solid. 
 
M.p. (°C): 176-178. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.09 (s, 2H), 3.49 (s, 3H), 3.44 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 183.4, 153.9, 147.0, 93.5, 91.5, 43.8, 39.5. 
IR (ATR, cm-1) ṽ = 2935, 1544, 1409, 1394, 1216. 
MS (EI, 70 eV, %) m/z = 432 (100), 178 (17), 88 (55), 72 (40). 
HRMS (EI, 70 eV) m/z: calc. for C7H2I3OS: 514.6960; found: 514.7058. 
 




Compound 171r was prepared via TP5 using 2,4,6-triiodophenol (1.18 g, 2.50 mmol), NaH (60% 
dispersion in mineral oil, 110 mg, 2.75 mmol) and dry DMF (7 mL).  After stirring at 0 °C for 30 min, 
benzyl chloromethyl ether (0.41 mL, 3.00 mmol) was added and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.43) to give the product 171r (1.40 g, 2.37 mmol, 
95%) as an orange solid. 
 
M.p. (°C): 80-82. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.08 (s, 2H), 7.46 – 7.28 (m, 5H), 5.25 (s, 2H), 5.02 (s, 2H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 156.9, 147.6, 137.3, 128.6, 128.1 (2 C), 98.3, 92.7, 89.7, 72.7. 
IR (ATR, cm-1) ṽ = 2941, 1436, 1394, 1158, 923. 
MS (EI, 70 eV, %) m/z = 562 (10), 472 (11), 91 (100). 
HRMS (EI, 70 eV) m/z: calc. for C14H11I3O2: 591.7893; found: 591.7886. 
 




Compound 171s was prepared via TP5 using 2,4,6-triiodophenol (1.18 g, 2.50 mmol), NaH (60% 
dispersion in mineral oil, 110 mg, 2.75 mmol) and dry DMF (5 mL).  After stirring at 0 °C for 30 min, 
(chloromethyl)(phenyl)sulfane (0.40 mL, 3.00 mmol) was added and the reaction solution was allowed 
to warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.57) to give the product 171s (1.22 g, 2.06 mmol, 
82%) as an off-white solid. 
 
M.p. (°C): 101-103. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.03 (s, 2H), 7.68 – 7.55 (m, 2H), 7.42 – 7.20 (m, 3H), 5.42 (s, 
2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 157.3, 147.6, 134.8, 131.5, 129.1, 127.6, 92.7, 90.2, 78.3. 
IR (ATR, cm-1) ṽ = 3447, 3052, 1436, 1137, 737. 
MS (EI, 70 eV, %) m/z = 467 (17), 124 (17), 123 (100), 45 (17). 
HRMS (EI, 70 eV) m/z: calc. for C13H9I3OS: 593.7508; found: 593.7496. 
 




2,3,5-triiodobenzoic acid (10.0 g, 20.0 mmol) and EtOH (60 mL) were placed in a round bottom flask 
equipped with a reflux condenser and a stirring bar. H2SO4 (96%, 3 mL) was added and the mixture 
was heated to reflux overnight. The reaction solution was allowed to cool down to room temperature 
 
211 Adapted procedure from: X. Yang, T. Rotter, C. Piazza, P. Knochel, Org. Lett. 2003, 5,1229. 
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overnight. The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted with water (10 
mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were dried over 
Na2SO4, filtered and concentrated in vacuo. The crude product was recrystallized from pentane/MeOH 
to give the product 171t (6.39 g, 12.1 mmol, 61%) as an off-white solid. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.29 (d, J = 2.0 Hz, 1H), 7.72 (d, J = 2.0 Hz, 1H), 4.39 (q, J = 
7.1 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 148.8, 141.9, 137.0, 113.4, 106.6, 93.8, 62.7, 14.2. 
 
The spectra matched those of the literature.211 
 




A 50 mL round-bottom flask, equipped with a magnetic stirring bar and a dropping funnel was charged 
with water (5.7 mL) and H2SO4 (96%, 5.25 mL). Glacial acetic acid (5.25 mL) and 4-iodo-2-nitroaniline 
(1.98 g, 7.50 mmol) were added at 0 °C. Afterwards, a solution of NaNO2 (569 mg, 8.25 mmol, in 2.25 
mL H2O) was added dropwies over a period of 1 h. On completion of the addition the mixture was 
stirred for 30 min and a solution of KI (1.50 g, 9.00 mmol, in 2.25 mL H2O) was added dropwise with 
a strong evolution of gas (N2). On completion of addition the sticky mixture was heated to 60 °C for 1 
h, cooled again to 0 °C and diethyl ether was added until all precipitate was dissolved and the reaction 
mixture was poured into saturated NaHCO3(aq) solution (30 mL) in a separatory funnel. After extraction 
with diethyl ether (2 x 30 ml) the organic phases were washed with brine, dried over Na2SO4, filtered 
and concentrated in vacuo. The residue was recrystallized from ethanol to give compound 171u (2.13 
g, 5.68 mmol, 76%) as a yellow-orange powder. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.14 (d, J = 2.0 Hz, 1H), 7.73 (d, J = 8.3 Hz, 1H), 7.56 (dd, J 
= 8.3, 2.0 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.6, 143.2, 142.5, 134.2, 93.0, 85.7. 
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5,7-diiodoquinolin-8-ol (3.97 g, 10.0 mmol) was dissolved in dry THF (10 mL) and NaOH (3.75 M in 
H2O, 8.8 mL, 33.0 mmol) was added. Tosyl chloride (2.29 g, 12.0 mmol) was then added at 0 °C and 
the mixture was stirred at room temperature overnight. The mixture was quenched with a sat. aq. NH4Cl 
solution (10 mL), diluted with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
product was washed with pentane to give the product 174a (5.30 g, 9.60 mmol, 96%) as a white solid. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.72 (dd, J = 4.2, 1.6 Hz, 1H), 8.49 (s, 1H), 8.30 (dd, J = 8.6, 
1.6 Hz, 1H), 8.00 – 7.92 (m, 2H), 7.49 (dd, J = 8.5, 4.2 Hz, 1H), 7.37 (d, J = 8.1 Hz, 2H), 2.49 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.6, 149.9, 145.6, 145.3, 142.6, 140.4, 135.4, 131.2, 129.6, 
129.1, 123.9, 97.0, 92.7, 22.0. 
 
The spectra matched those of the literature.30 
 




2-hydroxy-3,5-diiodobenzonitrile (3.90 g, 10.0 mmol) was dissolved in dry pyridine (10 mL) in a round 
bottom flask equipped with an air condenser and a stirring bar. DMAP (120 mg, 1.00 mmol) and 
diisopropyl carbamoyl chloride (1.64 g, 10.0 mmol) were then added at 25 °C and the mixture was 
heated to reflux for 2 days. The mixture was quenched with a sat. aq. NH4Cl solution (10 mL), diluted 
with water (10 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic extracts were 
dried over Na2SO4, filtered and concentrated in vacuo. The crude product was purified via column 
chromatography (isohexane, Rf = 0.17) to give the product 174b (1.47 g, 2.80 mmol, 28%) as a white 
solid. 
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M.p. (°C): 121-123. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.82 (dd, J = 4.2, 1.6 Hz, 1H), 8.46 (s, 1H), 8.28 (dd, J = 8.5, 
1.6 Hz, 1H), 7.47 (dd, J = 8.5, 4.2 Hz, 1H), 4.27 – 4.15 (m, 1H), 4.15 – 4.05 (m, 1H), 1.50 (dd, J = 11.7, 
6.8 Hz, 6H), 1.34 (t, J = 6.2 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.4, 151.4, 151.0, 144.7, 142.6, 140.3, 131.0, 123.5, 94.5, 
92.7, 47.1, 47.1, 22.2, 21.7, 20.8, 20.6. 
IR (ATR, cm-1) ṽ = 2968, 1708, 1304, 1204, 1038, 745. 
MS (EI, 70 eV, %) m/z = 398 (10), 397 (100), 369 (6), 270 (21), 269 (8), 242 (21), 241 (11), 143 (11), 
128 (42), 115 (22), 114 (17), 87 (6), 86 (72), 43 (14). 
HRMS (EI, 70 eV) m/z: calc. for C16H18I2N2O2: 523.9458; found: 523.9455. 
 




Compound 174c was prepared via TP5 using 2,4,6-triiodopyridin-3-ol (2.84 g, 6.00 mmol), NaH (60% 
dispersion in mineral oil, 264 mg, 6.60 mmol) and dry DMF (12 mL).  After stirring at 0 °C for 30 min, 
MeI (0.45 mL, 7.20 mmol) was added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 99:1, Rf = 0.29) to give the product 174c (1.40 g, 2.89 mmol, 48%) as a 
yellowish solid. 
 
M.p. (°C): 112-114. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.04 (s, 1H), 3.89 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 157.7, 143.8, 113.8, 109.6, 102.4, 61.3. 
IR (ATR, cm-1) ṽ = 3075, 1733, 1419, 1394, 1202. 
MS (EI, 70 eV, %) m/z = 487 (100), 360 (53), 345 (21), 330 (38), 233 (27), 190 (41), 127 (29). 
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A dry and argon flushed Schlenk-flask, equipped with a magnetic stirring bar and a septum, was charged 
with TMPMgCl·LiCl13 (11.0 mmol, 1.12 M in THF, 9.8 mL, 1.1 equiv) and 2,4-dimethoxypyrimidine 
(10.0 mmol, 1.40 g, 1.0 equiv) dissolved in dry THF (10 mL) was added dropwise at –40 °C. The 
reaction mixture was stirred for 12 h at this temperature and the completion of the deprotonation was 
checked by GC-analysis of reaction aliquots quenched with iodine using decane as internal standard. 
Iodine (11.0 mmol, 2.80 g, 1.2 equiv) was added and the reaction mixture was stirred for 2 h at –30 °C. 
The mixture was warmed to –30 °C and TMPMgCl·LiCl (15.0 mmol, 1.12 M, 13.4 mL, 1.5 equiv) was 
added dropwise. The mixture was warmed to 0 °C and stirred for 2 h. Iodine (20.0 mmol, 5.14 g, 2.0 
equiv) was added at 25 °C and the mixture was stirred for 3 h. The reaction mixture was quenched with 
sat. aq. Na2S2O3 (60 mL) solution at 0 °C, extracted with EtOAc (3 x 50 mL), the organic layer was 
washed with brine and dried over Na2SO4. After work-up, the crude product was purified via column 
chromatography (isohexane, Rf = 0.63) to give the product 174e (3.68 g, 9.39 mmol, 94%) as a white 
solid. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 3.99 (s, 3H), 3.97 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 169.1, 163.7, 142.0, 84.3, 56.0, 55.8. 
 










212 Adapted procedure from: M. Mosrin, N. Boudet, P. Knochel, Org. Biomol. Chem. 2008, 6, 3237. 
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5.4 Preparation of Compounds 173 to 176 




Allylated tosylate 173a was prepared via TP6 using ethyl 3,5-diiodo-2-(tosyloxy)benzoate (171a, 229 
mg, 0.40 mmol) and dry toluene (0.80 mL). Then, pTol2Zn·2LiOR (167, 0.24 mL, 0.24 mmol) was 
added at 0 °C. After stirring at 0 °C for 20 min, CuI (7.60 mg, 40 µmol) and methallyl bromide (49 µL, 
0.48 mmol) were added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 
92:8, Rf = 0.28) to give the product 173a (123 mg, 246 µmol, 61%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.02 (d, J = 2.3 Hz, 1H), 7.86 – 7.69 (m, 2H), 7.63 (d, J = 2.3 
Hz, 1H), 7.35 (d, J = 8.1 Hz, 2H), 4.84 (t, J = 1.7 Hz, 1H), 4.68 – 4.54 (m, 1H), 4.28 (q, J = 7.1 Hz, 
2H), 2.94 (s, 2H), 2.47 (s, 3H), 1.53 (t, J = 1.1 Hz, 3H), 1.38 (t, J = 7.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.4, 145.9, 145.7, 142.7, 142.3, 138.5, 137.3, 133.1, 130.1, 
129.5, 128.6, 114.4, 91.5, 62.1, 37.5, 22.1, 21.9, 14.2. 
IR (ATR, cm-1) ṽ = 2979, 1729, 1285, 1178, 1088.  
MS (EI, 70 eV, %) m/z = 345 (21), 299 (29), 219 (14), 218 (100), 173 (14), 172 (52), 155 (18), 116 
(13), 115 (21), 91 (63), 65 (10). 
HRMS (EI, 70 eV) m/z: calc. for C20H21IO5S: 500.0154; found: 500.0155. 
 




Anisole 173b was prepared via TP6 using 2,4,6-triiodoanisole (171b, 243 mg, 0.50 mmol) and dry 
toluene (5.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added at 0 °C. After stirring 
at 0 °C for 20 min, CuI (7.60 mg, 40 µmol) and allyl bromide (52 µL, 0.60 mmol) were added and the 
reaction solution was allowed to warm to room temperature overnight. After work-up, the crude product 
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was purified via column chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.33) to give the product 
173b (186 mg, 465 µmol, 93%) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.95 (d, J = 2.1 Hz, 1H), 7.46 (d, J = 2.1 Hz, 1H), 5.91 (ddt, J 
= 16.8, 10.1, 6.6 Hz, 1H), 5.31 – 4.97 (m, 2H), 3.76 (s, 3H), 3.40 (dt, J = 6.5, 1.6 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 158.0, 145.2, 139.6, 136.7, 135.9, 117.3, 93.5, 89.0, 61.3, 34.5. 
IR (ATR, cm-1) ṽ = 2933, 1456, 1411, 1224, 996.  
MS (EI, 70 eV, %) m/z = 400 (74), 371 (40), 258 (83), 257 (37), 244 (82), 146 (80), 132 (10), 131 
(100), 115 (43), 103 (67), 102 (15), 89 (15), 77 (19).  
HRMS (EI, 70 eV) m/z: calc. for C10H10I2O: 399.8821; found: 399.8815. 
 




Benzonitrile 173c was prepared via TP6 using 3,5-diiodo-2-methoxybenzonitrile (171c, 193 mg, 
0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added 
at 0 °C. After stirring at 0 °C for 20 min, CuI (9.50 mg, 50 µmol) and methallyl bromide (60 µL, 0.60 
mmol) were added and the reaction solution was allowed to warm to room temperature overnight. After 
work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 98:2, 
Rf = 0.38) to give the product 173c (131 mg, 418 µmol, 84%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.73 (d, J = 2.3 Hz, 1H), 7.67 (d, J = 2.3 Hz, 1H), 4.88 (d, J = 
0.9 Hz, 1H), 4.74 – 4.52 (m, 1H), 3.99 (s, 3H), 3.29 (s, 2H), 1.71 (t, J = 1.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.8, 144.3, 143.2, 140.1, 136.4, 115.4, 113.3, 107.7, 86.0, 
62.3, 37.3, 22.5. 
IR (ATR, cm-1) ṽ = 2935, 2232, 1470, 1422, 1221.  
MS (EI, 70 eV, %) m/z = 313 (100), 284 (28), 186 (90), 171 (78), 170 (37), 157 (65), 156 (86), 154 
(26), 143 (38), 115 (51).  





C. EXPERIMENTAL PART    229 
 




Methyl benzoate 173d was prepared via TP6 using methyl 3,5-diiodo-2-methoxybenzoate (171d, 209 
mg, 0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was 
added at 0 °C. After stirring at 0 °C for 20 min, CuI (9.50 mg, 50 µmol) and methallyl bromide (60 µL, 
0.60 mmol) were added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane, Rf = 0.58) to 
give the product 173d (132 mg, 381 µmol, 76%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.98 (d, J = 2.3 Hz, 1H), 7.64 (d, J = 2.3 Hz, 1H), 4.87 (s, 1H), 
4.65 (s, 1H), 3.91 (s, 3H), 3.79 (s, 3H), 3.33 (s, 2H), 1.72 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 165.5, 158.6, 143.9, 143.3, 138.5, 137.2, 126.7, 113.1, 86.9, 
62.7, 52.6, 37.3, 22.6. 
IR (ATR, cm-1) ṽ = 2980, 1715, 1658, 1265, 1101, 712. 
MS (EI, 70 eV, %) m/z = 346 (44), 315 (14), 314 (100), 313 (30), 299 (22), 286 (16), 283 (49), 259 
(12), 188 (13), 187 (95), 172 (45), 171 (11), 159 (18), 145 (21), 144 (30), 129 (31), 128 (39), 116 (24), 
115 (41), 91 (11). 
HRMS (EI, 70 eV) m/z: calc. for C13H15IO3: 346.0066; found: 346.0061. 
 




Benzonitrile 173e was prepared via TP6 using 2-(benzyloxy)-3,5-diiodobenzonitrile (171e, 231 mg, 
0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added 
at 0 °C. After stirring at 0 °C for 20 min, CuI (9.50 mg, 50 µmol) and allyl bromide (52 µL, 0.60 mmol) 
were added and the reaction solution was allowed to warm to room temperature overnight. After work-
up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 99:1, Rf = 
0.24) to give the product 173e (146 mg, 389 µmol, 78%) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.78 (d, J = 2.2 Hz, 1H), 7.69 (dd, J = 2.2, 0.7 Hz, 1H), 7.48 – 
7.44 (m, 2H), 7.43 – 7.35 (m, 3H), 5.81 (ddt, J = 16.7, 10.0, 6.5 Hz, 1H), 5.16 (s, 2H), 5.13 (dq, J = 
10.1, 1.4 Hz, 1H), 5.05 (dq, J = 17.0, 1.6 Hz, 1H), 3.31 (dt, J = 6.6, 1.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.0, 144.1, 140.1, 137.3, 135.7, 135.1, 128.9, 128.8, 128.7, 
117.8, 115.6, 108.6, 86.6, 77.1, 33.6. 
IR (ATR, cm-1) ṽ = 3066, 2232, 1445, 1211, 696. 
MS (EI, 70 eV, %) m/z = 283 (2), 157 (3), 117 (6), 102 (2), 92 (8), 91 (100), 65 (5). 
HRMS (EI, 70 eV) m/z: calc. for C17H14INO: 375.0120; found: 375.0108. 
 




Benzyl ether 173f was prepared via TP6 using 2-(benzyloxy)-1,3,5-triiodobenzene (171f, 281 mg, 
0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added 
at 0 °C. After stirring at 0 °C for 20 min, CuI (9.50 mg, 50 µmol) and 3-bromocyclohexene (69 µL, 
0.60 mmol) were added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane, Rf = 0.44) to 
give the product 173f (147 mg, 285 µmol, 57%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.98 (d, J = 2.1 Hz, 1H), 7.52 (d, J = 7.1 Hz, 2H), 7.48 (d, J = 
2.1 Hz, 1H), 7.41 (td, J = 6.1, 1.3 Hz, 2H), 7.39 – 7.33 (m, 1H), 5.94 – 5.88 (m, 1H), 5.50 (dd, J = 10.0, 
2.5 Hz, 1H), 4.97 (d, J = 10.7 Hz, 1H), 4.86 (d, J = 10.8 Hz, 1H), 3.74 (ddt, J = 8.6, 5.7, 2.8 Hz, 1H), 
2.14 – 2.01 (m, 2H), 2.01 – 1.93 (m, 1H), 1.75 – 1.67 (m, 1H), 1.62 – 1.55 (m, 1H), 1.50 – 1.43 (m, 
1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.2, 145.0, 143.7, 138.7, 136.6, 129.6, 129.2, 128.7, 128.5, 
128.2, 93.8, 89.5, 75.9, 36.0, 31.7, 24.9, 21.3. 
IR (ATR, cm-1) ṽ = 2924, 1430, 1219, 972, 695. 
MS (EI, 70 eV, %) m/z = 425 (19), 423 (3), 359 (5), 298 (5), 207 (6), 152 (3), 128 (4), 115 (6), 92 (8), 
91 (100), 89 (3), 65 (4). 
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Tert-butyl benzoate 173g was prepared via TP6 using tert-butyl 2-(benzyloxy)-3,5-diiodobenzoate 
(171g, 214 mg, 0.40 mmol) and dry toluene (0.80 mL). Then, pTol2Zn·2LiOR (167, 0.24 mL, 0.24 
mmol) was added at 0 °C. After stirring at 0 °C for 20 min, CuI (7.60 mg, 40 µmol) and methallyl 
bromide (49 µL, 0.48 mmol) were added and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 95:5, Rf = 0.56) and HPLC to give the product 173g (163 mg, 351 µmol, 
88%) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.87 (d, J = 2.3 Hz, 1H), 7.60 (d, J = 2.3 Hz, 1H), 7.51 – 7.40 
(m, 2H), 7.39 – 7.35 (m, 2H), 7.35 – 7.30 (m, 1H), 4.93 (s, 2H), 4.85 (t, J = 1.7 Hz, 1H), 4.62 (dt, J = 
2.2, 1.0 Hz, 1H), 3.26 (s, 2H), 1.81 – 1.63 (m, 3H), 1.56 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.6, 156.4, 144.0, 142.4, 137.9, 137.3, 137.1, 129.5, 128.6, 
128.2, 127.9, 113.2, 87.2, 82.3, 76.8, 37.4, 28.3, 22.6. 
IR (ATR, cm-1) ṽ = 2975, 1718, 1292, 1140, 696. 
MS (EI, 70 eV, %) m/z = 408 (18), 131 (17), 91 (100). 
HRMS (EI, 70 eV) m/z: calc. for C22H25IO3: 464.0848; found: 464.0852. 
 





Phosphoramide 173h was prepared via TP6 using bis-(N,N-dimethylamido)-O-2,4-diiodo-6-
cyanophenylphosphate (171h, 202 mg, 0.40 mmol) and dry toluene (0.80 mL). Then, pTol2Zn·2LiOR 
(167, 0.24 mL, 0.24 mmol) was added at 0 °C. After stirring at 0 °C for 20 min, CuI (15 mg, 80 µmol) 
and 3-bromocyclohexene (55 µL, 0.48 mmol) were added and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
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chromatography (isohexane:ethyl acetate = 1:1, Rf = 0.20) to give the product 173h (113 mg, 246 µmol, 
62%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.86 – 7.57 (m, 2H), 5.97 (dtd, J = 9.9, 3.7, 2.4 Hz, 1H), 5.68 
– 5.50 (m, 1H), 3.93 (ddt, J = 8.3, 5.6, 2.8 Hz, 1H), 2.80 (d, J = 0.7 Hz, 6H), 2.77 (d, J = 0.7 Hz, 6H), 
2.17 – 2.06 (m, 2H), 2.07 – 1.97 (m, 1H), 1.74 – 1.66 (m, 1H), 1.65 – 1.55 (m, 1H), 1.42 (dddd, J = 
13.3, 10.4, 8.2, 3.0 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 150.6 (d, J = 7.0 Hz), 143.4 (2 C), 139.9 (d, J = 1.7 Hz), 130.2, 
128.4, 115.4 (d, J = 1.4 Hz), 109.5 (d, J = 3.1 Hz), 88.2 (d, J = 2.5 Hz), 36.9 (dd, J = 12.0, 4.6 Hz), 35.2 
(d, J = 0.8 Hz), 31.1, 24.9, 21.0. 
IR (ATR, cm-1) ṽ = 2928, 1448, 1231, 993, 751. 
MS (EI, 70 eV, %) m/z = 459 (21), 415 (5), 352 (12), 258 (5), 207 (6), 182 (4), 153 (13), 135 (100), 
127 (8), 92 (9), 44 (9). 
HRMS (EI, 70 eV) m/z: calc. for C17H23IN3O2P: 459.0573; found: 459.0569. 
 




Carbamate 173i was prepared via TP6 using 2,4,6-triiodophenyl diisopropylcarbamate (171i, 240 mg, 
0.40 mmol) and dry toluene (0.80 mL). Then, pTol2Zn·2LiOR (167 0.24 mL, 0.24 mmol) was added at 
0 °C. After stirring at 0 °C for 20 min, CuI (15 mg, 80 µmol) and allyl bromide (42 µL, 0.48 mmol) 
were added and the reaction solution was allowed to warm to room temperature overnight. After work-
up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 98:2, Rf = 
0.18) to give the product 173i (145 mg, 283 µmol, 71%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.97 (d, J = 2.0 Hz, 1H), 7.48 (d, J = 2.1 Hz, 1H), 5.85 (ddt, J 
= 16.9, 10.2, 6.7 Hz, 1H), 5.22 – 4.99 (m, 2H), 4.26 (p, J = 6.8 Hz, 1H), 3.86 (p, J = 6.7 Hz, 1H), 3.36 
– 3.13 (m, 2H), 1.48 – 1.21 (m, 12H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.1, 150.3, 144.9, 139.1, 137.0, 135.0, 117.5, 94.2, 90.6, 
47.4, 46.6, 35.3, 21.8, 21.6, 20.7, 20.6. 
IR (ATR, cm-1) ṽ = 2969, 2361, 1717, 1419, 1316. 
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MS (EI, 70 eV, %) m/z = 386 (11), 257 (15), 132 (26), 131 (25), 128 (80), 127 (11), 103 (17), 86 (100), 
77 (13), 43 (20). 
HRMS (EI, 70 eV) m/z: calc. for C16H21I2NO2: 512.9662; found: 512.9662. 
 




Compound 173j was prepared via TP6 using 2-cyano-4,6-diiodophenyl diisopropylcarbamate (171j, 
199 mg, 0.40 mmol) and dry toluene (0.80 mL). Then, pTol2Zn·2LiOR (167, 0.26 mL, 0.26 mmol) was 
added at 0 °C. After stirring at 0 °C for 20 min, CuI (15 mg, 80 µmol) and methallyl bromide (48 µL, 
0.48 mmol) were added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 
97:3, Rf = 0.37) to give the product 173j (152 mg, 357 µmol, 89%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.80 (d, J = 2.1 Hz, 1H), 7.74 (d, J = 2.1 Hz, 1H), 4.89 (t, J = 
1.6 Hz, 1H), 4.68 (t, J = 1.6 Hz, 1H), 4.14 (dq, J = 12.4, 6.9 Hz, 1H), 3.93 (p, J = 6.9 Hz, 1H), 3.23 (s, 
2H), 1.90 – 1.55 (m, 3H), 1.35 (d, J = 7.0 Hz, 6H), 1.31 (d, J = 6.9 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 152.0, 151.3, 143.9, 142.2, 139.4, 137.0, 114.4, 113.8, 110.8, 
88.8, 47.3, 47.2, 38.2, 22.3, 21.4, 20.5. 
IR (ATR, cm-1) ṽ = 2971, 1723, 1424, 1315, 1195. 
MS (EI, 70 eV, %) m/z = 299 (21), 284 (12), 128 (100), 86 (84), 43 (46). 
HRMS (EI, 70 eV) m/z: calc. for C18H23IN2O2: 426.0804; found: 426.0799. 
 




Pivalate 173k was prepared via TP6 using 2-cyano-4,6-diiodophenyl pivalate (171k, 182 mg, 
0.40 mmol) and dry toluene (0.80 mL). Then, pTol2Zn·2LiOR (167, 0.22 mL, 0.22 mmol) was added 
at 0 °C. After stirring at 0 °C for 20 min, CuI (15 mg, 80 µmol) and ethyl 2-(bromomethyl)acrylate (67 
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µL, 0.48 mmol) were added and the reaction solution was allowed to warm to room temperature 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 9:1, Rf = 0.42) to give the product 173k (86 mg, 195 µmol, 49%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.94 – 7.80 (m, 1H), 7.75 (dd, J = 2.3, 1.0 Hz, 1H), 6.31 (d, J 
= 1.3 Hz, 1H), 5.40 (d, J = 1.7 Hz, 1H), 4.20 (qd, J = 7.2, 1.2 Hz, 2H), 3.49 (d, J = 1.6 Hz, 2H), 1.38 
(d, J = 1.7 Hz, 9H), 1.26 (td, J = 7.0, 1.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 175.6, 166.1, 151.2, 144.1, 139.9, 137.2, 135.6, 127.8, 113.9, 
110.3, 89.5, 61.3, 39.5, 31.7, 27.1, 14.3. 
IR (ATR, cm-1) ṽ = 2977, 1714, 1456, 1185, 1077. 
MS (EI, 70 eV, %) m/z = 357 (30), 312 (11), 311 (100), 282 (10), 184 (8), 156 (8). 
HRMS (EI, 70 eV) m/z: calc. for C18H20INO4: 441.0437; found: 441.0434. 
 




Pivalate 173l was prepared via TP6 using 2,4,6-triiodophenyl pivalate (171l, 222 mg, 0.40 mmol) and 
dry toluene (0.80 mL). Then, pTol2Zn·2LiOR (167, 0.24 mL, 0.24 mmol) was added at 0 °C. After 
stirring at 0 °C for 20 min, CuI (15 mg, 80 µmol) and ethyl 2-(bromomethyl)acrylate (67 µL, 0.48 
mmol) were added and the reaction solution was allowed to warm to room temperature overnight. After 
work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 97:3, 
Rf = 0.24) to give the product 173l (166 mg, 306 µmol, 77%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.02 (d, J = 2.0 Hz, 1H), 7.46 (d, J = 2.0 Hz, 1H), 6.30 (q, J = 
1.1 Hz, 1H), 5.36 (q, J = 1.4 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.45 (s, 2H), 1.38 (s, 9H), 1.27 (t, J = 
7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 175.2, 166.4, 150.1, 145.6, 139.6, 137.6, 134.8, 127.5, 93.3, 
91.0, 61.2, 39.6, 32.7, 27.4, 14.3. 
IR (ATR, cm-1) ṽ = 2974, 1756, 1714, 1436, 1092. 
MS (EI, 70 eV, %) m/z = 458 (44), 413 (12), 412 (100), 285 (18), 257 (12), 57 (15). 
HRMS (EI, 70 eV) m/z: calc. for C17H20I2O4: 541.9451; found: 541.9455. 
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Methoxyethylether 173m was prepared via TP6 using 1,3,5-triiodo-2-(2-methoxyethoxy)benzene 
(171m, 265 mg, 0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 
mmol) was added at 25 °C. After stirring at 25 °C for 10 min, CuI (9.50 mg, 50 µmol) and 3-
bromocyclohexene (69 µL, 0.60 mmol) were added at 0 °C and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane, Rf = 0.37) to give the product 173m (181 mg, 374 µmol, 75%) as a 
yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.93 (d, J = 2.1 Hz, 1H), 7.45 (d, J = 2.1 Hz, 1H), 6.06 – 5.76 
(m, 1H), 5.66 – 5.31 (m, 1H), 4.10 (dt, J = 10.2, 4.6 Hz, 1H), 3.96 (dt, J = 10.0, 4.7 Hz, 1H), 3.83 (dt, 
J = 5.7, 2.8 Hz, 1H), 3.78 (t, J = 4.7 Hz, 2H), 3.46 (s, 3H), 2.09 (td, J = 5.5, 2.7 Hz, 2H), 2.02 (dtt, J = 
12.4, 5.9, 2.5 Hz, 1H), 1.73 (ddt, J = 9.8, 6.2, 3.3 Hz, 1H), 1.68 – 1.60 (m, 1H), 1.44 (dddd, J = 12.9, 
11.1, 8.5, 3.1 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 156.4, 144.9, 143.6, 138.6, 129.4 (2 C), 93.5, 89.4, 73.3, 71.7, 
59.4, 35.6, 31.8, 25.0, 21.4. 
IR (ATR, cm-1) ṽ = 2926, 1431, 1222, 1125, 1044. 
MS (EI, 70 eV, %) m/z = 426 (75), 425 (52), 359 (38), 312 (39), 298 (100), 270 (38), 230 (39), 198 
(78), 172 (76), 171 (61), 157 (37), 152 (38), 144 (47), 141 (37), 128 (70), 115 (98). 







Benzonitrile 173n was prepared via TP6 using 3,5-diiodo-2-((4-methoxybenzyl)oxy)benzonitrile 
(171n, 160 mg, 0.327 mmol) and dry toluene (0.66 mL). Then, pTol2Zn·2LiOR (167, 0.19 mL, 0.19 
mmol) was added at 25 °C. After stirring at 25 °C for 10 min, CuI (6.22 mg, 32.7 µmol) and 3-
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bromocyclohexene (45 µL, 0.39 mmol) were added at 0 °C and the reaction solution was allowed to 
warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.36) to give the product 173n (140 mg, 314 
µmol, 96%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.75 (d, J = 2.2 Hz, 1H), 7.67 (d, J = 2.3 Hz, 1H), 7.50 – 7.31 
(m, 2H), 7.01 – 6.83 (m, 2H), 5.93 (dtd, J = 10.0, 3.7, 2.4 Hz, 1H), 5.62 – 5.33 (m, 1H), 5.11 (d, J = 1.4 
Hz, 2H), 3.82 (s, 3H), 3.70 (ddt, J = 8.4, 5.6, 2.8 Hz, 1H), 2.07 (qd, J = 5.2, 2.7 Hz, 2H), 1.88 (dtd, J = 
12.8, 6.3, 2.8 Hz, 1H), 1.66 (dtd, J = 11.8, 8.9, 6.0 Hz, 1H), 1.61 – 1.50 (m, 1H), 1.46 – 1.33 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 160.2, 158.8, 143.8, 143.0, 139.8, 130.5, 130.2, 128.4, 127.9, 
115.9, 114.2, 108.6, 86.7, 77.3, 55.5, 34.8, 31.2, 24.9, 21.1. 
IR (ATR, cm-1) ṽ = 2929, 1514, 1447, 1249, 1174. 
MS (EI, 70 eV, %) m/z = 121 (100). 
HRMS (EI, 70 eV) m/z: calc. for C21H20INO2: 445.0539; found: 445.0529. 
 





Tert-butyl benzoate 173o was prepared via TP6 using tert-butyl 3,5-diiodo-2-((4-
methoxybenzyl)oxy)benzoate (171o, 226 mg, 0.40 mmol) and dry toluene (0.80 mL). Then, 
pTol2Zn·2LiOR (167, 0.24 mL, 0.24 mmol) was added at 25 °C. After stirring at 25 °C for 10 min, CuI 
(7.60 mg, 40 µmol) and 3-bromocyclohexene (55 µL, 0.48 mmol) were added at 0 °C and the reaction 
solution was allowed to warm to room temperature overnight. After work-up, the crude product was 
purified via column chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.41) to give the product 
173o (186 mg, 357 µmol, 89%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.83 (d, J = 2.3 Hz, 1H), 7.58 (d, J = 2.4 Hz, 1H), 7.42 – 7.29 
(m, 2H), 7.06 – 6.76 (m, 2H), 6.04 – 5.80 (m, 1H), 5.50 – 5.35 (m, 1H), 5.03 – 4.88 (m, 1H), 4.84 (d, J 
= 10.6 Hz, 1H), 3.82 (s, 3H), 3.73 (ddt, J = 8.4, 5.5, 2.8 Hz, 1H), 2.06 (ddt, J = 9.2, 6.3, 3.1 Hz, 2H), 
1.93 – 1.80 (m, 1H), 1.73 – 1.66 (m, 1H), 1.58 (s, 9H), 1.56 – 1.50 (m, 1H), 1.44 – 1.37 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 164.7, 159.7, 155.7, 143.9, 141.1, 137.5, 129.7, 129.5, 129.4, 
129.3, 129.2, 114.0, 87.3, 82.2, 77.1, 55.5, 34.7, 31.5, 28.3, 25.0, 21.3. 
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IR (ATR, cm-1) ṽ = 2974, 1721, 1514, 1247, 1143. 
MS (EI, 70 eV, %) m/z = 121 (100). 
HRMS (EI, 70 eV) m/z: calc. for C25H29IO4: 520.1111; found: 520.1100. 
 




Diiodobenzene 173p was prepared via TP6 using 1,3,5-triiodo-2-((4-methoxybenzyl)oxy)benzene 
(171p, 296 mg, 0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 
mmol) was added at 25 °C. After stirring at 25 °C for 10 min, CuI (19 mg, 100 µmol) and methallyl 
bromide (60 µL, 0.60 mmol) were added at 0 °C and the reaction solution was allowed to warm to room 
temperature overnight. After work-up, the crude product was purified via column chromatography 
(isohexane:ethyl acetate = 98:2, Rf = 0.22) and HPLC to give the product 173p (194 mg, 373 µmol, 
75%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.00 (d, J = 2.1 Hz, 1H), 7.64 – 7.33 (m, 3H), 6.98 – 6.80 (m, 
2H), 4.89 (t, J = 1.8 Hz, 1H), 4.81 (s, 2H), 4.74 – 4.53 (m, 1H), 3.83 (s, 3H), 3.32 (s, 2H), 1.69 (t, J = 
1.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.9, 156.9, 145.3, 143.8, 139.9, 136.7, 130.2, 128.7, 114.1, 
113.4, 94.0, 89.1, 75.3, 55.5, 38.4, 22.6. 
IR (ATR, cm-1) ṽ = 2932, 1611, 1514, 1439, 1246. 
MS (EI, 70 eV, %) m/z = 400 (22), 394 (26), 258 (20), 207 (67), 159 (55), 131 (25), 127 (23), 121 
(100), 115 (24), 108 (35), 91 (27), 77 (25). 










C. EXPERIMENTAL PART    238 
 




Dimethylcarbamothioate 173q was prepared via TP6 using O-(2,4,6-triiodophenyl) 
dimethylcarbamothioate (171q, 224 mg, 0.40 mmol) and dry toluene (0.80 mL). Then, pTol2Zn·2LiOR 
(167, 0.24 mL, 0.24 mmol) was added at 0 °C. After stirring at 0 °C for 20 min, CuI (7.60 mg, 40 µmol) 
and methallyl bromide (49 µL, 0.48 mmol) were added at 0 °C and the reaction solution was allowed 
to warm to room temperature overnight. After work-up, the crude product was purified via column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.31) to give the product 173q (112 mg, 230 
µmol, 57%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.00 (d, J = 2.1 Hz, 1H), 7.51 (d, J = 2.0 Hz, 1H), 5.09 – 4.83 
(m, 1H), 4.71 (dt, J = 2.1, 1.0 Hz, 1H), 3.48 (s, 3H), 3.38 (s, 3H), 3.30 (d, J = 15.5 Hz, 1H), 3.17 (d, J 
= 15.5 Hz, 1H), 1.68 (t, J = 1.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 184.7, 152.5, 145.0, 142.7, 139.4, 137.0, 113.5, 94.4, 91.3, 
43.7, 39.8, 39.2, 22.4. 
IR (ATR, cm-1) ṽ = 2933, 1533, 1393, 1210, 1108. 
MS (EI, 70 eV, %) m/z = 361 (14), 360 (100), 233 (14), 88 (53), 72 (36). 
HRMS (EI, 70 eV) m/z: calc. for C13H15I2NOS: 486.8964; found: 486.8962. 
 




Diiodobenzene 173r was prepared via TP6 using 2-((benzyloxy)methoxy)-1,3,5-triiodobenzene (171r, 
296 mg, 0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was 
added at 25 °C. After stirring at 25 °C for 10 min, CuI (19 mg, 100 µmol) and 3-bromocyclohexene (69 
µL, 0.60 mmol) were added at 0 °C and the reaction solution was allowed to warm to room temperature 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
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acetate = 95:5, Rf = 0.47) and HPLC to give the product 173r (203 mg, 372 µmol, 74%) as a colorless 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.96 (d, J = 2.1 Hz, 1H), 7.47 (d, J = 2.1 Hz, 1H), 7.41 – 7.29 
(m, 5H), 6.01 – 5.80 (m, 1H), 5.53 (dq, J = 9.8, 2.3 Hz, 1H), 5.19 (d, J = 6.0 Hz, 1H), 5.15 (d, J = 6.1 
Hz, 1H), 4.88 (d, J = 3.5 Hz, 2H), 3.90 (ddt, J = 8.3, 5.6, 2.8 Hz, 1H), 2.15 – 1.99 (m, 3H), 1.74 – 1.64 
(m, 1H), 1.55 (ddt, J = 10.9, 7.1, 2.4 Hz, 1H), 1.50 – 1.39 (m, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 155.7, 144.9, 143.9, 138.5, 137.2, 129.5, 129.3, 128.7, 128.1, 
128.0, 98.5, 94.0, 89.6, 72.0, 35.9, 31.5, 25.0, 21.3. 
IR (ATR, cm-1) ṽ = 2929, 1431, 1215, 1078, 946. 
MS (EI, 70 eV, %) m/z = 425 (29), 91 (100). 
HRMS (EI, 70 eV) m/z: calc. for C20H20I2O2: 545.9553; found: 545.9548. 
 





Diiodobenzene 173s was prepared via TP6 using phenyl((2,4,6-triiodophenoxy)methyl)sulfane (171s, 
297 mg, 0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was 
added at 25 °C. After stirring at 25 °C for 10 min, CuI (19 mg, 100 µmol) and 3-bromocyclohexene (69 
µL, 0.60 mmol) were added at 0 °C and the reaction solution was allowed to warm to room temperature 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 9:1, Rf = 0.21) and HPLC to give the product 173s (149 mg, 272 µmol, 54%) as a white solid. 
 
M.p. (°C): 192-194. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.20 – 7.96 (m, 2H), 7.88 (d, J = 2.1 Hz, 1H), 7.78 – 7.68 (m, 
1H), 7.62 (dd, J = 8.5, 7.0 Hz, 2H), 7.45 (d, J = 2.1 Hz, 1H), 5.92 (dq, J = 9.8, 3.5 Hz, 1H), 5.46 (dq, J 
= 10.0, 2.4 Hz, 1H), 5.04 (d, J = 10.5 Hz, 1H), 4.83 (d, J = 10.5 Hz, 1H), 3.60 (ddt, J = 8.5, 5.7, 2.8 Hz, 
1H), 2.05 (tq, J = 5.5, 2.8 Hz, 2H), 1.86 (dtd, J = 12.7, 6.2, 2.6 Hz, 1H), 1.64 (dqd, J = 12.5, 5.1, 2.8 
Hz, 1H), 1.59 – 1.44 (m, 1H), 1.34 (ddt, J = 12.9, 10.5, 5.5 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 154.0, 145.3, 143.4, 139.0, 136.9, 134.7, 130.1, 129.5 (2C), 
128.4, 91.5, 91.1, 84.8, 35.5, 31.6, 24.8, 21.1. 
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IR (ATR, cm-1) ṽ = 2924, 1446, 1330, 1151, 740. 
MS (EI, 70 eV, %) m/z = 439 (20), 438 (100), 410 (27), 383 (10), 359 (13), 128 (21), 127 (13), 115 
(11), 79 (11), 77 (17), 44 (13). 
HRMS (EI, 70 eV) m/z: calc. for C13H13I2O: 438.9056; found: 438.9044. 
 




Ethyl diiodobenzoate 173t was prepared via TP6 using ethyl 2,3,5-triiodobenzoate (171t, 264 mg, 
0.50 mmol) and dry toluene (5.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added 
at 0 °C. After stirring at 0 °C for 20 min, CuI (9.50 mg, 50 µmol) and 4-chlorobenzoyl chloride (193 
µL, 1.50 mmol) were added and the reaction solution was allowed to warm to room temperature 
overnight. After work-up, the crude product was purified via column chromatography (isohexane:ethyl 
acetate = 95:5, Rf = 0.28) to give the product 173t (151 mg, 279 µmol, 56%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.43 (q, J = 1.6 Hz, 2H), 7.71 (d, J = 8.0 Hz, 2H), 7.55 – 7.34 
(m, 2H), 4.17 (q, J = 7.2 Hz, 2H), 1.14 (t, J = 7.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 195.0, 163.2, 151.0, 145.0, 140.2, 139.2, 134.1, 131.5, 130.7, 
129.4, 95.2, 94.2, 62.5, 13.9. 
IR (ATR, cm-1) ṽ = 2980, 1717, 1265, 921, 747. 
MS (EI, 70 eV, %) m/z = 540 (19), 429 (46), 401 (56), 150 (19), 141 (32), 139 (100), 111 (12). 
HRMS (EI, 70 eV) m/z: calc. for C16H11ClI2O3: 539.8486; found: 539.8490. 
 




Nitrobenzene 173u was prepared via TP6 using 1,4-diiodo-2-nitrobenzene (171u, 188 mg, 0.50 mmol) 
and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.35 mL, 0.35 mmol) was added at –15 °C. 
After stirring at –15 °C for 20 min, CuI (9.50 mg, 50 µmol) and allyl bromide (69 µL, 0.80 mmol) were 
added and the reaction solution was allowed to warm to room temperature overnight. After work-up, 
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the crude product was purified via column chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.40) 
to give the product 173u (107 mg, 370 µmol, 74%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.22 (d, J = 1.8 Hz, 1H), 7.84 (dd, J = 8.2, 1.8 Hz, 1H), 7.11 
(d, J = 8.1 Hz, 1H), 5.92 (ddt, J = 16.7, 10.1, 6.5 Hz, 1H), 5.13 (dq, J = 10.1, 1.4 Hz, 1H), 5.08 (dq, J = 
17.1, 1.6 Hz, 1H), 3.62 (dt, J = 6.5, 1.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 149.8, 142.0, 134.7, 134.5, 133.6, 133.4, 117.8, 90.7, 36.7. 
IR (ATR, cm-1) ṽ = 3079, 2916, 1521, 1342, 804. 
MS (EI, 70 eV, %) m/z = 288 (23), 272 (36), 259 (24), 145 (70), 133 (62), 117 (58), 115 (100), 89 
(40). 
HRMS (EI, 70 eV) m/z: calc. for C9H8INO2: 288.9600; found: 288.9551. 
 




Quinoline 176a was prepared via TP6 using 5,7-diiodoquinolin-8-yl 4-methylbenzenesulfonate (174a, 
276 mg, 0.50 mmol) and dry toluene (5.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was 
added at 0 °C. After stirring at 0 °C for 20 min, CuI (9.50 mg, 50 µmol) and allyl bromide (52 µL, 0.60 
mmol) were added and the reaction solution was allowed to warm to room temperature overnight. After 
work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 80:20, 
Rf = 0.36) to give the product 176a (125 mg, 269 µmol, 54%) as a yellow solid. 
 
M.p. (°C): 128-130. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.71 – 8.60 (m, 1H), 8.28 (dd, J = 8.5, 1.5 Hz, 1H), 8.03 (s, 
1H), 8.01 – 7.94 (m, 2H), 7.41 (dd, J = 8.6, 4.2 Hz, 1H), 7.35 (d, J = 8.0 Hz, 2H), 5.94 (ddt, J = 17.9, 
9.3, 6.7 Hz, 1H), 5.20 – 5.18 (m, 1H), 5.16 (dq, J = 6.7, 1.6 Hz, 1H), 3.64 (dt, J = 6.7, 1.5 Hz, 2H), 2.48 
(s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.0, 145.1, 144.8, 142.8, 140.2, 139.3, 136.3, 134.9, 134.4, 
130.1, 129.5, 129.0, 122.9, 118.0, 96.4, 34.7, 21.9. 
IR (ATR, cm-1) ṽ = 2922, 1363, 1173, 1068, 750. 
MS (EI, 70 eV, %) m/z = 401 (27), 386 (33), 183 (53), 182 (54), 155 (24), 154 (100), 128 (20), 127 
(31), 91 (72), 65 (28). 
HRMS (EI, 70 eV) m/z: calc. for C12H9INO: 309.9729; found: 309.9714. 
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Quinoline 176b was prepared via TP6 using 5,7-diiodoquinolin-8-yl 4-methylbenzenesulfonate (174b, 
262 mg, 0.50 mmol) and dry toluene (10 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was 
added at 25 °C. After stirring at 25 °C for 10 min, CuI (19 mg, 100 µmol) and allyl bromide (52 µL, 
0.60 mmol) were added and the reaction solution was allowed to warm to room temperature overnight. 
After work-up, the crude product was purified via column chromatography (isohexane, Rf = 0.22) to 
give the product 176b (138 mg, 315 µmol, 63%) as a white solid. 
 
M.p. (°C): 65-67. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.80 (dd, J = 4.1, 1.6 Hz, 1H), 8.26 (dd, J = 8.5, 1.6 Hz, 1H), 
7.98 (s, 1H), 7.40 (dd, J = 8.5, 4.1 Hz, 1H), 5.99 (ddt, J = 16.7, 10.0, 6.6 Hz, 1H), 5.19 – 5.12 (m, 2H), 
4.24 – 4.04 (m, 2H), 3.54 (d, J = 6.6 Hz, 2H), 1.46 (d, J = 6.8 Hz, 6H), 1.33 (d, J = 6.8 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.5, 150.8, 146.8, 143.0, 140.0, 139.0, 135.5, 134.3, 129.8, 
122.6, 117.2, 110.2, 93.7, 46.9, 34.5, 21.8, 20.7. 
IR (ATR, cm-1) ṽ = 2968, 1706, 1427, 1281, 1144. 
MS (EI, 70 eV, %) m/z = 311 (25), 297 (12), 296 (100), 184 (12), 182 (14), 169 (18), 167 (6), 166 
(21), 154 (24), 128 (38), 127 (6), 86 (79), 43 (12). 
HRMS (EI, 70 eV) m/z: calc. for C19H23IN2O2: 438.0804; found: 438.0805. 
 




Pyridine 176c was prepared via TP6 using 2,4,6-triiodo-3-methoxypyridine (174c, 243 mg, 0.50 mmol) 
and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added at 25 °C. After 
stirring at 25 °C for 10 min, CuI (19 mg, 100 µmol) and 3-bromocyclohexene (69 µL, 0.60 mmol) were 
added at 0 °C and the reaction solution was allowed to warm to room temperature overnight. After 
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work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 99:1, 
Rf = 0.26) to give the product 176c (168 mg, 381 µmol, 76%) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.43 (s, 1H), 6.09 – 5.87 (m, 1H), 5.58 – 5.40 (m, 1H), 3.85 (s, 
3H), 3.78 – 3.60 (m, 1H), 2.11 (ddt, J = 7.9, 5.0, 2.6 Hz, 2H), 2.02 (dtd, J = 12.6, 6.1, 2.8 Hz, 1H), 1.78 
– 1.68 (m, 1H), 1.68 – 1.59 (m, 1H), 1.45 (dddd, J = 12.9, 10.6, 8.4, 3.2 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 155.7, 151.3, 134.8, 130.7, 127.3, 116.0, 110.0, 62.3, 35.7, 
30.9, 24.8, 21.0. 
IR (ATR, cm-1) ṽ = 2924, 1448, 1312, 987, 749. 
MS (EI, 70 eV, %) m/z = 442 (11), 441 (100), 426 (10), 186 (10), 172 (7), 116 (7), 115 (7). 
HRMS (EI, 70 eV) m/z: calc. for C12H13I2NO: 440.9087; found: 440.9077. 
 




Iodopyridine 176da was prepared via TP6 using 2,5-diiodopyridine (166 mg, 0.50 mmol) and dry 
toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added at 25 °C. After stirring 
at 25 °C for 10 min, CuI (57 mg, 0.30 mmol) and 4-chlorobenzoyl chloride (193 µL, 1.50 mmol) were 
added at 0 °C and the reaction solution was allowed to warm to room temperature overnight. After 
work-up, the crude product was purified via column chromatography (isohexane:ethyl acetate = 99:1, 
Rf = 0.31) to give the product 176da (115 mg, 335 µmol, 67%). 
 
M.p. (°C): 131-133. 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.68 (dd, J = 2.5, 0.8 Hz, 1H), 7.91 (dd, J = 8.1, 0.8 Hz, 1H), 
7.80 – 7.64 (m, 3H), 7.58 – 7.40 (m, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 193.0, 151.5, 140.3, 138.2, 135.2, 134.8, 132.3, 131.4, 129.3, 
123.1. 
IR (ATR, cm-1) ṽ = 2923, 1651, 1567, 1072, 752. 
MS (EI, 70 eV, %) m/z = 309 (13), 308 (100), 232 (8), 207 (10), 204 (11), 141 (23), 139 (70), 111 (8). 
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Allylated pyridine 176db was prepared via TP6 using 2,5-diiodopyridine (166 mg, 0.50 mmol) and dry 
toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added at 25 °C. After stirring 
at 25 °C for 10 min, CuI (9.50 mg, 50 µmol) and methallyl bromide (60 µL, 0.60 mmol) were added at 
0 °C and the reaction solution was allowed to warm to room temperature overnight. After work-up, the 
crude product was purified via column chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.27) to 
give the product 176db (93 mg, 359 µmol, 72%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 8.20 (d, J = 2.6 Hz, 1H), 7.63 (d, J = 8.0 Hz, 1H), 7.17 (dd, J 
= 8.1, 2.6 Hz, 1H), 4.85 (t, J = 1.7 Hz, 1H), 4.72 – 4.68 (m, 1H), 3.24 (s, 2H), 1.67 (t, J = 1.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.5, 143.4, 138.5, 135.0, 134.6, 115.3, 113.4, 41.0, 22.2. 
IR (ATR, cm-1) ṽ = 2933, 1447, 1375, 1070, 894. 
MS (EI, 70 eV, %) m/z = 259 (51), 150 (10), 132 (100), 130 (15), 117 (39), 115 (11). 
HRMS (EI, 70 eV) m/z: calc. for C9H10IN: 258.9858; found: 258.9851. 
 




Pyrimidine 176e was prepared via TP6 using 4,5-diiodo-2,6-dimethoxypyrimidine (174e, 196 mg, 
0.50 mmol) and dry toluene (1.00 mL). Then, pTol2Zn·2LiOR (167, 0.30 mL, 0.30 mmol) was added 
at 0 °C. After stirring at 0 °C for 20 min, CuI (9.50 mg, 50 µmol) and allyl bromide (52 µL, 0.60 mmol) 
were added and the reaction solution was allowed to warm to room temperature overnight. After work-
up, the crude product was purified via column chromatography (isohexane, Rf = 0.67) to give the 
product 176e (112 mg, 366 µmol, 73%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 5.81 (ddt, J = 17.6, 9.7, 6.0 Hz, 1H), 5.11 – 5.04 (m, 1H), 5.04 
(t, J = 1.7 Hz, 1H), 3.96 (s, 3H), 3.96 (s, 3H), 3.36 (dt, J = 6.1, 1.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.5, 162.4, 134.1, 133.6, 118.2, 116.3, 55.3, 54.8, 35.9. 
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IR (ATR, cm-1) ṽ = 2954, 1529, 1365, 1219, 1016. 
MS (EI, 70 eV, %) m/z = 306 (100), 305 (51), 291 (33), 277 (36), 275 (18), 179 (93), 177 (12), 164 
(21), 163 (24), 149 (15), 122 (52), 121 (17), 119 (10), 107 (18), 94 (42), 83 (10), 81 (10), 78 (12). 
HRMS (EI, 70 eV) m/z: calc. for C9H11IN2O2: 305.9865; found: 305.9862. 
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6 Iron-Catalyzed Cross-Coupling of Functionalized Benzylmanganese 
Halides with Alkenyl Iodides, Bromides and Triflates 
6.1 Typical Procedures 
Typical Procedure for the Preparation of Benzylic Manganese Chlorides 177a–177k (TP 7) 
 
A dry and argon-flushed Schlenk-tube, equipped with a magnetic stirring bar and a rubber septum, was 
charged with magnesium turnings (583 mg, 24.0 mmol, 2.40 equiv), followed by freshly distilled THF 
(5.00 mL) or MTBE (6.25 mL) and a solution of MnCl2·2LiCl (12.5 mL, 12.5 mmol, 1.20 equiv, 1.00 
M in THF). The solution was then cooled to –5 °C. Subsequently, the corresponding benzyl chloride 
(178a–178k, 10.0 mmol, 1.00 equiv) was added drop by drop and the reaction mixture was stirred at –
5 °C until a complete conversion of the starting material was observed. The reaction progress was 
monitored by GC-analysis of hydrolyzed and iodolyzed aliquots. When the metalation was completed, 
the black solutions of the benzylmanganese chlorides 177a–177k were separated from the magnesium 
turnings using a syringe and subsequently transferred into another pre-dried and argon-flushed Schlenk-
tube, which was cooled to –5 °C. To determine the concentration of the manganese chlorides 177a–
177k a titration against iodine in freshly distilled THF was performed.  
 
Typical Procedure for the Fe-catalyzed Cross-Coupling Reactions of Benzylic metallic species 
177a–177k, 181, 182 with different Elecrophiles 179a–179n (TP 8) 
 
A pre-dried and argon-flushed Schlenk-tube equipped with a magnetic stirring bar and a rubber septum 
was charged with FeCl2 (4.20 mg, 33.0 µmol, 10 mol%), the corresponding electrophile (179a–179n, 
333 µmol, 1.00 equiv), tetradecane as internal standard (20 µL) and freshly distilled THF (0.30 mL) as 
solvent. The reaction mixture was cooled to 0 °C and the benzylic metallic species solution (177a–
177k, 181, 182, 1.20 equiv) was added dropwise. After the addition was complete, the reaction mixture 
was allowed to warm to 25 °C and the completion of the cross-coupling reaction was monitored by GC-
analysis of hydrolyzed aliquots. Thereupon, a saturated aqueous solution of NH4Cl was added and the 
aqueous layer was extracted with EtOAc (3 x 100 mL). The combined organic layers were dried over 
MgSO4, filtered and concentrated under reduced pressure. Purification of the crude products by flash 
column chromatography afforded the desired cross-coupling reaction products (180a–180z). 
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6.2 Starting Materials and Organometallic Reagents 




A dry and argon-flushed Schlenk-tube, equipped with a magnetic stirring bar and a rubber septum, was 
charged with magnesium turnings (292 mg, 12.0 mmol), followed by freshly distilled THF (4.00 mL). 
3-methoxybenzyl chloride (178a, 783 mg, 5.00 mmol) diluted in THF (10.0 mL) was added to the 
reaction mixture: 1.00 mL was added until the solution gets warm then an autopulsed syringe was used 
(rate: 0.02 mL/min). Iodine (10.0 mg, 40.0 µmol) was added to activate the magnesium turnings. The 
reaction mixture was stirred at room temperature until a complete conversion of the starting material 
was observed. The reaction progress was monitored by GC-analysis of hydrolyzed and iodolyzed 
aliquots. When the metalation was completed, the solution of the benzylmagnesium chloride was 
separated from the magnesium turnings using a syringe and subsequently transferred into another pre-
dried and argon-flushed Schlenk-tube. To determine the concentration of the magnesium chloride, a 
titration against iodine in freshly distilled THF was performed. 3-methoxybenzylmagnesium chloride 
(181) was obtained (0.27 M, 48%). 
 




A dry and argon-flushed Schlenk-tube, equipped with a magnetic stirring bar and a rubber septum, was 
charged with LiCl (318 mg, 7.50 mmol) and heated up to ca. 450 °C for 5 min under high vacuum using 
a heat gun. After cooling to room temperature under vigourous stirring, ZnCl2 (900 mg, 6.60 mmol) 
was added under argon, the Schlenk-tube was heated to ca. 320 °C for 5 min under vacuum using a heat 
gun, cooled to room temperature and charged with magnesium turnings (340 mg, 14.4 mmol). Freshly 
distilled THF (5.00 mL) and 3-methoxybenzyl chloride (178a, 940 mg, 6.00 mmol) were added and the 
reaction mixture was stirred at room temperature until a complete conversion of the starting material 
was observed. The completion of the metalation was monitored by GC-analysis of hydrolyzed and 
iodolyzed aliquots. When the oxidative insertion was complete, the solution 3-methoxybenzylzinc 
chloride was separated from the resulting salts via a syringe equipped with a filter and transferred to 
another pre-dried and argon-flushed Schlenk-tube, before being titrated against iodine. 3-
methoxybenzylzinc chloride (182) was obtained (0.39 M, 42%). 
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For this reaction, 2,2-diphenylacetaldehyde (5.00 g, 4.52 mL, 25.5 mmol), potassium tert-butoxide 
(4.05 g, 36.1 mmol) and THF (150 mL) were used. The reaction mixture was refluxed for 4 h and 
quenched with N-phenyl-bis(trifluoromethanesulfonimide) (10.9 g, 30.6 mmol). Purification by flash 
column chromatography (isohexane, Rf = 0.34) afforded the desired product 179e (4.47 g, 13.6 mmol, 
54%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.45 – 7.33 (m, 6H), 7.31 – 7.22 (m, 4H), 7.05 (s, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 136.6, 134.3 (2C), 132.0, 129.8, 129.1, 128.9 (2C), 128.6 (2C), 
118.6 (q, J = 321.2 Hz). 
19F-NMR (377 MHz, CDCl3, ppm)  = –73.7. 
IR (ATR, cm-1) ṽ = 1446, 1422, 1244, 1205, 1165, 1137, 1035, 1014, 947, 914, 828, 807, 775, 759, 
694.  
MS (EI, 70 eV, %) m/z = 195 (60), 167 (100), 165 (79), 152 (39). 
HRMS (EI, 70 eV) m/z: calc. for C15H11F3O3S: 328.0381; found 328.0373. 
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6.3 Additional Results and Screening Table 
 
Scheme 63: Screening of other organometallic species. 
Table 21: Cosolvent screening of the reaction between benzylic manganese chlorides and (E)-1-
iodooctene. 
 
Entry THF:NMP Yield [%][a] 
1 1:1 97 
2 3:1 93 
3 THF only 97 
[a] Yield determined by GC-analysis of water quenched reaction aliquots. 
 
Table 22: Catalyst loading screening of the reaction between benzylic manganese chlorides and (E)-
1-iodooctene. 
 
Entry [FeCl2] (mol%) Yield [%][a] 
1 10 98 
2 5.0 73 
3 2.5 79 
4 1.0 79 
[a] Yield determined by GC-analysis of water quenched reaction aliquots. 
C. EXPERIMENTAL PART    250 
 
6.4 Preparation of Benzylic Manganese Reagents 177 




Based on TP7, magnesium turnings (583 mg, 24.0 mmol), THF (5.00 mL) and a solution of 
MnCl2·2LiCl (12.5 mL, 12.5 mmol, 1.00 M in THF) were used. Subsequently, 3-methoxybenzyl 
chloride (178a, 1.45 mL, 10.0 mmol) was added dropwise at –5 °C and the reaction mixture was stirred 
for 1 h at the given temperature. The concentration of 3-methoxybenzylmanganese chloride (177a) was 
determined against iodine in THF (0.39 M, 78%). 
 




Based on TP7, magnesium turnings (350 mg, 14.4 mmol), THF (3.00 mL) and a solution of 
MnCl2·2LiCl (7.50 mL, 7.50 mmol, 1.00 M in THF) were used. Subsequently, 4-(methylthio)benzyl 
chloride (178b, 0.91 mL, 6.00 mmol) was added dropwise at –5 °C and the reaction mixture was stirred 
for 1 h at the given temperature. The concentration of 4-(methylthio)benzylmanganese chloride (177b) 
was determined against iodine in THF (0.36 M, 69%). 
 




Based on TP7, magnesium turnings (583 mg, 24.0 mmol), THF (5.00 mL) and a solution of 
MnCl2·2LiCl (12.5 mL, 12.5 mmol, 1.00 M in THF) were used. Subsequently, benzylchloride (178c, 
1.15 mL, 10.0 mmol) was added dropwise at –5 °C and the reaction mixture was stirred for 0.5 h at the 
given temperature. The concentration of benzylmanganese chloride (177c) was determined against 
iodine in THF (0.34 M, 65%). 
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Based on TP7, magnesium turnings (180 mg, 7.20 mmol), THF (3.00 mL) and a solution of 
MnCl2·2LiCl (3.80 mL, 3.80 mmol, 1.00 M in THF) were used. Subsequently, 1-(tert-butyl)-4-
(chloromethyl)benzene (178d, 0.58 mL, 3.00 mmol) was added dropwise at –5 °C and the reaction 
mixture was stirred for 1 h at the given temperature. The concentration of 4-(tert-
butyl)benzylmanganese chloride (177d) was determined against iodine in THF (0.37 M, 84%). 
 




Based on TP7, magnesium turnings (350 mg, 14.4 mmol), THF (3.00 mL) and a solution of 
MnCl2·2LiCl (7.50 mL, 7.50 mmol, 1.00 M in THF) were used. Subsequently, 4-isopropylbenzyl 
chloride (178e, 0.66 mL, 6.00 mmol) was added dropwise at –5 °C and the reaction mixture was stirred 
for 1.5 h at the given temperature. The concentration of 4-isopropylbenzylmanganese chloride (177e) 
was determined against iodine in THF (0.37 M, 68%). 
 




Based on TP7, magnesium turnings (175 mg, 7.20 mmol), THF (1.50 mL) and a solution of 
MnCl2·2LiCl (3.80 mL, 3.80 mmol, 1.00 M in THF) were used. Subsequently, 2-fluorobenzyl chloride 
(178f, 0.36 mL, 3.00 mmol) was added dropwise at –5 °C and the reaction mixture was stirred for 1.5 
h at the given temperature. The concentration of 2-fluorobenzylmanganese chloride (177f) was 
determined against iodine in THF (0.40 M, 67%). 
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Based on TP7, magnesium turnings (175 mg, 7.20 mmol), THF (1.50 mL) and a solution of 
MnCl2·2LiCl (3.80 mL, 3.80 mmol, 1.00 M in THF) were used. Subsequently, 3-fluorobenzyl chloride 
(178g, 0.36 mL, 3.00 mmol) was added dropwise at –5 °C and the reaction mixture was stirred for 0.5 
h at the given temperature. The concentration of 3-fluorobenzylmanganese chloride (177g) was 
determined against iodine in THF (0.30 M, 68%). 
 




Based on TP7, magnesium turnings (175 mg, 7.20 mmol), MTBE (1.90 mL) and a solution of 
MnCl2·2LiCl (3.80 mL, 3.80 mmol, 1.00 M in THF) were used. Subsequently, 3-
(trifluoromethyl)benzyl chloride (178h, 0.47 mL, 3.00 mmol) was added dropwise at –5 °C and the 
reaction mixture was stirred for 1 h at the given temperature. The concentration of 3-
(trifluoromethyl)benzylmanganese chloride (177h) was determined against iodine in THF (0.31 M, 
58%). 
 




Based on TP7, magnesium turnings (583 mg, 24.0 mmol), MTBE (6.25 mL) and a solution of 
MnCl2·2LiCl (12.5 mL, 12.5 mmol, 1.00 M in THF) were used. Subsequently, 2-chlorobenzyl chloride 
(178i, 1.16 mL, 10.0 mmol) was added dropwise at –5 °C and the reaction mixture was stirred for 1 h 
at the given temperature. The concentration of 2-chlorobenzylmanganese chloride (177i) was 
determined against iodine in THF (0.22 M, 44%). 
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Based on TP7, magnesium turnings (350 mg, 14.4 mmol), THF (3.00 mL) and a solution of 
MnCl2·2LiCl (7.50 mL, 7.50 mmol, 1.00 M in THF) were used. Subsequently, 3-chlorobenzyl chloride 
(178j, 0.78 mL, 6.00 mmol) was added dropwise at –5 °C and the reaction mixture was stirred for 1.5 
h at the given temperature. The concentration of 3-chlorobenzylmanganese chloride (177j) was 
determined against iodine in THF (0.47 M, 86%). 
 




Based on TP7, magnesium turnings (180 mg, 7.20 mmol), THF (3.00 mL) and a solution of 
MnCl2·2LiCl (3.80 mL, 3.80 mmol, 1.00 M in THF) were used. Subsequently, 1-bromo-4-
(chloromethyl)benzene (178k, 620 mg, 3.00 mmol) was added dropwise at –5 °C and the reaction 
mixture was stirred for 2 h at the given temperature. The concentration of 4-bromo-benzylmanganese 
chloride (177k) was determined against iodine in THF (0.22 M, 50%). 
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6.5 Synthesis of Compounds 180 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (E)-1-iodooctene (179a, 79.0 mg, 333 
µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was cooled to 0 °C and 3-
methoxybenzylmanganese chloride (177a, 1.03 mL, 400 µmol, 0.39 M) was added dropwise before the 
mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography (isohexane, 
Rf = 0.41) afforded the desired cross-coupling reaction product 180a (75.0 mg, 323 µmol, 97%) as a 
colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.24 – 7.18 (m, 1H), 6.81 – 6.77 (m, 1H), 6.76 – 6.73 (m, 2H), 
5.61 – 5.47 (m, 2H), 3.80 (s, 3H), 3.31 (d, J = 5.1 Hz, 2H), 2.08 – 1.98 (m, 2H), 1.42 – 1.33 (m, 2H), 
1.33 – 1.23 (m, 6H), 0.93 – 0.83 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.7, 142.9, 132.5, 129.4, 128.6, 121.0, 114.3, 111.3, 55.3, 
39.2, 32.7, 31.9, 29.6, 29.0, 22.8, 14.3. 
IR (ATR, cm-1) ṽ = 2955, 2924, 2854, 1601, 1585, 1488, 1465, 1454, 1435, 1257, 1148, 1046, 966, 
874, 771, 726, 693. 
MS (EI, 70 eV, %) m/z = 232 (80), 175 (11), 161 (31), 150 (10), 147 (87), 136 (16), 134 (100), 128 
(10), 122 (99), 117 (17), 91 (48). 
HRMS (EI, 70 eV) m/z: calc. for C16H24O: 232.1827; found 232.1821. 
 




In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), 2-bromovinyltrimethylsilane (179b, 
Z/E = 10:90, 0.15 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture 
was cooled to 0 °C and 3-methoxybenzylmanganese chloride (177a, 3.08 mL, 1.20 mmol, 0.39 M) was 
added dropwise before the mixture was allowed to warm to 25 °C for 12 h. Purification by flash column 
chromatography (SiO2, isohexane:ethyl acetate= 99:1, Rf = 0.54) afforded the desired cross-coupling 
reaction product 180b (202 mg, Z/E = 6:94, 920 µmol, 92%) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.26 (dd, J = 14.1, 6.3 Hz, 1H), 7.02 – 6.66 (m, 3H), 6.45 (dt, 
J = 13.8, 7.4 Hz, 0.06H), 6.18 (dt, J = 18.8, 6.4 Hz, 0.93H), 5.75 (dt, J = 18.4, 1.5 Hz, 0.93H), 5.73 (t, 
J = 1.5 Hz, 0.06H), 3.83 (s, 3H), 3.46 (dd, J = 6.2, 1.0 Hz, 2H), 0.18 – 0.02 (m, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.8, 146.7, 145.0, 142.1, 141.8, 131.8, 130.4, 129.6, 129.5, 
121.3, 121.0, 114.6, 114.3, 111.6, 111.5, 55.3, 43.4, 39.7, 38, 0.5, –1.1. 
IR (ATR, cm-1) ṽ = 2954, 2898, 2834, 1600, 1584, 1490, 1466, 1454, 1436, 1316, 1286, 1258, 1246, 
1162, 1150, 1052, 1046, 990, 938, 860, 834, 766, 748, 692. 
MS (EI, 70 eV, %) m/z = 220 (28), 205 (100), 193 (12), 190 (60), 175 (47), 146 (71), 121 (15), 115 
(23), 91 (13), 75 (14), 73 (58), 59 (18). 
HRMS (EI, 70 eV) m/z: calc. for C13H20OSi: 220.1283; found 220.1277. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (1-bromovinyl)trimethylsilane (179c, 
60.0 mg, 333 µmol) and freshly distilled THF (0.3 mL) were used. The reaction mixture was cooled to 
0 °C and 4-(methylthio)benzylmanganese chloride (177b, 1.11 mL, 400 µmol, 0.36 M) was added 
dropwise before the mixture was allowed to warm to 25 °C for 12 h. Purification by flash column 
chromatography (isohexane:ethyl acetate = 98:2, Rf = 0.83) afforded the desired cross-coupling reaction 
product 180c (73.0 mg, 308 µmol, 92%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.19 (d, J = 8.3 Hz, 2H), 7.10 – 7.05 (m, 2H), 5.49 – 5.40 (m, 
2H), 3.42 (d, J = 1.3 Hz, 2H), 2.47 (s, 3H), 0.00 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 151.4, 137.4, 135.5, 129.9, 126.9, 126.0, 42.3, 16.4, –1.3. 
IR (ATR, cm-1) ṽ = 2955, 2921, 1492, 1436, 1404, 1258, 1247, 1093, 922, 836, 800, 759, 691. 
MS (EI, 70 eV, %) m/z = 236 (83), 221 (79), 206 (11), 191 (15), 181 (11), 137 (37), 115 (21), 73 (100). 
HRMS (EI, 70 eV) m/z: calc. for C13H20SSi: 236.1055; found 236.1047. 
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According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (E)-1-iodooctene (179a, 79.0 mg, 333 
µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was cooled to 0 °C and 
benzylmanganese chloride (177c, 1.18 mL, 400 µmol, 0.34 M) was added dropwise before the mixture 
was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography (isohexane, Rf = 
0.73) afforded the desired cross-coupling reaction product 180d (52.0 mg, 256 µmol, 77%) as a 
colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.34 – 7.25 (m, 2H), 7.23 – 7.17 (m, 3H), 5.65 – 5.43 (m, 2H), 
3.34 (d, J = 5.8 Hz, 2H), 2.07 – 1.97 (m, 2H), 1.43 – 1.33 (m, 2H), 1.30 (ddd, J = 10.5, 4.5, 2.2 Hz, 6H), 
0.93 – 0.81 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 141.3, 132.3, 128.8, 128.6, 128.4, 126.0, 39.2, 32.7, 31.9, 29.6, 
29.0, 22.8, 14.3. 
IR (ATR, cm-1) ṽ = 2955, 2926, 2856, 1741, 1720, 1706, 1495, 1453, 965, 746, 696. 
MS (EI, 70 eV, %) m/z = 202 (10), 129 (12), 117 (71), 115 (28), 104 (100), 91 (43).  
HRMS (EI, 70 eV) m/z: calc. for C15H22: 202.1722; found 202.1714. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (E)-1-bromo-2-(2-iodovinyl)benzene 
(179d, 103 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was 
cooled to 0 °C and benzylmanganese chloride (177c, 1.18 mL, 400 µmol, 0.34 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane, Rf = 0.54) afforded the desired cross-coupling reaction product 180e (79.0 mg, 289 µmol, 
87%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.50 (ddd, J = 17.3, 7.9, 1.5 Hz, 2H), 7.36 – 7.28 (m, 2H), 7.28 
– 7.19 (m, 4H), 7.05 (td, J = 7.7, 1.7 Hz, 1H), 6.81 (dt, J = 15.6, 1.6 Hz, 1H), 6.28 (dt, J = 15.6, 7.0 Hz, 
1H), 3.59 (dd, J = 7.1, 1.5 Hz, 2H). 
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13C-NMR (101 MHz, CDCl3, ppm)  = 139.9, 137.4, 133.0, 132.4, 130.1, 128.8, 128.7, 128.5, 127.5, 
127.1, 126.4, 123.4, 39.6. 
IR (ATR, cm-1) ṽ = 3408, 3062, 3028, 1696, 1587, 1496, 1467, 1454, 1438, 1265, 1200, 1023, 964, 
745, 697. 
MS (EI, 70 eV, %) m/z = 272 (16), 193 (100), 191 (25), 189 (15), 178 (73), 165 (22), 115 (98), 91 (11). 
HRMS (EI, 70 eV) m/z: calc. for C15H13Br: 272.0201; found 272.0196. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), 2,2-diphenylvinyl 
trifluoromethanesulfonate (179e, 109 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. 
The reaction mixture was cooled to 0 °C and 4-tertbutylbenzylmanganese chloride (177d, 1.08 mL, 400 
µmol, 0.37 M) was added dropwise before the mixture was allowed to warm to 25 °C for 12 h. 
Purification by flash column chromatography (isohexane, Rf = 0.59) afforded the desired cross-coupling 
reaction product 180f (103 mg, 315 µmol, 95%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.39 (dd, J = 7.1, 1.2 Hz, 2H), 7.33 (dd, J = 7.9, 1.9 Hz, 3H), 
7.28 – 7.21 (m, 7H), 7.16 (d, J = 8.3 Hz, 2H), 6.29 (t, J = 7.6 Hz, 1H), 3.46 (d, J = 7.6 Hz, 2H), 1.32 (s, 
9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 148.9, 142.6, 142.4, 140.0, 138.0, 130.1, 128.4, 128.2 (2C), 
128.1, 127.5, 127.2, 127.1, 125.5, 35.5, 34.5, 31.5. 
IR (ATR, cm-1) ṽ = 2961, 2868, 1699, 1661, 1606, 1600, 1514, 1494, 1446, 1363, 1318, 1276, 1176, 
1109, 1026, 1019, 829, 762, 697. 
MS (EI, 70 eV, %) m/z = 326 (13), 269 (100), 191 (87), 178 (15), 115 (12), 91 (15). 
HRMS (EI, 70 eV) m/z: calc. for C25H26: 326.2035; found 326.2024. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (E)-1-bromo-3,3-diethoxyprop-1-ene 
(179f, 70.0 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was 
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cooled to 0 °C and 4-isopropylbenzylmanganese chloride (177e, 1.08 mL, 400 µmol, 0.37 M) was added 
dropwise before the mixture was allowed to warm to 25 °C for 12 h. Purification by flash column 
chromatography (isohexane:triethylamine = 97:3, Rf = 0.50) afforded the desired cross-coupling 
reaction product 180g (69.0 mg, 263 µmol, 79%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.17 – 7.09 (m, 4H), 5.27 (dt, J = 1.9, 0.9 Hz, 1H), 4.87 (q, J = 
1.7 Hz, 1H), 4.73 (s, 1H), 3.52 (ddq, J = 60.2, 9.4, 7.1 Hz, 4H), 3.37 (d, J = 1.4 Hz, 2H), 2.88 (p, J = 
6.9 Hz, 1H), 1.23 (dd, J = 8.2, 7.0 Hz, 12H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 146.7, 146.1, 136.6, 129.4, 126.4, 114.5, 102.6, 61.6, 37.5, 
33.8, 24.2, 15.3. 
IR (ATR, cm-1) ṽ = 2962, 2928, 2873, 1513, 1326, 1116, 1098, 1052, 1020, 1008, 979, 915, 849, 808. 
MS (EI, 70 eV, %) m/z = 173 (100), 145 (60), 129 (27), 117 (15). 
HRMS (EI, 70 eV) m/z: calc. for C17H26O2: 262.1933; found 262.1924. 
 




Adapted from TP8 (1.00 equiv of benzylic manganese chloride instead of 1.20 equiv); for this reaction 
FeCl2 (4.20 mg, 33.0 µmol), 1,2-dibromocyclopent-1-ene (179g, 75.0 mg, 333 µmol) and freshly 
distilled THF (0.30 mL) were used. The reaction mixture was cooled to 0 °C and 4-
isopropylbenzylmanganese chloride (177e, 0.90 mL, 333 µmol, 0.37 M) was added dropwise before the 
mixture was allowed to warm to 25 °C for 12 h. Purification by flash column chromatography 
(isohexane, Rf = 0.73) afforded the desired cross-coupling reaction product 180h (54.0 mg, 193 µmol, 
58%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.18 – 7.10 (m, 4H), 3.46 (s, 2H), 2.89 (p, J = 6.9 Hz, 1H), 2.67 
(t, J = 7.2 Hz, 2H), 2.23 (t, J = 7.1 Hz, 2H), 1.90 (p, J = 7.5 Hz, 2H), 1.25 (d, J = 6.8 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 146.8, 140.1, 136.1, 128.6, 126.6, 116.6, 40.1, 36.1, 33.8 (2C), 
24.2, 21.7. 
IR (ATR, cm-1) ṽ = 2959, 2925, 2868, 1710, 1622, 1512, 1463, 1431, 1420, 1315, 1176, 1082, 1054, 
1020, 935, 841, 817, 808. 
MS (EI, 70 eV, %) m/z = 278 (10), 199 (70), 171 (29), 157 (55), 155 (43), 153 (16), 143 (29), 141 
(18), 129 (100), 117 (13), 115 (23), 91 (19), 79 (13). 
HRMS (EI, 70 eV) m/z: calc. for C15H19Br: 278.0670; found 278.0647. 
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According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), 1-benzyl-4-bromo-1,2,3,6-
tetrahydropyridine (179h, 84.0 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The 
reaction mixture was cooled to 0 °C and 2-fluorobenzylmanganese chloride (177f, 1.00 mL, 400 µmol, 
0.40 M) was added dropwise before the mixture was allowed to warm to 25 °C for 12 h. Purification by 
flash column chromatography (isohexane:ethyl acetate = 85:15, Rf = 0.35) afforded the desired cross-
coupling reaction product 180i (79.0 mg, 281 µmol, 84%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)   = 7.30 – 7.21 (m, 4H), 7.21 – 7.07 (m, 3H), 7.03 – 6.90 (m, 2H), 
5.29 (dt, J = 3.3, 1.7 Hz, 1H), 3.51 (s, 2H), 3.25 (s, 2H), 2.91 (dt, J = 3.7, 2.2 Hz, 2H), 2.49 (t, J = 5.8 
Hz, 2H), 2.03 (dt, J = 5.9, 3.4 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)   = 161.4 (d, J = 245.2 Hz), 138.4, 134.7, 131.4 (d, J = 4.8 Hz), 
129.4, 128.3, 127.9 (d, J = 8.1 Hz), 127.2, 126.5 (d, J = 16.0 Hz), 124.0 (d, J = 3.6 Hz), 121.0, 115.3 
(d, J = 22.3 Hz), 62.8, 53.0, 49.9, 36.0 (d, J = 2.9 Hz), 29.1. 
19F-NMR (377 MHz, CDCl3, ppm)   = –118.2. 
IR (ATR, cm-1) ṽ = 2908, 2798, 2749, 1584, 1491, 1454, 1364, 1229, 1149, 1112, 1094, 1028, 970, 
827, 753, 729, 698. 
MS (EI, 70 eV, %) m/z = 172 (68), 109 (11), 91 (100). 
HRMS (EI, 70 eV) m/z: calc. for C19H20FN: 281.1580; found 281.1494. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (E)-1-iodooctene (179a, 79.0 mg, 333 
µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was cooled to 0 °C and 3-
fluorobenzylmanganese chloride (177g, 1.33 mL, 400 µmol, 0.30 M) was added dropwise before the 
mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography (isohexane, 
Rf = 0.80) afforded the desired cross-coupling reaction product 180j (69.0 mg, 313 µmol, 94%) as a 
colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.28 – 7.20 (m, 1H), 6.96 (d, J = 7.7 Hz, 1H), 6.89 (t, J = 8.4 
Hz, 2H), 5.60 – 5.44 (m, 2H), 3.33 (d, J = 3.7 Hz, 2H), 2.04 (dt, J = 10.4, 6.2 Hz, 2H), 1.45 – 1.19 (m, 
8H), 0.94 – 0.84 (m, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 163.1 (d, J = 245.1 Hz), 143.9 (d, J = 7.1 Hz), 133.0, 129.8 (d, 
J = 8.3 Hz), 128.0, 124.2 (d, J = 2.8 Hz), 115.4 (d, J = 21.0 Hz), 112.8 (d, J = 21.1 Hz), 38.9 (d, J = 1.7 
Hz), 32.7, 31.9, 29.5, 29.0, 22.8, 14.2. 
19F-NMR (377 MHz, CDCl3, ppm)  = –113.9. 
IR (ATR, cm-1) ṽ = 2956, 2927, 2856, 1615, 1586, 1487, 1467, 1448, 1266, 1249, 1139, 966, 948, 871, 
778, 754, 723, 685. 
MS (EI, 70 eV, %) m/z = 135 (27), 122 (100), 109 (18).   
HRMS (EI, 70 eV) m/z: calc. for C15H21F: 220.1627; found 220.1620. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (2-bromoethene-1,1,2-triyl)tribenzene 
(179i, 112 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was 
cooled to 0 °C and 3-(trifluoromethyl)benzylmanganese chloride (177h, 1.29 mL, 400 µmol, 0.31 M) 
was added dropwise before the mixture was allowed to warm to 25 °C for 12 h. Purification by flash 
column chromatography (isohexane, Rf = 0.18) afforded the desired cross-coupling reaction product 
180k (120 mg, 290 µmol, 87%) as a white solid. 
 
M.p. (°C): 121-123. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.39 – 7.23 (m, 9H), 7.13 – 6.99 (m, 8H), 6.97 – 6.93 (m, 2H), 
3.92 (s, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 143.0, 142.6, 142.5, 141.7, 141.2, 137.2, 132.1 (d, J = 1.1 Hz), 
130.8, 130.5 (d, J = 31.8 Hz), 130.0, 129.4, 128.7, 128.5, 128.1, 127.7, 127.2, 126.6, 126.3, 125.7 (q, J 
= 3.7 Hz), 124.3 (q, J = 272.9 Hz), 122.8 (d, J = 3.9 Hz), 41.4. 
19F-NMR (377 MHz, CDCl3, ppm)  = –62.7. 
IR (ATR, cm-1) ṽ = 1489, 1445, 1330, 1311, 1281, 1160, 1154, 1120, 1095, 1079, 1031, 1001, 956, 
922, 908, 872, 814, 800, 780, 764, 748, 712, 695, 659. 
MS (EI, 70 eV, %) m/z = 414 (78), 336 (100), 323 (28), 283 (12), 267 (19), 265 (19), 259 (12), 255 
(30), 252 (44), 239 (34), 191 (20), 189 (12), 178 (45), 176 (15), 167 (93), 165 (59), 152 (27), 126 (13). 
HRMS (EI, 70 eV) m/z: calc. for C28H21F3: 414.1595; found 414.1592. 
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According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (Z)-4-(2-bromovinyl)benzonitrile 
(179j, 70.0 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was 
cooled to 0 °C and 2-chlorobenzylmanganese chloride (177i, 1.82 mL, 400 µmol, 0.22 M) was added 
dropwise before the mixture was allowed to warm to 25 °C for 12 h. Purification by flash column 
chromatography (isohexane:ethyl acetate = 95:5, Rf = 0.30) afforded the desired cross-coupling reaction 
product 180l (83.0 mg, 327 µmol, 98%) as a white solid. 
 
M.p. (°C): 100-102. 
1H-NMR (400 MHz, CDCl3, ppm)   = 7.69 – 7.58 (m, 2H), 7.47 – 7.32 (m, 3H), 7.25 – 7.12 (m, 3H), 
6.62 (dd, J = 11.6, 1.9 Hz, 1H), 5.97 (dt, J = 11.6, 7.5 Hz, 1H), 3.73 (dd, J = 7.5, 1.8 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 141.8, 137.5, 134.1, 132.3 (2C), 129.9, 129.7, 129.4 (2C), 
128.0, 127.2, 119.1, 110.6, 32.7. 
IR (ATR, cm-1) ṽ = 2230, 1474, 1215, 1052, 858, 744, 668. 
MS (EI, 70 eV, %) m/z = 253 (10), 218 (100), 216 (12), 203 (21), 190 (11), 140 (48), 115 (27). 
HRMS (EI, 70 eV) m/z: calc. for C16H12ClN: 253.0658; found 253.0651. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (Z)-1-(2-iodovinyl)-4-
(trifluoromethyl)benzene (179k, 99.0 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. 
The reaction mixture was cooled to 0 °C and 3-chlorobenzylmanganese chloride (177j, 0.85 mL, 400 
µmol, 0.47 M) was added dropwise before the mixture was allowed to warm to 25 °C for 1 h. Purification 
by flash column chromatography (isohexane, Rf = 0.46) afforded the desired cross-coupling reaction 
product 180m (97.0 mg, 327 µmol, 98%) as a colorless oil. 
C. EXPERIMENTAL PART    262 
 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.61 (d, J = 8.1 Hz, 2H), 7.43 – 7.37 (m, 2H), 7.26 – 7.19 (m, 
3H), 7.09 (ddq, J = 7.4, 1.5, 0.8 Hz, 1H), 6.65 (d, J = 11.6 Hz, 1H), 5.94 (dt, J = 11.6, 7.6 Hz, 1H), 3.63 
(dd, J = 7.6, 1.8 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 142.3, 140.6 (d, J = 1.4 Hz), 134.6 (2C), 131.8, 130.0, 129.6 
(2C), 129.1 (q, J = 32.5 Hz), 128.6, 126.6 (d, J = 6.0 Hz), 125.4 (q, J = 3.8 Hz), 124.32 (d, J = 271.9 
Hz), 34.3. 
19F-NMR (377 MHz, CDCl3, ppm)  = –62.5. 
IR (ATR, cm-1) ṽ = 1618, 1597, 1574, 1476, 1321, 1161, 1109, 1080, 1066, 1016, 849, 778, 747, 734, 
684. 
MS (EI, 70 eV, %) m/z = 296 (12), 261 (100), 246 (19), 227 (12), 221 (11), 192 (26), 189 (16), 183 
(59), 149 (14), 115 (61). 
HRMS (EI, 70 eV) m/z: calc. for C16H12ClF3: 296.0580; found 296.0572. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), 2,2-diphenylvinyl 
trifluoromethanesulfonate (179e, 109 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. 
The reaction mixture was cooled to 0 °C and 4-bromobenzylmanganese chloride (177k, 1.82 mL, 400 
µmol, 0.22 M) was added dropwise before the mixture was allowed to warm to 25 °C for 12 h. 
Purification by flash column chromatography (isohexane, Rf = 0.39) afforded the desired cross-coupling 
reaction product 180n (50.0 mg, 143 µmol, 43%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.42 – 7.35 (m, 4H), 7.35 – 7.25 (m, 2H), 7.25 – 7.19 (m, 6H), 
7.06 (d, J = 8.4 Hz, 2H), 6.20 (t, J = 7.6 Hz, 1H), 3.41 (d, J = 7.6 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 143.1, 142.3, 140.0, 139.7, 131.6, 130.3, 129.9, 128.5, 128.3, 
127.5, 127.4, 127.3, 127.0, 119.9, 35.4. 
IR (ATR, cm-1) ṽ = 3057, 3026, 2924, 1710, 1700, 1659, 1590, 1486, 1446, 1402, 1318, 1277, 1070, 
1011, 800, 754, 696. 
MS (EI, 70 eV, %) m/z = 348 (10), 272 (16), 270 (17), 269 (38), 192 (47), 191 (100), 190 (11), 189 
(22), 178 (38), 165 (29), 91 (11). 
HRMS (EI, 70 eV) m/z: calc. for C21H17Br: 348.0514; found 348.0506. 
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According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), (Z)-1-(2-iodovinyl)-4-
(trifluoromethyl)benzene (179k, 99.0 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. 
The reaction mixture was cooled to 0 °C and 4-bromobenzylmanganese chloride (177k, 1.82 mL, 400 
µmol, 0.22 M) was added dropwise before the mixture was allowed to warm to 25 °C for 1 h. Purification 
by flash column chromatography (isohexane, Rf = 0.56) afforded the desired cross-coupling reaction 
product 180o (60.0 mg, 176 µmol, 53%) as a yellowish oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.60 (d, J = 8.2 Hz, 2H), 7.46 – 7.35 (m, 4H), 7.11 – 7.04 (m, 
2H), 6.63 (d, J = 11.5 Hz, 1H), 5.93 (dt, J = 11.5, 7.6 Hz, 1H), 3.60 (dd, J = 7.6, 1.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 140.6 (d, J = 1.3 Hz), 139.2, 132.1, 131.8, 130.1, 129.4, 129.1 
(q, J = 32.5 Hz),129.0, 125.4 (q, J = 3.8 Hz), 124.3 (d, J = 272.0 Hz), 120.2, 34.1.  
19F-NMR (377 MHz, CDCl3, ppm)  = –62.5. 
IR (ATR, cm-1) ṽ = 1618, 1487, 1322, 1162, 1120, 1109, 1066, 1011, 855, 817, 797, 744. 
MS (EI, 70 eV, %) m/z = 340 (10), 261 (57), 246 (21), 221 (14), 191 (42), 189 (27), 183 (58), 171 
(10), 169 (11), 165 (20), 159 (10), 151 (18), 133 (12), 115 (100), 102 (11), 91 (21), 89 (28), 69 (12). 
HRMS (EI, 70 eV) m/z: calc. for C16H12BrF3: 340.0074; found 340.0066. 
 




In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), (Z)-ethyl 3-iodoacrylate (179l, 226 mg, 
0.13 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture was cooled 
to 0 °C and 3-methoxybenzylmanganese chloride (177a, 3.08 mL, 1.20 mmol, 0.39 M) was added 
dropwise before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column 
chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.23) afforded the desired cross-coupling reaction 
product 180p (218 mg, 980 µmol, 98%) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.22 (t, J = 7.5 Hz, 1H), 6.89 – 6.71 (m, 3H), 6.34 (dt, J = 11.4, 
7.5 Hz, 1H), 5.85 (dt, J = 11.4, 1.8 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 4.00 (dd, J = 7.5, 1.7 Hz, 2H), 
3.80 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.5, 160.0, 147.9, 141.2, 129.7, 121.1, 120.1, 114.5, 111.9, 
60.1, 55.3, 35.3, 14.4. 
IR (ATR, cm-1) ṽ = 2980, 2938, 2836, 1714, 1642, 1600, 1584, 1490, 1466, 1454, 1438, 1410, 1388, 
1314, 1284, 1258, 1198, 1160, 1148, 1112, 1094, 1038, 996, 932, 910, 862, 822, 780, 760, 696. 
MS (EI, 70 eV, %) m/z = 220 (32), 174 (69), 163 (12), 160 (15), 147 (100), 145 (67), 131 (43), 117 
(13), 115 (48), 103 (24), 91 (36), 77 (11). 
HRMS (EI, 70 eV) m/z: calc. for C13H16O3: 220.1099; found 220.1091. 
 




In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), (Z)-ethyl 3-iodoacrylate (179l, 226 mg, 
0.13 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture was cooled 
to 0 °C and 4-methylthiobenzylmanganese chloride (177b, 3.33 mL, 1.20 mmol, 0.36 M) was added 
dropwise before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column 
chromatography (isohexane:ethyl acetate = 19:1, Rf = 0.56) afforded the desired cross-coupling reaction 
product 180q (180 mg, 760 µmol, 76%) as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.24 – 7.19 (m, 2H), 7.18 – 7.13 (m, 2H), 6.31 (dt, J = 11.4, 
7.6 Hz, 1H), 5.85 (dt, J = 11.4, 1.8 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.98 (dd, J = 7.6, 1.7 Hz, 2H), 
2.47 (s, 3H), 1.31 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.5, 147.8, 136.4 (2C), 129.3, 127.4, 120.2, 60.2, 34.7, 16.4, 
14.4. 
IR (ATR, cm-1) ṽ = 2982, 2922, 1712, 1642, 1494, 1478, 1464, 1438, 1412, 1386, 1296, 1234, 1192, 
1160, 1114, 1094, 1036, 1018, 968, 926, 912, 842, 806, 734, 722. 
MS (EI, 70 eV, %) m/z = 236 (54), 207 (15), 190 (82), 179 (21), 163 (17), 161 (100), 147 (18), 144 
(27), 128 (21), 121 (11), 115 (78). 
HRMS (EI, 70 eV) m/z: calc. for C13H16O2S: 236.0871; found 236.0864. 
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According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), ethyl (E)-3-iodoacrylate (179m, 76.0 
mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was cooled to 0 
°C and 4-tertbutylbenzylmanganese chloride (177d, 1.08 mL, 400 µmol, 0.37 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane:ethyl acetate = 99:1, Rf = 0.26) afforded the desired cross-coupling reaction product 180r 
(45.0 mg, 183 µmol, 55%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.35 (s, 1H), 7.33 (s, 1H), 7.15 – 7.06 (m, 3H), 5.82 (dt, J = 
15.5, 1.7 Hz, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.49 (dd, J = 6.9, 1.6 Hz, 2H), 1.36 – 1.27 (m, 12H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.7, 149.7, 147.7, 134.8, 128.6, 125.7, 122.3, 60.4, 38.1, 
34.6, 31.5, 14.4. 
IR (ATR, cm-1) ṽ = 2962, 2906, 2870, 1717, 1655, 1513, 1464, 1366, 1320, 1265, 1196, 1154, 1110, 
1040, 984, 842, 828, 815, 803, 715. 
MS (EI, 70 eV, %) m/z = 246 (26), 231 (100), 203 (24), 185 (61), 157 (49), 144 (30), 129 (19), 117 
(19), 115 (17). 
HRMS (EI, 70 eV) m/z: calc. for C16H22O2: 246.1620; found 246.1612. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), ethyl (Z)-3-iodobut-2-enoate (179n, 
80.0 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was cooled 
to 0 °C and 4-isopropylbenzylmanganese chloride (177e, 1.08 mL, 400 µmol, 0.37 M) was added 
dropwise before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column 
chromatography (isohexane:ethyl acetate = 98:2, Rf = 0.27) afforded the desired cross-coupling reaction 
product 180s (64.0 mg, 260 µmol, 78%) as a yellowish oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.21 – 7.05 (m, 4H), 5.76 (d, J = 1.3 Hz, 1H), 4.19 (d, J = 7.1 
Hz, 2H), 3.98 (s, 2H), 2.87 (p, J = 6.9 Hz, 1H), 1.80 (d, J = 1.3 Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H), 1.23 
(d, J = 6.9 Hz, 6H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.7, 158.1, 146.9, 136.3, 129.0, 126.6, 117.0, 59.8, 38.6, 
33.8, 24.8, 24.2, 14.5. 
IR (ATR, cm-1) ṽ = 2960, 1712, 1649, 1512, 1442, 1376, 1242, 1161, 1136, 1097, 1050, 1020, 864, 
844, 800. 
MS (EI, 70 eV, %) m/z = 246 (10), 158 (100), 131 (24), 129 (36), 115 (14), 91 (12). 
HRMS (EI, 70 eV) m/z: calc. for C16H22O2: 246.1620; found 246.1613. 
 




In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), (Z)-ethyl 3-iodoacrylate (179l, 226 mg, 
0.13 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture was cooled 
to 0 °C and 2-fluorobenzylmanganese chloride (177f, 3.00 mL, 1.20 mmol, 0.40 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane:ethyl acetate = 19:1, Rf = 0.54) afforded the desired cross-coupling reaction product 180t 
(202 mg, 970 µmol, 97%) as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.41 – 7.17 (m, 2H), 7.17 – 6.83 (m, 2H), 6.36 (dt, J = 11.4, 
7.5 Hz, 1H), 5.89 (dt, J = 11.4, 1.8 Hz, 1H), 4.24 (q, J = 7.1 Hz, 2H), 4.08 (d, J = 7.5 Hz, 2H), 1.34 (t, 
J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.4, 161.2 (d, J = 245.6 Hz), 146.5, 130.9 (d, J = 4.7 Hz), 
128.3 (d, J = 8.0 Hz), 126.5 (d, J = 15.9 Hz), 124.3 (d, J = 3.6 Hz), 120.6, 115.5 (d, J = 21.8 Hz), 60.2, 
28.7 (d, J = 3.1 Hz), 14.4. 
19F-NMR (377 MHz, CDCl3, ppm)  = –118.2. 
IR (ATR, cm-1) ṽ = 2982, 1716, 1646, 1586, 1492, 1456, 1412, 1388, 1298, 1286, 1230, 1198, 1180, 
1162, 1114, 1098, 1032, 864, 846, 818, 754. 
MS (EI, 70 eV, %) m/z = 208 (38), 180 (27), 162 (66), 151 (21), 135 (75), 133 (100), 123 (10), 115 
(36), 109 (23), 83 (15). 
HRMS (EI, 70 eV) m/z: calc. for C12H13O2F: 208.0900; found 208.0891. 
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According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), ethyl (E)-3-iodoacrylate (179m, 76.0 
mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was cooled to 0 
°C and 2-fluorobenzylmanganese chloride (177f, 1.00 mL, 400 µmol, 0.40 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane:ethyl acetate = 95:5, Rf = 0.29) afforded the desired cross-coupling reaction product 180u 
(46.0 mg, 221 µmol, 66%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)   = 7.19 – 7.07 (m, 2H), 7.06 – 6.94 (m, 3H), 5.73 (dtd, J = 15.6, 
1.7, 0.6 Hz, 1H), 4.11 (q, J = 7.1 Hz, 2H), 3.48 (dt, J = 6.7, 1.5 Hz, 2H), 1.21 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)   = 166.5, 161.1 (d, J = 246.1 Hz), 145.8, 131.0 (d, J = 4.4 Hz), 
128.7 (d, J = 8.1 Hz), 124.9 (d, J = 15.9 Hz), 124.4 (d, J = 3.7 Hz), 122.8, 115.6 (d, J = 21.8 Hz), 60.5, 
31.7 (d, J = 3.2 Hz), 14.4. 
19F-NMR (377 MHz, CDCl3, ppm)   = –118.1. 
IR (ATR, cm-1) ṽ = 2982, 2932, 1716, 1654, 1585, 1492, 1456, 1368, 1332, 1267, 1230, 1202, 1157, 
1098, 1037, 982, 830, 754, 701. 
MS (EI, 70 eV, %) m/z = 208 (36), 180 (37), 173 (15), 162 (58), 153 (14), 151 (11), 135 (100), 133 
(51), 125 (12), 115 (36), 109 (15).  
HRMS (EI, 70 eV) m/z: calc. for C12H13FO2: 208.0900; found 208.0889. 
 




In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), (Z)-ethyl 3-iodoacrylate (179l, 226 mg, 
0.13 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture was cooled 
to 0 °C and 3-fluorobenzylmanganese chloride (177g, 4.00 mL, 1.20 mmol, 0.30 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane:ethyl acetate = 19:1, Rf = 0.51) afforded the desired cross-coupling reaction product 180v 
(148 mg, 710 µmol, 71%) as a pale-yellow oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.49 – 7.21 (m, 1H), 7.03 (d, J = 7.6 Hz, 1H), 6.94 (ddd, J = 
10.8, 8.8, 2.0 Hz, 2H), 6.34 (dt, J = 11.4, 7.6 Hz, 1H), 5.90 (dt, J = 11.4, 1.8 Hz, 1H), 4.24 (q, J = 7.1 
Hz, 2H), 4.05 (dd, J = 7.6, 1.5 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.4, 163.1 (d, J = 245.8 Hz), 146.9, 142.1 (d, J = 7.3 Hz), 
130.1 (d, J = 8.3 Hz), 124.4 (d, J = 2.8 Hz), 120.7, 115.6 (d, J = 21.3 Hz), 113.4 (d, J = 21.0 Hz), 60.2, 
34.9 (d, J = 1.9 Hz), 14.4. 
19F-NMR (377 MHz, CDCl3, ppm)  = –113.3. 
IR (ATR, cm-1) ṽ = 2984, 1714, 1644, 1616, 1588, 1488, 1466, 1448, 1412, 1388, 1298, 1284, 1270, 
1250, 1196, 1162, 1136, 1096, 1076, 1038, 1028, 952, 926, 892, 862, 824, 782, 766, 692. 
MS (EI, 70 eV, %) m/z = 208 (34), 180 (13), 162 (50), 151 (16), 135 (100), 133 (93), 115 (28), 109 
(19), 83 (11). 
HRMS (EI, 70 eV) m/z: calc. for C12H13O2F: 208.0900; found 208.0892. 
 




According to TP8, for this reaction FeCl2 (4.20 mg, 33.0 µmol), ethyl (Z)-3-iodobut-2-enoate (179n, 
80.0 mg, 333 µmol) and freshly distilled THF (0.30 mL) were used. The reaction mixture was cooled 
to 0 °C and 3-fluorobenzylmanganese chloride (177g, 1.33 mL, 400 µmol, 0.30 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane:ethyl acetate = 99:1, Rf = 0.30) afforded the desired cross-coupling reaction product 180w 
(51.0 mg, 230 µmol, 69%) as a colorless oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.26 – 7.19 (m, 1H), 7.02 (d, J = 7.6 Hz, 1H), 6.96 (dt, J = 10.0, 
1.9 Hz, 1H), 6.90 (td, J = 8.3, 2.1 Hz, 1H), 5.83 – 5.77 (m, 1H), 4.19 (q, J = 7.1 Hz, 2H), 4.02 (s, 2H), 
1.79 (d, J = 1.3 Hz, 3H), 1.30 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.5, 163.1 (d, J = 245.4 Hz), 156.8, 141.5 (d, J = 7.4 Hz), 
129.9 (d, J = 8.4 Hz), 124.8 (d, J = 2.8 Hz), 117.7, 115.9 (d, J = 21.3 Hz), 113.3 (d, J = 21.2 Hz), 59.9, 
38.6 (d, J = 1.6 Hz), 24.7, 14.4. 
19F-NMR (377 MHz, CDCl3, ppm)  = –113.6. 
IR (ATR, cm-1) ṽ = 2981, 1709, 1651, 1614, 1588, 1486, 1445, 1371, 1351, 1243, 1168, 1136, 1096, 
1075, 1050, 951, 859, 783, 760, 690. 
MS (EI, 70 eV, %) m/z = 222 (10), 176 (100), 148 (57), 133 (21), 128 (10), 109 (20). 
HRMS (EI, 70 eV) m/z: calc. for C13H15FO2: 222.1056; found 222.1079. 
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In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), (Z)-ethyl 3-iodoacrylate (179l, 226 mg, 
0.13 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture was cooled 
to 0 °C and 3-(trifluoromethyl)benzylmanganese chloride (177h, 3.90 mL, 1.20 mmol, 0.31 M) was 
added dropwise before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column 
chromatography (isohexane:ethyl acetate = 99:1, Rf = 0.23) afforded the desired cross-coupling reaction 
product 180x (130 mg, 500 µmol, 50%) as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.83 – 7.35 (m, 4H), 6.32 (dt, J = 11.4, 7.6 Hz, 1H), 5.91 (dt, J 
= 11.4, 1.7 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 4.09 (dd, J = 7.6, 1.6 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.3, 146.5, 140.5, 132.2, 131.1 (q, J = 32.1 Hz), 129.2, 125.4 
(q, J = 3.8 Hz), 124.3 (q, J = 272.3 Hz), 123.4 (q, J = 3.8 Hz), 121.0, 60.3, 34.9, 14.4. 
19F-NMR (377 MHz, CDCl3, ppm)  = –62.6. 
IR (ATR, cm-1) ṽ = 2984, 1716, 1646, 1450, 1412, 1388, 1330, 1238, 1194, 1160, 1120, 1096, 1072, 
1038, 1002, 936, 918, 900, 868, 822, 798, 762, 702, 656. 
MS (EI, 70 eV, %) m/z = 258 (55), 230 (50), 213 (61), 210 (12), 201 (13), 193 (30), 185 (59), 183 (34) 
181 (11), 175 (11), 173 (13), 165 (87), 164 (50), 161 (32), 159 (22), 146 (16), 133 (22), 115 (100), 109 
(15). 
HRMS (EI, 70 eV) m/z: calc. for C13H13O2F3: 258.0868; found 258.0858. 
 




In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), (Z)-ethyl 3-iodoacrylate (179l, 226 mg, 
0.13 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture was cooled 
to 0 °C and 2-chlorobenzylmanganese chloride (177i, 5.45 mL, 1.20 mmol, 0.22 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane:ethyl acetate = 99:1, Rf = 0.26) afforded the desired cross-coupling reaction product 180y 
(113 mg, 500 µmol, 50%) as a pale-yellow oil. 
C. EXPERIMENTAL PART    270 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.36 (dd, J = 7.4, 1.8 Hz, 1H), 7.30 (dd, J = 7.2, 2.1 Hz, 1H), 
7.23 – 7.13 (m, 2H), 6.33 (dt, J = 11.4, 7.4 Hz, 1H), 5.88 (dt, J = 11.4, 1.8 Hz, 1H), 4.19 (ddd, J = 10.8, 
9.2, 4.5 Hz, 4H), 1.32 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.4, 146.3, 137.4, 134.2, 130.8, 129.6, 128.0, 127.2, 120.7, 
60.2, 33.1, 14.4. 
IR (ATR, cm-1) ṽ = 2982, 2928, 1714, 1644, 1474, 1444, 1410, 1386, 1298, 1286, 1234, 1192, 1162, 
1126, 1096, 1052, 1032, 926, 842, 806, 750, 680, 668. 
MS (EI, 70 eV, %) m/z = 224 (51), 215 (16), 213 (11), 193 (12), 179 (100), 178 (45), 167 (11), 165 
(19), 151 (16), 149 (19), 144 (13), 127 (23), 125 (75), 115 (39), 89 (11). 
HRMS (EI, 70 eV) m/z: calc. for C12H13O2Cl: 224.0604; found 224.0614. 
 




In relation to TP8, for this reaction FeCl2 (13.0 mg, 100 µmol), (Z)-ethyl 3-iodoacrylate (179l, 226 mg, 
0.13 mL, 1.00 mmol) and freshly distilled THF (1.00 mL) were used. The reaction mixture was cooled 
to 0 °C and 3-chlorobenzylmanganese chloride (177j, 2.55 mL, 1.20 mmol, 0.47 M) was added dropwise 
before the mixture was allowed to warm to 25 °C for 1 h. Purification by flash column chromatography 
(isohexane:ethyl acetate = 19:1, Rf = 0.54) afforded the desired cross-coupling reaction product 180z 
(163 mg, 730 µmol, 73%) as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.42 – 7.18 (m, 3H), 7.14 (dd, J = 7.0, 1.8 Hz, 1H), 6.32 (dt, J 
= 11.4, 7.6 Hz, 1H), 5.90 (dt, J = 11.4, 1.7 Hz, 1H), 4.24 (q, J = 7.1 Hz, 2H), 4.03 (dd, J = 7.6, 1.7 Hz, 
2H), 1.34 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.4, 146.8, 141.6, 134.5, 130.0, 128.9, 127.0, 126.7, 120.7, 
60.3, 34.8, 14.4. 
IR (ATR, cm-1) ṽ = 2982, 1714, 1644, 1598, 1574, 1476, 1430, 1410, 1388, 1298, 1286, 1236, 1194, 
1160, 1114, 1094, 1080, 1036, 1000, 932, 860, 886, 818, 780, 756, 736, 702, 682. 
MS (EI, 70 eV, %) m/z = 224 (28), 179 (23), 178 (35), 167 (16), 153 (18), 151 (53), 149 (30), 144 
(25), 138 (14), 133 (10), 125 (14), 116 (22), 115 (100), 103 (12), 89 (16). 
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7 Iron-Catalyzed Cross-Coupling of Functionalized Bis-(aryl)manganese 
Nucleophiles with Alkenyl Halides 
7.1 Typical Procedures 
Typical Procedure for the One-Pot Preparation of Bis-(aryl)manganese Reagents 181a–181g (TP 
9) 
 
A dry and argon-flushed Schlenk-tube, equipped with a magnetic stirring bar and a rubber septum, was 
charged with LiCl (0.610 g, 14.4 mmol, 2.40 equiv), heated to 450 °C under high vacuum and then 
cooled to room temperature. After being switched to argon, the same procedure was applied after MnCl2 
was added (453 mg, 3.60 mmol, 0.60 equiv). After cooling to room temperature, magnesium turnings 
were added (0.350 g, 14.4 mmol, 2.40 equiv), followed by freshly distilled THF (12 mL). After the 
reaction mixture was cooled to −5 °C, the aryl bromides 182a–182g were then added drop by drop (6.0 
mmol, 1.00 equiv) and the reaction mixture was stirred until a complete conversion of the starting 
material was observed. The reaction progress was monitored by GC-analysis of hydrolyzed and 
iodolyzed aliquots. When the metalation was completed, the concentration of the bis-(aryl)manganese 
species was determined by titration against iodine in freshly distilled THF. The black solutions of the 
aryl reagents 181a–181g were then separated from the magnesium turnings using a syringe and 
subsequently transferred into another pre-dried and argon-flushed Schlenk-tube, which was cooled to 
−5 °C. After a titration against iodine in freshly distilled THF was performed, the reagent was ready to 
be used for Cross-Couplings. 
 
Typical Procedure for the Fe-catalyzed Cross-Coupling Reactions of Bis-(aryl)manganese 
Reagents 181a–181g with different Elecrophiles 183a–183e (TP 10) 
 
A pre-dried and argon-flushed Schlenk-tube equipped with a magnetic stirring bar and a rubber septum 
was charged with Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), the corresponding electrophile (183a–183e, 
1.00 mmol, 1.00 equiv), tetradecane as internal standard (50 µL) and freshly distilled THF (1.0 mL) as 
solvent. The reaction mixture was cooled to 0 °C and the bis-(aryl)manganese solution (181a–181g, 
0.60 equiv) was added dropwise whereupon a color change to dark brown could be recognized. After 
the addition was complete, the reaction mixture was stirred for a given time at room temperature. 
Thereupon, a saturated aqueous solution of NH4Cl was added and the aqueous layer was extracted with 
EtOAc (3 x 100 mL). The combined organic layers were dried over MgSO4, filtered and concentrated 
under reduced pressure. Crude products purified by flash column chromatography, affording the desired 
cross-coupling reaction products (184a–184n). Yield of 180l determined by GC and 1H-NMR. 
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7.2 Preparation of Bis-(aryl)manganese Reagents 181 




Based on TP9, LiCl (814 mg, 19.2 mmol, 2.40 equiv), magnesium turnings (467 mg, 19.2 mmol), 
MnCl2 (605 mg, 4.8 mmol), THF (16.0 mL) and 1-bromo-4-methoxybenzene (182a, 1.496 g, 1.00 mL, 
8.0 mmol) were used. After stirring for 1 h at the given temperature, the concentration of bis-(4-
methoxyphenyl)manganese (181a) was determined against iodine in THF (0.25 , 87%). 
 




Based on TP9, LiCl (305 mg, 7.2 mmol), magnesium turnings (175 mg, 7.2 mmol), MnCl2 (227 mg, 
1.8 mmol), THF (6.0 mL) and 5-bromo-1,2-dimethoxybenzene (182b, 868 mg, 3.0 mmol) were used. 
After stirring for 2 h, the concentration of bis-(3,4-dimethoxyphenyl)manganese (181b) was determined 
against iodine in THF (0.15 , 30%). 
 




Based on TP9, LiCl (814 mg, 19.2 mmol), magnesium turnings (467 mg, 19.2 mmol), MnCl2 (605 mg, 
4.8 mmol), THF (16.0 mL) and 5-bromo-1,2,3-trimethoxybenzene (182c, 1.977 g, 8.0 mmol) were used. 
After stirring for 1 h at the given temperature, the concentration of bis-(3,4,5-
trimethoxyphenyl)manganese (181c) was determined against iodine in THF (0.23 , 68%). 
 
Preparation of Bis-(4-(trifluoromethoxy)phenyl)manganese (181d) 
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Based on TP9, LiCl (814 mg, 19.2 mmol), magnesium turnings (467 mg, 19.2 mmol), MnCl2 (605 mg, 
4.8 mmol), THF (16.0 mL) and 1-bromo-4-trifluoromethoxybenzene (182d, 1.496 g, 1.00 mL, 8.0 
mmol) were used. After stirring for 1 h at the given temperature, the concentration of bis-(4-
trifluoromethoxyphenyl)manganese (181d) was determined against iodine in THF (0.25 , 74%). 
 




Based on TP9, LiCl (305 mg, 7.2 mmol), magnesium turnings (175 mg, 7.2 mmol), MnCl2 (227 mg, 
1.8 mmol), THF (6.0 mL) and (3-bromophenyl)trimethylsilane (182e, 688 mg, 0.57 mL, 3.0 mmol) 
were used. After stirring for 1 h at the given temperature, the concentration of bis-(3-
(trimethylsilyl)phenyl)manganese (181e) was determined against iodine in THF (0.13 , 52%). 
 




Based on TP9, LiCl (814 mg, 19.2 mmol), magnesium turnings (467 mg, 19.2 mmol), MnCl2 (605 mg, 
4.8 mmol), THF (16.0 mL) and 5-bromobenzo[d][1,3]dioxole (182f, 1.608 g, 0.95 mL, 8.0 mmol) were 
used. After stirring for 1 h at the given temperature, the concentration of bis-benzo[d][1,3]dioxol-5-
ylmanganese (181f) was determined against iodine in THF (0.29 , 79%). 
 




Based on TP9, LiCl (814 mg, 19.2 mmol), magnesium turnings (467 mg, 19.2 mmol), MnCl2 (605 mg, 
4.8 mmol), THF (16.0 mL) and mesityl bromide (182g, 1.592 g, 1.22 mL, 8.0 mmol) were used. After 
stirring for 1.5 h at the given temperature, the concentration of bis-(mesityl)manganese (181g) was 
determined against iodine in THF (0.27 , 83%). 
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7.3 Synthesis of Compounds 184 




According to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), (Z)-ethyl 3-iodoacrylate 
(183a, 226 mg, 0.13 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The reaction 
mixture was cooled to 0 °C and bis-(4-methoxyphenyl)manganese (181a, 3.0 mL, 1.20 mmol, 0.21 ) 
was added dropwise before the mixture was stirred for 1 h at the given temperature. Purification by 
flash column chromatography (isohexane:EtOAc = 19:1, Rf = 0.20) afforded the desired cross-coupling 
reaction product 184a (0.163 g, 0.79 mmol, 79%) as a pale-yellow solid. 
 
M.p. (°C): 50-52. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.64 (d, J = 16.0 Hz, 1H), 7.47 (d, J = 8.7 Hz, 2H), 6.90 (d, J 
= 8.8 Hz, 2H), 6.30 (d, J = 16.0 Hz, 1H), 4.25 (q, J = 7.1 Hz, 2H), 3.83 (s, 3H), 1.33 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.4, 161.5, 144.4, 129.8, 127.3, 115.9, 114.4, 60.4, 55.5, 
14.5. 
IR (ATR, cm-1) ṽ = 2972, 2930, 2898, 2870, 1708, 1632, 1604, 1512, 1458, 1442, 1372, 1316, 1302, 
1288, 1252, 1206, 1164, 1096, 1026, 1006, 984, 930, 828, 778. 
MS (EI, 70 eV, %) m/z = 206 (54), 178 (16), 162 (11), 161 (100), 134 (58), 133 (36), 118 (13), 89 
(14). 
HRMS (EI, 70 eV) m/z: calc. for C12H14O3: 206.0943; found 206.0937. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), 2-
bromovinyltrimethylsilane (183b, Z/E = 10/90, 179 mg, 0.15 mL, 1.00 mmol) and freshly distilled THF 
(1.0 mL) were used. The reaction mixture was cooled to 0 °C and bis-(4-methoxyphenyl)manganese 
(181a, 3.0 mL, 1.20 mmol, 0.21 )  was added dropwise before the mixture was stirred for 0.5 h at the 
given temperature. Purification by flash column chromatography (isohexane:EtOAc = 19:1, Rf = 0.71) 
afforded the desired cross-coupling reaction product 184b (0.202 g, 0.98 mmol, 98%) as a pale-yellow 
solid. 
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M.p. (°C): 50-52. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.41 – 7.33 (m, 2H), 6.86 (m, 2H), 6.82 (d, J = 19.2 Hz, 1H), 
6.31 (d, J = 19.1 Hz, 1H), 3.82 (s, 3H), 0.15 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 159.7, 143.1, 131.5, 127.7, 126.8, 114.0, 55.5, –1.0. 
IR (ATR, cm-1) ṽ = 2954, 2898, 2836, 1606, 1572, 1508, 1488, 1464, 1440, 1418, 1304, 1296, 1244, 
1196, 1172, 1106, 1032, 992, 864, 832, 796, 748, 738, 726, 690. 
MS (EI, 70 eV, %) m/z = 209 (12), 206 (42), 193 (20), 192 (10), 191 (100), 183 (12), 176 (10), 175 
(37), 165 (36).  
HRMS (EI, 70 eV) m/z: calc. for C12H18OSi: 206.1127; found 206.1119. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), (Z)-ethyl 3-iodoacrylate 
(183a, 226 mg, 0.13 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The reaction 
mixture was cooled to 0 °C and bis-(3,4-dimethoxyphenyl)manganese (181b, 4.0 mL, 0.60 mmol, 0.15 
) was added dropwise before the mixture was stirred for 0.5 h at the given temperature. Purification 
by flash column chromatography (isohexane:EtOAc = 8:2, Rf = 0.37) afforded the desired cross-
coupling reaction product 184c (0.165 g, 0.69 mmol, 69%) as a pale-yellow solid. 
 
M.p. (°C): 55-57. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.61 (d, J = 15.9 Hz, 1H), 7.09 (dd, J = 8.3, 2.0 Hz, 1H), 7.04 
(d, J = 2.0 Hz, 1H), 6.85 (d, J = 8.3 Hz, 1H), 6.30 (d, J = 15.9 Hz, 1H), 4.24 (q, J = 7.1 Hz, 2H), 3.90 
(s, 6H), 1.32 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.3, 151.2, 149.3, 144.6, 127.6, 122.7, 116.1, 111.1, 109.7, 
60.5, 56.0 (2C), 14.5. 
IR (ATR, cm-1) ṽ = 2984, 2960, 2938, 2836, 1692, 1628, 1598, 1582, 1512, 1466, 1454, 1438, 1424, 
1364, 1246, 1224, 1176, 1160, 1142, 1096, 1044, 1024, 986, 976, 968, 936, 870, 860, 802, 776, 752. 
MS (EI, 70 eV, %) m/z = 237 (14), 236 (100), 191 (67), 164 (20), 105 (15), 70 (10), 61 (15), 44 (10), 
43 (16), 42 (60).  
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In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), 2-
bromovinyltrimethylsilane (183b, Z/E = 10/90, 179 mg, 0.15 mL, 1.00 mmol) and freshly distilled THF 
(1.0 mL) were used. The reaction mixture was cooled to 0 °C and bis-(3,4,5-
trimethoxyphenyl)manganese (181c, 3.2 mL, 0.60 mmol, 0.22 ) was added dropwise before the 
mixture was stirred for 0.5 h at the given temperature. Purification by flash column chromatography 
(isohexane:EtOAc = 19:1, Rf = 0.29) afforded the desired cross-coupling reaction product 184d (0.215 
g, 0.80 mmol, 80%) as a white solid. 
 
M.p. (°C): 44-46. 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.79 (d, J = 19.0 Hz, 1H), 6.67 (s, 2H), 6.37 (d, J = 19.0 Hz, 
1H), 3.87 (d, J = 17.1 Hz, 9H), 0.16 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.4, 143.5, 138.3, 134.2, 128.9, 103.5, 61.0, 56.2, –1.1. 
IR (ATR, cm-1) ṽ = 3000, 2952, 2900, 2838, 2828, 1574, 1504, 1464, 1450, 1432, 1414, 1328, 1238, 
1202, 1184, 1148, 1124, 1006, 996, 982, 862, 834, 804, 782, 742, 732, 690. 
MS (EI, 70 eV, %) m/z = 267 (13), 266 (100), 251 (64), 239 (10), 236 (41), 235 (12), 221 (45), 220 
(15), 219 (12), 205 (21), 194 (17), 179 (13), 161 (16), 89 (10).  
HRMS (EI, 70 eV) m/z: calc. for C14H22O3Si: 266.1338; found 266.1326. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), (Z)-ethyl 3-iodoacrylate 
(183a, 226 mg, 0.13 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The reaction 
mixture was cooled to 0 °C and bis-(3,4,5-trimethoxyphenyl)manganese (181c, 3.2 mL, 0.60 mmol, 
0.22 ) was added dropwise before the mixture was stirred for 0.5 h at the given temperature. 
Purification by flash column chromatography (isohexane:EtOAc = 19:1, Rf = 0.41) afforded the desired 
cross-coupling reaction product 184e (0.151 g, 0.57 mmol, 57%) as a yellow-orange solid. 
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M.p. (°C): 70-72. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.59 (d, J = 15.9 Hz, 1H), 6.74 (s, 2H), 6.34 (d, J = 15.9 Hz, 
1H), 4.25 (q, J = 7.1 Hz, 2H), 3.97 – 3.76 (m, 9H), 1.33 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.9, 153.4, 144.5, 140.1, 130.0, 117.5, 105.2, 61.0, 60.5, 
56.1, 14.3. 
IR (ATR, cm-1) ṽ = 2974, 2944, 2928, 2838, 1700, 1632, 1582, 1504, 1470, 1452, 1432, 1414, 1340, 
1310, 1272, 1242, 1174, 1148, 1118, 1034, 996, 982, 922, 872, 824, 790, 760. 
MS (EI, 70 eV, %) m/z = 267 (14), 266 (100), 251 (55), 223 (15), 221 (19), 179 (11), 177 (21), 163 
(21), 135 (10).  
HRMS (EI, 70 eV) m/z: calc. for C14H18O5: 266.1154; found 266.1142. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), 2-bromovinylbenzene 
(183c, Z/E = 18:82, 183 mg, 0.13 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The 
reaction mixture was cooled to 0 °C and bis-(3,4,5-trimethoxyphenyl)manganese (181c, 3.2 mL, 0.60 
mmol, 0.22 ) was added dropwise before the mixture was stirred for 0.5 h at the given temperature. 
Purification by flash column chromatography (isohexane:EtOAc = 19:1, Rf = 0.12) afforded the desired 
cross-coupling reaction product 184f (0.223 g, 0.82 mmol, 82%) as a pale-yellow solid. 
 
M.p. (°C): 106-108. 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.54 (d, J = 7.2 Hz, 2H), 7.39 (t, J = 7.6 Hz, 2H), 7.29 (tt, J = 
6.8, 1.2 Hz, 1H), 7.18 – 6.95 (m, 2H), 6.77 (s, 2H), 3.95 (s, 6H), 3.91 (s, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.8, 138.4, 137.6, 133.5, 129.1, 129.0, 128.6, 128.0, 126.9, 
104.1, 61.4, 56.6. 
IR (ATR, cm-1) ṽ = 2924, 2854, 1582, 1506, 1460, 1448, 1428, 1418, 1346, 1326, 1260, 1238, 1150, 
1128, 1074, 1006, 984, 972, 846, 816, 784, 748, 692. 
MS (EI, 70 eV, %) m/z = 271 (18), 270 (100), 256 (14), 255 (83), 195 (25), 181 (10), 180 (13), 167 
(26), 165 (26), 153 (10), 152 (28), 141 (22), 115 (16).  
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In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), (E)-1-iodo-1-octene 
(183d, 238 mg, 0.17 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The reaction 
mixture was cooled to 0 °C and bis-(3,4,5-trimethoxyphenyl)manganese (181c, 3.2 mL, 0.60 mmol, 
0.22 ) was added dropwise before the mixture was stirred for 1 h at the given temperature. Purification 
by flash column chromatography (isohexane:EtOAc = 9:1, Rf = 0.36) afforded the desired cross-
coupling reaction product 184g (0.242 g, Z/E = 9/91, 0.87 mmol, 87%) as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 6.57 (s, 2H), 6.30 (d, J = 15.7 Hz, 1H), 6.14 (dt, J = 15.7, 6.8 
Hz, 1H), 3.85 (d, J = 15.5 Hz, 9H), 2.26 – 2.10 (m, 2H), 1.71 – 1.19 (m, 8H), 0.89 (t, J = 6.9 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 153.4, 137.4, 133.9, 131.0, 129.7, 103.1, 61.1, 56.2, 33.1, 31.9, 
29.5, 28.9, 22.8, 14.3. 
IR (ATR, cm-1) ṽ = 2954, 2926, 2872, 2854, 1580, 1506, 1454, 1430, 1416, 1340, 1324, 1236, 1184, 
1152, 1124, 1104, 1042, 1008, 960, 844, 808, 780, 688. 
MS (EI, 70 eV, %) m/z = 281 (13), 279 (14), 278 (79), 263 (12), 225 (21), 207 (54), 196 (11), 195 
(11), 182 (23), 181 (53), 179 (33), 177 (16), 176 (100), 175 (14), 167 (13), 161 (32), 153 (18), 151 (30), 
133 (12), 115 (15), 91 (27), 79 (15), 77 (11), 67 (12).  
HRMS (EI, 70 eV) m/z: calc. for C17H26O3: 278.1882; found 278.1871. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), (Z)-ethyl 3-iodoacrylate 
(183a, 226 mg, 0.13 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The reaction 
mixture was cooled to 0 °C and bis-(4-(trifluoromethoxy)phenyl)manganese (181d, 4.4 mL, 0.60 mmol, 
0.14 ) was added dropwise before the mixture was stirred for 0.5 h at the given temperature. 
Purification by flash column chromatography (isohexane:EtOAc = 9:1, Rf = 0.50) afforded the desired 
cross-coupling reaction product 184h (0.200 g, 0.77 mmol, 77%) as a colorless oil. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.65 (d, J = 16.0 Hz, 1H), 7.59 – 7.48 (m, 2H), 7.22 (d, J = 8.0 
Hz, 2H), 6.41 (d, J = 16.0 Hz, 1H), 4.27 (q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 166.8, 150.5 (q, J = 1.8 Hz), 142.9, 133.2, 129.6, 121.3, 120.5 
(q, J = 258.0 Hz), 119.4, 60.8, 14.4. 
19F-NMR (377 MHz, CDCl3, ppm)  = –57.8. 
IR (ATR, cm-1) ṽ = 2986, 1710, 1642, 1606, 1588, 1508, 1418, 1368, 1312, 1248, 1210, 1154, 1106, 
1036, 1018, 980, 946, 922, 884, 836, 810, 798, 700, 668. 
MS (EI, 70 eV, %) m/z = 260 (37), 232 (16), 215 (11), 214 (100), 187 (13), 186 (28), 101 (14).  
HRMS (EI, 70 eV) m/z: calc. for C12H11F3O3: 260.0660; found 260.0646. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), (Z)-ethyl 3-iodoacrylate 
(183a, 226 mg, 0.13 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The reaction 
mixture was cooled to 0 °C and bis-(3-trimethylsilylphenyl)manganese (181e, 4.6 mL, 0.60 mmol, 0.13 
) was added dropwise before the mixture was stirred for 1 h at the given temperature. Purification by 
flash column chromatography (isohexane:EtOAc = 19:1, Rf = 0.44) afforded the desired cross-coupling 
reaction product 184i (0.160 g, 0.64 mmol, 64%) as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.71 (d, J = 16.0 Hz, 1H), 7.66 (s, 1H), 7.56 – 7.49 (m, 2H), 
7.37 (t, J = 7.5 Hz, 1H), 6.46 (d, J = 16.0 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 1.35 (t, J = 7.1 Hz, 3H), 
0.29 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.2, 145.1, 141.6, 135.4, 133.8, 133.3, 128.4, 128.4, 118.3, 
60.6, 14.5, –1.1. 
IR (ATR, cm-1) ṽ = 2978, 2956, 1710, 1638, 1474, 1396, 1366, 1306, 1264, 1248, 1206, 1166, 1126, 
1112, 1096, 1036, 982, 912, 900, 862, 834, 794, 752, 726, 684. 
MS (EI, 70 eV, %) m/z = 251 (34), 248 (25), 234 (11), 233 (100), 205 (43), 187 (40), 131 (53), 115 
(11), 75 (29), 73 (13).  
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In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), 2-
bromovinyltrimethylsilane (183b, Z/E = 10:90, 179 mg, 0.15 mL, 1.00 mmol) and freshly distilled THF 
(1.0 mL) were used. The reaction mixture was cooled to 0 °C and bis-benzo[d][1,3]dioxol-5-
ylmanganese (181f, 2.5 mL, 0.60 mmol, 0.28 ) was added dropwise before the mixture was stirred 
for 0.5 h at the given temperature. Purification by flash column chromatography (isohexane:EtOAc = 
19:1, Rf = 0.74) afforded the desired cross-coupling reaction product 184j (0.171 g, 0.78 mmol, 78%) 
as a pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.00 (d, J = 1.7 Hz, 1H), 6.87 (dd, J = 8.0, 1.6 Hz, 1H), 6.78 
(d, J = 18.9 Hz, 1H), 6.77 (s, 1H), 6.27 (d, J = 19.1 Hz, 1H), 5.95 (s, 2H), 0.15 (s, 9H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 148.2, 147.6, 143.1, 133.3, 127.4, 121.5, 108.3, 105.6, 101.2, 
–1.0. 
IR (ATR, cm-1) ṽ = 2954, 2894, 1594, 1502, 1488, 1444, 1354, 1244, 1204, 1186, 1120, 1096, 1038, 
982, 942, 928, 862, 834, 786, 758, 742, 728, 690. 
MS (EI, 70 eV, %) m/z = 220 (67), 206 (10), 205 (100), 189 (20), 179 (10), 175 (63), 165 (10), 149 
(17), 148 (10), 147 (26), 145 (17).  
HRMS (EI, 70 eV) m/z: calc. for C12H16O2Si: 220.0920; found 220.0911. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), (Z)-ethyl 3-iodoacrylate 
(183a, 226 mg, 0.13 mL, 1.00 mmol) and freshly distilled THF (1.0 mL) were used. The reaction 
mixture was cooled to 0 °C and bis-benzo[d][1,3]dioxol-5-ylmanganese (181f, 2.5 mL, 0.60 mmol, 0.28 
) was added dropwise before the mixture was stirred for 1 h at the given temperature. Purification by 
flash column chromatography (isohexane:EtOAc = 19:1, Rf = 0.25) afforded the desired cross-coupling 
reaction product 184k (0.186 g, 0.84 mmol, 84%) as a white solid. 
 
M.p. (°C): 68-70. 
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1H-NMR (400 MHz, CDCl3, ppm)  = 7.58 (d, J = 15.9 Hz, 1H), 6.95 (ddd, J = 78.4, 42.1, 4.8 Hz, 
3H), 6.25 (d, J = 15.9 Hz, 1H), 6.00 (s, 2H), 4.24 (q, J = 7.1 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 167.3, 149.7, 148.5, 144.4, 129.0, 124.5, 116.4, 108.7, 106.6, 
101.7, 60.5, 14.5. 
IR (ATR, cm-1) ṽ = 2922, 2854, 1702, 1640, 1610, 1504, 1490, 1474, 1448, 1440, 1368, 1356, 1242, 
1192, 1174, 1142, 1118, 1096, 1028, 1002, 926, 854, 804. 
MS (EI, 70 eV, %) m/z = 221 (13), 220 (100), 192 (23), 191 (18), 175 (80), 174 (12), 173 (11), 148 
(64), 147 (23), 146 (18), 145 (82), 117 (33), 89 (45), 63 (10).  
HRMS (EI, 70 eV) m/z: calc. for C12H12O4: 220.0736; found 220.0728. 
 




In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), 4-(2-
bromovinyl)benzonitrile (183e, Z/E = 98:2, 208 mg, 1.00 mmol) and freshly distilled THF (1.0 mL) 
were used. The reaction mixture was cooled to 0 °C and bis-(4-(trifluoromethoxy)phenyl)manganese 
(181d, 4.4 mL, 0.60 mmol, 0.14 ) was added dropwise before the mixture was stirred for 1 h at the 
given temperature. Purification by flash column chromatography (isohexane:EtOAc = 99:1, Rf = 0.18) 
afforded the desired cross-coupling reaction product 184m (0.214 g, 0.74 mmol, 74%) as a pale-yellow 
oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.58 – 7.45 (m, 2H), 7.37 – 7.28 (m, 2H), 7.24 – 7.15 (m, 2H), 
7.13 – 7.03 (m, 2H), 6.72 (d, J = 12.2 Hz, 1H), 6.62 (d, J = 12.2 Hz, 1H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 148.7, 141.7, 134.9, 132.3, 131.8, 130.4, 129.6, 129.4, 121.0, 
120.5 (d, J = 257.5 Hz), 118.9, 111.0. 
19F-NMR (377 MHz, CDCl3, ppm)  = –57.8. 
IR (ATR, cm-1) ṽ = 2228, 1605, 1507, 1407, 1252, 1210, 1198, 1156, 1110, 1018, 948, 922, 885, 832, 
813, 779, 760, 741, 670. 
MS (EI, 70 eV, %) m/z = 290 (17), 289 (98), 249 (11), 205 (17), 204 (100), 203 (32), 202 (36), 190 
(31), 177 (21), 165 (16). 
HRMS (EI, 70 eV) m/z: calc. for C16H10F3NO: 289.0714; found 289.0708. 
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In relation to TP10, for this reaction Fe(acac)3 (35 mg, 0.10 mmol, 10 mol%), 4-(2-
bromovinyl)benzonitrile (183e, Z/E = 98:2, 208 mg, 1.00 mmol) and freshly distilled THF (1.0 mL) 
were used. The reaction mixture was cooled to 0 °C and bis-(3-trimethylsilylphenyl)manganese (181e, 
4.6 mL, 0.60 mmol, 0.13 ) was added dropwise before the mixture was stirred for 1 h at the given 
temperature. Purification by flash column chromatography (isohexane:EtOAc = 99:1, Rf = 0.30) 
afforded the desired cross-coupling reaction product 184n (0.182 g, Z/E = 7:3, 0.66 mmol, 66%) as a 
pale-yellow oil. 
 
1H-NMR (400 MHz, CDCl3, ppm)  = 7.67 – 7.46 (m, 3.3H), 7.41 – 7.31 (m, 3H), 7.28 – 7.16 (m, 
2H), 7.10 (d, J = 16.4 Hz, 0.3H), 6.67 (ddd, J = 74.6, 12.2 Hz, 1.4H). 
13C-NMR (101 MHz, CDCl3, ppm)  = 142.5, 142.1, 141.4, 140.8, 135.6, 135.4, 134.0, 133.8, 133.7, 
132.9, 132.8, 132.6, 132.3, 132.1, 129.7, 129.4, 128.4, 128.4, 128.0, 127.1, 127.0, 126.7, 119.2, 119.1, 
110.6, 110.5, –1.0, –1.2. 
IR (ATR, cm-1) ṽ = 2954, 2226, 1603, 1504, 1414, 1403, 1377, 1261, 1248, 1176, 1112, 965, 926, 898, 
884, 858, 831, 801, 750, 712, 689. 
MS (EI, 70 eV, %) m/z = 280 (27), 277 (40), 263 (17), 262 (100).  
HRMS (EI, 70 eV) m/z: calc. for C18H19NSi: 277.1287; found 277.1280. 
